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independent vasodilation was normal in both groups.
Exercise increased both cGMP and nitrite concentrations (+33.1% and +92.2%, 
respectively, p <0.05), and decreased plasma concentrations of ADMA (-12.3%, p <0.05). 
Despite increasing in vitro LDL resistance to oxidation, plasma concentration of oxLDL 
was not signiﬁcantly decreased by exercising (-5.2%, p >0.05).
Conclusions: In this study, the results suggest that improvement of endothelial function 
by short-term exercising in MetS occurs via decrease in ADMA concentration and do not 
support a major role for plasma oxLDL in this effect.
The possibility that exercise prevents tissue LDL oxidation modulating endothelial 
responses cannot be rule out.
9:30 a.m.
1013-95 Intensive LDL-C Reduction Can Induce Cholesterol 
Plaque Regression: Data From Coronary Intravascular 
Ultrasound and Coronary Angiography Studies
Leon Shao, Haseeb Jafri, Alawi Alsheikh-Ali, Richard Karas, Tufts Medical Center, 
Boston, MA
Background: While LDL cholesterol (LDL-C) lowering has been shown to reduce 
cardiovascular events, the degree of LDL-C lowering required to induce atherosclerotic 
plaque regression is unknown. In this study, we examined the relationship of LDL-C 
reduction and plaque burden in randomized control trials (RCTs), as assessed by 
intravascular ultrasound (IVUS) or coronary angiography.
Methods: A MEDLINE search identiﬁed lipid-altering RCTs with q 6 months of follow-
up, providing values for coronary plaque burden, reported as change in total atheroma 
volume for IVUS and as change in the minimum luminal diameter for angiography, as 
well as baseline and follow-up LDL-C levels. Meta regression analysis evaluated the 
relationship between changes in LDL-C and changes in plaque size.
Results: 8 IVUS RCTs (12 intervention arms with 2855 person-years of follow-up) and 
21 angiography RCTs (24 intervention arms and 7,482 person-years of follow-up) were 
identiﬁed. Favorable changes in plaque burden were signiﬁcantly correlated with % 
LDL-C reduction for IVUS (p = 0.05) and with both % and absolute LDL-C reduction for 
angiography (p = 0.04 and p = 0.03, respectively). Both modalities showed a transition 
from slowing of plaque progression to plaque regression when LDL-C was lowered by q
35-40% (FIGURE).
Conclusion: LDL-C lowering is directly correlated with favorable changes in 
atherosclerotic plaque burden detectable by IVUS and angiography. Measurable plaque 
regression requires LDL-C lowering at levels q 35-40%. 
9:30 a.m.
1013-96 Genetic Polymorphism On Methyl-Tetrahydrofolate-
Reductase Affects Vascular Superoxide Generation 
and Nitric Oxide Bioavailability By Regulating eNOS 
Coupling in Human Arteries and Veins
Charalambos A. Antoniades, Cheerag Shirodaria, Paul Leeson, Tim Van-Assche, 
Chandi Ratnatunga, Ravi Pillai, Colin Cunnington, Dimitris Tousoulis, Alexios S. 
Antonopoulos, Christodoulos Stefanadis, Helga Refsum, Keith M. Channon, University 
of Oxford, Oxford, United Kingdom, 1st Cardiology Department, Hippokration Hospital, 
Athens Medical School, Athens, Greece
Background: 5-methyl-tetrahydrofolate (5MTHF) administration improves endothelial 
nitric oxide synthase (eNOS) coupling in human vessels. However, it is unclear whether 
endogenous variations of vascular 5MTHF levels due to the functional 5MTHF-reductase 
(MTHFR) polymorphism C677T, has an impact on vascular function. We examined the 
effect of this polymorphism on vascular 5MTHF levels, NO bioavailability and eNOS 
coupling in human vessels.
Methods: The C677T polymorphism was determined in 218 patients undergoing 
coronary bypass surgery. Saphenous veins (SV) and internal mammary arteries (IMA) 
were obtained to determine vasomotor responses of SV to acetylcholine (ACh) ex-vivo, 
vascular O2- production (+/- eNOS inhibitor LNAME, by chemilumineschence) and 
vascular 5MTHF (by HPLC).
Results: The genotype distribution was CC:100(46%) CT:94(43%) and TT:24(11%). This 
polymorphism had a strong effect on vascular (Fig. a) and plasma 5MTHF (p<0.001). 
Furthermore, the T allele was associated with lower vasomotor responses of SV to Ach 
(Fig. b) as well as higher vascular O2- (Fig. c) and greater LNAME inhibitable O2- (Fig d., 
suggesting eNOS uncoupling) in IMA segments.
Conclusions: The C677T polymorphism on MTHFR gene is a strong determinant of 
vascular 5MTHF, and has a signiﬁcant effect on NO bioavailability and vascular redox 
state, by modifying eNOS coupling in human vessels. 
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1013-93 Paclitaxel and Sirolimus Differentially Modulate the 
Expression of Vascular Endothelial Growth Factor in 
Human Coronary Artery Smooth Muscle Cells
Katharina M. Katsaros, Christoph Kaun, Svitlana Demyanets, Kathrin Rychli, Stefan P. 
Kastl, Kurt Huber, Gerald Maurer, Johann Wojta, Walter S. Speidl, Medical University of 
Vienna, Vienna, Austria, Wilhelminenhospital, Vienna, Austria
Background: Incomplete endothelial coverage after implantation of drug eluting stents 
may be associated with late stent thrombosis. Recently, it has been suggested that 
sirolimus-eluting stents show a decreased re-endothelialization compared to paclitaxel-
eluting stents. The aim of this study was to assess the effects of paclitaxel and sirolimus 
on the expression of vascular endothelial growth factor (VEGF) in human coronary artery 
smooth muscle cells (HCASMC).
Methods and Results: VEGF protein, as determined by ELISA, increased dose and 
time dependently up to 1.5-fold (p<0.05) when HCASMC where treated with paclitaxel 
(1-100nmol/L) for up to 24 hours. In contrast, sirolimus (2.2-220pmol/L) suppressed the 
expression of VEGF in HCASMC as compared to control by 85% (p<0.001). Additionally, 
paclitaxel increased and sirolimus decreased VEGF mRNA levels as detected by RealTime 
PCR. Cytotoxic effects were excluded as paclitaxel up to 100nmol/L and sirolimus up to 
220pmol/L did not increase the release of lactate dehydrogenase. In a scratch wound 
assay using human coronary artery endothelial cells (HCAEC), supernatant of pacliatxel-
treated HCASMC showed a signiﬁcantly increased re-endothelialization as compared to 
the supernatant of HCASMC that were treated with sirolimus.
Conclusion: Paclitaxel increases and sirolimus decreases the expression of VEGF 
in HCASMC in vitro. If this mechanism is also effective in vivo it may affect re-
endothelialization after implantation of drug-eluting stents.
9:30 a.m.
1013-94 Improvement of Endothelial Function By Short-Term 
Exercise Training in Metabolic Syndrome Occurs Via 
Decrease in Asymmetric Dimethylarginine and Without 
Changes in Plasma Concentration of Oxidized Low-
Density Lipoprotein
Antonio Casella-Filho, Ivani C. Trombetta, Fernando Y. Cesena, Mauricio P. Landim, 
Paulo M. Dourado, Celise Denardi, Paulo J. Bertini, Carlos E. Negrao, Protasio L. 
DaLuz, Antonio CP Chagas, Heart Institute-InCor HCFMUSP, Sao Paulo, Brazil
Background: Mechanisms involved in the beneﬁts of exercise training on endothelial 
function in patients with metabolic syndrome (MetS) are not fully elucidated. Oxidized LDL 
(oxLDL) is known to harm the endothelium and upregulate arginine N-methyltransferase, 
a protein responsible for the synthesis of asymmetric dimethylarginine (ADMA), an 
endogenous nitric oxide synthase inhibitor.
This study aimed at evaluating the role of LDL oxidation and ADMA in the effects of short-
term exercising on endothelial function.
Methods: Thirty sedentary persons were studied (20 with MetS, 10 controls). Those with 
MetS were subjected to a 3 times/week moderate training load (45 min/day) for 3 months 
on a bicycle ergometer.
Endothelial function was analyzed by ﬂow-mediated vasodilation of the brachial artery 
assessed by ultrasound.
Plasma concentrations of oxLDL, ADMA and cyclic-guanosine monophosphate (cGMP, a 
cyclic nucleotide that reﬂects nitric oxide production) were assayed by ELISA. Blood nitrite 
was determined by chemiluminescence. LDL was isolated by plasma ultracentrifugation 
and its in vitro resistance to oxidation was evaluated by the formation of conjugated 
dienes after incubation with CuSO4.
Results: Short-term exercise training did not signiﬁcantly modify plasma levels of HDL-
cholesterol and LDL-cholesterol.
Exercise enhanced endothelium-dependent vasodilation in MetS group (from 6.2 ± 4.5% 
to 11.8 ± 7.6%, p <0.05), reaching values similar to the control group. Endothelium-
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1013-97 Eosinophil Cationic Protein: A New Marker of Coronary 
Atherosclerotic Burden
Giampaolo Niccoli, Nicola Cosentino, Micaela Conte, Simona Giubilato, Giuseppe 
Ferrante, Marco Bacà, Vito Sabato, Domenico Schiavino, Giampiero Patriarca, Filippo 
Crea, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy, 
Institute of Allergology, Catholic University of the Sacred Heart, Rome, Italy
BACKGROUND: Recent studies have shown that eosinophils play a role in coronary 
atherosclerosis. We aimed at assessing the association of eosinophil cationic protein 
(ECP), a sensitive marker of eosinophil activation, with the severity and extent of coronary 
atherosclerotic (ATS) burden in consecutive patients undergoing coronary angiography.
METHODS: One hundred and ninety eight patients [91 pts with stable angina (SA) (age 
64±9, male sex 74%), 57 pts with acute coronary syndrome (ACS) (age 65±12, male 
sex 77%) and 50 controls with atypical chest pain (NC) (age 64±8, male sex 68%) found 
to have normal coronary arteries by angiography] were included in the study. Coronary 
angiography was evaluated by two expert angiographers who assessed disease severity 
and extent according to the Sullivan’s score and coronary lesion morphology (smooth or 
complex). In all patients, serum levels of ECP were measured by ELISA on admission.
RESULTS: ECP serum levels were signiﬁcantly higher in patients with SA and ACS 
compared with NC (31 μg/l (15-47) vs 9.6 μg/l (6-13.6), p=0.012 and 18 μg/l (6-41) vs 9.6 
μg/l (6-13.6), p=0.0001) but were similar in patients with SA and ACS (31 μg/l (15-47) vs 
18 μg/l (6-41), p=0.17). At multivariable analysis ECP serum levels were the only predictor 
of disease severity (p=0.0001), while age was the only independent predictor of disease 
extent with ECP levels having a borderline statistical signiﬁcance (p=0.009 and p=0.12 
respectively). ECP serum levels were similar in patients with at least one complex lesion 
compared to those without any complex lesion (p=0.95).
CONCLUSIONS: ECP levels are associated with the severity of coronary ATS burden, 
but not with an acute coronary syndrome as clinical presentation, nor with complex lesion 
morphology.
9:30 a.m.
1013-98 Intravenous ApoA-I Mimetic Peptide (ETC-642) Discs 
Inhibit the Progression of Atherosclerosis in Myocardial 
Infarction-Prone Watanabe-Heritable Hyperlipidemic 
(WHHL-MI) Rabbits: An Intravascular Ultrasound Study
Atsushi Iwata, Boo Zhang, Satoshi Imaizumi, Shin-ichiro Miura, Keijiro Saku, Fukuoka 
University Hospital, Fukuoka, Japan
Background: Reconstituted high-density lipoprotein (rHDL) therapy is a promising strategy 
to decrease atherosclerosis burden. The aim of the present study is to investigate the 
effects of ETC-642 discs, a complex of a 22-amino acid peptide [an apolipoprotein(Apo)
A-I mimetic] and phospholipids, on plaque burden present in Watanabe heritable 
hyperlipidemic (WHHL) rabbits as assessed by intravascular ultrasound (IVUS).
Methods: WHHL rabbits of either sex at 6-15 months of age were used for this study. 
Animals were divided into 3 groups: low-dose ETC-642 (15 mg/kg), high-dose ETC-642 
(50mg/kg), and placebo. The test article was injected into an auricular vein twice/week 
for a period of 12 weeks and IVUS analyses were performed at baseline and 12 weeks 
follow-up. After anesthesia, an IVUS catheter was inserted into the femoral artery and 
advanced to the left subclavian artery, which was used as an anatomical landmark, and 
we mechanically pulled back the catheter from the left subclavian artery to celiac trunk. 
Plaque volume (PV) in WHHL rabbit aorta was analyzed in the range 1-4cm apart from 
the left subclavian artery. After IVUS image acquisition, the catheter was removed and the 
femoral artery was ligated, and the animal was allowed to recover. Lipid proﬁles were also 
analyzed by ultracentrifugation and capillary isotachophoresis (cITP).
Results: The absolute change in total PV (follow-up −baseline) was -0.8±2.5 mm3 with 
high dose ETC-642, 7.8±6.2 mm3 for low dose ETC-642 and 18.7±4.5 mm3 with placebo, 
respectively. After 12 weeks injections of high dose ETC-642, PV was slightly reduced, 
whereas placebo accelerates atherosclerosis very rapidly. ETC-642 reduced charge-
modiﬁed low-density lipoprotein (LDL) by converting more negative-charged modiﬁed 
LDL to less negative charged LDL as analyzed by cITP, and reduced small, dense LDL by 
converting small, dense LDL into large, buoyant LDL.
Conclusions: These results indicate that short-term injections of high dose ETC-642 
discs can Inhibit the progression of in WHHL-MI rabbits.
9:30 a.m.
1013-99 In Coronary Artery Disease Microparticles Release Is 
Related to Disease Activity and not to Atherosclerotic 
Burden
Italo Porto, Luigi M. Biasucci, Luca Di Vito, Giovanni Tinelli, Giovanni Luigi De Maria, 
Alessandra Tritarelli, Antonio Maria Leone, Marco Filipponi, Maurizio C. Capogrossi, 
Filippo Crea, Department of Cardiovascular Medicine Catholic University of the 
Sacred Heart, Rome, Italy, Laboratorio di Patologia Vascolare, Istituto Dermopatico 
Immacolata–IRCCS, Rome, Italy
Background: microparticles (MP) are fragments released from different cells on 
activation or apoptosis. We assessed the pattern of MP release in patients with chronic 
stable angina (SA) without evidence of peripheral vascular disease (single site), with 
evidence of peripheral vascular disease (multi-site), and in patients presenting with acute 
coronary syndromes (ACS).
Methods: seventy-three patients, 46 with ACS (27 Non ST Elevation and 19 with ST 
Elevation Myocardial Infarction) and 27 with SA with (16 pts) or without (11 pts) evidence 
of peripheral vascular disease (deﬁned as presence of at least one haemodynamically 
signiﬁcant atherosclerotic extra-coronary vascular stenosis) were included. Peripheral 
blood samples were drawn at hospital admission to assess three type of MP: CD31+/
AnnexinV+ Apoptotic MP (AMP), CD31+/CD42- Endothelial MP (EMP), CD31+/ CD42+ 
Platelet MP (PMP) by ﬂow cytometry. High sensitivity C-reactive protein (CRP). All patients 
underwent coronary angiography and Doppler scan of carotid and femoral arteries.
Results: AMP (in MPs/μL) were higher in the ACS 56.6 (19.1-125.3, IQR; overall ANOVA 
p=0.02) than in the multi-site 14.1(7.3-67.5;p=0.05) and single-site SA group 19.6 (13.6-
36.1;p=0.05). PMP were higher in the ACS 803.8 (260.1-1620; p=0.01) than in the multi-
site 153.5 (112.2-511.7;p=0.005) and single site group 260.4 (207.1-357.6; p=0.03). A 
larger amount of EMP were detected in ACS 196.7 (35-422; p=0.02) than in the other 
groups 134 (60.1-360.1;p=0.05) and 196.7 (36-422;p=0.05). Hs-CRP levels (in mg/l) were 
13.3 (4.5-25.1 , p<0.001) in ACS, 4.1 (2.3-7.1 p=0.009) in the multi-site and 3.3 (1.7-6.5; 
p=0.001) in the single-site groups. No signiﬁcant difference was observed between multi-
site and single-site patients in terms of AMP (p=0.9), PMP (p=0.9), EMP (p=0.9) and 
hs-CRP(p=0.6).
Conclusions: Higher apoptotic, platelet and endothelial MP were observed in ACS 
than either multi-site or single site SA patients, despite these differences suggest that 
microparticle release does not correlate with the atherosclerotic burden, but is likely to 
reﬂect the systemic inﬂammatory activation.
9:30 a.m.
1013-100 Platelet Glycoprotein GP VI 13254C Allele Is an 
Independent Risk Factor of Premature Myocardial 
Infarction
Zuzana Motovska, Petr Widimsky, Jaroslava Hajkova, Denisa Odvodyova, Robert Petr, 
Stanislav Katina, Jan Kvasnicka, Third Medical Faculty Charles Univ and Univ. Hosp. 
Vinohrady, Prague, Czech Republic, Thrombosis Center of General University Hosp., 
Prague, Czech Republic
Background:The purpose of this study was to asses the impact of haemostatic and 
platelet receptor gene polymorphisms as an inherited risk factor for premature onset of 
myocardial infarction (MI).
Methods:The prevalence of ten gene polymorphisms was investigated in 105 consecutive 
patients who were affected by a premature MI and treated with primary (STE) or early 
(NSTE) PCI; men <50y. and women <55y. This was compared with the same gene 
polymorphism prevalence in a group of 132 patients in which CAD was excluded and with 
a normal coronary angiography. Contingency tables analysis and logistic regression were 
performed. Genotyping was accomplished using PCR, followed by melting curve analysis 
using speciﬁc ﬂuorescent hybridization probes.
Results:Signiﬁcant association was found between GP VI 13254C allele and premature 
onset of MI (Table). In logistic regression analysis that took other cardiovascular risk 
factors into account, a signiﬁcance (p=0.0248) of the studied GP VI genotype and 
vascular risk was conﬁrmed (OR 4.065).
Conclusions:GP VI plays a crucial role in platelet activation and aggregation. This 
study for ﬁrst time suggests that the GP VI 13254C allele is an independent predictor 
of premature MI.
Prevalence of polymorphisms in patients with premature MI and in 
patients without CAD
Polymorphism
Patients with premature 
MI
N = 105
Patients without 
CAD
N = 132
Risk
Ratio
P
value
Leiden mutation 8.6 % 4.5 % 1.39 0.099
Factor II (G20210A) 
mutation 2.9 % 3.0 % 0.97 0.47
P2Y12 H1/H2 haplotyp 20.2 % 24.2 % 0.87 0.26
P2Y12 (32C/T) 55.8 % 55.3 % 1.01 0.47
GPVI (13254C/T) 31.4 % 20.5 % 1.36 0.03
GPIa (807C/T) 64.6 % 60.6 % 1.13 0.24
GPIIIa (PlA1/PlA2) 27.9 % 28.8 % 0.97 0.43
PAR-1 (IVSn-14A/T) 32.7 % 33.3 % 0.98 0.46
COX-1 (-842A/G) 9.6 % 15.9 % 0.70 0.12
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1013-101 Marked Differences in Thrombotic and Thrombolytic 
Status Between Japanese and Western Subjects
Smriti Saraf, Hiromitsu Ishii, Junichiro Yamamoto, Yukio Yamori, Diana A. Gorog, Imperial 
College, London, United Kingdom, East & North Hertfordshire NHS Trust, Welwyn 
Garden City, United Kingdom
Background: Incidence of coronary heart disease (CHD) and AMI in Japan remains 
lower than in Western countries. Primary genetic effects are unlikely, given the increased 
CHD in Japanese migrants. For men, cholesterol and blood pressure have been similar 
in Japan and the U.S. Dietary factors are implicated, but how these effect CHD is unclear. 
Differences in thrombotic status may contribute.
Methods: We measured thrombotic and thrombolytic status in 100 healthy Japanese [J] 
from Japan and 100 healthy Westerners [W] from the U.K. using the Global Thrombosis 
Test (GTT). The GTT employs non-anticoagulated blood to create platelet-rich thrombi 
under high shear (occlusion time OT; sec), and then measures the restart of blood ﬂow, 
due to spontaneous thrombolysis (lysis time LT; sec).
Results: OT was longer in [J] compared to [W] (530 v 378, p<0.0001) (Fig 1a). LT was 
longer in [J] than in [W] (2145 v 1115, p<0.0001) (Fig 1b). Distribution of LT in [J] did not 
conform to a normal population, with markedly impaired thrombolytic status (LT>3000s) 
in 13%, compared to none of the Westerners (p<0.0001).
Conclusions: There are marked differences in thrombotic and thrombolytic status, with 
[J] having a less prothrombotic (longer OT) but less favourable endogenous thrombolytic 
proﬁle (longer LT). This may be important in the aetiology of thrombotic events. Since 
platelets and thrombolysis were both inhibited in [J] and yet incidence of AMI is lower, OT 
would seem more important than LT as a determinant of overall throbotic risk. 
9:30 a.m.
1013-102 Effect of Combination Statin and Antihypertensive 
Therapies on Nitric Oxide Bioavailability in Human 
Endothelial Cells
R. Preston Mason, Ruslan Kubant, Adam M. Jacoby, Robert F. Jacob, Tadeusz Malinski, 
Harvard Medical School, Boston, MA, Ohio University, Athens, OH
Background: HMG-CoA reductase inhibitors and certain antihypertensive agents 
improve endothelial-dependent nitric oxide (NO) release, but their combined effects are 
not well understood. We assessed the effects of co-administration of a statin (atorvastatin) 
and a calcium channel blocker (amlodipine), with the addition of different RAAS inhibitors 
(losartan or perindopril), on NO bioavailability in human endothelial cells.
Methods: Nanosensors were used to measure simultaneously NO and ONOO- release 
in single human umbilical vein endothelial cells (HUVECs) obtained from healthy donors. 
The effects of treatment (1 h) using aatorvastatin and amlodipine along with either 
losartan or perindopril (each drug at 1.0 μM) were tested by maximum stimulation of NO 
synthase with calcium ionophore (1.0 μM). As a positive control, we also tested the effect 
of metoprolol as it does not inﬂuence NO release.
Results: Treatment with amlodipine and atorvastatin increased NO release capacity in 
HUVECs by 60% from 386 ± 23 nM to 634 ± 37 nM in an apparent synergistic fashion. 
The combination also caused a 20% reduction in ONOO- release. The addition of either 
RAAS inhibitor to the statin/CCB combination caused a further increase in NO release 
that was two-fold greater than control levels: perindopril and losartan increased NO levels 
to 740 ± 43 nM and 767 ± 43 nM, respectively. The NO/ONOO- ratio, an indicator of 
eNOS function, increased by more than two-fold with the statin/CCB/RAAS inhibitor 
combination. By contrast, addition of metoprolol to the CCB/statin combination failed to 
increase NO release capacity.
Conclusion: Combination therapy with a statin and two different antihypertensive 
agents, a CCB and RAAS inhibitor, caused pronounced and incremental increases in NO 
bioavailability. These ﬁndings indicate that statins and certain antihypertensive agents 
have complimentary effects on eNOS activation mechanisms.
9:30 a.m.
1013-103 The Neuro-Survival Factor Humanin Is Expressed in 
Human Endothelial Cells and Has a Cytoprotective 
Effect Against Oxidative Stress
Adi R. Bachar, Lea Scheffer, Laura J. Cobb, Lilach O. Lerman, Richard E. Pagano, 
Pinchas Cohen, Amir Lerman, Mayo Clinic, Rochester, MN, UCLA, Los Angeles, CA
Background:Humanin (HN) is a novel peptide with neuroprotective effects. The presence 
and role of HN expression in the cardiovascular system is not fully explored. Oxidized 
LDL (OxLDL) has a deleterious effect on human endothelial cells (EC) by increasing 
production of reactive oxygen species (ROS) and is known to promote atherosclerosis. 
We evaluated the expression of HN in, and its ability to protect human EC from OxLDL.
Methods: 1. HN immunoreactivity was determined in human internal mammary 
arteries (IMA) (n=3) and atherosclerotic diseased coronary arteries (n=9) using 
immunohistochemistry staining with a ligand afﬁnity puriﬁed antibody. 2. Human aortic 
endothelial cell cultures (HAEC) were pre-incubated with HN (10 μM for 24 hours) and 
subsequently treated with OxLDL (50μg/ml; 30 min. at 37°C). ROS production was 
assessed by quantitative ﬂuorescence microscopy using Dihydroethidine (DHE).
Results: 1. HN expression was equally detected in EC of both normal and atherosclerotic 
segments. 2. Pretreatment of HAEC with HN prior to addition of OxLDL signiﬁcantly 
reduced ﬂuorescence intensity of the ROS marker product (EtBr) from 1837±305 to 
896±86 relative ﬂuorescence units, p< 0.0001 (ﬁgure).
Conclusions: This study demonstrates for the ﬁrst time that HN is expressed in human 
vascular endothelial cells and is able to attenuate formation of ROS in response to OxLDL. 
This ﬁnding suggests a protective role of HN on endothelial cells against oxidative stress 
and potentially atherosclerosis.
9:30 a.m.
1013-104 HDL-Cholesterol as a Mediator of Inhibiting the 
Oxidized LDL Predicts Coronary Endothelial Function 
in Postmenopausal Women
Akiko Yoshikawa, Shuichi Hamasaki, Sanemasa Ishida, Tetsuro Kataoka, Keishi 
Saihara, Hideki Okui, Takuro Shinsato, Shoji Fujita, Naoya Oketani, So Kuwahata, 
Hitoshi Ichiki, Takuro Takumi, Satoshi Yoshino, Yasuhisa Iriki, Takuro Kubozono, Chuwa 
Tei, Kagoshima University, Kagoshima, Japan
Background:There are a number of reports about gender-speciﬁc differences regarding 
the development and prognosis of coronary heart disease (CHD). In woman, risks of 
CHD drastically increase after menopause. Although, it remains unclear what is a major 
contributor to the ﬂow-mediated dilation of the coronary artery in postmenopausal 
women. Methods:The ﬂow-mediated dilation of the coronary artery was determined in 50 
consecutive postmenopausal women (68±8 yrs) with normal or mildly diseased coronary 
artery. Ninety-three age-matched men (66±8 yrs) served as control subjects. Using 
quantitative coronary angiography, we measured coronary artery diameter of the left 
anterior descending coronary artery at rest and in response to reactive hyperemia (with 
increased ﬂow causing an endothelium-dependent vasodilation) induced by papaverine 
(12.5mg/20sec) (%FMD). Endothelium-independent vasodilation of the coronary artery 
was also assessed by administration of nitroglycerin (%NTG). Vascular responses 
were compared between men and women. Body mass index, C-reactive protein, LDL-
cholesterol, HDL-cholesterol (HDL-C), triglyceride, fasting blood sugar, and insulin 
resistance (HOMA-R), and systolic blood pressure were also measured. Moreover, plasma 
level of malondialdehyde-modiﬁed LDL (MDA-LDL) was also measured and used as an 
index of the oxidative stress.Results:When only subjects of women were considered, in a 
univariate analysis, %FMD had an inverse correlation with triglycerides (r=-0.30, p<0.05) 
and a positive correlation with HDL-C (r=0.38, p<0.01). A logistic regression analysis 
revealed that HDL-C was associated with %FMD (odds ratio 1.08, 95% conﬁdence 
interval 1.01 to 1.16, p=0.02). In age-matched men, no signiﬁcant correlation existed 
between %FMD and any parameters. Additionally, HDL-C level inversely correlated 
with MDA-LDL level in women (r=-0.45, p<0.02) but not in men. Conclusions:These
data suggest that, in postmenopausal women, high concentrations of HDL-C is strongly 
associated with favorable endothelial function of the conductance coronary artery, which 
may be associated with concomitant decreases in oxidized LDL.
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1013-105 Polyvascular Disease and Regression of Coronary 
Atherosclerosis After Statin Therapy in Patients With 
Acute Coronary Syndrome. A JAPAN-ACS (Japanese 
Assessment of Pitavastatin and Atrovastatin in Acute 
Coronary Syndrome) Substudy
Kiyoshi Hibi, Takeshi Kimura, Kazuo Kimura, Takeshi Morimoto, Izumi Miki, Saeko 
Minematsu, Takafumi Hiro, Katsumi Miyauchi, Yoshihisa Nakagawa, Masakazu 
Yamagishi, Yukio Ozaki, Satoshi Saito, Tetsu Yamaguchi, Hiroyuki Daida, Masunori 
Matsuzaki, fot the JAPAN-ACS Investigators, Yokohama City University Medical Center, 
Yokohama, Japan, Kyoto University Graduate School of Medicine, Kyoto, Japan
Background: Previous prospective observational studies have shown that patients (pts) 
with atherosclerosis in multiple vascular territories (polyvascular disease) had higher 
cardiovascular event rates compared with those with single territory. Although intensive 
lipid lowering therapy has been demonstrated to reduce plaque volume as well as cardiac 
events, it remains unclear whether these effects of statin are different according to the 
presence or absence of polyvascular disease.
Methods: 307 pts with ACS who underwent percutaneous coronary interventions to the 
culprit lesion at 33 centers in Japan were treated with atorvastatin or pitavastatin. Pts 
who had been treated with lipid lowering therapy were excluded. Polyvascular disease 
was deﬁned as coexistent established, clinically recognized arterial disease other 
than coronary artery disease (CAD) (cerebral, aortic, or lower extremity). Intravascular 
ultrasound was performed to assess non culprit coronary atherosclerosis with mild to 
moderate stenosis at baseline and 8 to 12 months follow-up, and 252 pts had evaluable 
serial IVUS examinations. Atheroma volume and percent change in atheroma volume for 
the target plaque was assessed.
Results: Pts with polyvascular disease (n=19) were older (68 vs. 62 years old, p=0.03), 
had fewer frequency of hyperlipidemia (16 vs. 41%, p=0.03) than those without (n=233), 
whereas low density lipoprotein cholesterol (LDL-C) levels at follow up were similar 
(81 vs. 83 mg/dl, p=0.8). Although the baseline plaque volume was similar (59 vs. 57 
mm3, p=0.7), those with polyvascular disease showed less regression of atherosclerosis 
than those without (-9% vs. -18%, p=0.005). This difference remained signiﬁcant after 
adjusting for statin assignment and coronary risk factors including age and serum LDL-C 
levels (p=0.03).
Conclusions: Less regression of coronary atherosclerosis was observed in CAD pts 
who had atherosclerosis in multiple vascular territories, indicating that aggressive risk 
reduction using lifestyle and pharmacological interventions in addition to statin therapy 
would be particularly important for preventing recurrent cardiovascular events in this 
patient subgroup at high risk.
9:30 a.m.
1013-106 One Week of Clopidogrel Therapy Improves Endothelial 
Function in Subjects With Stable Coronary Artery 
Disease: A Randomized Control Study
Lee-Jen Luu, Scott R. Willoughby, James D. Cameron, Adam J. Nelson, Stephen G. 
Worthley, Matthew I. Worthley, MonasHeart, Melbourne, Australia, Royal Adelaide 
Hospital, Adelaide, Australia
Background: Clopidogrel therapy has been shown to reduce adverse cardiovascular 
outcomes in patients with acute coronary syndromes. Limited data is available to evaluate 
its effectiveness in subjects with stable coronary artery disease (CAD). Furthermore the 
contribution of the ‘non-platelet’ effects of clopidogrel therapy to this beneﬁcial outcome is 
poorly understood. Therefore, we evaluated the effects of 1 week of clopidogrel therapy 
on endothelial function in subjects with stable CAD.
Methods: 40 subjects were randomised to clopidogrel therapy (75mg/day) or control. 
Platelet aggregation and endothelial function testing occurred at baseline and at one 
week following randomization. Platelet function was assessed by adenosine diphosphate 
(ADP)-induced whole blood impedance aggregation (5 and 20μmol/L of ADP). Endothelial 
function (using reactive hyperemic index (RHI)) was assessed via changes in peripheral 
arterial tonometry utilising the EndoPat 2000™ system (Itamar Medical, Israel).
Results: The mean age of the cohort was 63.8 ± 1.5 (SE) of which 88% were male. All 
patients were on aspirin therapy and 95% on statin therapy. 45% of subjects had had a 
previous percutaneous coronary intervention, with 38% previous coronary artery bypass 
grafting. The baseline mean RHI for the cohort was 1.78 ± 0.08. There was a signiﬁcant 
increase in % RHI in the clopidogrel group (19.7 ± 10%) compared to the control group 
(-5.1 ± 5%), p=0.035 at one week. No signiﬁcant difference was observed between 
these groups in regards to baseline aggregation. As expected a signiﬁcant reduction in 
platelet aggregation was noted in the clopidogrel treated group (5.25 ± 0.6 vs 0.9 ± 0.4 
Ohms at 5μmol/L ADP concentration and 6.2 ± 0.4 vs 1.7 ± 0.6 Ohms at the 20μmol/L
concentration) compared to no change observed in the control group. No correlation 
existed between platelet aggregation and endothelial function in this cohort at baseline or 
in response to clopidogrel therapy at one week.
Conclusions: Clopidogrel therapy is associated with improved endothelial function in 
patients with stable CAD. The endothelial and anti-platelet effects of this medication are 
mutually exclusive.
9:30 a.m.
1013-107 Inhibition of p38MAPK Reduces Inﬂammatory Burden 
in Subjects Undergoing Elective PCI
Lea Sarov-Blat, John Morgan, Pedro Fernandez, Rachel James, John J. Lepore, Zixing 
Fang, Dennis L. Sprecher, Glaxo Smith Kline, king of Prussia, PA
Percutaneous coronary intervention (PCI) results in induction of C-reactive protein(CRP), 
peaking at 48h post-PCI. This is believed to be partially mediated by p38 mitogen-
activated protein kinase (p38MAPK) and to involve systemic ampliﬁcation of local cytokine 
signaling after stress or trauma to the endothelium. We hypothesized that p38MAPK 
inhibition would limit this systemic inﬂammatory response, leading to a decrease in the 
post-PCI CRP rise.
Methods: Subjects (n=74) with coronary artery disease who were on stable statin therapy 
and were undergoing elective PCI were randomized to either SB681323 (a potent, highly 
speciﬁc A/B p38MAPK inhibitor) 7.5mgBID (n=39) or placebo (n=35) for 28 days, starting 
3 days prior to PCI. The primary outcome was the placebo-adjusted change in plasma 
hsCRP from baseline on the day of PCI (Day 3 of therapy) compared with the value at two 
days post-PCI (Day 5 of therapy) and at the end of treatment (Day 28).
Results: As previously reported, hsCRP peaked 48hrs post-PCI. The ratio of hsCRP on 
both Day 5 and Day 28 to the baseline value was signiﬁcantly lower in the SB-681323 
group than the placebo group (-37% p=0.023, -46.8% p=0.0006, respectively). There was 
no signiﬁcant ratio change in IL6 serum protein level at these same time points, even 
though the change from baseline to day 5 and 28 for both hsCRP and IL6 correlated 
(Person correlation R=0.63 , 0.53, respectively P< 0.0001). In the unstressed state, 
i.e. prior to PCI, but after 3 days of treatment with SB-681323 there was a signiﬁcant 
lowering of serum myeloperoxidase, IL6, IL8 and hsCRP levels(-30% [p=0.0263],-19.4% 
[p=0.0217], -30.9% [p=0.0004],-33% [p=0.0025], respectively). There were no observed 
safety or tolerability signals. In a post hoc analysis a reduction in anginal episodes in the 
SB-681323 group (24% placebo vs. 7% SB-681323; p=0.037) was observed..
Conclusions: Inhibition of p38MAPK with SB-681323 attenuated the systemic 
inﬂammatory signals generated following elective PCI and was generally safe and well 
tolerated. Additional studies will be required to determine whether p38MAPK inhibition 
may improve post-PCI clinical outcomes.
9:30 a.m.
1013-108 Clopidogrel Resistance as Assessed by P2Y(12) 
Receptor Inhibition Is Not Reﬂective of Global 
Thrombotic Status
Smriti Saraf, Sumeet Sharma, Imen Ben Salha, Diana A. Gorog, Imperial College, 
London, United Kingdom, East & North Hertfordshire NHS Trust, Welwyn Garden City, 
United Kingdom
Background: The laboratory phenomenon of “clopidogrel resistance”, occuring in up to 
40% of individuals, is well-described. However, its contribution to the overall thrombotic 
status and its clinical signiﬁcance is debatable, as many publications have failed to 
demonstrate increased CV events in those deemed “clopidogrel resistant” based on 
laboratory testing. We aimed to measure global thrombotic status and relate this to 
thienopyridine-responsiveness.
Methods: Patients with stable coronary disease (CD), taking aspirin and clopidogrel daily, 
were tested using the Global Thrombosis Test (GTT). This induces platelet-rich thrombus 
formation in ﬂowing non-anticoagulated blood under high shear stress (occlusion time, 
OT). We simultaneously assessed thienopyridine sensitivity by measuring ADP and PGE1-
induced aggregation with the P2Y(12) assays using VerifyNow. Data are reported as % 
inhibition of P2Y(12) reaction units (100% inhibition= maximal P2Y(12) receptor inhibition).
Results: In healthy volunteers, GTT sensitively detected the effect of 300 mg clopidogrel 
(OT 379 v 477s pre- & post-clopidogrel; n=20, p<0.0001). Global thrombotic status of 
CD patients (OT 438±13s, n=55) compared favourably with healthy volunteers not taking 
medication (OT 378±10 s, n=100; p=ns). In only 3% patients was OT below the lower 
quartile of the normal range (a criterion for prothrombotic state or drug resistance). 
However, despite this favourable overall thrombotic status, clopidogrel non-responsiveness 
was frequent in patients, with mean 33% inhibition (range 0-97%). More than a third of 
patients demonstrated very marked “clopidogrel resistance” with <10% P2Y(12) receptor 
inhibition. There was no relationship between global thrombotic status and thienopyridine 
sensitivity as measured by P2Y(12) assay (r=0.2, p=ns).
Conclusions: The favourable global thrombotic status in our patients, despite insufﬁcient 
P2Y(12) receptor inhibition, suggests that clopidogrel may exert favourable effects on 
thrombotic status through alternative or additional pathways, and that clopidogrel 
resistance as assessed by P2Y(12) receptor inhibition is not reﬂective of overall 
thrombotic status.
9:30 a.m.
1013-109 Peri-coronary Epicardial Adipose Tissue is Related 
to Coronary Artery Disease in Patients Undergoing 
Cardiac Computed Tomography
Daniele Iaccarino, Emilio Chiurlia, Andrea Di Girolamo, Federica Fiocchi, Rosario Rossi, 
Renato Romagnoli, Maria Grazia Modena, Institute of Cardiology. Policlinico Hospital. 
University of Modena and Reggio Emilia, Modena, Italy, Institute of Radiology, Policlinico 
Hospital. University of Modena and Reggio Emilia, Modena, Italy
Background: Epicardial adipose tissue (EAT) is closely related to indices of abdominal 
visceral adiposity and metabolic risk factors, as insulin resistance and hypertension. 
EAT is reported to contribute to the development of coronary atherosclerosis due to the 
paracrine production of inﬂammatory cytokines. The aim of our study is to determine the 
relation between EAT and coronary atherosclerosis and coronary artery calcium (CAC) in 
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patients with suspected coronary artery disease (CAD).
Methods: We evaluated 375 patients (36.4 % women; age 35-76 years, mean 60) 
undergoing 64-multislice computed tomography. In all patients cardiovascular risk factors 
and anthropometric data were assessed. Peri-coronary fat was measured as thickness 
in area of right coronary artery (RCA), left descending anterior artery (LAD) and left 
circumﬂex artery (LCX). Severity of coronary atherosclerosis was assessed by the 
presence of a stenotic (> or =50%) coronary vessel and by the number of vessels involved; 
extent of coronary artery calcium (CAC) was determined by the Agatston score.
Results: Age and LAD thickness were associated with coronary atherosclerosis (mean: 
57.2 vs 61.7 years; p=0.020 and 7.6 vs 9.0 mm; p<0.001 respectively), with the number of 
stenotic coronary vessels (r=0.199; p=0.012 and r=0.314; p<0.001 respectively) and with 
CAC (r=0,341; p<0.001 and r=0,353; p<0.001 respectively). Neither of cardiovascular risk 
factors nor anthropometric data were associated to indices of coronary atherosclerosis. 
Age and LAD thickness were respectively associated (r=0.242; p=0.002); furthermore, 
on multiple logistic analysis, LAD thickness above 75th percentile (> 9,7 mm) was an 
independent factor of CAD (odds ratio = 4.432; 95% CI 1.831 to 8.730; p<0.001).
Conclusions: EAT thickness in LAD area is strongly and independently related to 
indices of CAD. Our ﬁnding suggest that adipose tissue surrounding coronary arteries 
may stimulate the progression of atherosclerosis and could be an adjunctive marker to 
classical risk factors for the prediction of CAD.
9:30 a.m.
1013-110 Combinatorial Interference of Toll-Like Receptor Two 
and Four Remarkably Stabilizes Atherosclerotic Plaque 
in Apolipoprotein E-Knockout Mice
Li Hang Qi, Ying Wang, Cheng Zhang, Shi Fang Ding, Mei Ni, Jin Bo Feng, Yun Zhang,
The Key Laboratory of Cardiovascular Remodeling and Function Research, Jinan, 
People’s Republic of China
Background: Toll-like receptors (TLRs) are a group of receptors that play a key role 
in innate immune signaling and initiating inﬂammatory response. The purpose of this 
study was to test the hypothesis that TLR2 and TLR4 may have a synergistic effect on 
the vulnerability of atherosclerotic plaques and combinatorial interference is superior to 
isolated interference of TLR2 and TLR4 in stabilization of vulnerable plaques.
Methods: Lentiviruses carrying small interfering RNA (siRNA) of TLR2 or TLR4 were 
constructed which knocked down mRNA and protein expression of TLR2 or TLR4 
signiﬁcantly in vitro. One hundred and forty apolipoprotein E (apoE)-/- mice, aged 10 to12
weeks, were fed a high-fat diet for 12 weeks and were randomly divided into the control, 
mock, TLR2i, TLR4i and TLR2+4i groups (n=28 in each group)after a constrictive collar 
was placed around the carotid artery of these mice to induce plaque formation. At the 
end of week 8, TLR2i and TLR4i viral suspension was transfected into the carotid plaques 
separately in TLR2i and TLR4i groups or together in TLR2+4i group.
Results: Four weeks after lentivirus transfection, compared with the control and mock 
groups, the mRNA and protein expression of TLR2 in the carotid plaques of the TLR2i and 
TLR2+4i groups, the mRNA and protein expression of TLR4 in the carotid plaques of the 
TLR4i and TLR2+4i groups, the mRNA expression of IL-1B, IL-6, TNF-A and MCP-1 in the 
carotid plaques and the plaque content of lipid and macrophages in the TLR2i, TLR4i or 
TLR2+4i groups were all signiﬁcantly reduced. In contrast, the plaque content of collagen 
in the TLR2i, TLR4i or TLR2+4i groups were signiﬁcantly increased, leading to a lowered 
plaque vulnerability index in these intervention groups (all P<0.05). Factorial ANOVA analysis 
revealed that there was a synergistic effect between TLR4i and TLR2i in attenuating local 
expression TLR2 or TLR4 in plaques and in lowering plaque vulnerability index.
Conclusion: TLR2 and TLR4 have a synergistic effect on vulnerable atherosclerotic 
plaques and combinatorial interference of TLR2 and TLR4 reduces local inﬂammation 
and stabilizes plaques more effectively than interference of TLR2 or TLR4 alone.
9:30 a.m.
1013-111 B-Type Natriuretic Peptides in a Population-Based 
Sample of Elderly Subjects Are Not Associated With 
Vascular Pathologies
Kai M. Eggers, Bertil Lindahl, Per Venge, Lars Lind, University Hospital Uppsala, 
Uppsala, Sweden, Uppsala Clinical Research Center, Uppsala, Sweden
Background: B-type natriuretic peptides are elevated in many cardiac pathologies and 
have also been related to preclinical states of vascular disease such as endothelial 
dysfunction and coronary atherosclerosis. The aim of the present study was to further 
evaluate whether B-type natriuretic peptides could serve as screening markers for the 
detection of preclinical vascular disease in the community.
Methods: B-type natriuretic peptide (BNP) and NT-proBNP were analyzed in 1000 
apparently healthy subjects aged 70 years participating in the PIVUS (Prospective 
Investigation of the Vasculature in Uppsala Seniors) study, and were related to different 
measures of endothelial function (EDV, EIDV, FMD) and activation (E-selectin, P-selectin, 
sICAM-1, sVCAM-1), arterial compliance, intima-media thickness and atherosclerosis in 
the carotid arteries, and echocardiographic ﬁndings.
Results: The median levels were 110.7 ng/L for NT-proBNP and 42.0 ng/L for BNP. 
On multiple linear regression analysis, both B-type natriuretic peptides were related to 
female gender, elevated cardiac troponin I, previous manifestations of cardiovascular 
disease, and inversely related to renal function, body mass index and hyperlipidemia. 
On multivariable analysis adjusted for cardiovascular risk factors, cardiac troponin I and 
renal function, both B-type natriuretic peptides were signiﬁcantly related to increased 
left ventricular mass (p<0.001), depressed left ventricular ejection fraction (p<0.001) and 
diastolic function (p<0.001) but not to any of the assessed markers reﬂecting preclinical 
vascular disease.
Conclusions: B-type natriuretic peptides are strong markers of increased left ventricular 
mass and impaired cardiac performance in elderly subjects from a general community 
population, but are not independently associated to endothelial dysfunction, arterial 
stiffness or carotid atherosclerosis. B-type natriuretic peptides can therefore, not be 
regarded useful as screening markers for the detection of preclinical states of vascular 
disease in community populations.
9:30 a.m.
1013-112 Factors Inﬂuencing Arterial Stiffness in HIV Infected 
Patients
Ignatios Ikonomidis, John Lekakis, Sotirios Tsiodras, Loukianos Rallidis, Ioannis 
Palios, Anastasia Antoniadou, Garyfalia Poulakou, Periklis Panagopoulos, Antonios 
Papadopoulos, Helen Giamarellou, Dimitrios Th Kremastinos, ‘ATTIKON’ University 
Hospital, Athens, Greece
Background: The use of highly active antiretroviral therapy (HAART) in HIV (+) individuals 
reduced mortality rates but it has been associated with adverse metabolic effects and 
increase in the risk of myocardial infarction. Arterial stiffness is a marker of subclinical 
atherosclerosis with prognostic signiﬁcance. The aim of the study was a) to examine the 
factors inﬂuencing arterial stiffness in HIV (+) individuals and b) to compared HIV patients 
with patients with hypertension, a disease with abnormal arterial stiffness.
Methods: Sixty-nine HIV (+) patients (mean age 41.8 ± 13 yrs, 88.5 % male) attending 
a tertiary care center were compared to 27 patients with never-treated hypertension and 
27 healthy subjects. Both control groups had similar age, sex and atherosclerotic risk 
factors to HIV patients. Of the 69 HIV patients, 45 were treated with HAART. Carotid to 
femoral pulse wave velocity (PWV-Complior apparatus) was used as estimate of arterial 
stiffness.
Results: By ANOVA, HIV patients treated with HAART had higher PWV compared to HIV 
patients without HAART and compared to normal controls (8.38 ±1.5 vs 7.4 ±1.3 vs 7.2 
±1.15 m/sec, p=0.007). No difference was found between HIV patients without HAART 
and healthy controls (p=0.9) or HIV patients treated with HAART and hypertensive 
subjects (8.38 ±1.5 vs. 9 ±1.1 p=0.19). Patients receiving HAART had higher glucose 
(p=0.032), total cholesterol (p<0.001), LDL-cholesterol (p=0.002) and triglycerides 
(p=0.03) compared to patients without HAART. In univariate regression analyses PWV 
was related with age, mean blood pressure, HAART, duration of HAART, total cholesterol, 
LDL-cholesterol and triglycerides (p < 0.05 for all associations), but not with viral load. 
In multivariate regression analysis mean blood pressure (p=0.01) and triglyceride levels 
(p=0.04) were the most important determinants for increased PWV
Conclusions: Compared to HIV-infected patients without HAART, those receiving 
HAART have increased arterial stiffness similar to that observed in hypertensive patients. 
Arterial stiffness is not related to viral load but to parameters of metabolic syndrome 
namely blood pressure and triglycerides
9:30 a.m.
1013-113 Different Inﬂuence of Insulin Resistance and Low-
Density Lipoprotein Cholesterol on the Tissue 
Components of Culprit and Nonculprit Plaques in 
Patients With Unstable Angina
Takayuki Mitsuhashi, Kiyoshi Hibi, Naoki Nakayama, Naohiro Komura, Fumiyuki Otsuka, 
Nobuhiko Maejima, Masayoshi Kiyokuni, Kazutoshi Minami, katsutaka Hashiba, Tatsuya 
Nakachi, Noriaki Iwahashi, Jun Okuda, Kengo Tsukahara, Yoshio Tahara, Masami 
Kosuge, Toshiaki Ebina, Shinichi Sumita, Satoshi Umemura, Kazuo Kimura, Yokohama 
City University Medical Center, Yokohama, Japan
Background: Increased lipid area determined by integrated backscatter intravascular 
ultrasound (IB-IVUS) has been reported to be associated with greater cardiac events. 
Insulin resistance (IR) and low density lipoprotein cholesterol (LDL-C) have been 
reported to inﬂuence lipid contents, however, whether these factors similarly affect culprit 
(advanced stage of atherosclerosis) and non-culprit (early stage of atherosclerosis) 
lesions remains unclear. To clarify this issue, we studied the association between IR and 
lipid proﬁle and tissue characteristics of both culprit and non-culprit plaques in patients 
with unstable angina (UAP).
Methods: Culprit and non-culprit lesions in 43 patients with UAP were examined by IB-
IVUS using 40-MHz intravascular catheter. Since precise IR can not be determined in 
patients with overt diabetes, those with previous diagnosis of diabetes and HbA1c of more 
than 6.5% were excluded. Non culprit plaque had to be a lesion with angiographically 
no more than 50% luminal narrowing and at least 5 mm apart from any percutaneous 
coronary intervention site. Both culprit and non-culprit plaques were evaluated by IB-IVUS 
at 1mm intervals for 10 mm length and average value of each plaque component (lipid, 
ﬁbrosis, dense ﬁbrosis, and calciﬁcation) was calculated. Homeostasis model assessment 
of IR (HOMA-IR) was used as a marker of IR. We examined the inﬂuence of HOMA-IR 
and lipid proﬁle on plaque components in culprit and non-culprit lesions.
Results: As expected, culprit lesions for UAP had greater plaque area (9.1 vs. 6.8 mm2,
p<0.01) and plaque burden (77 vs. 45%, p<0.01) compared with non-culprit lesions. In 
culprit lesions, both higher HOMA-IR (R=0.32, p<0.05) and LDL-C (R=0.35, p<0.05) were 
correlated with greater %lipid area. In non-culprit lesions, higher HOMA-IR was correlated 
with greater %lipid area (R=0.39, p<0.05), however, no correlation was observed between 
LDL-C and %lipid area (R=0.08, p=0.62).
Conclusions: Impaired IR may accelerate lipid accumulation from early stage of coronary 
atherosclerosis, whereas LDL-C may affect advanced atherosclerosis only, suggesting 
that distinct mechanisms may exist during atherosclerosis development.
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1013-114 Lymphotoxin Alpha3-Induced Monocyte Endothelial 
Interaction Mediated By Tumor Necrosis Factor 
Receptor I /Nuclear Factor Kappa B Signaling Pathway
Shinichiro Suna, Yasuhiko Sakata, Masahiko Shimizu, Masaya Usami, Sen Matsumoto, 
Seiji Takashima, Hiroshi Takeda, Masatsugu Hori, Hiroshi Sato, Osaka University 
graduate school of Medicine, Suita, Japan
Background. Lymphotoxin (LT) is a member of the tumor necrosis factor (TNF) family 
that plays a critical role in inﬂammation and lymphoid organ development. We recently 
reported that the single nucleotide polymorphisms of the LTA gene are closely related 
to the occurrence and mortality of acute myocardial infarction. However, the precise 
mechanisms by which LTA plays the pivotal roles in atherogenesis and thus contributes 
to develop myocardial infarction remain unclear. We hypothesized that LTA3, a 
secreted homotrimer of LTA, mediates monocyte-endothelial interactions via the tumor 
necrosis factor receptor (TNFR)/ nuclear factor kappa B (NFkB) signaling to develop 
the atherosclerotic lesions. Methods and Results. To investigate the role of LTA3 in 
monocyte-endothelial cell adhesion, changes of protein expression in cultured human 
umbilical vein endothelial cells (HUVEC) were examined by Western blotting. LTA3
stimulation induced both vascular cell adhesion molecule 1 (VCAM1) and intercellular 
adhesion molecule 1 (ICAM1) dose-dependently (1pg/ml to 10ng/ml). LTA3 activated 
both p50 and p65, but none of p52, Rel-B or C-Rel subunits of NFkB, suggesting the 
involvement of not the noncanonical, but the classical NFkB pathway in LTA3 signaling. 
LTA3 also induced phospholylation of Akt and inhibitor of NFkB (IkB), and then degraration 
of IkB, all of which were antecedent to nuclear translocation of NFkB, and subsequently 
LTA3 also induced adhesion of THP1 monocytes to the HUVEC monolayer by adhesion 
assay. And furthermore, we elucidated that all of these effects were mediated by TNFR I 
rather than TNFR II using siRNA technique, and were attenuated by a phosphatidylinositol 
triphosphate-kinase inhibitor LY294002, but not by an extracellular signal-regulated protein 
kinase inhibitor. Conclusion. LTA3 mediated the monocyte-endothelial interaction via the 
classical NFkB pathway following TNFR I/ PI3K activation. The roles of LTA to develop 
coronary artery disease may be explained by this mechanism.
9:30 a.m.
1013-115 Rescue of Vascular Repair by In Vivo Caspase-Inhibition 
Results in Decreased Apoptosis of c-Kit-Positive 
Progenitor Cells and Attenuated Plaque Inﬂammation 
and Atherosclerosis Progression in a Mouse Model
Randolph Hutter, Walter Speidl, Carolina Valdiviezo, Valentin Fuster, Juan Jose 
Badimon, Mount Sinai School of Medicine, New York, NY
Background: Recent reports indicate a key role of progenitor cells (PC) in vascular 
repair. PC’s appear to be inversely related to vascular inﬂammation and are exposed 
to pro-apoptotic ox-LDL particles in lipid-rich plaque. Therefore, PC apoptosis and 
increased inﬂammation could be a key factor for accelerating plaque progression. To 
test this hypothesis we evaluated the effect of caspase-inhibition (CI) on PC apoptosis, 
inﬂammation and atherosclerosis progression in a mouse model.
Methods and results: Apo-E -/- mice (n=30) were fed a Western Diet for 7 months. 
Animals were randomized into treatment (TR) (n=20) and control group (CT) (n=10) 
receiving either 3 weeks of continuous CI treatment (daily i.p. injection of Q-VD-OPH 
general caspase-inhibitor at escalating doses of 10 mcg/kg and 30 mcg/kg) or control 
peptide. Plasma cholesterol levels were similar in both groups (948±62mg/dl and 
822±51mg/dl for TR and CT, P>0.05). CI signiﬁcantly reduced the number of apoptotic 
circulating c-kit positive PC (10%±2 vs. 38%±4, P<0.05) as measured by AnnexinV FACS. 
Content of c-kit positive PC of intimal cells in aortic plaque was similar in both groups, 
albeit with a dramatically reduced rate of apoptosis in these cellls with CI (7%±2 vs. 
48%±4, P<0.01). In addition, CI signiﬁcantly reduced MOMA-2 expression compared to 
CT (9%±3 vs. 28%±5, P<0.01, respectively). CI also signiﬁcantly reduced atherosclerosis 
burden when comparing plaque size at the aortic root level (0.54±0.05 vs. 0.78±0.14, 
P<0.01) and Sudan IV staining of abdominal aorta. 
Conclusion: Our data point to the key importance of PC viability for adequate vascular 
repair and attenuation of atherosclerosis progression. Insufﬁcient vascular repair in 
hyperlipidemic conditions is linked to increased plaque inﬂammation and seems to 
be caused by insufﬁcient quality rather than quantity of the PC response. Therefore, 
increasing numbers of PC’s alone without providing the conditions for these cells to 
survive inside the atherosclerotic lesion is futile. Instead, reducing PC apoptosis by 
caspase-inhibitors combined with stimulating the PC response could become a powerful 
tool to better treat atherosclerosis progression.
9:30 a.m.
1013-116 The Novel Protease-Activated Receptor Type-1 
Antagonist, F16618, Reduces Thrombus Formation in a 
Clinical Model of Thrombosis
Raj K. Chelliah, Laura Tattersall, Shruti Daga, Andrew Lucking, Karolina Skorupskaite, 
Bruno Le Grand, Michel Perez, David E. Newby, The University of Edinburgh, Edinburgh, 
United Kingdom
Background: Thrombin plays a central role in thrombus formation. The Protease-Activated 
Receptor type 1 (PAR-1) is the principal thrombin receptor in man. Its activation leads to 
platelet activation and thrombus formation. We assessed the effects of the novel PAR-1 
antagonist, F16618, on thrombus formation in an ex vivo model of thrombosis in man.
Methods: Ex vivo thrombus formation was assessed using the Badimon chamber at low 
and high shear rates with porcine aortic tunica media as the thrombogenic substrate. In 
a double-blind randomised crossover study, thrombus formation was assessed in ﬂowing 
venous blood from 12 healthy volunteers during extracorporeal administration of F16618 
(estimated chamber concentrations 100 μM), in comparison to the glycoprotein IIb/IIIa 
receptor antagonist, tiroﬁban (200 ng/mL), and saline. Thrombus area was measured 
histologically by computerised planimetry. SFLLRN (PAR-1 activating peptide) stimulated 
platelet aggregation and activation was assessed using aggregometry and ﬂow cytometry 
respectively in the presence and absence of F16618.
Results: F16618 reduced thrombus formation under low and high shear conditions: 20% 
(change in thrombus area 1762 μm2, 95% CI -30 to 3554 μm2, P=0.053) and 21% (change 
in thrombus area 1953 μm2, 95% CI 898.2 to 3007 μm2, P=0.0018) reduction respectively. 
As anticipated, tiroﬁban reduced thrombus area in both low and high shear chambers: 
26% (change in thrombus area 2126 μm2, 95% CI 616.6 to 3636 μm2, P=0.0101) and 
78% (change in thrombus area 7307 μm2, 95% CI 5026 to 9588 μm2, P<0.0001) reduction 
respectively. Both SFLLRN induced platelet aggregation and activation were inhibited in a 
dose-dependent manner by F16618 (P<0.0001 for both).
Conclusions: The novel PAR-1 antagonist, F16618, inhibits PAR-1 mediated platelet 
activation and aggregation, and ex vivo thrombus formation in man. Novel PAR-
1 antagonists, such as F16618, may thus represent a novel therapeutic agent in the 
treatment of atherothrombotic disorders in man.
This work was supported by an award from Pierre Fabre
9:30 a.m.
1013-117 Protective Effects of 1A, 25-Dihydroxyvitamin D3 
on Endothelial and Platelet Activity Markers of 
Atherosclerosis
Thorsten Kaelsch, Ksenija Stach, Xuan Duc Nguyen, Elif Elmas, Stefan Kralev, Tom 
Oberheiden, Martin Borggrefe, 1st Department of Medicine, University Hospital 
Mannheim, University of Heidelberg, Mannheim, Germany, Institute of Transfusion 
Medicine and Immunology, University of Heidelberg, Mannheim, Germany
Background: Inﬂammation contributes to an increased expression of various activity 
markers on platelets and endothelial cells, which lead to the progression of atherosclerotic 
changes in the vascular wall. The purpose of this study was to investigate possible 
protective effects of 1A, 25-Dihydroxyvitamin D3 in an in vitro endothelial cell model.
Methods: After a 24 hour incubation with 1A, 25-Dihydroxyvitamin D3 human umbilical 
vein endothelial cells were stimulated for one hour with LPS, and were then incubated in 
direct contact with platelets. The expression of CD40L and CD62P on platelets and ICAM-
1, VCAM, uPAR, and MT1-MMP on endothelial cells was measured by ﬂow cytometry.
Results: The increased expression of VCAM and MT1-MMP on endothelial cells by 
proinﬂammatory stimulation with LPS and by direct contact with activated platelets was 
signiﬁcantly reduced through pre-incubation with vitamin D3. Furthermore, platelets in 
contact with pre-incubated endothelial cells showed a signiﬁcant reduction in CD62P 
expression compared to platelets incubated with untreated endothelial cells. Treatment 
with vitamin D3 did not have a signiﬁcant effect on ICAM-1 and uPAR expression on 
HUVEC or CD40L expression on platelets.
Conclusion: 1A, 25-Dihydroxyvitamin D3 has a protective effect on the expression of 
proatherogenic activity and progression markers on platelets and endothelial cells under 
proinﬂammatory conditions and could have early therapeutic relevance in atherosclerotic 
diseases. 
9:30 a.m.
1013-118 Effect of Rosuvastarin on Arterial Elastic Properties in 
Patients With Inherited Dyslipidemias
Constantina Masoura, Christos Pitsavos, Ioannis Skoumas, Konstantinos Aznaouridis, 
Charalambos Vlachopoulos, Stavroula Raftopoulou, Lambros Papadimitriou, 
Christodoulos Stefanadis, Hippokration Hospital, Athens, Greece
Background: Heterozygous familial hypercholesterolemia (hFH) and familial combined 
hyperlipidemia (FCH) are genetic dyslipidemias which are associated with increased 
cardiovascular risk. Arterial function is an important predictor for cardiovascular disease. 
We explored the effect of rosuvastatin on arterial elastic properties in patients with hFH 
or FCH.
Methods: We studied 22 hFH patients (mean age 35.6years, 12 men) and 22 FCH 
patients (mean age 43.6 years, 16 men). All patients were never treated, normotensives, 
non-diabetics, and had no history of cardiovascular disease. Carotid-femoral pulse wave 
velocity (PWV, an index of aortic stiffness) and aortic augmentation index (AIx, a composite 
marker of arterial stiffness and wave reﬂections) were measured non-invasively, before 
and 6 months after treatment with rosuvastatin 20 mg daily.
Results: Levels of total cholesterol and LDL-cholesterol were dramatically reduced after 
rosuvastatin in both dyslipidemic groups (P<0,001, for all). Moreover, triglycerides and 
apo-B levels showed an important reduction in FCH group (P<0.001, for both). Rosuvastatin 
treatment decreased signiﬁcantly PWV both in hFH patients (7.8±1.2 vs.7.2±1.2 m/sec, 
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P<0.001) and in FCH patients (8.5±1.0 vs. 7.8±1.0 m/sec, P<0.001). We did not observe 
any change in AIx in hFH patients (7.9±14.0% vs.7.5±17.0%, P=NS), or in FCH patients 
(17.9±8.8 vs.18.7±10.5, P=NS). We did not ﬁnd any signiﬁcant correlation between the 
change of PWV and the amelioration of lipid proﬁle in these two dyslipidemic populations 
(P=NS for all correlations of PWV change with change of lipid levels).
Conclusions: In patients with hFh or FCH, rosuvastatin improves aortic stiffness. 
It seems that the effect of treatment on the lipid proﬁle does not fully account for this 
improvement.
9:30 a.m.
1013-119 Clopidogrel Provides Protection Against Diabetes-
Induced Vascular Damage
John A. McClung, Adam L. Kruger, Ambra Ferraris, Peter Tsenovoy, Melvin B. Weiss, 
Nader G. Abraham, New York Medical College, Valhalla, NY
Background: Clopidogrel, a potent thienopyradine, has been investigated for its effect 
on inﬂammatory markers as well as atherogenesis and has been shown to enhance 
endothelial production of NO and prostacyclin in tissue culture. We have previously 
described the presence of a marked increase in circulating endothelial cells (CEC) 
associated with type 2 diabetes mellitus. CEC have been reported to be an ex vivo 
indicator of vascular injury. We hypothesized that treatment with clopidogrel would result in 
a decreased number of CEC and an increase in activity of the phosphorylated Akt (pAkt) 
and phosphorylated AMP kinase (pAMK) signaling pathways in circulating endothelial 
progenitor cells (EPC) in patients with type 2 diabetes mellitus.
Methods: Mature CEC were isolated from the peripheral blood of 9 patients with type 2 
diabetes mellitus using anti-CD146-coated immunomagnetic Dynabeads™. Cells were 
stained with acridine orange dye and counted by ﬂuorescence microscopy. Concurrently, 
EPC were isolated in a similar fashion using anti-CD34 and assayed for expression 
pAkt and pAMPK. Patients were then treated with clopidogrel 75mg daily for thirty days, 
following which repeat blood specimens were analyzed.
Results: As previously observed, patients with diabetes mellitus had an elevated number 
of circulating endothelial cells (mean 79, range 20-110 cells/ml of peripheral blood). Similar 
to prior observations, the increase in circulating endothelial cells did not correlate with the 
levels of HbA1C. Clopidogrel treatment resulted in a signiﬁcant decrease in CEC to a mean 
of 10, range 0-40 cells/ml (P<0.001). Treatment was also associated with a signiﬁcant 
increase in expression of both pAkt and pAMPK (p = 0.04 and 0.05 respectively).
Conclusions: Clopidogrel treatment is associated with a reduction of endothelial cell 
sloughing as measured by CEC levels accompanied by an increase in the expression of 
pAkt and pAMPK in EPC in the peripheral blood of patients with Type 2 diabetes mellitus. 
This represents a novel additional mechanism by which this agent may promote improved 
vascular function, protect against oxidative stress, inhibit apoptosis, and attenuate 
vascular damage in diabetic patients.
9:30 a.m.
1013-120 Healthy Aging Is Not Associated With a Decline in the 
Level of Circulating Endothelial Progenitor Cells
Konstantinos Aznaouridis, Sarfraz Ali, Nino Kavtaradze, Ibhar Al Mheid, Muhiddin 
Ozkor, Jonathan Murrow, Riyaz Patel, Saurabh Dhawan, Cornelia Weyand, Jorg 
J. Goronzy, R Wayne Alexander, Arshed A. Quyyumi, Emory University School of 
Medicine, Atlanta, GA
Background: Endothelial progenitor cells (EPCs) contribute to vascular repair and their 
circulating level may be predictor of outcome. Recent studies indicate that the circulating 
levels of EPCs decrease with age in several populations. However, the effect of “normal 
aging” (absence of cardiovascular risk factors or disease) on the levels of EPCs in 
currently unknown.
Methods: We studied 68 strictly phenotyped healthy, non-obese subjects free of 
cardiovascular risk factors (age 43±13 years, BMI 24.1±3.4 kg/m2, 38 men).The CD34+ 
haematopoietic progenitors, which represent generic progenitor cells and the CD34+/
CD133+, CD34+/KDR+ and CD34+/CD133+/KDR+cells, which are considered to be 
enriched for endothelial progenitors, were measured by ﬂow cytometry.
Results: There was a progressive decline of the CD34+ count with age (left ﬁgure).
In contrast, increasing age was not associated with any decrease in the dual positive 
cells CD34+/CD133+ (r=0.16, P=0.2) or CD34+/KDR+ (middle ﬁgure). Interestingly, the 
level of the triple positive cells CD34+/CD133+/KDR+ increased with age (right ﬁgure). 
Multivariable analysis showed that this latter ﬁnding was mainly driven by the gender, as 
women were younger (39±10 vs 46±15 years, P=0.04) and had a lower CD34+/CD133+/
KDR+ count (0.42±0.27 vs 0.67±0.40 cells/μL, P=0.003).
Conclusions: Although healthy aging is associated by a progressive decline of the 
hemopoietic progenitor cells, the levels of EPCs do not decrease with age. 
9:30 a.m.
1013-121 Evidence for Extrinsic Apoptotic Pathway Activation in 
Lipid- Rich Plaque Macrophages In Vivo and In Vitro
Melanie Wijetunga, Randolph Hutter, Walter Spiedel, Valentin Fuster, Juan J. Badimon, 
Mount Sinai School of Medicine, New York, NY
Background: Macrophages undergoing apoptosis in areas of lipid-rich plaque contribute to 
plaque vulnerability. Although key regulatory molecules have been identiﬁed in the control 
of the apoptotic process in vitro, there is only limited knowledge of plaque component and 
expression of apoptosis regulatory proteins in human atheroma in vivo. Here, we studied 
apoptotic pathways in human plaques in vivo and cultured monocytes in vitro.
Methods: In human carotid (n=12) and coronary (n=6) atherosclerotic plaques, the 
expression of p17 active Caspase-3 (aCS-3), extrinsic Fas-Receptor (CD-95), and 
intrinsic regulators bax and bcl-xL was evaluated by immunohistochemical staining 
of serial sections and morphometric analysis (as mean % of cells ± SD). For in vitro 
studies, CD-14 positive monocytes were isolated from peripheral blood using magnetic 
cell sorting (MACS), cultured in RPMI for 2 h, and treated with 75 μg/ml oxidized-LDL 
(ox-LDL) ± caspase 8 or caspase 9 inhibitor for 6 h. Apoptosis was measured by FACS 
labeling for Annexin V.
Results: The expression of aCS-3 was increased in lipid-rich vs. ﬁbrous plaque components 
(22 ± 6 % vs. 3 ± 2 %, P<.01), demonstrating the occurrence of apoptosis in lipid-rich 
plaques. CD-95 expression showed a similar increase in lipid vs. ﬁbrous plaques (17 ± 7 
% vs. 2 ± 1 %, P<.01). The proteins were found to be co-localized, and their expression 
correlated with a high macrophage content (P<.05). There was no signiﬁcant difference in 
the expression of bax and bcl-xL between lipid-rich and ﬁbrous plaque components (26 ± 7 
% vs. 18 ± 9 %, P=NS, 17 ± 5 % vs. 14 ± 4 %, P=NS, respectively). In cultured monocytes, 
caspase 8 inhibition signiﬁcantly decreased apoptosis induced by ox-LDL (4 ± 2 % vs. 
13 ± 3 %, P<.05), whereas caspase 9 inhibition did not (12 ± 2 % vs. 13 ± 3 %, P=NS). 
Monocytes treated with ox-LDL demonstrated positive staining for CD-95.
Conclusions: We found increased expression of CD-95 in apoptotic lipid-rich plaques vs. 
non-apoptotic ﬁbrous plaques. Apoptosis induced by ox-LDL in monocytes was signiﬁcantly 
decreased by caspase 8 inhibition. These results show clear evidence for extrinsic apoptotic 
pathway activation in lipid-rich plaque macrophages in vivo and in vitro.
9:30 a.m.
1013-122 Chamber Speciﬁc Platelet Reactivity in Patients 
With Atrial Fibrillation: Implications for Left Arial 
Thrombogenesis
Scott R. Willoughby, Han Sung Lim, Ross Roberts-Thomson, Anisha Prabhu, Paul 
DeSciscio, Christopher Wong, Bobby John, Anthony Brooks, Matthew Worthley, 
Prashanthan Sanders, University of Adelaide, Adelaide, Australia
Background: Atrial ﬁbrillation (AF) is associated with increased risk of thrombus formation 
primarily in the left atria (LA); however, the mechanisms underlying this phenomenon are 
unknown. Platelets are an integral component of the thrombosis cascade and platelet 
activation has been observed when measured in peripheral blood in AF patients. However, 
whether there are chamber speciﬁc differences in platelet activation is not known.
Methods: 19 consecutive patients (13 males: 60±2 years) with AF undergoing ablation 
were studied. All patients ceased warfarin 7 days and enoxaparin 12 hours prior to the 
procedure. Anticoagulated blood samples were obtained at the start of the procedure 
immediately after transseptal puncture from the femoral vein (FV), the left atria (LA) and 
the right atria (RA), prior to the administration of heparin. Unstimulated blood samples 
were incubated with the platelet speciﬁc antibody against P-selectin (CD62P) or control 
and analysed by whole blood ﬂow cytometry. Blood samples had evaluation of platelet 
aggregation utilizing ADP (2.5 and 5μM)-induced whole blood impedance aggregometry
Results: In patents with AF, P-selectin levels were signiﬁcantly elevated in the LA 
(ANOVA p=0.01; Bonferroni’s post test left atria [10.2±2.4 %] vs RA [8.6±2.3 %] p<0.05). 
Similarly platelet aggregation was signiﬁcantly elevated in the LA at ADP 2.5μM (ANOVA 
p<0.01; Dunn’s post test left atria [5.2±0.6 Ohms] vs femoral vein [4.3±0.6 Ohms] p<0.05) 
and ADP 5μM (ANOVA p<0.03; Dunn’s post test left atria [7.2±0.5 Ohms] vs femoral vein 
[6.3±0.7 Ohms] p<0.05).
Conclusions: Patients with AF have increased left atrial platelet P-selectin expression 
and platelet aggregation compared to the right atria or femoral vein, respectively. This 
data suggests the presence of chamber speciﬁc activation of platelet reactivity in patients 
with AF and may in part explain the propensity for left atrial thrombus in these patients. 
Platelet activity within the left atria may play an important role in the pathogenesis of 
thrombus formation in AF.
9:30 a.m.
1013-123 Accelerated Vascular Aging in CuZnSOD-Deﬁcient 
Mice: Impact on EPC Function and Ischemia-Induced 
Neovascularization.
Jessika Groleau, Sylvie Dussault, Julie Turgeon, Paola Haddad, Fritz Maingrette, Alain 
Rivard, CRCHUM Notre-Dame, Montreal, QC, Canada
Background: We have previously shown that aging is associated with an impaired 
angiogenic response following ischemia. Because aging leads to an increased generation 
of reactive oxygen specie (ROS), here we investigated the effect of CuZnSOD deﬁciency 
on vascular aging and ischemia-induced neovascularisation.
Methods and results: Hindlimb ischemia was surgically induced in young (6-8 weeks) 
and older (8 months) CuZnSOD-/- and CuZnSOD+/+ mice. We found that older mice had 
a signiﬁcantly slower rate of blood ﬂow recovery when compared to young mice, as 
assessed by Doppler Flow Ratios (DFR) between the ischemic and normal hindlimbs 
at day 7 after surgery (0.52 ± 0.03 vs 0.72 ± 0.03; p<0.01). In both groups of mice, 
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CuZnSOD deﬁciency was associated with a further reduction of blood ﬂow recovery. 
Accordingly, the resulting blood ﬂow perfusion in a young CuZnSOD-/- mouse was similar 
to that of an older WT mouse (DFR 0.57 ± 0.05 vs 0.52 ± 0.03; p=0.42). In addition, 
both aging and CuZnSOD deﬁciency were associated with increased levels of oxidative 
stress in ischemic tissues (nitrotyrosine immunostaining). Therefore, oxidative stress 
levels in ischemic tissues of young CuZnSOD-/- mice were similar to those of older WT 
mice. To investigate potential mechanisms involved in the inhibition of neovascularization 
by CuZnSOD deﬁciency, endothelial progenitor cells (EPCs) were isolated from the 
bone marrow of the different groups of mice. We found that the number of EPCs was 
signiﬁcantly reduced in CuZnSOD deﬁcient mice compared to controls, both in young and 
old animals. Similarly, the functional activities of EPCs (proliferation, migration, adhesion 
and integration into tubules) were also signiﬁcantly impaired in CuZnSOD deﬁcient mice. 
These defects were associated with signiﬁcant increased oxidative stress levels (DCFDA 
and DHE staining) in CuZnSOD-deﬁcient EPCs.
Conclusions: CuZnSOD deﬁciency is associated with accelerated vascular aging and 
impaired ischemia-induced neovascularization. Potential mechanisms include increased ROS 
generation together with a reduction in the number and the functional activities of EPCs.
9:30 a.m.
1013-124 Functional Characterization of Potassium Channels and 
Their Role in the Modulation of Smooth Muscle Cell 
Phenotype in the Arterial Wall
Laura Novensà, Pilar Cidad, Leire Barquín, Álex Moreno-Domínguez, Magda Heras, Mª 
Teresa Pérez, José Ramón López, Mercè Roqué, Hospital Clínic. IDIBAPS, Barcelona, 
Spain, Universidad de Valladolid, Valladolid, Spain
Background: Potassium channels (K+) play an important role in the process of vascular 
repair after injury. Our study aims to determine the role of K+ channels in vascular smooth 
muscle cells (VSMC) proliferation in hypertensive (BPH) and normotensive (BPN) mice.
Methods: VSMC proliferation after endoluminal injury was determined in femoral 
arteries of BPH (n=26) and BPN (n=18) mice at 48h, 7 and 28 days. The proliferative 
pattern of VSMC was also studied in vitro in cultured VSMC from BPH and BPN.The 
role of K+ channel subtypes was determined by patch-clamp technique. In addition, a 
pharmacological approach was used to study the effect of selective K+ channel blockade 
with Correolide (for Kv1) and Margatoxine (for Kv 1.3) on immunohistochemical and 
mRNA expression of K+ channels.
Results: Four weeks after injury, a robust proliferative response was observed in the 
vessel wall of BPH and BPN mice. Hypertension did not induce any signiﬁcant difference 
in the response-to-injury (luminal stenosis 80±25% in BPH vs 76±24% in BPN; p=NS). 
These data correlate with in vitro studies, where no differences on VSMC proliferation 
were observed between BPH and BPN cell lines. Functional characterization of K+ 
channels showed a decrease in Kv1 current and an increase in Kv 1.3 current after 
injury (proliferative phenotype), compared with uninjured arteries (contractile phenotype). 
Selective blockade of Kv1 with Correolide, markedly inhibited the in vivo and in vitro
currents (by 40% and 75%, respectively; p<0.001). Blockade of Kv 1.3 with Margatoxine 
inhibited the in vivo current by 10% and by 50% in culture; (p<0.05)
Conclusions: Modulation of K+ channel expression is emerging as a potential therapeutic 
target in the control of restenosis after percutaneous coronary interventions. Moderate 
hypertension has no signiﬁcant effect in vascular response-to-injury in this model.
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1022-93 Celecoxib Atherogenicity: Promotion of Foam Cell 
Formation (FCF) and Inhibition of ABCA1 in THP-1 
Human Macrophages
Allison B. Reiss, Sari D. Edelman, Kamran Anwar, Edwin S. Chan, Peter A. Wirkowski, 
Steven E. Carsons, Winthrop University Hospital, Mineola, NY, NYU School of Medicine, 
New York, NY
Background: Cyclooxygenase-2 (COX-2) inhibitors possess analgesic and anti-
inﬂammatory efﬁcacy, but associated cardiovascular (CV) risks are a major safety 
concern. Celecoxib is the only COX-2 inhibitor available in the USA. Multiple mechanisms 
have been proposed to explain the increase in CV risk with COX-2 inhibitors. Little is 
known of the impact of these drugs on the cholesterol transport system. We previously 
showed that COX-2 inhibition (NS398) impedes reverse cholesterol transport (RCT). 
The current study evaluates the atherogenic response of the THP-1 human monocyte/
macrophage cell line to celecoxib and COX-2 silencing.
Methods: THP-1 monocytes and differentiated macrophages were treated with celecoxib 
(0-50μM) or transfected with silencing RNA (siRNA) or mock-transfected. Macrophages 
were cholesterol-overloaded with acetylated LDL (50μg/ml, 48h). Expression of ABCA1, 
an atheroprotective protein that promotes macrophage cholesterol efﬂux constituting the 
ﬁrst step of RCT, was assessed by endpoint PCR and immunoblot. FCF was expressed 
as percent foam cells/total cells after oil red O staining.
Results: Celecoxib (50μM) signiﬁcantly decreased ABCA1 message and protein (by 
65.1±1.5% vs control, p=0.003 and 25.6±1.3%, p<0.0001, respectively). The decrease in 
ABCA1 with celecoxib occurred in a dose-dependent manner. COX-2 siRNA attenuated 
ABCA1 message by 22.9±4.9% vs mock, p= 0.03. Celecoxib markedly enhanced FCF (to 
95.0±0.7% vs. 39.1±5.4% for control, p=0.003) while siRNA increased FCF by 58.3±1.6% 
vs mock, p=0.003.
Conclusion: Our results provide further evidence that COX-2 inhibitors are pro-
atherogenic agents. Blocking the COX-2 enzyme leads to deﬁciency of cholesterol efﬂux 
proteins and vulnerability to cholesterol overload. Both pharmacologic COX-2 inhibition 
and COX-2 silencing impede RCT protein expression and encourage FCF. FCF plays a 
fundamental role in the pathogenesis of atheromatous CV disease. These ﬁndings add to 
our understanding of the mechanisms underlying increased CV risk with COX-2 inhibitors. 
Strategies to develop COX-2 inhibitors that do not interfere with RCT may provide a novel 
approach to pain relief without associated CV risk.
3:30 p.m.
1022-94 Uncovering the Links Between Low-Grade 
Inﬂammation, Endothelial and Cardiorenal Dysfunction: 
The Role of Asymmetric Dimethylarginine in Essential 
Hypertension
Costas Tsiouﬁs, Kyriakos Dimitriadis, Eirini Andrikou, Anastasia Mazaraki, Giorgos Metallinos, 
Antigoni Miliou, Dimitris Tousoulis, Ioannis Kallikazaros, Christodoulos Stefanadis, First 
Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece
Background: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of the 
nitric oxide synthase, emerges as a marker of cardiovascular risk. We investigated the 
relationships of urinary albumin excretion, expressed as the albumin to creatinine ratio 
(ACR), with high-sensitivity C-reactive protein (hs-CRP), adiponectin and ADMA in 
essential hypertensives.
Methods: Our population consisted of 158 newly diagnosed untreated non-diabetics 
with stage I to II essential hypertension [106 men, mean age=49 years, ofﬁce blood 
pressure (BP)=151/97 mmHg]. According to the ACR values determined as the mean of 
two non-consecutive morning spot urine samples, the study population was divided into 
microalbuminurics (n=32) (mean ACR=30-300 mg/g) and normoalbuminurics (n=126) 
(mean ACR<30 mg/g).
Results: Microalbuminurics compared to normoalbuminurics had higher 24-h systolic BP 
(144±11 vs 133±12 mmHg, p=0.001), while did not differ regarding sex and metabolic 
proﬁle (p=NS). Moreover, microalbuminurics compared to normoalbuminurics exhibited 
higher levels of ADMA (0.61±0.04 vs 0.55±0.03 μmol/l, p=0.001) and hs-CRP (4.5±1.7 vs 
2±1.1 mg/l, p<0.0001), whereas had lower adiponectin values (5.8±1.5 vs 9±2.6 μg/ml, 
p=0.019). In the total population, ACR was positively related to ADMA (r=0.366, p<0.0001), 
hs-CRP (r=0.318, p<0.0001) and negatively related to adiponectin (r=-0.169, p=0.004). 
Regarding ADMA, it was associated with 24-h pulse pressure (r=0.404, p<0.0001), hs-
CRP (r=0.221, p<0.0001) and adiponectin (r=-0.222, p<0.0001). Multiple regression 
analysis revealed that 24-h systolic BP, hs-CRP and ADMA were the independent 
predictors of ACR (R2=0.58, p<0.0001). Furthermore, analysis of covariance showed that 
ADMA, adiponectin and hs-CRP values were signiﬁcantly different between groups even 
after adjustment for confounders (p<0.05).
Conclusion: Microalbuminuric hypertensives exhibit pronounced inﬂammatory activation, 
endothelial dysregulation and hypoadiponectinemia. Moreover, the close association of 
ADMA with hs-CRP and adiponectin, further establishes endothelial dysfunction as an 
integrative factor in the interpretation of ACR-related risk.
3:30 p.m.
1022-95 Studies on Regulatory Mechanism of Vascular 
Smooth Muscle Cell Killing Mediated by Activated 
T-Lymphocytes From Unstable Angina Patients
Bok-Soo Lee, Joo Yun Kim, Ji Yeon Lee, JinYong Choi, Jo Yoon Yi Lee, Jeong Euy Park, 
Samsung Medical Center, Seoul, South Korea
Background: As atherosclerosis progresses, medial smooth muscle cells (SMC) disappear 
especially in the area where inﬂammation is severe. We have investigated whether T cells 
from patients with coronary artery diseases, esp., unstable angina, are involved in smooth 
muscle cell (SMC) killing and tried to elucidate the possible mechanism.
Methods: Patients with CAD (244 subjects) were divided into 4 subgroups: normal (NL), 
unstable angina (UA), stable angina (SA), and acute myocardial infarction (AMI). First, we 
measured inﬂammatory cytokines/chemokines in patient’s sera using cardiovascular 7plex 
assay kit (Bender MedSystems) and CD137 level by sandwich ELISA. To study the possible 
mechanism, we prepared primary SMCs and co-cultured with CD4 or CD8 lymphocytes 
from patients. SMC cell death was estimated by counting the number of fragmented nuclei 
after DAPI staining. Results: We found that sCD40L, MCP-1, IL8, or IL6 levels were not 
signiﬁcantly different among subgroups. Tissue plasminogen activator (tPA) level was 
signiﬁcantly higher in SA group compared with other subgroups. Although CD137 level 
showed wide variation within group, we found that 24% of UA patients and 22% of AMI 
patients showed above 0.2 ng/ml of CD137 while only 4% of the patients in SA group 
showed that level. SMC cell death appeared in 19.4% (p<0.01) and 44.9% (p<0.01) of 
cells when CD4+ cells from normal and UA patients were added and it increased to 41.9% 
(p<0.05) and 50.6% (p<0.01) in cells treated with phorbol myristate acetate (PMA) and 
Ionomycin, respectively. Interestingly, there was no signiﬁcant differences of SMC cell death 
by CD8+ cells among subgroups (50 ± 9%, p<0.12) or by stimulation. When the CD4+ cells 
from normal persons were activated by stimulating with CD137 ligand (CD137L), the cells 
dramatically enhanced surface CD137 expression, however, it did not affect SMC cell death. 
Conclusions: Common inﬂammatory cytokines revealed no signiﬁcant differences among 
subgroups in sera from CAD patients but CD137 level was increased in sera from UA and 
AMI compared to SA. Both CD8+ and CD4+ cells are critical in SMC death and CD137 in 
activated CD4+ cells from UA patients might play an important role for the SMC death.
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1022-96 Macrophage Hemoglobin Scavenger Receptor CD163 Is 
Functionally Linked to Heme-Oxygenase-1 and Ferritin 
Expression in Human Diabetic Atherosclerotic Plaques
Meerarani Purushothaman, K-Raman Purushothaman, Andrew P. Levy, Elias A. Zias, 
Patrick A. Lento, John T. Fallon, Valentin Fuster, Pedro R. Moreno, Mount Sinai School of 
Medicine, New York, NY
Background: The macrophage hemoglobin scavenging receptor CD163 plays a major 
role in clearance of hemoglobin (Hb) released from lysed red blood cells after intraplaque 
hemorrhage (IPH). Heme liberated from Hb is degraded by hemeoxygenase-1 (HO-1) 
to free iron, which is rapidly sequestered by ferritin. We hypothesize that impairment in 
CD163 expression may alter HO-1 and ferritin defense mechanism in clearance of Hb in 
diabetes (DM) inducing atherothrombosis.
Methods: Thirty-three human DM atherosclerotic plaques and 49 no-DM plaques were 
characterized using H&E. The macrophage (CD68) and CD163 protein expressions were 
quantiﬁed by double label immunochemistry and gene expression in serial sections by 
real time PCR. The ferritin protein expression was graded by immunohistochemistry.
Results: The mean percentage of macrophages expressing CD163 was signiﬁcantly 
decreased in DM plaques (DM 26.2 % ± 2 Vs no-DM 66.9 % ± 2, p=0.0001, Figure A). 
The CD163 and HO-1 mRNA expressions were down regulated in DM (DM 0.0689±0.017 
Vs no-DM 0.3078±0.055, p=0.002, and DM 0.002±0.0006 vs Non-DM 0.0369±0.012, 
P=0.005, Figure B) respectively. Furthermore, protein expression of ferritin was also 
decreased in DM plaques (DM 0.7±0.1 Vs no-DM 2.6±0.2, p=0.0001, Figure C) when 
compared to no-DM plaques.
Conclusions: CD163 may have a functional role in induction of HO-1 and ferritin 
expression. Thus, impairment in CD163 expression may alter HO-1 and ferritin defense 
mechanism leading to atherothrombosis in DM plaques.
3:30 p.m.
1022-97 A Balance of Arachidonic Acid (AA) to 
Eicosapentaenoic Acid (EPA) Reﬂect Plaque 
Vulnerability in Both Acute Coronary Syndrome and 
Sstableangina Pectoris: A Study With Radiofrequency 
Intravascular Ultrasound
Yoichi Takaya, Masayuki Ueeda, Yukari Nakano, Satoko Ukawa, Kazuhiro Dan, Nobuhiko 
Ohnishi, Atsushi Takaishi, Atsushi Hirohata, Shozo Kusachi, Kazuhumi Nakamura, Kengo 
Kusano, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 
Japan, Division of Cardiology, Mitoyo General Hospital, Kanonnji, Japan
Background: Recent advancement of radiofrequency intravascular ultrasound (VH-
IVUS) enabled us to speculate plaque histology in vivo, and increased necrotic core 
(NC) are considered as one of the characteristics of vulnerable plaque. Meanwhile, we 
have reported that the balance of omega 6 to 3 polyunsaturated fatty acids (PUFAs), 
particularly AA/EPA is important for the pathogenesis of coronary heart disease.In this 
study, we investigated whether amount of NC would be inﬂuenced by AA/EPA in acute 
coronary syndrome (ACS) and stable anginapectosis (SAP).
Methods: A total of 85 patients, with 56 SAP and 29 ACS, were enrolled. All patients 
received successful coronary intervention with an assistance of VH-IVUS. To exclude the 
artiﬁcial effect of thrombus to the analysis of VH-IVUS, all of 29 ACS patients received 
aspiration of thrombus before IVUS. One centimeter length, which is 11 frames, of the 
culprit lesion was examined with an auto-pullback system. We analyzed four plaque 
components, which are ﬁbrous, ﬁbro-fatty, NC and dense calcium. The means of four 
components were compared with the classical coronary risk factors (T.Cho, HDL-C, 
LDL-C, TG, blood sugar, HbA1c) and PUFAs. We used Pearson’s correlation analysis and 
one-way regression analysis for statistics.
Results: The volume and percentage of NC are signiﬁcantly higher in the culprit 
lesion of ACS than SAP (2.02±1.14 vs 1.36±0.73 mm2 and 2.02±1.14 vs 1.36±0.73%, 
both p=0.002). No classical coronary risk factors except for HDL-C in SAP (r=-0.31, 
p=0.02) were related to the volume of NC, and nothing to percentage of NC and other 
components. The signiﬁcant correlations were observed between volume or percentage 
of NC and omega 6 to 3 balance, particularly AA/EPA in both ACS and SAP. The r value 
between %NC and AA/EPA were 0.45 (P=0.014) and 0.44 (p=0.0007) for ACS and SAP, 
respectively. These results suggested that the balance of AA/EPA reﬂect the amount and 
percentage of NC in culprit lesion of both ACS and SAP, indicating it is an important 
determinant factor for plaque vulnerability.
Conclusions: A balance of AA/EPA could reﬂect the volume and percentage of NC in 
both SAP and ACS, indicating it would be an important pathogenic factor.
3:30 p.m.
1022-98 Immune-Modulating Serpins With Anti-Atherogenic 
Activity, Demonstrate Anti-inﬂammatory Shifts in TH1, 
TH2, and TH17 Lymphocyte Subsets
Ganesh Munuswamy Ramanujam, Mira Shnabel, Tolga Barker, Yuming Sun, Karim Khan, 
Jakob Richardson, Erbin Dai, Minoru Satoh, David Lomas, Alexandra Lucas, University of 
Florida, Gainesville, FL, University of Cambridge, Cambridge, United Kingdom
Background: In atherosclerosis, T lymphocytes migrate into plaque, are activated, 
and differentiate into T-Helper, TH1 and TH2 subgroups as well as other TH subsets. 
TH differentiation plays a central role in aggravation or remission of vascular disease. 
Prior studies have detected links between the TH subsets, cytokine expression and 
plasminogen activators (PAs). Serine proteinase inhibitors, termed serpins, mammalian 
neuroserpin (NSP) and myxomaviral Serp-1 regulate thrombolytic and inﬂammatory 
pathways; NSP inhibits tPA, uPA and Serp-1 inhibits tPA, uPA, plasmin and fXa. . Prior 
work has demonstrated that NSP reduces cerebral stroke volume and both NSP and 
Serp-1 reduce inﬂammation and vascular plaque growth after angioplasty injury or 
transplant in rodent models. We have assessed the capacity of NSP and Serp-1 to alter 
the balance of pro-inﬂammatory TH1 and anti-inﬂammatory TH2 lymphocyte subsets. The 
more recently studied TH17 cell subset with a pro-active role in auto-immune disease 
was also examined.
Methods: TH1, TH17 and TH2 lymphocyte populations were measured in splenocytes 
isolated from mice after aortic allograft transplant (C57Bl/6 to Balb/c) and in mouse 
ascites after MCP-1 CC chemokine injection with and without NSP or Serp-1 treatment. 
CD4+, IL-4, IFNG and IL-17 markers were used to detect TH2, TH1 and TH17 populations 
by FACS analysis. 
Results: All serpins signiﬁcantly (p<0.004) reduced blood mononuclear cell and 
lymphocytes in mouse ascites after MCP-1 injection. Serp-1 and NSP (p<0.0364) 
increased the TH2/TH1 ratio at early time points. Serp-1, but not NSP, reduced total CD4+
cells when compared (p<0.0037) to saline controls at early time points (1 & 24 h) after 
aortic transplant. At 4 weeks the ratio shifted back towards the TH1 population for Serp-1 
and NSP treatment. Only Serp-1 signiﬁcantly (p<0.0433) decreases the TH17 population 
at 24h and 4 w time points.
Conclusions: Anti-inﬂammatory serpins, mammalian NSP and viral Serp-1, block 
vascular inﬂammation and transplant vasculopathy in part mediated through increased 
polarization towards anti-inﬂammatory TH2 lymphocyte subsets. Serp-1 also reduces the 
TH17 cell subset.
3:30 p.m.
1022-99 Relationship Between Apolipoprotein B/Apolipoprotein 
A-1 Ratio and Coronary Plaque Progression of Non-
culprit Intermediate Lesion in Acute Myocardial 
Infarction
Naoki Nozawa, Kiyoshi Hibi, Mitsuaki Endou, Tsutomu Endo, Kazuo Kimura, Division 
of Cardiology, Saiseikai Yokohama City Southern Hospital, Yokohama, Japan, 
Cardiovascular Division of Yokohama City University Medical Center, Yokohama, Japan
Background: Recently, it was reported that apolipoprotein B (ApoB)/apolipoprotein A1 
(ApoA1) ratio was signiﬁcantly related to acute myocardial infarction (AMI). Infusion of 
recombinant ApoA1 Milano has been reported to promote rapid regression of coronary 
atherosclerosis. Prior intravascular ultrasound (IVUS) trials have demonstrated that 
coronary plaque regression associated with reduction of low-density lipoprotein cholesterol 
(LDL-C) in statin therapy. However, no data is available evaluating the relation between 
ApoB/ApoA1 and progression of coronary atherosclerosis. The aim of this study was to 
investigate the association with ApoB/ApoA1 ratio and coronary plaque progression of 
non-culprit intermediate lesion in AMI.
Methods: IVUS interrogation was performed in 61 patients with AMI who admitted within 
24 hours from onset. All patients underwent percuteneous coronary intervention (PCI) to 
culprit lesions. IVUS ﬁndings for non-culprit intermediate plaque were analyzed at acute 
phase and at 7-month follow-up. The target plaque had to be a minor lesion (ie, a diameter 
stenosis of < 50% on angiography) and had to be at least 10 mm apart from any PCI site. 
The percent plaque volume changes (%$PV) were analyzed.
Results: Average lesion length was 10.5 ± 3.1 mm. Vessel volume, lumen volume, and 
plaque volume showed no remarkable change from baseline to follow-up (222 ± 101 mm3
to 223 ± 100 mm3, p=0.691, 106 ± 47 mm3 to 108 ± 47 mm3, p=0.122, 116 ± 61 mm3 to 114 
± 61 mm3, p=0.299, respectively). Although high-density lipoprotein cholesterol (HDL-C), 
LDL-C, and LDL-C/HDL-C ratio at baseline were not associated with %$PV (r=-0.24, 
p=0.06, r=0.06, p=0.675, and r=0.23, p=0.07, respectively), ApoA1 and ApoB/ApoA1 
ratio at baseline were associated with %$PV (r=-0.31, p=0.015 and r=0.28, p=0.027). 
ApoB at baseline was not associated with %$PV (r=0.08, p=0.538). ApoB/ApoA1 ratio 
> 0.88 was deﬁned as high group (n=30) and a 0.88 was low group (n=31). %$PV was 
larger in high group than in low group (1.4 ± 8.7% versus -4.7 ± 8.8%, p=0.009).
Conclusions: Our results suggest that ApoB/ApoA1 ratio correlated with plaque 
progression of non-culprit intermediate lesion in AMI.
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1022-100 The Long-Term Coronary Endothelial Function After 
Coronary Intervention Could be Different Among 
The Various Types Of Stent: A Six To Nine Month 
Comparison Of Three Types Of Drug-Eluting Stent and 
Bare Metal Stent
Dong-IL Shin, Ki-Bae Seung, Hoon Joon Park, Man-Young Lee, Sang Hong Baek, The 
Catholic University of Korea, Seoul, South Korea
Background: The coronary endothelial function after intervention has emerged as a major 
concern for long-term prognosis of coronary disease. We compared coronary endothelial 
function after various types of stent implantation; 3 types of drug-eluting stent (DES) and 
bare metal stent (BMS). Methods: Patients with one stent implantation for single lesion in 
left anterior descending artery were enrolled. Endothelial function was assessed only in 
patients with no restenosis on 6 to 9 month-follow up angiography. Endothelium-dependent 
vasomotion was assessed by measuring the change of diameter after intracoronary injection 
of acetylcholine (Ach, 10-6 mol/L). Endothelium-independent vasomotion was measured 
after injection of 2mg-nitrates. The measuring was done at 5 segments; near proximal and 
proximal, distal and far distal, and stented segments by quantitative coronary angiography. 
Results: Total 47 patients (42 DES, 5 BMS) were included. DES group consists of Cypher 
(19), TAXUS (11) and Endeavor (12 patients) groups. In stented segments, no signiﬁcant 
vasomotion was observed. In distal and far distal segments, Cypher and TAXUS groups 
showed signiﬁcant vasoconstriction by Ach (p<0.05 vs baseline), but Endeavor and BMS 
group did not (distal: -32.6±12.2%, -26.8±15.1%, 1.6±1.5%, 0.7±0.5, far distal: -28.7±12.3%, 
-29.4±14.9%, 0.3±2.3%, -0.9±1.3%, for Cypher, TAXUS, Endeavor, BMS, respectively). 
Comparing to Endeavor and BMS groups, these vasoconstrictions of Cypher and TAXUS 
groups were statistically signiﬁcant (p<0.05 for distal and far distal). In proximal portion, 
only TAXUS group showed trend of mild vasoconstriction (-4.1±8.3%, p=0.07 vs baseline). 
The vasomotor response of Endeavor was similar to that of BMS group (p>0.05 for all 
segments). The endothelium-independent vasodilatation by nitrates was intact in all groups. 
Conclusion: The impairment of endothelium-dependent vasomotion in distal portion 
was observed in Cypher and TAXUS groups but not in Endeavor and BMS groups. Our 
results suggest that Cypher and TAXUS could be associated with the long-term coronary 
endothelial dysfunction, while Endeavor could have physiologic endothelial function similar 
to that of BMS.
3:30 p.m.
1022-101 Variable Response in Platelet Reactivity to 600 mg 
Clopidogrel-Loading Dose Inﬂuences Prognosis in ST-
Segment Elevation Myocardial Infarction.
Zenon Huczek, Krzysztof J. Filipiak, Janusz Kochman, Marcin Michalak, Marek Roik, 
Grzegorz Opolski, The Medical University of Warsaw, Warsaw, Poland
Background: Despite greater inhibition of platelet aggregation with 600 mg clopidogrel-
loading dose (CLD) as compared with 300 mg, substantial interindividual variability in 
its antiaggregatory effect is observed. The aim of the study was to assess whether high 
post-CLD platelet reactivity is associated with worse prognosis in ST-segment elevation 
myocardial infarction (STEMI) undergoing primary PCI with stent implantation.
Methods: Platelet reactivity was measured 6h after CLD with the Verify Now assay, 
indicating the extent of P2Y12 receptor blockade by clopidogrel (Accumetrics, San Diego) 
in 103 patients with STEMI treated with primary angioplasty. The primary end-point of 
the study was the cumulative incidence of cardiovascular death, non-fatal myocardial 
infarction (MI) and urgent target lesion revascularization (TLR) in 30 days follow-up.
Results: The mean post-CLD platelet reactivity expressed in P2Y12 reaction units (PRU) 
was 206.5+/-78.8. Patients were stratiﬁed into quartiles according to increasing values of 
PRU. Patients in the fourth quartile (PRU >/=289; n=25) indicating greatest reactivity had 
signiﬁcantly higher cumulative rates of death, MI and TLR than those in the remaining 
three lower quartiles (28% vs. 7.7%, P=0.042). In multivariate regression analysis PRU 
>/=296 was independent predictor of the combined endpoint (hazard ratio, 2.3; 95% 
conﬁdence interval, 1.2-7.2; P=0.03).
Conclusions: In the acute phase of STEMI patients with lowest P2Y12 receptor blockade 
as indicated by point-of-care test are at increased risk of adverse events in short-term 
follow-up. This group of patients may be a subject to alternative maintenance dosing 
regimens with clopidogrel or usage of other non-standard platelet inhibitors.
3:30 p.m.
1022-102 Signiﬁcant Differential Metabolic Effects of Pravastatin 
and Simvastatin In Hypercholesterolemic Patients
Kwang K. Koh, Michael J. Quon, Seung H. Han, Wook-Jin Chung, Eak K. Shin, Gachon 
University Gil Medical Center, Incheon, South Korea
Background: Lipophilic and hydrophilic statins have different effects on adiponectin and 
insulin resistance in experimental studies and different effects on the rate of onset of new 
diabetes in large scale clinical studies. Therefore, we hypothesized that simvastatin and 
pravastatin may have differential metabolic effects in hypercholesterolemic patients.
Methods: This was a randomized, double-blind, placebo-controlled, and parallel study. 
Age, sex, and body mass index were matched. All patients were recommended low fat 
diet. Each forty-three patients were given placebo, simvastatin 20 mg, and pravastatin 40 
mg, respectively daily during a 2 month treatment period.
Results: Placebo signiﬁcantly reduced total cholesterol, LDL cholesterol, and HDL 
cholesterol levels, however, did not signiﬁcantly change plasma adiponectin levels 
and insulin sensitivity (determined by QUICKI) relative to baseline measurements. 
Simvastatin and pravastatin therapy signiﬁcantly changed lipoprotein levels and improved 
ﬂow-mediated dilation after 2 months when compared with baseline (P<0.001) or placebo 
treatment (P<0.001 by ANOVA). Simvastatin therapy signiﬁcantly increased insulin levels 
(mean % changes; 127%, P=0.014) and decreased plasma adiponectin levels (10%, 
P=0.012) and insulin sensitivity as assessed by QUICKI (6%, P=0.007) when compared 
with baseline. By contrast, pravastatin therapy did not signiﬁcantly change insulin levels 
(-3%, P=0.437) but signiﬁcantly increased plasma adiponectin levels (9%, P=0.011) and 
insulin sensitivity (6%, P=0.008) when compared with baseline. In addition, these effects 
of simvastatin were signiﬁcant when compared with pravastatin (P<0.001 for insulin levels 
by ANOVA on Ranks, P<0.001 for adiponectin and P=0.001 for QUICKI by ANOVA). 
When compared with baseline, simvastatin signiﬁcantly increased plasma leptin levels 
(35%, P=0.028), but pravastatin did not (1%, P=0.822). 
Conclusions: Despite causing comparable changes in lipoprotein and endothelium-
dependent dilation, simvastatin and pravastatin therapy had differential metabolic effects 
in hypercholesterolemic patients that may be clinically relevant.
3:30 p.m.
1022-103 Preintervention Eosinophil Cationic Protein Serum 
Levels Predict Clinical Outcome Following Implantation 
of Drug Eluting Stent
Giampaolo Niccoli, Flavia Belloni, Micaela Conte, Giuseppe Ferrante, Nicola Cosentino, 
Rocco A. Montone, Matia Martucci, Maurizio Pieroni, Vito Sabato, Domenico Schiavino, 
Giampiero Patriarca, Filippo Crea, Institute of Cardiology, Catholic University of the 
Sacred Heart, Rome, Italy, Institute of Allergology, Catholic University of the Sacred 
Heart, Rome, Rome, Italy
Aims: Eosinophils have been identiﬁed in post-mortem studies as important players of 
both restenosis and thrombosis after drug eluting stent (DES) implantation. We aimed at 
assessing the association between baseline levels of eosinophil cationic protein (ECP), a 
marker of eosinophil activation, and recurrence of clinical events in a consecutive series 
of patients who underwent DES implantation.
Methods and results: Two hundred patients (age 63±10.4, male sex 75%) undergoing 
implantation of ﬁrst generation DES (Taxus or Cypher stents) were enrolled. We 
measured serum levels of ECP and total IgE by ELISA and of C-reactive protein (CRP) 
by high sensitivity nephelometry prior to percutaneous coronary intervention. A clinical 
follow-up was planned 18 months after discharge. Major adverse cardiac events (MACEs) 
[cardiac death, recurrent myocardial infarction (MI) or clinically driven target lesion 
revascularization (TLR)] were the end-point of the study. Twenty-two patients (11%) had 
MACEs at follow-up (4 cardiac deaths, 1 non fatal MI and 17 TLR). Patients with MACEs 
had higher serum levels of ECP [30.5 (14.4-50) vs 12.2 (4.4-31) μg/l, p = 0.004] as 
compared to those who did not experienced MACEs, whereas both IgE and CRP levels 
were similar between patients with and those without MACEs (p=NS). At multivariable 
analysis, independent predictors of MACEs were: use of Taxus stent (HR 3.36, 95% CI 
1.2-9.4, p=0.02), longer stent length (HR 1.02, 95% CI 1.004-1.05, p=0.02), higher serum 
levels of ECP (HR 1.02, 95% CI 1.001-1.03, p=0.03).
Conclusions: This study shows for the ﬁrst time that ECP is an independent predictor of 
MACEs in patients undergoing implantation of DES. Further studies are warranted to establish 
whether in this setting ECP is a risk marker or play a contributory pathogenetic role.
3:30 p.m.
1022-104 Measurement of Segmental Coronary Thermal 
Heterogeneity: New Insights in the Detection of High 
Risk Plaques
Maria Drakopoulou, Konstantinos Toutouzas, Andreas Synetos, Eleftherios Tsiamis, 
John Karampelas, Maria Riga, Costas Tsiouﬁs, Elli Stefanadi, Dimitrios Tousoulis, 
Christodoulos Stefanadis, First Department of Cardiology, Hippokration Hospital, 
Athens, Greece
Background: Several methods have been applied for the functional assessment of 
atheromatic plaques. In intermediate lesions the temperature may be underestimated. 
We measured the heat energy (Q) produced at the culprit coronary arterial segments in 
patients with coronary artery disease.
Methods: We enrolled 41 patients with stable angina (SA) and 23 with acute coronary 
syndromes (ACS). The region of interest (ROI) was designated as 5mm proximally (T1) 
to 5mm distally (T2) to the culprit lesion. According to the ﬁrst law of thermodynamics Q 
is calculated with the formula: Q = Cp x mass x change in blood temperature between T2 
and T1 ($T). Cp is a constant and mass is calculated with the formula: mass = 1060 kg/
m3 x velocity x Area at point T1 (Area, measured by quantitative coronary angiography). 
A ﬂow wire was advanced to the ROI and blood velocity was measured at T1. A highly 
sensitive wire (Radi Medical Systems) was used for $4 measurements. We then 
calculated Q in kWatt.
Results:There were no differences in angiographic characteristics, mean velocity and 
area between the two groups. Mean $T (distal-proximal) was 0.03±0.04ºC. $T was higher 
ACS compared to SA (0.07±0.06 vs 0.01±0.03ºC p<0.01). Mean Q was 0.31±0.44 kWatt. 
Mean Q was higher in patients with ACS compared to patients with SA (0.67±0.45 vs 
0.10±0.27 kWatt, p=0.03).
Conclusions: The present study introduces a new method for functional assessment 
of coronary arterial segments. Heat energy is increased in culprit arterial segments in 
patients with ACS 
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1022-107 The Optimal Antithrombotic Therapy for Patients With 
Atrial Fibrillation Undergoing Percutaneous Coronary 
Intervention With Stenting
Yusuke Iwasaki, Masatake Fukunami, Takahisa Yamada, Yuji Okuyama, Takasi Morita, 
Shoji Sanada, Yoshio Furukawa, Masaharu Masuda, Taku Yasui, Hiromichi Ueda, 
Takeshi Okada, Masato Kawasaki, Osaka general medical center, Osaka, Japan
Backgruond: It has been known that dual antiplatelet therapy (aspirin and ticlopidine 
hydrochloride) prevents stent thrombosis in patients undergoing percutaneous coronary 
intervention (PCI). Anticoagulant therapy (warfarin) reduces cerebral infarction in patients 
with atrial ﬁbrillation (AF). However, there is little information on the optimal antithrombotic 
therapy for patients with AF who underwent PCI with stenting.
Methods and Results: We followed up 83 patients (79.5% men, mean age 70.6±9.0) with 
AF undergoing PCI with stenting between 2003 and 2007. We recorded thromboembolism, 
all bleeding events, and cardiac events (death, acute myocardial infarction, target lesion 
revascularization, cardiac failure) during the follow up period of 956±512days in patients 
with or without anticoagulant therapy. Anticoagulant and antiplatelet therapy (warfarin, 
aspirin and/or ticlopidine hydrochloride) were used in 58 patients (69.9%), whereas 
antiplatelet therapy only was used in 25 patients (30.1%). There were no signiﬁcant 
differences in baseline clinical characteristic and stroke risk factors between patients 
with and without anticoagulant therapy. Kaplan-Meier analysis revealed that patients with 
anticoagulation therapy had a signiﬁcantly lower risk of thromboembolism events (3.4% 
vs. 20%; risk ratio = 6.15; [95% CI: 1.28 to 29.1]; p=0.01). On the other hand, there was 
no signiﬁcant difference in incident of all bleeding event and cardiac event between with 
and without anticoagulant therapy.
Conclusion: Anticoagulant therapy together with antiplatelet therapy would prevent 
thromboembolic events in patients with AF undergoing PCI with stenting, without the 
increasing risk of bleeding episodes and mortality.
3:30 p.m.
1022-108 Does Clopidogrel Suppress Vascular Inﬂammation 
Marked by C-Reactive Protein in Patients With Stable 
Coronary Artery Disease? Primary Results of a 
Randomized, Double-Blind, Prospective Trial: CATER
Joseph B. Muhlestein, Robert R. Pearson, Benjamin D. Horne, Heidi T. May, Peter K. 
Kennedy, T.J. Barnett, Jeffrey L. Anderson, Intermountain Medical Center, Murray, UT, 
University of Utah, Salt Lake City, UT
Background: Coronary artery disease (CAD) involves inﬂammatory and thrombotic 
mechanisms. Several agents that reduce CAD-related risk also reduce C-reactive protein 
(CRP). Several studies have linked platelet activation with inﬂammation, and platelet 
inhibition has been shown to inhibit the rise of CRP during acute coronary syndrome. 
However, whether platelet inhibition in CAD is associated with suppression of inﬂammation 
in stable patients is not known. Clopidogrel is an effective antiplatelet agent with a distinct 
mechanism of action. To determine its effect on CRP in patients with stable CAD, we 
performed a double-blind, randomized trial (CATER).
Methods: Consenting patients (N=109) with angiographic stable CAD on chronic doses of 
aspirin (325 mg/d) and statin therapy at baseline were randomized to clopidogrel (C) (75 
mg/d) or matching placebo (PL). High-sensitivity (hs) CRP (mg/L) was measured by the 
Immulite 2000 assay at baseline, 8, and 12 weeks. The primary endpoint was the change in 
hsCRP. The study was powered at 80% to detect a 25% reduction in hsCRP with SD of 2.0. 
Patients (N= 6) with hsCRP >10 were excluded. Intention-to-treat analyses were performed 
with the last-observation-carried-forward approach applied for missing data.
Results: Patients (N=84) averaged 69 years and 82% were male. Demographics did not 
differ between arms (all p>0.23). Baseline median levels of hsCRP were: C=1.3 (IQR: 
0.80 - 1.9) and PL=1.1 (IQR: 0.4 - 1.8) (p=0.34). At study completion, hsCRP levels were: 
C=1.2 (IQR: 0.6 -2.1) and PL=1.2 (IQR: 0.5 - 2.4) (p=0.87). Change scores for hsCRP 
were C=+0.07 (SD=2.5) and PL=+0.18 (SD=1.45), which were not signiﬁcantly different 
(p=0.79). During follow-up, no serious drug-related adverse events occurred.
Conclusion: The CATER study demonstrates that the addition of clopidogrel does not 
affect CRP levels in patients with stable CAD. Although platelet inhibition has been 
shown to prevent the rise of CRP in patients with acute coronary syndromes, this effect 
is not apparent during chronic therapy. This implies that an anti-inﬂammatory effect of 
platelet inhibition is most likely evident in circumstances associated with ongoing platelet 
activation.
3:30 p.m.
1022-109 Key Role of Low HDL Cholesterol for the Association of 
the Metabolic Syndrome With Inﬂammation in Coronary 
Patients
Philipp Rein, Christoph H. Saely, Stefan Beer, Alexander Vonbank, Magdalena Woess, 
Christian Boehnel, Vlado Jankovic, Heinz Drexel, Vorarlberg Institute for Vascular 
Investigation and Treatment (VIVIT), Feldkirch, Austria, Private University in the 
Principality of Liechtenstein, Triesen, Austria
Background: The association of the metabolic syndrome (MetS) and of the individual 
MetS stigmata with inﬂammation in patients with established coronary artery disease 
(CAD) has not been investigated yet.
Methods: We enrolled 759 consecutive patients with angiographically proven stable 
CAD. According to National Cholesterol Education Programme Adult Treatment Panel 
III criteria, the MetS was deﬁned in the presence of at least 3 out of the 5 quantitatively 
deﬁned criteria large waist circumference, low HDL cholesterol, high triglycerides, high 
3:30 p.m.
1022-105 General Measures of Central Obesity Are More Strongly 
Associated With Coronary Calcium Than More Direct 
Measures of Visceral Adiposity
John S. Ho, Shannon J. FitzGerald, Carolyn E. Barlow, William L. Haskell, Harold W. 
Kohl, III, John J. Cannaday, Cooper Clinic, Dallas, TX, The Cooper Institute, Dallas, TX
Background: Central obesity is a well-established risk factor for coronary heart disease. 
However, it is unclear whether the visceral component of central obesity is largely 
responsible for this increased risk. We thus investigated the association of various obesity 
parameters with coronary artery calcium (CAC), a surrogate for total atherosclerotic 
burden. Methods: In this study, 1044 men underwent Agatston CAC scoring and 
concomitant abdominal computed tomography (CT) scans. Cardiovascular disease (CVD) 
risk factors, body mass index (BMI) calculations, and abdominal girths were collected in 
all participants. Total fat (TFAT), visceral fat (VFAT), and subcutaneous fat (SFAT) areas 
were also quantiﬁed at the level of the umbilicus by standard CT techniques. An analysis 
relating the possible association of these various obesity parameters, comparing men with 
a CAC score a 10 to men with a CAC score > 10, was performed. Results: Participants 
with a CAC score > 10 exhibited a larger abdominal girth (97±12 vs 95±12 cm, p<0.001), 
a larger TFAT area (434 (339, 559) vs 413 (315,520) cm2, p=0.005), and a larger VFAT 
area (200 (143,256) vs 175 (123,224) cm2, p<0.001), than those with a CAC score a
10. Those with a CAC > 10 tended to also have a greater BMI and a larger SFAT area, 
although both of these measures did not achieve statistical signiﬁcance. After adjusting 
for traditional CVD risk factors, however, only a large abdominal girth > 102 cm (OR: 
1.4; 95% CI: 1.03, 2.03) and a TFAT area in the highest quartile (OR: 1.5; 95% CI: 1.06, 
2.1) remained signiﬁcantly associated with a CAC score > 10. Measures incorporating 
a more direct assessment of visceral fat were no longer signiﬁcant after adjustment for 
CVD risk factors. Conclusions: General measures of central obesity (i.e. abdominal 
girth or the TFAT area at the level of the umbilicus) were more strongly associated with 
CAC than either parameters assessing overall obesity (i.e. BMI) or other more direct 
measures of visceral adiposity (i.e. VFAT). These ﬁndings suggest that the total amount of 
central obesity is more important in the development of coronary calcium than the relative 
distribution of visceral vs subcutaneous fat.
3:30 p.m.
1022-106 Modulation of Bone Marrow Progenitor Cell Mediated 
Endothelial Repair by VEGF Modiﬁes Neointima 
Formation After Arterial Injury
Walter S. Speidl, Randolph Hutter, Valentin Fuster, Juan J. Badimon, Mount Sinai School 
of Medicine, New York, Medical University of Vienna, Vienna, Austria
Background: The rate of reendothelialization is critical in neointima formation after 
arterial injury. We wanted to test whether modulation of bone marrow derived progenitor 
cells (BMPC) by VEGF and the VEGF antagonist VEGF-trap modiﬁes BMPC mediated 
endothelial repair and neointima formation in a mouse model of arterial injury.
Methods and Results: C57BL/6 wild-type mice were lethally irradiated and transplanted 
with bone marrow cells from mice expressing enhanced green ﬂuorescent protein 
(eGFP). Six weeks after bone marrow transplantation, three groups underwent denuding 
endothelial injury one day after systemic injection of recombinant adenovirus expressing 
VEGF, VEGF-trap, or control adenovirus. Overexpression of VEGF increased the number 
of circulating Lin-/sca-1+ BMPC in peripheral blood (p<0.05) and resulted in accelerated 
re-endothelialization as determined by vWF-staining (VEGF vs. control: 76±8% vs 60±13%; 
p<0.05). Of note, most of the luminal endothelial cells detected at the neointimal surface 
in mice treated with VEGF were eGFP+ BMPC and expressed sca-1. (VEGF vs. control: 
45±6% vs. 12±4%; p<0.05). These endothelial-like cells were CD45 and c-kit negative. 
In contrast, overexpression of VEGF-trap resulted in impaired mobilization of Lin-/sca-1+ 
BMPC in peripheral blood and resulted in impaired reendothelialization (VEGF-trap vs. 
control: 25±5% vs. 60±13%; p<0.05). BMPC mediated endothelial repair was completely 
inhibited by VEGF-trap overexpression (VEGF-trap vs. control: 1±1% vs. 12±4%; p<0.05). 
Accelerated endothelial repair was associated with decreased neointima formation (VEGF 
vs. control vs. VEGF-trap 2.5±1.5x10-3 vs. 7.5±2.6x10-3 vs. 17.3±7x10-3 mm2, P<0.01).
Conclusions: This study shows for the ﬁrst time that VEGF not only modulates 
downstream EPC but also modulates upstream immature lin- BMPC that participate 
in luminal endothelial repair after arterial injury. Early lin- BMPC appear to be critical 
regulators of the degree of neointima formation in injured arteries warranting further 
studies also in other animal models and in man to corroborate this observation.
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1022-112 Effect of Long-Term Treatment With Continuous 
Positive Airway Pressure on Pulse Wave Velocity, 
Hypertension and Obesity in Obstructive Sleep Apnea 
With Metabolic Syndrome
Tsunenori Saito, Tsunehiro Saito, Shigeyuki Sugiyama, Kyoichi Mizuno, Nippon Medical 
School, Tokyo-to, Japan, Good Sleep Clinic, Tokyo-to, Japan
Background: Metabolic syndrome (MS) is a risk factor for atherosclerosis. Pulse wave 
velocity (PWV) reﬂects arterial stiffness, which indicates the degree of atherosclerosis. 
Continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA) patients 
helps to prevent progression of arterial stiffness. However, the effect of CPAP treatment 
on PWV and factors of MS in OSA patients have been little studied.
Methods: Eighty-eight Japanese men with severe OSA were treated with CPAP for 
2 years. MS was deﬁned using the National Cholesterol Education Program criteria 
especially modiﬁed using body mass indices (BMI: > 25 kg/m2) for Japanese subjects. 
The apnea-hypopnea index (AHI), Epworth sleepiness scale, CPAP pressure and blood 
chemistry data were evaluated at the baseline. BMI, percent body fat, heart rate HR) and 
systolic and diastolic pressure were measured at the start, and after 6, 12 and 24 months 
of CPAP therapy.
Results: Patients were divided into 2 groups: 67 MS patients (MS group) and 21 without 
MS (non-MS group). The MS group had a higher AHI (p < 0.05), CPAP pressure (p < 
0.025), body weight (p < 0.001), BMI (p < 0.001), percent body fat (p < 0.005), HR (p < 
0.05), systolic and diastolic pressure (p < 0.001 and 0.01, respectively), pulse pressure 
(p < 0.001), uric acid (p < 0.05), triglycerides (p < 0.001), fasting blood sugar (p < 0.001), 
and lower HDL cholesterol (p < <0.001) than the non-MS group at the baseline. After 
CPAP treatment, the non-MS group showed PWV progression (p = 0.034). However, in 
the MS group, PWV showed no worsening for 2 years. Body weight (p < 0.001), BMI (p 
< 0.001), percent body fat (p = 0.031), HR (p < 0.001), systolic and diastolic pressure 
(p = 0.013 and < 0.001, respectively) decreased signiﬁcantly with CPAP treatment. 
Multivariate regression analysis revealed that the independent predictors of PWV change 
after 24 months of CPAP treatment was presence of MS (p = 0.02).
Conclusions: In OSA patients with MS, CPAP therapy is effective not only for preventing 
the progression of arterial stiffness but also for improving obesity and blood pressure. 
CPAP therapy may thus be strongly recommended for OSA patients with MS.
3:30 p.m.
1022-113 AMPK Activation Blocks Interleukin-18-Mediated IKK/
NF- B/PTEN Activation and Endothelial Cell Death
Kaliyamurthi Venkatachalam, William H. Boylston, Steven R. Bailey, Bysani 
Chandrasekar, Department of Veterans Affairs South Texas Veterans Health Care 
System, San Antonio, TX, University of Texas Health Science Center, San Antonio, TX
Background: AMP activated protein kinase (AMPK) exerts potent antioxidant and anti-
apoptotic effects. Interleukin (IL)-18 is a pro-inﬂammatory and pro-apoptotic cytokine, and 
its circulating levels correlate inversely with the AMPK activator adiponectin in patients 
with coronary artery and cardiovascular diseases. Because of the opposing effects of IL-
18 and adiponectin on cell survival, we investigated whether AMPK activation blocks IL-
18-mediated endothelial cell death, and identiﬁed the underlying molecular mechanisms.
Methods: Primary human coronary artery endothelial cells (EC) were pre-treated with 
the AMPK activators adiponectin, AICAR, metformin, or fenoﬁbrate prior to IL-18 addition. 
Cell death was analyzed by MTT viability assay and DNA fragmentation; IKK activation 
by in vitro kinase assays; NF- B activation by gel shift, ELISA and reporter assays; 
PTEN expression by qRT-PCR and immunoblotting; Akt, APPL1, Bax, and caspase-3 
by immunoblotting; and PI3K activation by TLC of p85 immunoprecipitates. Downstream 
effectors were targeted by pharmacological inhibitors, adenoviral vectors, and siRNA-
mediated knockdown.
Results: Treatment with IL-18 suppressed Akt activity (blunted by Ad.dnAkt), induced IKK-
NF- B-dependent PTEN activation (attenuated by Ad.dnIKKB, Ad.dnI BA, Ad.ciPTEN), 
and promoted endothelial cell death (blocked by IL-18BP-Fc chimera). Pretreatment 
with adiponectin induced PI3K activation (blocked by Ad.dnPI3Kp85), APPL1-dependent 
AMPK activation (attenuated by APPL1 knockdown, Ad.kdAMPK, Ad.dnAMPK, AMPKA1
knockdown), reversed Akt suppression, blocked IKK-NF- B-PTEN signaling, reduced 
caspase-3 activation (attenuated Z-DEVD-FMK), and inhibited EC death (blocked 
by compound C). The pro-survival effects of adiponectin were recapitulated by the 
pharmacological AMPK activator AICAR. Metformin and fenoﬁbrate also blunted IL-18-
induced EC death via AMPK activation.
Conclusions: Collectively, these results demonstrate that activation of AMPK can 
reverse IL-18-mediated endothelial cell death, and that AMPK activators have therapeutic 
potential for reducing IL-18-dependent vascular injury.
3:30 p.m.
1022-114 The Oral Factor Xa Inhibitor DU-176b in Japanese 
Warfarin-Naive Patients With Atrial Fibrillation: Results 
of Two Phase II Open-Label, Dose-Escalation Studies
Yukihiro Koretsune, Hiroshi Inoue, Yohko Kawai, Shinichiro Uchiyama, Takenori 
Yamaguchi, Osaka National Hospital, Osaka, Japan, University of Toyama, Toyama, Japan
Background. The oral, direct factor Xa inhibitor DU-176b is in development for stroke 
prevention in patients with nonvalvular atrial ﬁbrillation (AF). Clinical efﬁcacy, safety, 
pharmacokinetic, pharmacodynamic (PD) and biomarkers of ascending doses of DU-
176b were investigated in two phase II trials.
Methods. Warfarin-naive AF patients with low risk were enrolled in Japan. In the low 
blood pressure, and elevated fasting glucose.
Results: In univariate analyses, hsCRP was higher in patients with the MetS (n = 339) 
than in those who did not have the MetS (0.48 ± 0.66 vs. 0.41 ± 0.78 mg/dl; p <0.001), and 
also was higher in patients who fulﬁlled the large waist (0.48 ± 0.67 vs. 0.39 ± 0.80 mg/
dl; p <0.001) and the low HDL (0.71 ± 1.16 vs. 0.37 ± 0.59 mg/dl; p <0.001) criteria than 
in those who did not. Importantly however, after adjustment for age, gender, smoking and 
LDL cholesterol by means of analysis of covariance only the low HDL cholesterol criterion 
(F = 21.99; p <0.001) remained signiﬁcantly associated with hsCRP. The signiﬁcant 
and independent association of low HDL with hsCRP was conﬁrmed after additional 
adjustment for all other MetS traits (F = 23.59; p <0.001).
Conclusion: We conclude that among patients with angiographically proven stable CAD, 
low HDL cholesterol drives the association between the MetS and subclinical inﬂammation. 
This observation is well in line with the paramount role of low HDL cholesterol as a marker 
of cardiovascular risk in this important patient population.
3:30 p.m.
1022-110 The Oral Direct Thrombin Inhibitor AZD0837 for the 
Prevention of Stroke and Systemic Embolism in 
Patients With Atrial Fibrillation: A Phase II Randomized 
Dose-Guiding, Safety and Tolerability Study
Gregory Y. Lip, Lars H. Rasmussen, Bertil Olsson, Anders Persson, Ulf Eriksson, 
Eva Jensen, Karin Wåhlander, University Department of Medicine, City Hospital, 
Birmingham, United Kingdom
Background: Oral anticoagulation with vitamin K antagonists (VKA) for stroke 
prevention in atrial ﬁbrillation (AF) is effective but has limitations. AZD0837 is a new oral 
anticoagulant, which is converted to a selective and reversible direct thrombin inhibitor. 
The safety, tolerability and pharmacodynamics of an extended-release formulation of 
AZD0837 in AF patients was assessed in a Phase II randomized, controlled, parallel, 
dose-guiding study (NCT00684307).
Methods: 955 AF patients with q1 additional risk factor for stroke were randomized to 
receive 1 of 4 doses of AZD0837 (150, 300 or 450 mg od or 200 mg bid, blinded treatment) 
or VKA (INR 2-3, open treatment) for 3-9 months. Approximately 30% of patients were 
VKA-naive. Fibrin D-dimer was measured as an index of thrombogenesis in AF.
Results: Total bleeding events were similar or less in all AZD0837 groups (5.3%-14.7%, 
mean exposure 141-145 days) compared with VKA (14.5%, mean exposure 161 days). 
Clinically relevant bleeding events (i.e. major + clinically relevant minor bleeding) in 
the whole cohort and the VKA-naive subgroup were numerically less common in the 
AZD0837 150 mg od and 300 mg od groups vs the AZD0837 450 mg od and 200 mg bid 
groups and VKA.
In VKA-naive subjects, D-dimer levels decreased in all treatment groups with median 
reductions comparable to VKA seen in the 300 mg od, 450 mg od and 200 mg bid treatment 
groups. D-dimer levels in the VKA pre-treated patients started low and remained low following 
treatment with AZD0837 or VKA. Few strokes and systemic embolic events occurred (3 of 
164 patients on AZD0837 150 mg od and 1 of 318 VKA patients).The proportion of patients 
with any adverse event (AE) was similar between the four AZD0837 doses and VKA. The 
most common AEs with AZD0837 were gastrointestinal disorders (eg. diarrhea, ﬂatulence 
or nausea). In the AZD0837 groups, mean S-creatinine increased by ~10% vs. baseline and 
returned to baseline following treatment cessation. A similar frequency of serum alanine 
aminotransferase (ALT) >3xULN was seen with AZD0837 vs VKA.
Conclusions: AZD0837 doses that resulted in similar suppression of thrombogenesis as 
well-controlled VKA were well tolerated, with a similar or lower bleeding rate than VKA.
3:30 p.m.
1022-111 Is It Possible to Predict Coronary Artery Stenosis 
Based on Carotid Artery Intima Media Thickness in 
Diabetic Patients?
Yun Seok Choi, Ho-Joong Youn, Woo-Sung Chung, Chul-Soo Park, Woo-Baek Chung, 
Jeong-Whan Park, Su-Sung Oh, Yong-Seog Oh, Kie-Bae Seung, The Catholic University 
of Korea, Seoul, South Korea
Background:Noninvasive measurement of carotid artery intima media thickness (IMT) 
has been widely used as a surrogate marker of coronary atherosclerosis. However, 
evidence for the clinical implications of increased carotid IMT in diabetic patients is not 
well established.The aim of this study was to determine if coronary artery disease (CAD) 
can be predicted based on carotid IMT, intimal, and medial thickness
Methods: A total of 569 type 2 diabetic patients (male:female=311:258, mean age=63±9 
years) who underwent coronary angiography were divided into two groups. Group 1 was 
composed of patients with no signiﬁcant CAD (n=105, male%=37.1%, mean age=61±10 
years) on angiography. Group 2 was composed of patients with signiﬁcant CAD (n=464. 
male%=58.6%, mean age=64±9 years). Signiﬁcant stenosis was deﬁned as over 70% 
stensosis in diameter at more than one vessel. Carotid intimal, medial thickness, and 
IMT were compared between the two groups. Sensitivity and speciﬁcity for detecting 
signiﬁcant CAD by carotid ultrasound were evaluated.
Results:There were signiﬁcant differences in the right maximal IMT, mean IMT, and 
medial thickness for both carotid arteries. However, there were no signiﬁcant differences 
in the left maximal IMT and intimal thickness (Table). A right IMT of 1.13 mm and a left 
IMT of 1.19 mm had 94% sensitivity and 80% speciﬁcity for CAD, respectively. A right 
medial thickness of 0.99 mm and a left medial thickness of 1.03 mm had 100% sensitivity 
and 86% speciﬁcity.
Conclusions: Carotid medial thickness and IMT were useful as screening methods for 
detecting signiﬁcant CAD in patients with diabetes.
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in the abacavir-treated patients than those not on abacavir (2.8% vs. 4.9%, p=0.01). After 
adjustment for traditional risk factors, HIV speciﬁc factors, and baseline brachial artery 
diameter, current abacavir use was independently associated with lower FMD (p=0.017). 
Duration of ART and CD4 count were not associated with reduced FMD.
Conclusions: Endothelial function, a central mechanism in atherosclerosis and a marker 
of cardiovascular risk, is impaired among ART-treated HIV patients with undetectable viral 
loads. Current use of abacavir was independently associated with impaired endothelial 
function. This ﬁnding suggests that abnormal endothelial function may underlie the 
clinically observed increased risk in myocardial infarction among abacavir-treated 
patients. Further studies will need to determine the mechanisms by which abacavir 
impairs endothelial function in HIV patients to reduce this risk for atherosclerosis.
3:30 p.m.
1022-116 Mediterranean Diet Improves Endothelial Function in 
Individuals With Abdominal Obesity
Loukianos S. Rallidis, John Lekakis, Georgia Vamvakou, Anastasia Kolomvotsou, 
Stamatis Efstathiou, Vassilis Sourides, Antonios Zampelas, Dimitrios T. Kremastinos, 
University General Hospital Attikon, Athens, Greece
Background: Abdominal obesity is associated with increased risk for cardiovascular 
disease and diabetes mellitus. We examined the effect of a Mediterranean-style diet on 
endothelial function in individuals with abdominal obesity.
Methods: We recruited 88 subjects with abdominal obesity (waist circumference >102 
cm for men and >88 cm for women) without cardiovascular disease or diabetes mellitus. 
Subjects were randomly allocated in two groups (intervention and control group). Subjects 
in the intervention group (n=44) were instructed to follow a Mediterranean-style diet for 2 
months consisting of 2-3 portions of low - fat dairy products, 2 salads daily, at least 3 fruits 
and they were also supplied with a concentrated fruit juice, an olive oil-based margarine, 
virgin olive oil, and red wine which were to be consumed according to instructions by 
a dietician. Individuals in the control group (n=44) followed a prudent diet according to 
ATPIII guidelines. Flow-mediated dilatation (FMD) of the brachial artery, lipid proﬁle and 
insulin resistance (assessed with the homeostasis model assessment [HOMA]) were 
measured at the beginning and after the completion of the study.
Results: Individuals who received Mediterranean-style diet had a signiﬁcant increase in 
FMD compared with baseline values (4.2±3.3% vs. 6.1±3.3%, p=0.009) while there was 
no change in the control group (4.7±3.7% vs. 4.4±3.9%, p=NS). HOMA was also reduced 
signiﬁcantly in individuals on the Mediterranean-style diet (3.8±2.7 vs. 2.9±1.7, p=0.004) 
while there was no change in the control group (3.4±1.6 vs. 3.7±2.2, p=NS). There was 
an inverse correlation between changes in FMD and changes in HOMA (r=-0.25, p=0.03). 
Linear regression for repeated measurements with dependent variable changes in FMD and 
independent variables type of intervention, sex, age and changes in body weight showed 
that Mediterranean-style diet independently affected FMD (b coefﬁcient=-0.28, p=0.01).
Conclusion: Mediterranean-style diet improves endothelial function in individuals with 
abdominal obesity. This could probably, at least partly, explain the beneﬁcial effect of 
Mediterranean-style diet on cardiovascular system.
3:30 p.m.
1022-117 An Apo(a) Variant Affects Platelet Response to Collagen 
Stimulation in the Johns Hopkins Sibling and Family 
Heart Study
Dov Shiffman, Lewis C. Becker, Charles M. Rowland, Judy Z. Louie, Robert J. Lagier, 
Lisa R. Yanek, Daniel I. Chasman, Paul M. Ridker, James J. Devlin, Diane M. Becker, 
Celera, Alameda, CA
Background: Apo(a), a protein component of Lp(a), is encoded by the LPA gene. Carriers 
of the 4399Met allele of rs3798220 in LPA have increased risk of cardiovascular disease 
(CVD). In the Women’s Health Study, a randomized trial of low dose aspirin in women 
aged 45 or older, carriers of the 4399Met allele had over 2 fold increased risk of CVD in 
the placebo group, but this risk was eliminated by aspirin treatment. Therefore, we asked if 
this LPA variant is associated with platelet aggregation before or after aspirin treatment.
Methods: Subjects were healthy siblings of probands with premature coronary disease. 
We measured platelet aggregation in response to collagen before and after 2 weeks of 
aspirin treatment (81mg/day). We assessed differences in platelet aggregation between 
carriers and noncarriers of the 4399Met allele adjusted for age, sex, race, and non-
independence of families.
Results: High dose collagen stimulation (10 and 20ug/ml) before aspirin treatment 
resulted in greater platelet aggregation among carriers of the 4399Met allele (N=27) than 
among noncarriers (N=734). Stimulation with 10ug/ml collagen resulted in 92% median 
aggregation among carriers and 88% among non carriers (P=0.02). Median aggregation 
responses were also consistently higher in carriers vs. noncarriers among both European 
American (92% vs. 88%, P=0.06), African Americans (94% vs. 89%, P=0.19), those with 
low (<40mg/dL) plasma Lp(a) (94.5% vs. 90%, P=0.047), or high plasma Lp(a) (94% vs. 
88%, P=0.08). After aspirin treatment, aggregation was lower among carriers than among 
noncarriers (50% vs. 55%, P=0.12).
Conclusion: Greater platelet aggregation in carriers of the 4399Met allele and its 
reversal by aspirin treatment is consistent with CVD event reduction by aspirin observed 
among carriers in the Women’s Health Study. The greater aggregation among carriers in 
response to stimulation by collagen, a major player in arterial thrombosis following plaque 
rupture, is independent of plasma Lp(a) level, suggesting a functional role for the 4399Met 
substitution in the LPA gene.
dose trial (N=24), DU-176b was titrated at 2 week intervals from 5 mg qd, to 15 mg 
qd, then 30 mg qd. In the high dose trial, patients received 30 mg bid for 2 weeks, 45 
mg bid for 4 weeks, then 60 mg bid for 4 weeks (N=32). Clinical efﬁcacy endpoint was 
incidence of thromboembolic events. Safety endpoints were adverse events and bleeding 
incidences. Pharmacokinetics were assessed by plasma concentration of analyte DU-
176. PD indices included prothrombin time, INR, activated partial thromboplastin time, 
anti-factor Xa activity and biomarkers included D-dimer, thrombin-antithrombin complex 
(TAT), prothrombin F1+2, soluble ﬁbrin monomer complex (SFMC) and plasmin-A2-plasmin
inhibitor complex (PIC).
Results. The effects of DU-176b on efﬁcacy, safety, PD and biomarkers are shown in 
the Table. There was a linear relationship between plasma concentration of DU-176 and 
PD indices. Decreases in D-dimer, TAT and F1+2 were observed in DU-176b from 5 mg 
qd to 60 mg bid.
Conclusions. DU-176b at doses up to 60 mg bid was tolerated and efﬁcacious when 
administered for up to 4 weeks to Japanese warfarin-naive AF patients. 
Low Dose Study High Dose Study
5 mg 
qd
n=24
15 mg 
qd
n=23
30 mg 
qd
n=23
30 mg 
bid
n=32
45 mg 
bid
n=29
60 mg 
bid
n=26
Efﬁcacy and Safety
Thromboembolic Event 0 0 0 0 0 0
Major Bleeding 0 0 0 0 0 0
Clinically Relevant Non-Major 
Bleeding, n (%) 0 0 0 1 (3.1) 1 (3.4) 1 (3.8)
Minor Bleeding, n (%) 0 0 3 (13.0) 6 (18.8) 5 (17.2) 6 (23.1)
PD Parameters, mean ± SD
Prothrombin time, sec
trough 11.8 ± 0.7
12.5 ± 
3.1
12.3 ± 
1.1*
13.4 ± 
1.3*
14.0 ± 
1.2*
15.0 ± 
2.1*
post-
dose1
12.5 ± 
1.2*
13.8 ± 
2.4*
16.0 ± 
3.5*
16.6 ± 
3.1*
21.0 ± 
12.9*
24.3 ± 
12.7*
INR
trough 1.1 ± 0.1
1.3 ± 
0.6
1.2 ± 
0.2*
1.4 ± 
0.2*
1.5 ± 
0.2*
1.7 ± 
0.4*
post-
dose1
1.3 ± 
0.2*
1.5 ± 
0.5*
1.9 ± 
0.7*
2.0 ± 
0.6*
2.4 ± 
0.8*
3.1 ± 
1.0*
Activated partial 
thromboplastin time, sec
trough 29.6 ± 2.4
30.0 ± 
3.4
31.1 ± 
3.2*
33.8 ± 
4.7*
34.1 ± 
3.8*
35.7 ± 
4.6*
post-
dose1
30.8 ± 
2.1*
32.8 ± 
3.1*
37.0 ± 
5.9*
37.9 ± 
5.5*
40.1 ± 
5.8*
43.7 ± 
6.5*
Anti-FXa, IU/mL
trough 0.10 ± 0.00
0.11 ± 
0.02
0.27 ± 
0.60
0.76 ± 
0.46*
1.14 ± 
0.39*
1.65 ± 
0.70*
post-
dose1
0.30 ± 
0.18*
0.88 ± 
0.60*
2.08 ± 
1.58*
2.33 ± 
1.71*
3.04 ± 
1.63*
4.86 ± 
2.19*
Biomarkers, mean ± SD
D-dimer, μg/mL
trough 0.34 ± 0.18*
0.30 ± 
0.14*
0.28 ± 
0.17*
0.24 ± 
0.24*
0.25 ± 
0.25*
0.24 ± 
0.27*
post-
dose1
0.33 ± 
0.17*
0.31 ± 
0.15*
0.30 ± 
0.17*
0.23 ± 
0.21*
0.22 ± 
0.20*
0.22 ± 
0.20*
TAT, ng/mL
trough 2.1 ± 0.8*
2.7 ± 
3.8
1.4 ± 
0.5*
1.4 ± 
0.5
1.3 ± 
0.3*
1.3 ± 
0.4
post-
dose1
1.9 ± 
0.7*
1.4 ± 
0.5*
1.4 ± 
0.8*
1.2 ± 
0.2
1.5 ± 
1.3
1.3 ± 
0.5
F1+2, pmol/L
trough 218 ± 96
188 ± 
87*
161 ± 
50*
135 ± 
42*
122 ± 
47*
121 ± 
53*
post-
dose1
194 ± 
85*
158 ± 
78*
159 ± 
47*
138 ± 
76*
115 ± 
48*
125 ± 
68*
SFMC μg/mL
trough 3.0 ± 0.0
3.6 ± 
1.9
3.0 ± 
0.0
3.0 ± 
0.0
3.0 ± 
0.0
3.0 ± 
0.0
post-
dose1
3.0 ± 
0.0
3.0 ± 
0.0
3.0 ± 
0.0
3.0 ± 
0.1
3.0 ± 
0.0
3.0 ± 
0.0
PIC, μg/mL
trough 0.5 ± 0.2
0.6 ± 
0.3
0.6 ± 
0.2
0.6 ± 
0.3*
0.5 ± 
0.3
0.5 ± 
0.3*
post-
dose1
0.6 ± 
0.2
0.6 ± 
0.2
0.7 ± 
0.4
0.6 ± 
0.3*
0.6 ± 
0.3
0.5 ± 
0.2*
*P <0.05 to baseline. 1Post-dose values are 1 to 3 hours after drug administration.
3:30 p.m.
1022-115 Association of Abacavir With Impaired Endothelial 
Function Among Treated HIV Patients
Priscilla Y. Hsue, Steven G. Deeks, Yuaner Wu, Amanda Schnell, Peter W. Hunt, Hiroyu 
Hatano, Jeffrey N. Martin, Peter Ganz, University of California, San Francisco, San 
Francisco, CA, San Francisco General Hospital, San Francisco, CA
Background: HIV patients have accelerated atherosclerosis which may be due to HIV 
infection, HIV medication, and/or traditional risk factors. Recently, abacavir, a commonly 
used nucleoside analog reverse transcriptase inhibitor, has been associated with increased 
risk of cardiovascular events, for reasons that remain to be elucidated. As endothelial 
dysfunction is central to the pathogenesis of atherosclerosis, we tested the hypothesis that 
current treatment with abacavir is associated with impaired endothelial function.
Methods: We studied a cohort of 61 antiretrovirally-treated (ART) patients who had 
undetectable plasma HIV RNA levels in whom abacavir was currently part of the treatment 
in half of the patients (n=30, 49%). Endothelial function was assessed as ﬂow-mediated 
vasodilation (FMD) of the brachial artery. We compared FMD in patients treated with vs. 
without abacavir, while adjusting for traditional risk factors and HIV-speciﬁc characteristics 
including CD4 count and duration of exposure to ART.
Results: The median age was 50 years (IQR 45-57). The median duration of HIV infection 
was 18 years, and the median CD4 cell count was 369 cells/mm3. Overall, the median 
FMD in the HIV patients was impaired (3.5%; IQR 2.3-5.6%). The FMD was more impaired 
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nitroxidative stress in animals with hypertension. The effect of clopidogrel on platelet NOS 
function was independent of ADP-induced platelet activation. These ﬁndings suggest a 
novel antiplatelet mechanism by which clopidogrel may regulate thrombosis formation 
under conditions of cardiovascular risk.
3:30 p.m.
1022-121 Visfatin Upregulates eNOS and Improves Endothelial 
Cell Function and Angiogenesis via the PI3 Kinase/Akt 
Pathway: A Novel Vasculoprotective Target
Fina Lovren, Yi Pan, Rishie Seth, Praphulla C. Shukla, Adrian Quan, Hwee Teoh, Mark 
D. Peterson, Mohammed Al-Omran, Lee Errett, Subodh Verma, St. Michael’s Hospital, 
Toronto, Canada, King Saud University, Riyadh, Saudi Arabia
Background: Improving eNOS bioactivity and endothelial function is an important target 
to limit native, vein graft and transplant atherosclerosis. Visfatin is a NAD biosynthetic 
enzyme regulating the activity of the cellular survival factor, Sirt1. We hypothesized that 
visfatin may improve eNOS expression, endothelial function and post-natal angiogenesis 
through the PI3/Akt-kinase pathway.
Methods: In human umbilical vein (HUVEC) and coronary artery endothelial cells, we 
evaluated the effects of recombinant human visfatin on eNOS protein and transcript 
expression, and mRNA stability, in the presence and absence of L-NAME and visfatin 
siRNA silencing. We also assessed visfatin-induced total Akt and Ser473-phospho-Akt
expression, and phosphorylation of Ser1177 within eNOS, in the presence and absence of 
PI3-kinase inhibition with LY294002. Finally, we evaluated the impact of visfatin on HUVEC 
migration, proliferation, inﬂammation-induced permeability and in-vivo angiogenesis.
Results: Visfatin (100 ng/ml) upregulated eNOS mRNA and stabilized eNOS mRNA. 
Visfatin-treated HUVEC demonstrated greater proliferation, migration, and capillary-
like tube formation but less TNFA-induced permeability; these effects were abolished in 
visfatin gene silenced cells. Visfatin increased total Akt and Ser473-phospho-Aktexpression 
with concomitant rises in eNOS phosphorylation at Ser1177; these effects were blocked by 
LY2940002. Visfatin matrigel implants showed an elevated number of inﬁltrating vessels, 
and signiﬁcant recovery of limb perfusion following hindlimb ischemia.
Conclusions: We report a novel effect of visfatin to modulate eNOS expression and 
function in endothelial cells, via the PI3-kinase/Akt pathway. Visfatin represents a novel 
target to limit endothelial dysfunction, native, vein graft and transplant atherosclerosis, 
and improve post-natal angiogenesis.
3:30 p.m.
1022-122 The Experience of Endothelial Progenitor Cell 
Capturing Aptamer for Coating of Intracoronary Stent
Youngkeun Ahn, Doosun Sim, Jin Sook Kwon, Yong Sook Kim, Hae Chang Chung, 
Young Joon Hong, Ju Han Kim, Hyung Wook Park, Myung Ho Jeong, Jeong Gwan Cho, 
Jong Chun Park, Jung Chaee Kang, Chonnam National University Hospital, Gwangju, 
South Korea
Background: One of the suggested mechanisms for stent thrombosis in drug-eluting 
stent is delayed re-endothelialization. Aptamers, capture molecules (oligonucleotides) 
for endothelial progenitor cells (EPCs), are able to recognize circulating EPCs and to 
bind them. Coating of bare-metal cobalt chromium stents with aminoparylene as a carrier 
substance and aptamer as an EPC-capturing oligonucleotide would be effective in the 
prevention of in-stent restenosis without increasing thrombus.
Methods: To evaluate effects of aptamer-coated stents, six 20 kg-Yorkshire pigs were 
utilized. Three different intracoronary stents were implanted in the three epicardial 
coronary arteries [(1: cobalt-chromium (CC), 2: TAXUS (TA), 3: aminoparylene and 
aptamer-coated stent (AA)] in a random fashion at 8 to 10 atm. Stent length was 18 mm 
and stent diameter 3 mm. Four weeks after stenting, the animals were studied with follow-
up coronary angiography and acetylcholine (10 ml, 3 ug/ml) stimulation tests for coronary 
spasm. After euthanization, the coronary arteries were harvested for histologic analysis 
and scanning electron microscopy.
Results: All three stents showed similar minimal luminal diameters (MLD) at baseline 
(3.0 ±0.2 mm, n=18). There was a decrease in MLD in all the three stents: CC (12.3±5.5 
%), TA (10.4±3.7 %), and AA (11.2±6.3 %) (p=NS). Neointimal hyperplasia (NIH) was 
similar in all three stents ranging between 1.77 ±0.57 mm2 for CC, 1.83±0.93 mm2 for 
TA, and 1.78± 1.69 mm2 for AA (p=NS). Histologic restenosis was 32.07±6.26 % for 
CC, 14.48±9.03 % for TA, and 28.15±15.35 % for AA (p=NS). During the Ach stimulation 
test, 1 severe spasm (total occlusion) in TA was detected at the proximal and distal stent 
edge. Hyperplasia appearance rate at the edge region was CC: 12.5 %, TA: 37.5 %, and 
AA: 75.0 %. Re-endothelialization score was CC: 3.4, TA: 1.3, and AA: 3.6. Thrombus 
appearance rate was CC: 0 % TA: 66.7 %, and AA: 16.7 %.
Conclusions: AA stents showed a tendency toward a lower incidence of stent thrombus 
without coronary spasm compared with TA. However, the inhibition of NIH was similiar 
between the 3 groups. Further histologic results will soon be presented.
3:30 p.m.
1022-123 BRCA1 Attenuates Inﬂammation Induced Apoptosis 
and Restores Endothelial Function: A Novel Role of 
BRCA1 in Vascular Homeostasis
Krishna K. Singh, Praphulla C. Shukla, Fina Lovren, Yi Pan, Adrian Quan, Hwee Teoh, 
Lee Errett, Subodh Verma, St. Michael’s Hospital, Toronto, ON, Canada
Endothelial cell (EC) apoptosis, in response to inﬂammatory, ischemic and hypoxic 
stressors is an essential target for therapies aimed at improving graft patency. BRCA1, 
a tumor suppressor gene, promotes DNA repair and afford protection against various 
genotoxic stimuli including immunosuppressant and chemotherapies often employed 
3:30 p.m.
1022-118 The Role of Ang-(1-7)-Mas Axis on the Vascular 
Response Induced by Arterial Denudation
Marco T. Castagna, Silvia Lacchini Lacchini, Ruben D. Sinisterra, Robson A. Santos, 
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
Background: Angiotensin-(1-7) [Ang-(1-7)] counter-regulates the Angiotensin II effects 
in the vasculature and Mas has been shown to be its cellular receptor. We aim to evaluate 
the role of Ang-(1-7)-Mas axis on the arterial injure by arterial denudation (AD).
Methods: C57BL/6 strain (n=25) and knock-out Mas receptor (Mas-/-) mice (n=5), 12 ± 
0,3 weeks old, 25 ± 2 g of weight, underwent left femoral artery (LFA) AD by angioplasty 
guidewire passage. Excepting Mas-/-, control group (AD without medication), and sham 
(surgery performed without AD), n=5 each, treatment included: Mas antagonist (A779) 
(n=5), Ang-(1-7) incorporated into hydroxi-propil B cyclo-dextrin [Ang-(1-7)-HPBCD]
(n=5), AVE 0991 (Mas non-peptide agonist) (n=5). After 28 days, histological specimen of 
LFA and right femoral arteries (RFA) of each group and of LFAs among the groups were 
compared. LA=luminal area, area of arterial lumen; MA=medial area, original medial layer 
encircled by the internal elastic lamina (IEL) and external elastic lamina (EEL); VA=vessel 
area, total arterial area encircled by the EEL; and IA= intimal area, area occupied by the 
neointima were measured. % stenosis =100 x IA / (LA+IA) was calculated.
Results: MA measurements in μ2 showed no difference between RFA and LFA, except for 
Mas-/-: 8809 ± 621 Versus 4406 ± 810, respectively, p=0,05.
LFA % stenosis were respectively: A779: 89%; Mas-/-: 97%; Control: 71%; AVE 0991: 34%; 
Ang-(1-7)-HPBCD: 35%; Sham: 0%.
Ang-(1-7)-Mas axis agonists, AVE 0991 and Ang-(1-7)-HPBCD, promoted a positive 
vascular remodeling, with a low % stenosis and maintained the LA; meanwhile, the axis 
blockage by its antagonist, A779, and by gene deletion of Mas receptor, induced a negative 
vascular remodeling, with a high % stenosis and reduced the LA After arterial AD.
Conclusions:  These results indicate that the Ang-(1-7)-Mas axis plays an important role 
in the vascular response induced by AD.
3:30 p.m.
1022-119 Pattern on Atherosclerosis for Coronary, Carotid and 
Aortic Arteries Calciﬁcation in Rheumatoid Arthritis: a 
Multi-detector Computed Tomography Study
Kai Hang Yiu, Silun Wang, Mo Yin Mok, Gaik Cheng Ooi, Pek-Lan Khong, Ka Fung Mak, 
Chak Sing Lau, Hung Fat Tse, University of Hong Kong, Hong Kong, Hong Kong
Background: Multi-detector computed tomography (MDCT) measured coronary, carotid 
and aortic artery calcium score (CS) reﬂecting calciﬁed atherosclerotic plaque (CAP) 
which are associated with coronary artery disease (CAD) and stroke. This study is 
designed to evaluate the prevalence and pattern of CS in asymptomatic rheumatoid 
arthritis (RA) patients compare with controls subjects.
Methods: 85 age and sex matched RA patients (mean age 53.9±11.8) and controls 
(mean age 56.3±10.0) were enrolled. All subjects underwent 64MDCT scan to evaluate 
CS in coronary, carotid arteries and the aorta.
Results: Presence of CAP were more prevalent in RA patients compared to controls in 
coronary artery (41% vs. 18%, p=0.013), carotid artery (19% vs. 6%, p=0.018) and aorta 
(64% vs. 12%, p<0.001). The prevalence of calcium was over 90% in RA patients at the 
age of 60 or above and in 55% of control subjects. After adjustment with age and sex, 
RA patients had a 5.0, 5.7 and 19.5 risk folds to have CAP in coronary, carotid and aortic 
artery. Aorta of RA patients had the highest frequency of CS > 0 (63.5%) compared with 
coronary artery in control subjects (11.8%) and this pattern remained the same upon age 
stratiﬁcation (42.9-85.2% in RA patients and 4.2-34.5% in control subjects).
Conclusions-RA patients have signiﬁcantly higher prevalence and extent of CAP 
compared with age and sex matched controls. In addition, a signiﬁcant different 
calciﬁcation pattern was noted between RA patients and control subjects.
3:30 p.m.
1022-120 Clopidogrel Enhances Platelet-Derived Nitric Oxide 
Bioavailability and Reduces Oxidative Stress in 
Animals With Hypertension
R. Preston Mason, Ruslan Kubant, Robert F. Jacob, Tadeusz Malinski, Harvard Medical 
School, Boston, MA, Ohio University, Athens, OH
Background: In hypertension, atherothrombotic events are mediated by activated 
platelets with reduced nitric oxide (NO) bioavailability. As an antiplatelet agent, clopidogrel 
may modulate platelet-derived NO bioavailability in a manner that complements inhibition 
of ADP-induced aggregation.
Methods: The effects of clopidogrel were measured in platelets isolated from spontaneous 
hypertension rats (SHR). Platelets were isolated from 14 week-old animals following 
administration (10 mg/kg/day) of clopidogrel and/or aspirin for four days. Production of 
NO and ONOO- was measured using electrochemical porphyrinic nanosensors following 
stimulation with inositol trisphosphate, independent of ADP-induced aggregation. Total 
platelet NO release was measured as a function of time.
Results: SHR animals had elevated mean blood pressure levels (134 ± 13 mmHg) versus 
controls (99 ± 8 mmHg). Platelet-derived NO/ONOO- release was reduced by > two-fold 
in SHR animals, as compared to vehicle treatment. Clopidogrel enhanced platelet NO 
synthase (NOS) function in SHR as evidenced by a 30% increase in NO release (from 
908 ± 101 to 1160 ± 86), a concomitant reduction in ONOO- levels (from 513 ± 51 to 
390 ± 34), and a two-fold increase in the NO/ONOO- release ratio. Aspirin paradoxically 
increased NO release while also increasing ONOO- production, an effect that was 
improved with clopidogrel.
Conclusion: Clopidogrel treatment restored platelet-derived NO release while reducing 
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were assigned integer values of 2 to 8 by rounding their hazard ratios, and summed per 
pt for a maximum possible risk score of 20.
Results: Predictors, and their respective hazard ratios (HR), included: treatment for 
failed brachytherapy (HR=8.15, P=0.004), renal disease (HR=3.81, P=0.010), prior 
myocardial infarction (HR=2.46, P=0.001), multiple stenting (HR=2.37, P=0.002),
known left main disease (HR=2.28, P=0.06), and baseline smoker (HR=1.87, P=0.029). 
Model discrimination was high, as indicated by an area under the receiver operating 
characteristics (ROC) curve of 0.7. Stratiﬁcation into Low, Medium, and High Risk groups 
revealed that in year 2 ST developed in 0.6% of pts with a score <5; 2.5% with a score 
6-10; and 13.3% with a score >10. The vast majority (92.8%) of pts were in the Low Risk 
group, whereas only 0.2% were at High Risk.
Conclusions: Using 6 readily available clinical and angiographic characteristics we 
deﬁned a tool enabling risk-based stratiﬁcation of pts for development of VLST following 
DES. Interestingly, our previous risk score for ST in year 1 identiﬁed discontinuation 
of thienopyridines by 6 months as the strongest predictor. However, discontinuation 
of thienopyridines either by 6 or 12 months is not a predictor of VLST in this analysis. 
Use of this VLST score may facilitate long term management of patients following DES 
placement.
9:30 a.m.
1031-95 Combination Treatment With Clopidogrel and Aspirin 
Enhances Platelet-Derived Nitric Oxide Bioavailability 
and Reduces Nitroxidative Stress
R. Preston Mason, Ruslan Kubant, Adam Jacoby, Robert F. Jacob, Tadeusz Malinski, 
Harvard Medical School, Boston, MA, Ohio University, Athens, OH
Background: Reduced nitric oxide (NO) bioavailability promotes platelet aggregation 
and atherothrombotic events. Like endothelial cells, platelets contain the L-arginine-NO 
synthase (NOS) pathway that uses NAD(P)H as substrate. As an antiplatelet agent, 
clopidogrel, in combination with aspirin, may modulate platelet-derived NO bioavailability 
through NOS, independent of ADP activation.
Methods: The separate versus combined effects of clopidogrel and aspirin on NO and 
peroxynitrite (ONOO-) release were measured ex vivo in platelets isolated from 14 
week old Wistar Kyoto (WKY) rats following administration (10 mg/kg/day) for four days. 
Platelet-derived production of NO and ONOO- were measured using electrochemical 
porphyrinic nanosensors following stimulation with inositol trisphosphate (IP3, 1.0 μM),
independent of ADP levels. Total platelet NO and ONOO- release levels were measured 
as a function of time.
Results: Treatment with clopidogrel increased the capacity of platelets to generate NO 
by 36% (from 1339 ± 90 to 1823 ± 139 molecules × 103, mean ± S.D.). Clopidogrel also 
improved NOS coupling efﬁciency (NO/ONOO- release ratio) by two-fold from 3.9 ± 0.4 
to 7.7 ± 0.9. Aspirin alone also enhanced NO release (1339 ± 90 to 2157 ± 170) but 
increased ONOO- release by 42%. Treatment with clopidogrel and aspirin in combination 
increased NO release over control levels by nearly two-fold (from 1339 ± 90 to 2357 
±188) and decreased aspirin-induced oxidative stress by 20%. The NO/ONOO- release 
ratio increased by 40% with clopidogrel versus aspirin alone. The effect of clopidogrel on 
aspirin-induced NO release was unrelated to ADP levels.
Conclusion: Clopidogrel enhanced platelet-derived NO release while reducing oxidative 
stress, independent of ADP activation. Aspirin had paradoxical actions on platelet function 
as it increased NO as well as ONOO- release. Clopidogrel and aspirin combination 
treatment produced the greatest increase in NO release while reducing the pro-oxidant 
effects of aspirin. These ﬁndings indicate direct effects of clopidogrel on platelet function 
and thrombus formation through enhanced NO bioavailability.
9:30 a.m.
1031-96 Higher Habitual Physical Activity Improves 
Mitochondrial Function and Endothelial Function in 
Patients With Stable Coronary Artery Disease
Ting-Hin Luk, Yuk-Ling Eunice Dai, Kai-Hang Yiu, Sydney Tam, Sheung-Wai Li, 
Raymond Hon-Wah Chan, Stephen Wai-Luen Lee, Chu-Pak Lau, Hung-Fat Tse,
Division of Cardiology, Department of Medicine, The University of Hong Kong, Hong 
Kong, Hong Kong
Background: Exercise training improves endothelial function in patients (pts) with 
coronary artery disease (CAD) through unclear mechanisms. We hypothesize that 
higher habitual physical activity level (PAL) improves endothelial function by reducing 
mitochondrial dysfunction (MD).
Methods: We assessed habitual PAL by a validated International Physical Activity 
Questionnaire in 105 pts (age 68±10; 87% men) with stable CAD. We measured brachial 
artery ﬂow-mediated dilation (FMD) by vascular ultrasound. Serum lactate, pyruvate, fasting 
glucose & lipid proﬁles were measured. MD was deﬁned by lactate/pyruvate ratioq18.
Results: There were no signiﬁcant differences in age, sex, prevalence of hypertension, 
diabetes, smoking & statin use between pts with different tertiles of PAL. With increasing 
PAL tertiles, there were signiﬁcant linear trends of higher FMD (B=0.79, P=0.004, Fig 
1) & lower prevalence of MD (#2 for trend=5.57, P=0.02, Fig 2). Multivariate logistic 
regression found that the lowest PAL tertile (OR=3.45, P=0.03) & smoking (OR=2.72, 
P=0.04) were independent predictors for MD. Also, the absence of MD (B=-1.19, P=0.01) 
& the highest PAL tertile (B=1.16, P=0.03) were both signiﬁcant independent predictors 
for higher FMD.
Conclusion: Higher habitual PAL in CAD pts was associated with higher FMD & lower 
prevalence of MD. Moreover, the absence of MD predicted a higher FMD, suggesting that 
attenuation of MD with higher habitual PAL improves endothelial function in pts with CAD.
post-transplantation. We hypothesized that BRCA1 is a novel target to limit inﬂammation-
induced EC apoptosis and to improve endothelial function.
Methods and Results: We used a gain-of-function approach by adenoviral mediated 
BRCA1 overexpression in human umbilical vein ECs (HUVECs). Ad-BRCA1-expressing 
HUVECs exhibited protection against TNFa-induced apoptosis, as assessed by FACS, 
DNA laddering and cleaved-caspase 3 (P<0.01). This response was mediated by 
complete prevention of TNFa-induced increase in ROS production (P<0.001). BRCA1 
overexpression prevented TNFa-induced reduction in tube formation (P<0.01) and EC 
migration (P<0.01). TNFa-induced up-regulation of adhesion molecules; VCAM1, ICAM1 
and SELE were down-regulated in BRCA1 overexpressing ECs (P<0.01). Cell-cycle 
analysis revealed that BRCA1 overexpression leads to growth arrest following TNFa 
treatment by up-regulating p21. The protective effects of BRCA1 were not mediated by 
changes in total/phosphorylated p53 (P=0.1) but were associated with a up-regulation 
(P<0.01) and phosphorylation of eNOS, along with activation of Akt, and up-regulation of 
VEGFa (P<0.01). Loss-of-function with siBRCA1 reversed the effects on EC apoptosis. 
Furthermore, in the ischemic hindlimb model, BRCA1 improved blood perfusion recovery 
(P<0.05) and capillary density (P<0.01).
Conclusions: BRCA1 protects EC against inﬂammation-induced apoptosis and restores 
endothelial functions, and improves blood perfusion and capillary density in ischemic 
hindlimb model. These data represents BRCA1 as a novel candidate to limit aberrant 
vascular remodelling and also suggest that patients with BRCA1 mutations or cancer 
syndromes may be at an exaggerated risk of native and transplant atherosclerosis and 
graft dysfunction, particularly in the setting of DNA damaging immunosuppressant.
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9:30 a.m.
1031-93 Atherosclerosis Equals Osteoporosis via Notch1/Lrp5 
Pathway
Nalini Marie Rajamannan, Northwestern University, Chicago, IL
Atherosclerosis and osteoporosis are the leading causes of mortality and morbidity in the 
World. Recent epidemiologic studies have demonstrated that these disease processes 
develop in parallel. Evidence indicates that hyperlipidemia plays a paradoxical role in both 
disease processes. However, the mechanism is not understood. We hypothesize lipids 
induce the Notch1 receptor to cleave and activate atherosclerosis within the bone and the 
heart which is responsible for the development of diseases in both of these tissues. To test 
this hypothesis in an experimental hypercholesterolemia model and to determine if statins 
play a protective role in this process. LDLR-/- mice (n=60). Group I (n=20) normal diet, 
Group II (n=20) 0.25% chol diet (w/w), and Group III (n=20) 0.25% (w/w) chol diet+atorv 
for the development of calciﬁcation. The aortic valve and aortas (AVA) was examined 
for proliferation, calciﬁcation, and bone matrix markers. Bone formation was assessed 
by micro Computed Tomography (microCT), Notch1, Lrp5, osteocalcin, cbfa-1 and 
osteopontin expression. Results: The cholesterol diet induced complex bone formations 
in the calciﬁed AVA with an increase in cellular proliferation, osteopontin, osteocalcin, 
cbfa-1 expression and Notch1 receptor cleavage(>3-fold(p<05). The hyperlipidemic 
bones expressed an increase in osteoclast numbers decreased bone formation by 
Goldner Stain, and decrease in the Lrp5, Cbfa1 and osteopontin and cleaved Notch1. 
Atorvastatin reduced bone formation, cellular proliferation, cbfa-1 and uncleaved Notch1 
levels in the AVA and increased bone formation within femurs including an increase in 
the Cbfa1, osteopontin and normal Notch1 uncleaved expression(p<0.05). Conclusion:
Notch1 receptor cleavage initiates Lrp5 mediated osteoblastogenesis in the aortic valve 
and decrease in bone formation and osteoporosis in the femurs. This model may have 
future implications in the treatment of cardiovascular calciﬁcation and osteoporosis with 
statin therapy.
9:30 a.m.
1031-94 A Clinical Risk Score for Prediction of Very Late Stent 
Thrombosis in Drug-Eluting Stent Patients
Kenneth W. Baran, Jr., John M. Lasala, David A. Cox, Aijun Song, Stephen R. Mascioli, 
for the ARRIVE Investigators, St. Paul Heart Clinic, St. Paul, MN
Background: We previously reported a clinically useful risk score for stent thrombosis 
(ST) in the ﬁrst year following drug-eluting stent (DES) implantation developed with data 
from the TAXUS ARRIVE 1 and 2 stent registries. A patient (pt) risk score predictive 
of very late ST (VLST; >1 year), based on analysis of 7,492 ARRIVE pts at 2 years, is 
described below.
Methods: Among 56 pts with 1-2 year ST (Academic Research Consortium Deﬁnite/
Probable) receiving a TAXUS® Express2TM (Boston Scientiﬁc, Natick, MA, US) stent, 38 
candidate baseline variables were considered based on clinical and statistical relevance. 
Cox modeling was then used to identify 6 signiﬁcant baseline predictors of VLST. These 
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1031-99 The Relation Between Platelet Reactivity and HbA1c 
in Diabetic Patients With Cardiovascular Disease on 
Maintenance Aspirin and Clopidogrel Therapy 
Anand Singla, Mark Antonino, Lookman Lawal, Spas Kotev, Kevin Bliden, Udaya S. 
Tantry, Paul A. Gurbel, Sinai Center for Thrombosis Research, Baltimore, MD
Introduction: The reason for high platelet reactivity (HPR) during aspirin and clopidogrel 
therapy in diabetics and the relation of platelet reactivity to glycemic control (GC) are 
unknown.
Methods: In a pilot study, platelet aggregation (PA) in response to 5 and 20uM ADP was 
compared in Type 2 diabetic (n=28) and non-diabetic patients (n=23) with coronary artery 
disease on chronic aspirin and clopidogrel maintenance therapy. PA was also compared 
in diabetic patients with a7% HBA1c (n=12) and >7%HbA1c (n=16). HPR was deﬁned 
as > 46% 5uM ADP- and > 59% 20uM ADP-induced PA based on previous studies 
associating these cutpoints with the occurrence of ischemic events.
Results: Diabetic patients had signiﬁcantly higher PA than non-diabetics (Table). Among 
diabetic patients with >7% HbA1c, the prevalence of HPR was 69% and 63% and among 
diabetic patients with a7% HbA1c the prevalence of HPR was 25% and 17% as measured 
by 5 and 20uM ADP- induced aggregation, respectively. Platelet reactivity increased as 
GC worsened. By ROC analysis, the cutpoint of HbA1c associated with HPR was 7.3%.
Conclusion: An important relation exists between GC and platelet reactivity in type 
2 diabetics treated with dual antiplatelet therapy. Poorly controlled diabetics have the 
greatest platelet reactivity and may require more potent antiplatelet strategies. Further 
clinical investigations to determine the mechanistic link between GC, platelet reactivity 
and treatment failure in diabetics on dual antiplatelet therapy are warranted. 
Diabetes (n=28) Non-Diabetes (n=23) p-value
5 uM ADP-induced Agg 46±18 32±13 0.003
20 uM ADP-induced Agg 53±19 38±13 0.0002
a7%HbA1c (n=12) >7%HbA1c (n=16)
5 uM ADP-induced Agg 34±15 56±13 0.003
20 uM ADP-induced Agg 39± 18 64±11 0.001
9:30 a.m.
1031-100 Procoagulant Activity of Adipose Derived Stromal Cells: 
Implications for Intracoronary Cell Therapy and Use of 
Hepain and Dimethyl Sulfoxide(DMSO)
Vineet Kumar, Malgorzata Maria Kamocka, Raja Shekhar Gangaraju, Elliot D Rosen, 
Brian H Johnstone, Keith March, Indiana University, Indianapolis, IN
Background:Adipose stromal cells (ASCs) are readily available autologous cells with 
potential for treatment of cardiac disease. Several trials of ASC involve intravascular 
delivery, including intracoronary delivery, and accordingly we wished to determine 
whether ASC exhibit procoagulant (PC) properties.
Methods:Human ASC from 3 donors either without passage (P0) or after 1 or 2 
passages in EGM2-MV were assessed for Tissue Factor(TF) Expression on cell surface 
by Immunoﬂuroscence under Confocal Microscopy .The effect of Passage and DMSO on 
TF and (Tissue Factor Pathway Inhibitor)TFPI m-RNA expression was studied by Real 
Time (RT)-PCR .The PC activity of ASC due to TF expression was evaluated in human 
plasma using single phase clotting assay in the absence of exogenously added puriﬁed 
human tissue factor.The time to coagulation was measured using change in viscosity by 
a Start 4 Coagulometer. The clotting assay was repeated in the presence of increasing 
concentrations of heparin and also with a neutralizing human anti-tissue factor antibody. 
Endothelial cells at same passage were used as control 
Results:The ASC consistently showed Immunoﬂuorescence for Tissue Factor exhibiting 
both cytoplasmic and cell surface staining patterns. The TF m-RNA expression decreased 
7 folds from PO to Passage 2(P2) .Culturing cells with DMSO reduced TF expression 
in a concentration dependent manner with 5 fold decrease at 5 %DMSO concentration 
.TFPI expression was not affected by DMSO. The time to coagulation in the clotting assay 
was dependent on ASC concentrations and was directly proportional to passage number. 
There was no coagulation in the absence of ASC’S and presence of equal number 
of endothelial cells. The PC activity of ASC was inhibited by neutralizing tissue factor 
antibody and also in a dose-dependent fashion by heparin, with full inhibition at 1 U 
heparin/106 ASC
Conclusions:ASC express TF in a passage dependent manner and may potentially 
increase thrombogenesis in vivo by activating the extrinsic coagulation pathway. Use of 
heparin with ASC’s or culturing cells with DMSO would be of potential utility for optimizing 
clinical safety, especially with intracoronary delivery
9:30 a.m.
1031-97 Interleukin-18 (IL-18), Endothline-1 andAldosterone 
Induce Smooth Muscle Senescence Via Rho/Rho-
kinase- and PPAR-Dependent Pathways
Takafumi Akagami, Tsuyosi Sakoda, Takashi Doi, Toshio Naka, Mitsumasa Ohyanagi, 
Hyogo College of Medicine, Department of Internal Medicine, Division of Coronary 
Heart Disease, Nishinomiya, Japan
Background: Interleukin-18 (IL-18) is a proinﬂammatory cytokine with multiple functions 
including modulating atherosclerotic lesion. We and others have already reported increased 
levels of circulating IL-18 are thought to be one of risk factors for myocardial infarction and 
restenosis after coronary angioplasty. Endothline-1 (ET-1) and Aldosterone (Ald) are known 
to be involved in a variety of pathophysiological processes which cause cardiovascular 
events through vascular inﬂammation, endothelial dysfunction, and ﬁbrosis. Angiotensin-II 
(Ang-II) and Ras have been reported to induce senescence of vascular smooth muscle 
cells (VSMCs). Cellular senescence has been known to lead age-related vascular disorder. 
However, there are no reports concerning about the effect of IL-18, ET-1 and Ald on 
senescence of VSMCs. In the present study, we examined the effect of IL-18, ET-1 and Ald 
on senescence of VSMCs, and contribution of Rho-kinase and PPARs.
Methods: Primary cultures of rat aortic smooth muscle cells were isolated from the 
media of thoracic aortas of Sprague-Dawley rats by enzymatic digestion. Senescence-
associated B-galactosidase (SA-B-gal) staining and enzyme activity were evaluated as a 
biomarker for cellular senescence with several stimulators and/or inhibitors.
Results: Not only IL-18, but ET-1 and Ald increased the number of SA-B-gal positive 
VSMCs with dose- and time-dependent manner. SA-B-gal enzyme activities in VSMCs 
were also up-regulated by IL-18, ET-1 or Ald stimulation. We have previously reported IL-
18 increased NF-kB activity through Rho/Rho-kinase pathway and PPARs. IL-18-, ET-1- 
and Ald-induced SA-B-gal positive VSMCs and SA-B-gal enzyme activities were inhibited 
by Rho-kinase inhibitor, Fasudil, PPARG agonist, Pioglitazone, HMG-CoA reductase 
inhibitor Pitavastatin and PPARA/G agonist, Bezaﬁbrate with dose-dependent manner.
Conclusions: These results ﬁrstly indicated IL-18, ET-1 and Ald induce VSMC 
senescence through Rho-kinase and PPARs. Inhibition of senescence of VSMCs by IL-
18, ET-1 and Ald might be one of the mechanisms of beneﬁcial cardiovascular effects of 
Rho-kinase inhibitor, HMG-CoA reductase inhibitor statin and PPAR agonists.
9:30 a.m.
1031-98 Insulin Resistance Is Associated With a Reduction in 
Circulating Endothelial Progenitor Cells and Iimpaired 
Endothelial Regeneration Following Wire-Induced 
Vascular Injury
Matthew Kahn, Richard Cubbon, Afroze Abbas, Hema Visvambharan, Nadira 
Yuldasheva, Mark Kearney, Stephen Wheatcroft, Division of Diabetes & Cardiovascular 
Disease Research, University of Leeds, Leeds, United Kingdom
Background: Prior data have demonstrated that bone marrow derived endothelial 
progenitor cells (EPCs) contribute to endothelial regeneration following endothelial 
damage accrued through exposure to various risk factors. Type 2 diabetes is associated 
with reduced EPC numbers, EPC dysfunction and impaired endothelial regeneration. 
However, the speciﬁc effect of insulin resistance on EPC biology and endothelial repair 
remains unknown.
Methods: We assessed metabolic and endothelial function, circulating EPCs and 
endothelial regeneration following wire-injury in mice hemizygous for deletion of the 
insulin receptor (IR+/-) and their littermate wild type (WT) controls.
Results: The metabolic phenotype of IR+/- mice was consistent with compensated insulin 
resistance, with hyperinsulinaemia after a glucose challenge but a normal blood glucose 
response to a glucose tolerance test. Endothelial function was impaired in aorta from IR+/-
mice, with decreased basal nitric oxide production and blunted eNOS activity in response 
to insulin. Sca-1/VEGFR-2 positive EPCs, measured in peripheral blood by ﬂow cytometry, 
were reduced in IR+/- mice compared to WT controls (67±6 vs 87±6 cells/100 000 events; 
P<0.05). Endothelial regeneration, assessed by Evan’s blue staining of femoral artery at 
intervals following denuding wire-injury, was signiﬁcantly delayed in IR+/- mice compared 
to WT controls (re-endothelialised area 35.8±4.8% vs 66.6±5.2% at day 5 following injury 
and 35.6±4.8% vs 59.8±6.6% at day 7 following injury; P<0.05).
Conclusions: These novel data demonstrate that mild insulin resistance reduces 
circulating EPCs and delays endothelial regeneration following injury. The ﬁndings 
support the hypothesis that insulin resistance may promote atherosclerosis by adversely 
affecting the balance between endothelial damage and repair.
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subepicardial extracellular matrix. We hypothesized that invasion of PE-derived cells in 
3D collagen matrices is regulated by LPA in MMP- dependent manner.
Methods: An in vitro A/2 96-well invasion assay was utilized to study the effects of LPA 
and MMPs on avian PE-derived cell invasion into 3.75 mg/ml 3D type I collagen gels. PE-
derived cells were seeded on surface of control or LPA containing gels. The base culture 
media (reduced serum supplement II, ascorbic acid and ﬁbroblast growth factor) either 
was added alone or contained VEGF-A and/or synthetic MMP inhibitor GM6001. After 24 
hours, cultures were ﬁxed and stained for imaging. The number of invading cells for each 
condition was counted manually at 10x magniﬁcation in each well; all conditions were run 
in triplicates. Data are reported as mean number of invading cells per well +/- S.E.
Results: PE-derived cells spontaneously invaded control collagen matrices and invasion 
was markedly enhanced by LPA (94+/-9.6 vs. 285.6+/-54.9). The combination of VEGF 
and LPA further enhanced this process (400.3+/-31.4, p<0.05). GM6001 completely 
blocked normal and LPA and LPA/VEGF-induced invasion in 3D collagen matrices.
Conclusions: PE-derived cells are able to spontaneously invade 3D collagen matrices 
and this process can be further enhanced by LPA and VEGF. MMPs play a key role in this 
process. Further studies are needed to determine a particular type of MMPs that regulate 
PE-derived cell invasion and collateral vessel recruitment.
9:30 a.m.
1031-104 Vascular Changes in the Coronary Microvasculature 
of SHR as a Model to Study Mechanisms of Coronary 
Arteriolar Remodeling in Cardiac Small Vessel Disease
Anabel Varela Carver, Massimiliano Mancini, Christina Kleinert, Howard T. Parker, 
Ornella Rimoldi, Giulia d’Amati, Paolo G. Camici, MRC CSC Imperial College London, 
London, United Kingdom, 1st School of Medicine, University La Sapienza, Rome, Italy
Background: Patients with arterial hypertension often have symptoms and 
electrocardiographic signs of ischemia despite normal coronary angiogram. These 
patients have severe impairment of coronary ﬂow reserve, secondary to remodeling of the 
coronary microvasculature. The spontaneously hypertensive rat (SHR) may represent a 
useful model to study the mechanisms of coronary microvascular remodeling in humans 
and explore the efﬁcacy of new drugs.
Methods: We performed histological and histomorphometric studies in SHR (n=10) 
ranging from 8 to 18 weeks and in matched control Wistar Kyoto rats (WKY, n=8). The 
weight of each heart was recorded and hearts were cut along the short axis at the 
mid-ventricular level. Multiple 4-μm thick sections from each heart were stained with 
hematoxylin-eosin, Masson’s trichrome and Picrosirius red. Images of all histological 
ﬁelds were acquired at a magniﬁcation of 20X, the number of intramural coronary arteries 
for each heart was recorded and the medial area of all intramural arteriolar vessels 
measured. The presence, type and extent of ﬁbrosis was also evaluated.
Results: Mean heart weight of SHR was 1.75g, versus 1.31g for controls. Hearts of SHR 
showed a concentric, symmetric left ventricular hypertrophy. Histological examination showed 
a diffuse medial hypertrophy of intramural arteries in SHR and increased adventitial ﬁbrosis, 
as compared to controls. The mean number of intramural arteries did not differ signiﬁcantly 
between SHR hearts and controls (10 vs 12). Histomorphometry revealed that the mean 
arteriolar wall area in SHR hearts at 8 weeks was 12300±8348 μm2 while in control hearts it 
was 4264±3096 μm2 (p<0.001). These results were conﬁrmed at 12 and 18 weeks.
Conclusions: Histological and histomorphometric analysis of SHR hearts shows that 
a signiﬁcant medial hypertrophy of intramural vessels is already developed at 8 weeks 
compared to controls. No further changes are observed at 12 and 18 weeks. The vascular 
changes in the coronary microvasculature of SHR are similar to those reported in patients 
with arterial hypertension. Thus, SHR may represent a good model to study mechanisms 
of coronary arteriolar remodeling in cardiac small vessel disease.
9:30 a.m.
1031-105 Contrast-Enhanced Ultrasound Imaging Detects Intra-
Plaque Neovascularization in an Experimental Model of 
Atherosclerosis
Chiara Giannarelli, Borja Ibanez, Giovanni Cimmino, Josè M. Garcia Ruiz, Randolph 
Hutter, Valentin Fuster, Mario Garcia, Juan J. Badimon, Cardiovascular Institute, Mount 
Sinai School of Medicine, New York, NY
Background: Intra-plaque neovascularization plays a key role in rapid lesion progression 
and vulnerability. A non-invasive technique for quantifying intra-lesion neovessels could 
be of clinical relevance in detecting high risk plaques. The objective of this study was to 
investigate the feasibility of contrast-enhanced ultrasound imaging (CE-USI) in visualizing 
intra-plaque neovascularization.
Methods: The study involved 13 atherosclerotic and 6 control rabbits. Aortic 
atherosclerosis was induced by a combination of 0.2% cholesterol-rich diet and dual 
balloon denudation. All animals underwent CE-USI by lipid microsphere i.v.. Lesions were 
characterized according to echogenic class (De Bray JM, Cerebrovasc Dis 1997) and 
signal enhancement within lesions was measured by a semiautomatic analysis program 
. After CE-USI, the animals were euthanized and aortas collected for plaque composition 
analysis by histological detection of macrophages (RAM-11) and vascular smooth muscle 
cells (actin) and for neovessel quantiﬁcation (lectin).
Results: Plaques were classiﬁed as class II-predominantly echolucent (ﬁbrous) or class 
III-predominantly echogenic (ﬁbro-fatty). A signiﬁcant signal enhancement was observed 
in ﬁbro-fatty (345±137%; p<0.01) but not in ﬁbrous lesions (16±11%;p=NS). In control 
rabbits, which showed no lesions, no enhancement was detected. Histology conﬁrmed 
a higher content of RAM-11+ cells in ﬁbro-fatty lesions than in ﬁbrous plaque with a 
signiﬁcantly lower A-actin/RAM-11 ratio (0.34±0.21 vs 5.4±4.3, respectively, p<0.01). The 
number of neovessels was signiﬁcantly (p<0.01) higher in ﬁbro-fatty-contrast enhanced 
lesions (136±70 neovessels/mm2) than in ﬁbrous plaques (19±8 neovessels/mm2). A 
strong correlation (r=0.99; p<0.01) was found between the number of neovessels and the 
9:30 a.m.
1031-101 Bevacizumab-Eluting Stent: A Novel Approach for the 
Inhibition of Plaque Neovascularization Long -Term 
Results From the First-In-Man Application
Konstantinos Toutouzas, Elli Stefanadi, John Karampelas, Andreas Synetos, Eleutherios 
Tsiamis, Dimitrios Tousoulis, Nicholas Kiphsidze, Christodoulos Stefanadis, 1st 
Cardiology Clinic, University of Athens, Medical School, Hippokration Hospital, Athens, 
Greece
Background : Neovascularization is mainly mediated by vascular endothelial growth 
factor. Bevacizumab is a monoclonal antibody speciﬁc for vascular endothelial growth 
factor. In this study we present the long-term results of the safety and efﬁcacy study of the 
ﬁrst-in-man application of bevacizumab-eluting stent.
Methods : Patients with acute coronary syndromes and > 2 angiographically signiﬁcant 
coronary artery stenoses were included in the study. The culprit lesions were successfully 
treated. The non-culprit lesions to be included were 50%, in vessels with reference 
diameter > 2.25mm). Local delivery of bevacizumab was accomplished via BiodivYsio 
stents, which bear a phosphorylcholine coating that adsorbs the drug with a “sponge-like” 
mechanism. Patients were discharged under aspirin (indeﬁnitely) and clopidogrel for 24 
months. All patients were scheduled for angiographic follow-up at 12 months and clinical 
follow-up up. Intravascular ultrasound of the target vessel was performed immediately 
after the procedure and at 12 months.
Results : Twenty consecutive patents were included. All stents were successfully 
delivered (mean stent length 13.55±4.1 mm) and all patients were discharged without 
any complication. During a follow-up period of 23.54±5.68 months there were no adverse 
cardiac events such as death, myocardial infarction and target vessel revascularization. 
Angiographic and intravascular ultrasound follow-up were performed at 12.03±2.92 
months. Acute, subacute or late thrombosis was not observed. Angiographic and 
intravascular ultrasound follow-up did not reveal any restenosis (50% vessel narrowing) 
in any target vessel. Stent malapposition was not observed in any patient. In-stent late 
loss was 0.15±0.9 mm, and in-lesion late loss was 0.16±0.09 mm. Mean neointimal 
hyperplasia in stented segments as measured with intravascular ultrasound was 0.7±0.39 
mm.
Conclusions: The implantation of bevacizumab-eluting stents in human coronary arteries 
is feasible and safe and elicits minimal neointimal proliferation. Additional placebo-
controlled trials are required to conﬁrm these promising results.
9:30 a.m.
1031-102 Insulin-Stimulated PI 3-Kinase Activity Is Blunted, but 
Akt Pphosphorylation Is Preserved in Aortas of Pigs 
With Diet-Induced Obesity
Gregory G. Schwartz, Boris Draznin, Jane E. B. Reusch, J. Wayne Leitner, Li Lu, Ya 
Xu, Clifford R. Greyson, Cecilia C. L. Wang, Denver VA Medical Center, Denver, CO, 
University of Colorado Denver - School of Medicine, Aurora, CO
Background: Insulin resistance increases cardiovascular disease risk. In rodent models 
of insulin resistance, adipose and skeletal muscle demonstrate blunted insulin-stimulated 
phosphatidylinositol 3-kinase (PI3K) activity not paralleled by reduced insulin stimulated 
Akt phosphorylation (pAkt). It is uncertain whether insulin signaling is similarly perturbed 
in arterial wall. This study determined whether abnormal insulin signaling develops in the 
arterial wall in a porcine model of insulin resistance.
Methods: Micropigs (n=16) were fed an intervention (16% w/w simple sugars, 27% fat) 
or control diet (2% w/w simple sugars, 4.5% fat). Insulin resistance was assessed using 
IV glucose tolerance tests (IVGTT). At 7 months of assigned diet, 10 U/kg of IV insulin 
was administered 10 min before euthanasia and removal of the thoracic aorta. IRS-1-
associated PI3K activity was determined by 32P incorporation in thin-layer chromatography; 
Akt and ERK 1/2 MAP kinase activity were determined by Western blot.
Results: Pigs fed intervention diet were obese and had higher fasting blood glucose 
(51+2 vs. 40+1 mg/dL, p<.001), lower insulin sensitivity by IVGTT (p=.02), and higher 
blood pressure compared with pigs fed control diet. Pigs fed intervention diet had lower 
IRS-1-associated PI3K activity in aortic tissue (4.33+5.2 vs. 10.91+3.2 arbitrary units, 
p<.05). However, total and phosphorylated forms of Akt and ERK 1/2 MAP kinase did not 
differ between groups.
Conclusions: In pigs with diet-induced systemic insulin resistance, vascular insulin 
resistance develops concurrently, evidenced by blunted aortic PI3K activity in response to 
insulin. However, blunted PI3K activity is not accompanied by reduced insulin-stimulated 
pAkt. This apparent disparity might be explained by differential effects of PI 3K on 
phosphorylation of individual Akt isoforms, compartmentalization of pAkt, increased pAkt 
due to other factors such as hypertension/shear stress, or requirement for only partial 
activation of PI3K to achieve full activation of Akt. On the other hand, total and pERK 1/2 
did not differ between groups, consistent with intact signaling through the MAP kinase 
pathway despite impaired PI3K activation.
9:30 a.m.
1031-103 Invasion of Proepicardium - Derived Cells in 3D 
Collagen I Matrices Is Enhanced by Lysophosphatidic 
Acid
Manavjot Sidhu, Karen Nickelson, Dmitri Baklanov, University of Missouri, Columbia, MO
Background: Proepicardium (PE) - derived cells contribute to coronary vessel formation 
in development and disease. Lysophosphatidic acid (LPA) is released from activated 
platelets and has been implicated in tumor cell invasion in matrix metalloproteinases 
(MMP)-dependent manner. Collagen I is the most abundant component of postnatal 
A436  ABSTRACTS - Vascular Disease JACC March 10, 2009
Va
sc
ul
ar
 D
is
ea
se
synthesis, and regulation of murine plasma cholesterol levels. However, no studies have 
linked the INSIG2 to cardiovascular disease. The objective of this study was to determine 
whether the obesity-related INSIG2 SNP is associated with cardiovascular phenotypes in 
a population undergoing percutaneous coronary intervention (PCI).
Methods: Nine hundred forty six patients undergoing PCI in wave 5 of the multicenter 
NHLBI Dynamic Registry were genotyped for the rs7566605 SNP variant near the INSIG2 
gene. Clinical variables including basic demographics, past medical history, coronary 
angiography data, and procedural variables were analyzed. Approximately 10% of 
patients were homozygous for the c allele of the INSIG2 SNP and 76.6% were male.
Results:The prevalence of peripheral vascular disease was signiﬁcantly higher in older 
males (>65) who were either homozygous or carriers of the c allele (n=171) compared to 
non-carriers (n=119) (14.2% versus 5.1%, p=0.01). This relationship was not seen in younger 
men. In older (>65) women, a signiﬁcant relationship with cerebrovascular disease was also 
identiﬁed with the c allele (carriers, n=79, non-carriers, n=72; 12.8% versus 2.8%, p=0.02). 
The INSIG2 SNP was not associated with hypercholesterolemia or BMI. The SNP was also 
not associated with other clinical or angiographic variables or the procedural outcomes of 
death, revascularization, or stent thrombosis within 1 year of stent implantation.
Conclusions: The INSIG2 obesity variant may be related to peripheral vascular disease 
in older men, and to cerebral vascular disease in older women, with pre-existing coronary 
artery disease. The variant was not associated with BMI or with lipid parameters 
consistent with previous studies. Further studies will be needed to clarify the role of the 
INSIG2 obesity variant on these cardiovascular phenotypes.
9:30 a.m.
1031-109 Use of Carotid Intima Media Thickness for Identiﬁcation 
of Patients With Diabetes Mellitus at High Risk for 
Coronary Artery Disease
Roxana Djaberi, Joanne D. Schuijf, Eelco J. de Koning, Ton J. Rabelink, Martin Spaans, 
Alberto M. Pereira, Jan W. Smit, Jeroen J. Bax, J. Wouter Jukema, Leiden University 
Medical Center, Leiden, The Netherlands
Background: Identiﬁcation of patients at risk for coronary artery disease (CAD) remains 
a challenge in diabetes mellitus (DM). We evaluated the potential of carotid intima media 
thickness (CIMT) to predict CAD in patients with DM.
Methods: Prospectively, CIMT of the common carotid arteries was assessed by 
B-mode ultrasound in 149 asymptomatic diabetic patients (mean age 50 yrs, male 83). 
Non invasive multislice CT coronary angiography was performed to relate CIMT to the 
presence and severity of CAD. For this purpose, patients were classiﬁed as having 1. no 
atherosclerosis, 2. non-obstructive atherosclerosis or 3. obstructive stenosis with q50%
luminal narrowing.
Results: Mean CIMT increased signiﬁcantly from 0.58±0.1 mm in patients with 
normal coronary arteries (n=59, 40%) to 0.66±0.1 mm in patients with non-obstructive 
atherosclerosis (n=52, 35%). Highest mean CIMT (0.75±0.1 mm) was observed in 
patients with obstructive stenosis (n=37, 25%, P<0.001). 
Only 6 (10%) patients with a CIMT <0.6 mm showed obstructive atherosclerosis on MSCT. 
Importantly, the prevalence of obstructive atherosclerosis increased to 11 (19%) in patients 
with a CIMT 0.6-0.75 mm and 20 (63%) in patients with a CIMT >0.75 mm (Fig 1).
Multivariate analysis of baseline risk factors showed CIMT to be an independent predictor 
of CAD (P=0.001).
Conclusion: A signiﬁcant relation was shown between CIMT and the presence and 
severity of CAD in patients with DM. Assessment of CIMT may be useful to identify 
patients with DM at higher risk for CAD.
9:30 a.m.
1031-110 Vascular Homocysteine Versus 5-Methyl-
Tetrahydrofolate As Regulators of Vascular Redox and 
Endothelial Function in Human Vessels
Charalambos A. Antoniades, Cheerag Shirodaria, Otto Baarholm, Paul Leeson, Tim 
Van-Assche, Colin Cunnington, Dimitris Tousoulis, Christodoulos Stefanadis, Helga 
Refsum, Keith M. Channon, Department of Cardiovascular Medicine, University of 
Oxford, Oxford, United Kingdom, 1st Cardiology Department, Hippokration Hospital, 
Athens Medical School, Athens, Greece
Background: Increased plasma total homocysteine (tHcy) is related with increased 
systemic oxidative stress, while 5-MTHF administration improves endothelial function and 
vascular redox state. We studied the impact of endogenous 5-MTHF and tHcy variability 
on vascular redox state in human vessels.
signal enhancement in ﬁbro-fatty lesions.
Conclusion: Ultrasound contrast enhancement shows an excellent correlation with the 
degree of intra-plaque neovascularization present in ﬁbro-fatty lesions. These ﬁndings 
highly suggest that CE-USI could represent a useful technique to characterize high risk 
plaque in clinical settings.
9:30 a.m.
1031-106 Reconstituted High Density Lipoprotein Attenuates 
Atherogenesis in Hyperlipidemic apoE-/- Mice
Jooyun Kim, JinYong Choi Choi, Bok-Soo Lee Lee, Ki-Yong Kim Kim, Jo woon yi 
Lee, Ji Yeun Lee, Jeong Euy Park, Division of Cardiology, Samsung Medical Center, 
Sungkyunkwan University School of Medicine, SEOUL, South Korea
Background: Maintaining low level of low density lipoprotein (LDL) and high level of 
high density lipoprotein (HDL) in plasma is the most important factor in the prevention 
of atherosclerosis. HDL has multiple antiatherogenic effects. We tried to investigate the 
antiatherogenic effects of reconstituted HDL (rHDL) and its mechanism of action in apo 
E-/- mice.Methods and Results: rHDL was prepared with plasma-derived apoA-I and 
soybean PC by a molar ratio of 1 to 150. Apo E-/- mice (n=10) at 8 weeks of age were fed 
with 0.15% high fat high cholesterol diet (HFHC) until 12 weeks. One hundred mg/kg of 
rHDL was administered in tail vein, twice a week during the last 4 weeks. Mice fed a HFHC 
diet only were used as reference group (n=10). After 12 weeks, mice were sacriﬁced and 
atherosclerotic lesions in aortic sinus were examined by oil red O staining. Oil red O 
positive areas in aorta were reduced by 30.8% in the mice coadministered with rHDL 
compared with reference group [reference; 0.405 ± 0.045 mm2 vs rHDL; 0.279 ± 0.0908 
mm2, (p <0.01)]. Macrophages inﬁltration by MOMA-2 staining was shown to decrease by 
30% in rHDL cotreated group (reference; 0.0981 ± 0.0357 mm2 vs rHDL; 0.0593 ± 0.0180 
mm2 (p<0.025). Smooth muscle cell destruction in medial layer was also signiﬁcantly 
preserved in rHDL cotreated group. Confocal microscopic analysis revealed that heat 
shock protein 27 (Hsp27) and tissue inhibitor of metalloproteinase(TIMP) expression were 
time-dependently increased but metalloproteinase 9(MMP9) was signiﬁcantly decreased 
in atherosclerotic lesions in rHDL cotreated mice group. Apolipoprotein B (apoB) stain 
positive area in the lesions were increased and gradually made bigger clumps in a 
time-dependent manner and rHDL cotreatment reduced apoB accumulation. Serum 
lipid proﬁles (total cholesterol, triglyceride, HDL, low density lipoprotein) were similar 
between two groups. Conclusion: rHDL effectively stabilized atherosclerotic lesion by 
decreasing atheroma volume, suppressing apoB accumulation and monocyte inﬁltration 
and subsequently ameliorated proatherogenic conditions by increasing Hsp27 expression 
and decreasing proteases activation in hyperlipidemic milieu of the apoE-/- mice.
9:30 a.m.
1031-107 Therapeutic Angiogenesis by Transplantation of Allogeneic 
Fetal Membrane-derived Mesenchymal Stem Cells
Shin Ishikane, Noritoshi Nagaya, Kenichi Yamahara, Masaharu Sada, Kazuhiko Harada, 
Kenichi Mishima, Katsunori Iwasaki, Michihiro Fujiwara, Tomoaki Ikeda, Department of 
Regenerative Medicine & Tissue Engineering, National Cardiovascular Center, Osaka, 
Japan, Department of Perinatology, National Cardiovascular Center, Osaka, Japan
Background:Bone marrow-derived mesenchymal stem cells (BM-MSC) have been 
demonstrated as an attractive therapeutic cell source for regenerative medicine. However, 
there are several limitations in using an autologous BM, such as invasiveness and inadequate 
cell number. Thus, an alternative source of MSC that can be obtained noninvasively and 
sufﬁciently is desirable. The purpose of this study is to investigate whether allogeneic 
transplantation of MSC obtained from fetal membranes (FM-MSC), which are generally 
discarded as medical waste, has therapeutic potential in hindlimb ischemia.
Methods & Results:FM-MSC were obtained from pregnant Lewis rats (15 days post 
conception), which had similar surface antigen expression and multipotency compared to 
BM-MSC. In mixed lymphocyte culture test, splenic T cells (STC) of MHC-mismatched ACI 
rats (ACI-STC) were cocultured with an equal number of STC (Lewis-STC) or FM-MSC 
(Lewis-FM-MSC) derived from Lewis rats for 5 days. Proliferative response of ACI-STC to 
Lewis-STC was signiﬁcantly high, whereas negligible responses were observed in Lewis-
FM-MSC. When Lewis-FM-MSC were transplanted into the hindlimb of allogeneic ACI 
rats, signiﬁcant small amount of T cell inﬁltration was observed compared to Lewis-STC 1 
week after transplantation, suggesting FM-MSC were immunologically inactive. Hindlimb 
ischemia was produced by left common iliac artery resection in ACI rats, and allogeneic 
Lewis-FM-MSC (5×106 cells) were transplanted into ischemic hindlimb 1 day after 
resection. At 3 weeks after transplantation, laser Doppler perfusion analyses showed that 
the ischemic/nonishemic blood ﬂow ratio was signiﬁcantly increased in FM-MSC group 
compared to control group (58.6 ± 2.6 vs. 42.6 ± 4.2%, respectively, n=10, P<0.05), and 
alkaline phosphatase staining indicated that the capillary/muscle ﬁber ratio of ischemic 
muscle was signiﬁcantly higher in FM-MSC group compared to control group.
Conclusions:Transplantation of allogenic FM-MSC enhanced neovascularization in a rat 
model of hindlimb ischemia without immune rejection. Allogenic FM-MSC may represent 
a new therapeutic strategy for treatment of peripheral vascular disease.
9:30 a.m.
1031-108 INSIG2 Association With Cardiovascular Phenotypes in 
Older Adults
Kimberly A. Skelding, Glenn S. Gerhard, Helen Vlachos, Faith Selzer, Sheryl F. Kelsey, 
David O. Williams, Kevin E. Kip, Geisinger Medical Center, Danville, PA
Background: A single nucleotide polymorphism (SNP) near the INSIG2 gene, has been 
associated with obesity in some, but not all, population based studies. The INSIG2 gene 
has been implicated in cholesterol metabolism, in vitro feedback inhibition of cholesterol 
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9:30 a.m.
1031-112 Effects of Telmisartan on Endothelial Function and 
Nitrate Tolerance in Patients with Coronary Artery 
Disease and the Metabolic Syndrome
Hideki Watanabe, Kunio Nakagawa, Masaaki Kakihana, Kinu Medical Association 
Hospital, Joso, Japan, Tsukuba Memorial Hospital, Tsukuba, Japan
Background: Continuous nitroglycerin (NTG) therapy has been reported to induce 
not only nitrate tolerance, but also NTG-induced endothelial dysfunction. We assessed 
effects of telmisartan on vascular function, exercise tolerance, and oxidative stress in 
patients with CAD and the metabolic syndrome.
Methods: Thirty patients with CAD and the metabolic syndrome were randomized to 
receive telmisartan (Telmisartan group, n=15) or not to receive telmisartan (Control group, 
n=15). Flow-mediated dilatation (FMD) and NTG-induced dilatation (NID) of brachial 
artery were measured by using ultrasound system. We assessed exercise tolerance by 
exercise time (ExT) to ST segment depression of 0.10 mV during a treadmill exercise test. 
These measurements were performed at baseline, and then at 4 weeks after the therapy 
with telmisartan (4 weeks) and at next 4 weeks after the concomitant therapy with NTG 
patch (8 weeks).
Results: At baseline, there were no differences in all parameters between two groups. 
FMD was increased at 8 weeks in the telmisartan group, but was decreased at 8 weeks in 
the control group (NTG-induced endothelial dysfunction). NID did not change during the 
study in the telmisartan groups, but was decreased at 8 weeks in the control group (nitrate 
tolerance). ExT was prolonged at 8 weeks in the telmisartan group, but was decreased 
at weeks in the control group.
Conclusions: Telmisartan not only improves endothelial function, but also prevents 
nitrate tolerance and NTG-induced endothelial dysfunction.
Baseline 4 weeks 8 weeks
FMD (%) Telmisartan 3.5±1.3 6.3±1.3* 6.8±1.3*†
Control 3.7±1.2 3.7±1.6 2.1±0.8*
NID (%) Telmisartan 14.3±2.4 14.6±2.3 14.1±2.3†
Control 14.3±2.3 14.4±2.3 10.5±2.8*
ExT (sec) Telmisartan 312±34 317±36 347±43*†
Control 312±39 316±36 295±30*
TBARS (nmol/mL) Telmisartan 3.28±0.60 1.55±0.36* 1.68±0.28*†
Control 3.23±0.54 3.01±0.57 4.03±0.19*
Data are mean ± SD. *p<0.01 vs. Baseline; †p<0.01 vs. Control group; TBARS, 
thiobarbituric acid reactive substance
9:30 a.m.
1031-113 Hot Flashes Predict Endothelial Dysfunction in Early 
Menopausal Women. Effect of Estrogen Receptors 
Gene Polymorphisms
Aris Bechlioulis, Katerina K. Naka, Sophia N. Kalantaridou, Anthoula Chatzikyriakidou, 
Odysseas Papanikolaou, Apostolos Kaponis, Konstantinos Vakalis, Anna Kotsia, 
Patra Vezyraki, Ioannis Georgiou, Lampros K. Michalis, Michaelidion Cardiac Center, 
University of Ioannina, Ioannina, Greece, Department of Cardiology, University of 
Ioannina, Ioannina, Greece
Background: Endothelial dysfunction has been associated with both menopause and 
ageing. Estrogen receptors alpha and beta (ER a & b) mediate the cardiovascular (CV) 
effects of estrogen and ER gene polymorphisms have been related to various CV risk 
factors and incidence of CV diseases. The aim of the study was to deﬁne predictors of 
endothelial function and the effect of ER gene polymorphisms on endothelial function in 
early menopausal women.
Methods: We studied 93 early menopausal women (aged <55 years and <5 years in 
menopause) with menopausal complaints and 10 premenopausal women of similar age 
who served as controls. None of the women had known CV disease or received any 
CV medication. Severity of menopause-related complaints was measured using the 
Menopause Rating Scale. Endothelium-dependent dilation of the brachial artery was 
assessed using ﬂow-mediated dilation (FMD). Genetic polymorphisms of ERa [PvuII 
(454-397T>C) and XbaI (454-351A>G)] and ERb [AluI (1730A>G)] were studied.
Results: Mean age of early menopausal and control women was 49±4 and 48±4 years 
respectively (p=NS). FMD was signiﬁcantly lower in menopausal women compared to 
controls (5.05±2.47 vs 10.55±3.07%, p<0.001). Severity of vasomotor symptoms (i.e. hot 
ﬂashes) was the only independent predictor of FMD (B -0.901, p<0.001). ERa PvuII C and 
XbaI G alleles were both associated with higher triglycerides levels (p=0.038 and p=0.012 
respectively). ERb AluI G allele was related to higher systolic (p=0.003) and diastolic blood 
pressure (p=0.033). ERb AluI GG genotype was associated with higher triglycerides levels 
(p=0.022) and more severe hot ﬂashes (OR 4.80, 95% CI 1.27-18.17, p=0.014).
Conclusions: Menopausal transition is clearly associated with endothelial dysfunction. In 
early menopausal women, severity of hot ﬂashes is the most important factor to indicate 
impaired vascular function. Speciﬁc ER gene polymorphisms are related to CV risk 
factors (lipid and blood pressure levels) and severity of hot ﬂashes. Therefore hot ﬂashes 
and identiﬁcation of these ER gene polymorphisms could have an impact on determining 
long term CV prognosis and thus preventive strategies in menopausal women.
Methods: Paired segments of internal mammary arteries (IMA) and saphenous veins 
(SV) were harvested from 218 pts undergoing CABG. Vasomotor responses of SVs 
to acetylcholine (Ach) and sodium nitroprusside (SNP) were determined ex-vivo. 
Superoxide (O2-) generation (±LNAME, ±NADPH) in IMAs and SVs was determined by 
chemiluminescence. Vascular 5-MTHF and tHcy were determined by HPLC.
Results: Low vascular 5-MTHF and high vascular tHcy were associated with higher 
vascular O2- in IMA (Fig. A and B). Vascular 5-MTHF affected only LNAME-inhibitable 
O2- (Fig. C), while tHcy affected only NADPH-stimulated O2- (Fig D). In multivariate 
analysis 5-MTHF was an independent predictor of LNAME-inhibitable O2- in IMA (beta
(SE)=0.531(0.242),p=0.033), while tHcy was a predictor of only NADPH-stimulated O2-
(beta(SE)=2040(732), p=0.008). Importantly, vascular 5-MTHF (Fig. E) but not tHcy (Fig. 
F) was a determinant of vasorelaxations of SV to ACh.
Conclusions: Vascular 5-MTHF is a regulator of eNOS coupling, while tHcy is a 
determinant of NADPH-oxidase activity in human vessels. These ﬁndings provide novel 
insights into the interactions between folates, homocysteine and vascular function. 
9:30 a.m.
1031-111 Differential Circadian Variation in Arterial Tone, 
Stiffness and Endothelial Function
Ibhar Al Mheid, Konstantinos Aznaouridis, Alanna Morris, Riyaz Patel, Nino Kavtaradze, 
Hamid Syed, Wayne Alexander, Arshed Quyyumi, Emory University, Atlanta, GA
Cardiovascular vulnerability follows a circadian pattern. Pathophysiological triggers that 
may explain this phenomenon include increased vascular tone and depressed endothelial 
function, however, the detailed 24 hour variation and interrelation of their noninvasive 
measures remain unknown. We hypothesized that changes by the time of day in vascular 
tone, arterial stiffness and endothelial function may differ.
Methods: In 12 healthy subjects (8 men, 42±18 yrs) we investigated the circadian 
variation of:
a- pulsatile arterial tonometry derived augmentation index (PAT-AIX, Itamar Inc), b- 
reactive hyperemia index, c- central augmentation index (C-AIX, SphygmaCor Inc), 
d- pulse wave velocity (PWV), e- brachial artery diameter and f- ﬂow mediated dilation 
(FMD) at 8 am, noon, 4pm, 8pm, midnight, and 8 am.
Results: ANOVA for repeated measures indicated signiﬁcant changes for brachial arterial 
diameter (p=0.06, lower at 12 am and 8 am), C-AIX (p<0.001, lower at noon and 4pm) and 
PAT-AIX (p=0.007, lower at 4pm). In contrast, FMD was maximal at midnight (p<0.001).
Conclusion: Vascular tone and endothelial function follow a differing circadian rhythm in 
healthy subjects. Arterial vasodilator tone is greatest at noon and 4 pm, as reﬂected by the 
higher brachial arterial diameter and lower arterial stiffness. FMD, however, was highest at 
midnight. The morning preponderance in CVD events compared to the remaining waking 
hours may be secondary to the greater vasodilator tone at these later time points. 
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glycated haemoglobin (HbA1c) level in diabetic patients who survived an AMI.
Methods: From the French regional RICO survey, 210 consecutive patients with known 
diabetes and surviving an AMI were included between the 1st January and the 31st
december 2005. Demographic, clinical, and lifestyle risk-factors, questionnaire-based 
wine consumption and HbA1c levels were collected at one-year follow-up. 
Results: At follow-up, 48% of patients reported moderate wine consumption (1-3 drink/
day). Moderate drinkers were older than non or high-drinkers (0 or >4 drink/day) (71(62-
75) vs 67(55-74) year, p=0.026). In the moderate drinkers group, HbA1c was lower 
than non or high-drinkers group (6.8(6.4-7.4) vs 7.3(6.7-8.7)%, p=0.021). In univariate 
analyses, smoking, body mass index, age were negatively associated with low HbA1c 
(<7.5%). In contrast, physical activity, insulin therapy, oral diabetic drug and moderate 
wine intake were positively associated with low HbA1c level. In multivariate analyses, 
insulin therapy (OR(95%CI) (0.22(0.07-0.67)) and moderate wine intake (OR(95%CI) 
(0.37(0.13-0.87)) were associated with low HbA1c.
Conclusion: Moderate wine intake was associated with low HbA1c level in diabetic 
patients after AMI, an association not explained by confounding factors. Our ﬁndings 
suggest that patients with high HbA1c may beneﬁt more from the favourable glycemic 
effect of a moderate wine consumption. Further intervention studiesare needed to conﬁrm 
the long-term effect of moderate wine intake in diabetic patient after an AMI.
9:30 a.m.
1031-117 Predictors and Outcomes of the No-Reﬂow 
Phenomenon
Michelle J. Butler, Andrew E. Ajani, Nick Andrianopoulos, David J. Clark, Christopher 
Reid, James Shaw, Angela Brennan, Robert Lew, Anthony M. Dart, Stephen J. Duffy, 
The Alfred Hospital, Melbourne, Australia, Monash University, Melbourne, Australia
Background: The no-reﬂow phenomenon is common and portends a poor prognosis. 
Recent advancements in pharmacological therapies and interventional techniques may 
have reduced this incidence. We aimed to assess contemporary predictors of no-reﬂow 
and the short-term (30-day) outcome of no-reﬂow.
Methods: We analysed data from 5286 patients who underwent PCI from a large registry 
who had 30-day follow up completed.
Results: Patients with transient (n=217) or persistent (n=38) no-reﬂow were more likely to 
present with ST-elevation myocardial infarction (MI) or cardiogenic shock (both p<0.0001). 
They were more likely to have complex lesions, lesions within a bypass graft, require 
an intra-aortic balloon pump, receive glycoprotein-IIb/IIIa inhibition, and have a longer 
mean stent length (all p<0.0001). In-hospital outcomes were signiﬁcantly worse in those 
patients with transient or persistent no-reﬂow with increased death, peri-procedural MI, 
renal impairment and major adverse cardiac events (MACE) (all p<0.0001). Similarly, 
transient or persistent no-reﬂow portends worse 30-day outcomes with graded increases 
in mortality, MI, target vessel revascularisation (TVR), and MACE (see Table).
Conclusions: Despite recent advancements in pharmacological and interventional 
techniques, transient or persistent no-reﬂow remains common and results in graded 
increases in in-hospital and 30-day adverse outcomes.
30-day outcomes for those with or without no-reﬂow
30-day Outcome Normal Flow
Transient No-
Reﬂow
Persistent No-
Reﬂow P-Value
Mortality 1.7% 5.5% 13.2% <0.0001
Cardiac Mortality 1.4% 5.5% 13.2% <0.0001
Myocardial Infarction 2.1% 4.1% 21.1% <0.0001
Target Vessel 
Revascularisation 1.9% 4.6% 13.2% <0.0001
Major Adverse Cardiac 
Events 4.8% 12.9% 36.8% <0.0001
9:30 a.m.
1031-118 Telmisartan Increased Production of Adiponectin 
in Coronary Circulation After Coronary Stenting in 
Hypertensive Patients With Coronary Artery Disease
Junji Kawagoe, Takuroh Imamura, Takeshi Ideguchi, Yasuko Nagoshi, Riichirou 
Kawamoto, Hisamitsu Onitsuka, Toshihiro Tsuruda, Haruhiko Date, Kazuo Kitamura, 
University of Miyazaki, Miyazaki, Japan
Background: We previously reported that adiponectin was produced in the coronary 
circulation, which was signiﬁcantly lesser in patients with than in those without coronary 
artery disease (CAD). It suggests that locally produced adiponectin in the coronary 
circulation may contribute to suppressing the progression of coronary atherosclerosis. 
Angiotensin II type 1 receptor blocker telmisartan is a partial agonist of peroxisome 
proliferator-activated receptor-gamma (PPAR- G), and is reported to increase plasma 
adiponectin level by the effect of partial agonist of PPAR- G. However, the inﬂuence of 
telmisartan on the local production of adiponectin in the coronary circulation is unknown.
Methods: Twenty hypertensive patients with CAD were randomly divided into 2 groups. 
Ten patients were treated with telmisartan (telmisaltan group) and remaining 10 patients 
were treated with antihypertensive drugs except for telmisartan (control group) after 
coronary stenting. Plasma adiponectin levels were measured in blood samples that were 
simultaneously collected from the oriﬁce of the left coronary artery (LCA) and the great 
cardiac vein (GCV) just before and 3 months after coronary stenting. The production of 
adiponectin in the coronary circulation was deﬁned as plasma adiponectin level at GCV 
minus that at LCA.
Results: Plasma adiponectin levels at LCA and GCV did not change between baseline 
and after treatment in 2 groups, respectively. However, adiponectin production in the 
9:30 a.m.
1031-114 Polymorphisms in the Gene Encoding for 
Cyclooxygenase-2 and the Risk of Recurrent 
Atherothrombotic Events
Jeroen Jaspers Focks, Nick Clappers, Martijn GH van Oijen, Wilbert HM Peters, Rene 
HM te Morsche, Hennie MJ Roelofs, Marc A. Brouwer, Joost PH Drenth, Freek WA 
Verheugt, Radboud University Nijmegen Medical Centre, Department of Cardiology, 
Nijmegen, The Netherlands
Background: Multiple single nucleotide polymorphisms (SNP’s) in the gene encoding 
for cyclooxygenase-2 (COX-2) have been identiﬁed. These SNP’s may modify risk of 
atherothrombotic events. The COX-2 G-765C SNP has been associated with decreased 
COX-2 activity and with signiﬁcantly lower odds of a ﬁrst atherothrombotic event. The 
G-1195A SNP on the other hand seems to be correlated with increased COX-2 activity, 
but has not been investigated in relation to atherothrombotic events. Our aim is to 
investigate whether these two functional COX-2 SNP’s are associated with the risk of 
recurrent atherothrombotic events.
Methods: Patients hospitalized between Apr 2002 and Jan 2004 with acute coronary 
syndrome were genotyped for the COX-2 G-765C and G-1195A SNP and followed up to 
July 2008. The primary endpoint was a composite of cardiovascular death, myocardial 
infarction and/or stroke. Multivariate analysis was performed.
Results: We included a cohort of 379 consecutive patients (median age 66 y (IQR 55-
73), 66% were males). Genotyping for the G-765C showed frequencies of 72% GG, 27% 
GC and 1% CC. For the G-1195A frequencies were 5% GG, 35% GA and 60% AA. There 
was strong linkage disequilibrium (D’=-1.0) between both SNP’s. The primary endpoint 
occurred in 82 patients (22%). The unadjusted hazard ratio for the -765GC/CC genotypes 
was 1.33 (95% conﬁdence intervals [CI] 0.84-2.10, p= 0.22) compared with -765GG, the 
adjusted hazard ratio was 1.16 (95% CI 0.72-1.88, p=0.54). Haplotype analysis of the 
combination of -1195- and -765-genotype, revealed no genetic subgroup at signiﬁcantly 
increased risk either.
Conclusions: Previously, the COX-2 G-765C SNP was associated with reduced risk for a 
ﬁrst atherothrombotic event. For the risk of recurrent events we found no effect. In addition 
we studied the combination with the functional G-1195A SNP of COX-2, which did not 
show a signiﬁcant effect on recurrent events either.
9:30 a.m.
1031-115 Noninvasive Indices of Arterial Stiffness in 
Hemodialysis Patients
Kiyo Ueyama, Masaaki Miyata, Takuro Kubozono, Shuichi Hamasaki, Satonori Ueyama, 
Chuwa Tei, Department of Cardiovascular, Respiratory and Metabosic Medicine, 
Kagoshima University, Kagoshima, Japan, Jinaikai Ueyama Hospital, Kagoshima, Japan
Background: The brachial-ankle pulse wave velocity (baPWV) is used to evaluate 
the degree of atherosclerosis and arterial stiffness. The major limitation of baPWV is 
that it is affected by changes in blood pressure (BP) during measurement. Recently, a 
novel atherosclerotic index, Cardio-Ankle Vascular Index (CAVI) has been developed by 
measuring PWV and BP. CAVI is adjusted for BP based on the stiffness parameter B and 
is expected to measure arterial stiffness independent of BP. The purpose of this study is 
to evaluate the validity of baPWV and CAVI in hemodialysis (HD) patients.
Methods: We studied 160 consecutive HD patients (mean age: 59 ± 13 years; 91 male 
and 69 female). CAVI was automatically calculated based on the pulse volume record, 
BP, and the vascular length from heart to ankle. We measured baPWV and CAVI using 
VaSera VS-1000, intima-media thickness (IMT) of carotid artery by ultrasonography, and 
laboratory data of blood samples. As a control, baPWV and CAVI were measured in age 
and gender matched health volunteers.
Results: Both baPWV and CAVI in HD patients were signiﬁcantly higher than those in 
control (baPWV: control vs. HD=1454±263 vs. 1698±355, P<0.0001; CAVI: control vs. 
HD=8.9±1.2 vs. 9.3±1.4, P<0.01). baPWV demonstrated a positive correlation with age 
(r=0.549, P<0.0001), systolic BP (SBP) (r=0.510, P<0.0001), diastolic BP (r=0.203, 
P<0.0001), pulse pressure (PP) (r=0.499, P<0.0001), Brinkman index (r=0.186, P<0.05) 
and IMT (r=0.285, P<0.001). CAVI showed a positive correlation with age (r=0.562, 
P<0.0001), SBP (r=0.395, P<0.0001), PP (r=0.490, P<0.0001), Brinkman index (r=0.238, 
P<0.01)and IMT (r=0.280, P<0.001). Multiple regression analysis demonstrated baPWV 
and CAVI independently correlated with age and SBP. Furthermore, in order to analyze 
the effect of BP changes on baPWV and CAVI, we measured these two indices at the 
two time points which showed a change in SBP more than 10 mmHg. Although baPWV 
increased in proportion to the increase in SBP, CAVI did not show a signiﬁcant change 
between the two measurements.
Conclusions: Both baPWV and CAVI are useful indices of arterial stiffness in HD 
patients. Specially, CAVI is not inﬂuenced by BP changes during measurement.
9:30 a.m.
1031-116 Moderate Wine Consumption and Glycated Haemoglobin 
Level in Diabetic Patients After an Acute Myocardial 
Infarction: A Prospective Observational Study
Pierre Sicard, Michel Farnier, Jack Ravisy, Charlotte Pernet-Gallay, Jean Claude Beer, 
Hamid Makki, Anne Cécile Lagrost, Michel Vincent-Martin, Yves Laurent, Luc Rochette, 
Marianne Zeller, Yves Cottin, RICO survey, Hospital University, Dijon, France, University 
of Burgundy, Dijon, France
Introduction: After acute myocardial infarction (AMI), glycemic control is a major 
determinant of the prognosis. Light to moderate wine intake may have beneﬁcial effects 
on the evolution of cardiovascular diseases. The aim of this prospective observational 
study was to investigate the association between moderate wine consumption and 
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Predicting Coronary Microcirculatory Dysfunction
Test N % (+) Sensitivity(95% CI)
Speciﬁcity
(95% CI)
Negative 
Predictive 
Value
(95% CI)
Positive 
Predictive 
Value
(95% CI)
Exercise Echocardiogram 99 40.4 38 (26, 51) 55 (38, 71) 36 (24, 49) 58 (41, 73)
Dobutamine 
Echocardiogram 21 33.3 29 (8, 58) 57 (18, 90) 29 (8, 58) 57 (18, 90)
Exercise Single Photon 
Emission Computed 
Tomography
131 38.2 40 (29, 51) 65 (49, 78) 38 (28, 50) 66 (51, 79)
Vasodilator Single Photon 
Emission Computed 
Tomography
64 50.0 51 (35, 68) 52 (31, 72) 41 (24, 59) 63 (44, 79)
Vasodilator Positron 
Emission Tomography 33 36.4 35 (16, 57) 60 (26, 88) 29 (11, 52) 67 (35, 90)
All imaging 365 41.4 41 (34, 47) 57 (49, 66) 36 (30, 43) 62 (54, 70)
Exercise 
Electrocardiogram 242 16.1 18 (12, 25) 80 (71, 88) 41 (33, 48) 69 (52, 83)
All imaging + 
Electrocardiogram 365 6.3 6 (3, 10) 90 (83, 94) 37 (32, 43) 61 (39, 80)
9:30 a.m.
1031-121 Impaired Endogenous Thrombolysis: A Novel Predictor 
of Recurrent Cardiovascular Events in Patients With 
Acute Coronary Syndrome
Smriti Saraf, Sumeet Sharma, Imen Ben Salha, David Wellsted, Diana A. Gorog,
Imperial College, London, United Kingdom, East & North Hertfordshire NHS Trust, 
Welwyn Garden City, United Kingdom
Background: ACS patients are at increased risk of CV events, despite optimal antiplatelet 
medication. Thrombotic events depend on the propensity for thrombus formation and 
the efﬁcacy of endogenous thrombolytic activity in preventing lasting arterial occlusion. 
Until recently, there has been no physiological test available to assess endogenous 
thrombolytic activity.
Methods: We measured endogenous thrombolytic status (Lysis Time, LT) in 214 ACS 
patients using the Global Thrombosis Test (GTT), a novel near-patient test which 
measures spontaneous thrombolysis in native blood (lysis of a platelet-rich thrombus in 
the absence of added plasminogen activators). Patients receiving aspirin and clopidogrel 
for q48 h were tested during their index admission and followed up for MACE (composite 
of recurrent ACS, stroke or CV death) over 253±11 d.
Results: LT in ACS patients showed a bimodal distribution when compared to healthy 
volunteers (Fig 1a). Majority of ACS patients had LT<5000s (Group1, 84%), but a second 
peak was seen at LT>5000s (Group 2, 16%). Using survival analysis (Fig 1b), MACE 
occurred in 40% of patients with LT>5000s compared to 14.6% in those with LT<5000s. 
Impaired LT was associated with increased MACE, with RR:2.7, and a hazard ratio of 
2.33 (p=0.006). Mean time to event was 125±19 d.
Conclusions: Endogenous thrombolytic activity is an important predictor of MACE. This 
could prove valuable in risk stratiﬁcation of ACS patients and therapeutic modulation of 
thrombolytic status in those at risk. 
9:30 a.m.
1031-122 Arterial Stiffness, Wave Reﬂection Amplitude and Left 
Ventricular Afterload Are Increased in Overweight 
Individuals
Wilmer W. Nichols, Aashish K. Desai, Scott Denardo J. Denardo, University of Florida, 
Gainesville, FL
Introduction: Reﬂected blood pressure (BP) waves from the lower body augments 
central systolic BP and increases left ventricular (LV) afterload and myocardial oxygen 
demand. Such changes are due to increased arterial stiffness and elevated pulse wave 
velocity (PWV). Overweight and obesity are risk factors for cardiovascular disease and 
coronary circulation in telmisaltan group was signiﬁcantly increased than that in control 
group (0.49 ± 0.28 μg/mL vs. -0.38 ± 0.28 μg/mL; p=0.039). Additionally, the change in 
body weight during 3 months signiﬁcantly correlated with that in adipoectin level at LCA 
(r=0.864, p=0.001) and GCV (r=0.675, p=0.033), respectively, in telmisaltan group, but 
not in control group.
Conclusions: Telmisartan increased adiponectin production in the coronary circulation 
of hypertensive patients with CAD. This result may be explained, at least in part, by the 
effect of PPAR- G with telmisartan.
9:30 a.m.
1031-119 Expression Proﬁling of the Vascular Endothelium in 
Patients With Heart Failure Using a Novel Methodology: 
Human Endothelial Sampling Coupled With Microarray 
Analysis
Paolo C. Colombo, Duygu Onat, Moritz Kebschull, Andrea Mignatti, Jenny Z. Xiang, 
Loredana Bucciarelli, Tessa Adams, Stathi Georgiou, Sanja Jelic, Ulrich P. Jorde, Panos 
N. Papapanou, Columbia University, New York, NY
Background: In humans, determination of endothelial function relies on measurement of 
endothelium-dependent vasodilation and circulating endothelial progenitor cells (EPCs). 
Both techniques have disclosed fundamental abnormalities in heart failure (HF); however, 
neither can identify the molecular events underlying these abnormalities. Herein, we 
introduce endothelial cell (EC) sampling coupled with gene expression proﬁling as a new 
method to characterize the pathobiology of endothelial dysfunction in HF. 
Methods: 5 ambulatory pts with non-ischemic HF (age 47±8 yrs) and 5 age-matched 
healthy subjects were studied. ECs were collected from arm veins using endovascular 
wires. ECs were puriﬁed; ampliﬁed RNA was hybridized with Affymetrix HG-U133 2.0. 
Endothelium-mediated dilation was measured by peripheral arterial pletismography; 
EPCs by FACS. Results: No adverse events were observed. 1,293 probe sets were 
differentially expressed in HF vs. health (F.D.R. <0.05). Gene ontology analysis identiﬁed 
16 differentially expressed classes linked to inﬂammation, immunity, and kinase signaling 
(Figure). Endothelium-mediated dilation and EPCs were lower in HF. Conclusions: We 
documented feasibility, safety, and potential clinical relevance of endothelial expression 
proﬁling in HF. This novel approach may identify processes relevant to the pathobiology of 
endothelial dysfunction in HF, disclose yet unrecognized biologic pathways and generate 
novel hypotheses to be tested further.
9:30 a.m.
1031-120 Lack of Correlation between Noninvasive Stress Tests 
and Invasive Coronary Microcirculatory Dysfunction in 
Patients With Nonobstructive Coronary Artery Disease
Andrew Cassar, Panithaya Chareonthaitawee, Charanjit S. Rihal, Abhiram Prasad, Ryan 
J. Lennon, Lilach O. Lerman, Amir Lerman, Mayo Clinic, Rochester, MN
Background: Despite a non-obstructive coronary angiogram, many patients may still have 
an abnormal coronary microcirculatory response to provocation and to myocardial demand 
during stress. The ability of non-invasive stress tests to predict coronary microcirculatory 
dysfunction (CMD) in patients with non-obstructive coronary artery disease is unknown.
Methods: All patients with non-obstructive coronary artery disease who had invasive 
coronary microcirculatory assessment and a non-invasive stress test (exercise ECG, stress 
echocardiography or stress nuclear imaging) within 6 months of the cardiac catheterization 
with provocation at our institution were identiﬁed (n=376). CMD was deﬁned as an increase 
in coronary blood ﬂow of a50% to intracoronary acetylcholine and/or a coronary ﬂow reserve 
ratio of a2.5 to intracoronary adenosine. We determined the sensitivity and speciﬁcity of 
various non-invasive stress tests to predict CMD in these patients.
Results: On invasive testing, 233 patients (63%) had CMD. The non-invasive stress tests 
had limited diagnostic accuracy for predicting CMD (Table). The exercise ECG test was 
more speciﬁc but less sensitive than the imaging tests.
Conclusions: The current study suggests that a negative non-invasive stress test does 
not rule out invasive CMD in symptomatic patients with non-obstructive coronary artery 
disease. This underscores the need for invasive assessment or novel more sensitive non-
invasive imaging for these patients.
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for controls) (latest levels). Univariate and multivariate odds ratios were estimated using 
conditional logistic regression.
Results: In univariate analyses log10 transformed baseline levels hsCRP, IL-6, and D-dimer 
were signiﬁcantly associated with a cardiovascular disease event. Odds ratios (ORs) 
associated a higher level corresponding to the inter-quartile range and (p-values) were 
1.4 (p=0.03) for hs-CRP, 1.6 (p=0.0005) for IL-6, and 1.5 (p=0.01) for D-dimer respectively. 
For IL-6 and D-dimer, signiﬁcant associations remained after adjustment for cardiovascular 
disease risk factors. Latest levels of D-dimer were also associated with an increased risk of 
cardiovascular disease independent of baseline levels (OR= 1.8; p=0.02).
Conclusions: Among HIV patients with relatively preserved CD4+ counts, elevated 
baseline levels of IL-6 and D-dimer were signiﬁcantly related to cardiovascular disese 
events independent of other cardiovascular disease risk factors.
ACC.POSTER CONTRIBUTIONS
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Orange County Convention Center, West Hall D
3:30 p.m.
1040-93 Hypertensive Retinal Damage and Aortic Stiffness: 
Micro and Macroangiopathy Weave Through Essential 
Hypertension
Vasiliki Katsi, George Souretis, Evangelos Chatzistamatiou, Ioannis Skiadas, 
Emmanouil Androulakis, George Moustakas, Christodoulos Stefanadis, Ioannis 
Kallikazaros, Hippocratio Hospital, Athens, Greece
Background: The clinical and prognostic signiﬁcance of hypertensive retinal changes, 
an established hypertension-related target organ damage (TOD), remains controversial. 
Therefore, we sought to investigate the relationship of retinal alterations with the 
aortic stiffness, an index strongly correlated to increased cardiovascular morbidity and 
mortality.
Methods: Our population consisted of 268 consecutive newly diagnosed, untreated 
essential hypertensives (aged= 60±13 years, 151 female, ofﬁce blood pressure= 152/90 
mmHg), without any history of cardiovascular disease or any other evident comorbidity. 
Blood samples were drawn for determination of metabolic proﬁle and ambulatory blood 
pressure monitoring (ABPM) was performed to all participants. All subjects underwent 
fundoscopy examination and were distributed to ﬁve groups according to Sheie’s grading 
system. (Groups A, B, C, D and E , for Sheie’s scale 0, I, II , III and IV, respectively). Aortic 
stiffness was evaluated, on the basis of carotid to femoral pulse wave velocity (c-f PWV) 
by means of a computerized method (Complior SP).
Results: The ﬁve groups (including 39, 87, 99, 35 and 8 subjects respectively) did not 
differ with regard to age, sex, mean blood pressure and their metabolic proﬁle (fasting 
glucose, serum lipids, uric acid) as well. However, hypertensives of higher Scheie’s 
category exhibited signiﬁcantly greater values of c-f PWV (8±1.3 , 9.1±1.8 , 9.4±2.1, 9.8±2 
and 9.9±2.4 m/sec respectively, p=0.005). Notably, there was a statistically signiﬁcant 
difference on pulse pressure among groups (53mmHg, 60mmHg, 63mmHg, 65 mmHg 
and 67, respectively) (p=0.04), another surrogate marker of arterial stiffness.
Conclusions: In hypertensive subjects there is a progressive stiffening of the aorta 
in parallel with the evolution of the fundus lesions according to Scheie’s scale. The 
pathophysiological substrate of these mechanisms remain unclear and further validation 
through large scale studies is necessary.
3:30 p.m.
1040-94 Left Ventricular Hypertrophy Is Accompanied by a State 
of Pronounced Endothelial Dysfunction, Inﬂammatory 
Activation and Arterial Stiffening in Essential 
Hypertension
Dimitris Syrseloudis, Costas Tsiouﬁs, Kyriakos Dimitriadis, Eirini Andrikou, Ioannis 
Andrikou, Panagiotis Tolis, Elli Stefanadi, Antigoni Miliou, Christodoulos Stefanadis, First 
Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece
Background: Endothelial dysfunction, low-grade inﬂammation and arterial stiffening are 
associated with adverse cardiovascular outcome, while left ventricular (LV) hypertrophy 
is an independent risk factor. We examined the interrelationship between augmented LV 
mass, high-sensitivity C-reactive protein (hs-CRP), asymmetric dimethylarginine (ADMA) 
and arterial stiffness in essential hypertensives.
Methods: Our population consisted of 195 newly diagnosed untreated non-diabetics with 
stage I to II essential hypertension [107 men, mean age=51 years, ofﬁce blood pressure 
(BP)=149/96 mmHg] that underwent echocardiographic examination and according to 
gender-speciﬁc criteria were divided into those with LV hypertrophy (n=73) and those 
with normal LV mass (n=122). Arterial stiffness was evaluated on the basis of carotid to 
femoral pulse wave velocity (PWV), by means of a computerized method (Complior SP).
Results: Patients with LV hypertrophy compared to those without LV hypertrophy were 
older (53±5 vs 44±6 years, p<0.005) and had greater 24-h systolic BP (139±10 vs 132±12 
mmHg, p<0.001). In the total population hs-CRP was associated with body mass index 
(r=0.278, p<0.0001), 24-h systolic BP (r=0.146, p<0.05), ADMA (r=0.188, p<0.05) and 
PWV (r=0.244, p<0.0001). Moreover, PWV was associated with age (r=0.371, p<0.0001), 
are known to increase arterial stiffness.
Hypothesis: Reﬂected BP waves from the periphery to the heart in overweight subjects 
return early and augment aortic systolic BP and LV afterload.
Methods: Radial artery BP waveforms were recorded by applanation tonometry and 
central aortic waveforms generated using a transfer function. Augmentation index (Al
a
)
and amplitude and timing of the reﬂected BP wave and LV wasted effort (E
w
) were 
calculated from the aortic BP waveform. Data were collected in 88 (age 53±17, mean±SD) 
overweight (BMI 30±5.0 kg/m2) subjects and compared to data collected from 88 normal 
weight (BMI 23±2.0, P<0.001) control subjects matched for gender, age, height, heart 
rate and ejection duration. Carotid-femoral PWV was assessed in a subgroup of 22 
overweight and 22 matched controls.
Results: Compared to controls, overweight subjects had higher brachial systolic (134±18 
vs 126±15 mmHg, P<0.002), mean (98±18 vs 94±9.8 mmHg, P<0.003 and pulse (58±19 
vs 50±12 mmHg, P<0.007) BP. Increased BMI was associated with an increase in aortic 
PWV (12±3.8 vs 9.8±3.1 M/sec, P<0.03), Al
a
 (28±9.3 vs 20±12%, P<0.001), reﬂected 
wave duration (176±28 vs 159±30 msec, P<0.004) and E
w
 (2516±1714 vs 1491±1368 
dsc−2, P<0.001) and a decrease in reﬂected wave travel time (67±7.0 vs 72±7.5 msec, 
P<0.001). These modiﬁcations in wave reﬂection characteristics in overweight subjects 
were associated with an increase in aortic systolic (124±17 vs 114±14 mmHg, P<0.001) 
and pulse (44±12 vs 37±12 mmHg, P<0.001) BP.
Conclusions: Overweight subjects have a stiffer arterial system which increases 
elastic artery PWV and causes the reﬂected BP wave to arrive earlier at the heart 
with increased amplitude and duration. Theses changes in arterial function and wave 
reﬂection characteristics cause an increase in LV afterload, myocardial oxygen demand 
and wasted LV effort.
9:30 a.m.
1031-123 Comparative Reproducibility of Noninvasive Ultrasound 
Methods for the Assessment of Vascular Function
Dragos Vinereanu, Andrea Ciobanu, Stefania Magda, Claudiu Stoicescu, Mircea 
Cinteza, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
Ultrasound assessment of vascular function is recommended by the current guidelines. 
However, to be clinically applicable, this has to be reproducible. So far, there are no 
enough data available regarding the comparative reproducibility of vascular function 
parameters. Methods: 15 patients (48±15 yrs, 6 men) had assessment (acquisition and 
measurement) of vascular function, performed by 2 observers, at the level of the right 
common carotid artery (“e-tracking” and “wave intensity analysis” with measurement of 
intima-media thickness - IMT, augmentation index - AIx, and ventriculo-arterial interaction 
parameters, “ﬁrst peak” - FP, “second peak” - SP, “negative area” - NA, B index of 
stiffness, and Young elastic module - EP); and at the level of the right brachial artery 
(ﬂow mediated dilation - FMD). Meanwhile, pulse wave velocity (PWV) was assessed 
(Complior method). Intra- and inter- observer reproducibility was measured during a ﬁrst 
SESSION WHEN  CONSECUTIVE ACQUISITIONS WERE MADE ST OBSERVER w ND OBSERVER w ST 
observer); repeatability was evaluated 1 week later, during a 4th examination. Results:
Coefﬁcients of variation (CV) are reported in the table. The most reproducible and 
repeatable parameters were PWV, IMT, and B index.Conclusion: Ultrasound assessment 
of vascular function has a good reproducibility and repeatability only for some of the 
currently recommended parameters. This should be taken into consideration when these 
methods are implemented in routine clinical practice.
CVs of vascular function parameters
Parameter Intraobserver variability Interobserver variability Repeatability
IMT +/- 6.3% +/- 7.2% +/- 8.0%
AIx +/- 17.7% +/- 8.5% +/- 36.5%
FP +/- 11.5% +/- 12.7% +/- 21.7%
SP +/- 14.5% +/- 25.3% +/- 29.8%
NA +/- 8.7% +/- 35.9% +/- 54.0%
Beta +/- 8.8% +/- 11.2% +/- 7.6%
EP +/- 6.5% +/- 10.4% +/- 10.4%
FMD +/- 18.5% +/- 10.8% +/- 9.8%
PWV +/- 4.4% +/- 4.2% +/- 4.5%
9:30 a.m.
1031-124 Inﬂammation, Coagulation and Cardiovascular Disease 
in the Strategies Management of Antiretroviral Therapy 
(SMART) Study
Daniel A. Duprez, INSIGHTSMARTGroup, University of Minnesota, Minneapolis, MN
Background: Advances in treatments for HIV have resulted in substantially increased 
life expectancy for individuals infected with HIV and cardiovascular disease has become 
a major problem in these patients. In the Strategies for Management of Anti-Retroviral 
Therapy (SMART) study, (5,472 HIV patients enrolled) intermittent use of antiretroviral 
therapy (ART) was associated with an increased risk of cardiovascular disease compared 
to continuous use of ART. We hypothesized that the 136 HIV patients in the SMART 
study who developed a cardiovascular disease event would have higher inﬂammatory and 
thrombotic/ﬁbrinolytic biomarker levels compared to those who did not
Methods: Using stored plasma samples from the 136 HIV patients (median age 49 
years, 20.6 % female) who had a cardiovascular disease event and 270 controls matched 
for age, gender, country and date of randomization, high sensitivity C-reactive Protein 
(hsCRP), interleuking-6 (IL-6), amyloid A, amyloid P, D-dimer, and prothrombin fragment 
1+2 were measured at baseline and at the visit prior to the event (same follow-up visit 
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absolute area change divided by carotid pulse pressure, respectively, using both diameter 
and LAC to measure area change.
Results: Distensibility and compliance by the LAC correlated better with determinants of 
carotid stiffness (age, SBP and IMT) than by the diameter method (Fig. 1).
Conclusion: In healthy individuals, CCA stiffness by LAC correlated better with age, 
systolic Bp and IMT than the conventional method.
* The two authors contributed equally to this study.
3:30 p.m.
1040-97 Relationship Between Circulating Levels of RANTES 
(Regulated on Activation, Normal T-Cell Expressed and 
Secreted) and Carotid Plaque Characteristics in the 
ARIC Carotid MRI Study
Salim S. Virani, Vijay Nambi, Ron C. Hoogeveen, Eric Boerwinkle, Bruce A. Wasserman, 
Gerardo Heiss, Josef Coresh, Lloyd E. Chambless, Thomas H. Mosley, Jr., Christie M. 
Ballantyne, Baylor College of Medicine, Houston, TX
Background: CCL5 or RANTES (regulated on activation, normal T-cell expressed, and 
secreted) is a CC chemokine stored in platelet alpha granules and mediates migration 
of mononuclear leucocytes into intima. There are limited data regarding how RANTES 
correlates with carotid atherosclerosis, and plaque characteristics.
Methods: High resolution gadolinium enhanced magnetic resonance imaging (MRI) 
using a 1.5 T magnet, of the carotid artery was performed in 1901 participants in The 
Atherosclerosis Risk in Communities (ARIC) Study. Measurements of wall thickness, wall 
volume, lipid core volume, and ﬁbrous cap thickness by MRI and plasma RANTES levels 
by ELISA were performed. Regression analysis was performed.
Results: Of 1769 participants with sufﬁcient quality scans and adherence to MRI protocol 
who were included, multivariate regression analysis revealed that total wall volume, 
maximum wall thickness, vessel wall area, and hs-CRP were positively associated with 
plasma RANTES levels. Mean segmental cap thickness, and mean minimum ﬁbrous cap 
thickness were also positively associated, though presence of lipid rich core showed a 
negative association with plasma RANTES levels (please see attached table).
Conclusions: Increasing plasma RANTES levels are positively associated with extent of 
carotid atherosclerosis, thick ﬁbrous caps, and hs-CRP, but inversely with the presence 
of lipid rich core on carotid MRI.
24-h systolic BP (r=0.248, p<0.0001) and ADMA (r=0.281, p<0.0001). Although the two 
groups did not differ regarding body mass index, smoking status and lipid levels (p=NS 
for all), hypertensives with LV hypertrophy as compared to those without exhibited higher 
levels of hs-CRP (3.1±0.5 vs 2.2±0.4 mg/l, p<0.05), ADMA (0.58±0.02 vs 0.51±0.04 
μmol/l, p<0.0001) and PWV (8.7±1.1 vs 7.6±1.3 m/sec, p<0.05). Analysis of covariance 
revealed that hs-CRP, ADMA and PWV values remained signiﬁcantly different between 
groups after adjustment for confounders (p<0.05).
Conclusion: LV hypertrophy in essential hypertensives is accompanied by pronounced 
inﬂammatory activation, endothelial dysregulation and impaired arterial properties. These 
ﬁndings may partially explain the augmented risk associated with LV hypertrophy in this 
setting.
3:30 p.m.
1040-95 Inﬂuence of Metabolic Syndrome on Cardiac Structure 
and Function and Arterial Stiffness in Healthy Children
Walter P. Abhayaratna, Satoru Sakuragi, Katrina Abhayaratna, Christine O’Reilly, Paul 
Waring, Richard D. Telford, Canberra Hospital, Canberra, Australia, Australian National 
University, Canberra, Australia
Background: There is limited information regarding the impact of clustered risk factors 
in metabolic syndrome (MetS) on cardiovascular phenotype in young children. In this 
community-based study of healthy children, we determined the association between 
MetS and cardiac structure and carotid-femoral pulse wave velocity (PWV), an index of 
central arterial stiffness.
Methods: Four hundred and thirty-nine non-diabetic children (mean age 10.1 ± 0.3 
years; 51% boys) underwent clinical examination, a fasting blood test, and assessment of 
cardiac structure and function by echocardiography. Cardiorespiratory ﬁtness and physical 
activity levels were determined using a 20 meter shuttle run and 7-day pedometer count, 
respectively. PWV was estimated by applanation tonometry. Classiﬁcation of MetS status 
was based on previously published criteria for children, including age- and sex-speciﬁc 
reference limits for waist circumference and blood pressure.
Results: Of the 8 (1.8%) subjects with 3 or more MetS components, 7 were girls (Table). 
Subjects with MetS components had higher body mass index and insulin levels, and 
lower cardiorespiratory ﬁtness. In multivariable analysis, MetS was positively associated 
with left atrial and ventricular volumes, left ventricular mass, pulse pressure and PWV (all 
p<0.01), independent of gender and cardiorespiratory ﬁtness.
Conclusion: MetS is associated with altered cardiac structure and increased arterial 
stiffness in healthy prepubescent children. 
Table: Characteristics of Study Participants
Metabolic Syndrome Score
0 1-2 3+
(n=330) (n=101) (n=8) p-value
Girls (%) 48.8 46.5 87.5 0.08
Pedometer count (steps^0.5) 99 97 99 0.28
Cardiorespiratory ﬁtness (Stage) 5.3 4.6 3.5 <0.001
Percentage body fat by DXA (%) 24 32 38 <0.001
Body mass index (kg/m2) 17.2 20.8 25.9 <0.001
Insulin (mU/L) 6 11 18 <0.001
HOMA-IR 1.4 2.4 3.9 <0.001
Heart rate (bpm) 77 79 74 0.36
Systolic BP (mmHg) 105 111 115 <0.001
Pulse pressure (mmHg) 44 47 50 <0.001
Pulse wave velocity (m/s) 4.3 4.6 4.6 <0.001
Left ventricular mass (g/m^2.7) 32 34 37 <0.001
Left end-diastolic volume 46 51 51 <0.001
Left atrial volume (mL/m^2.7) 9 10 12 0.01
Left ventricular ejection fraction (%) 62 62 62 0.29
Early diastolic mitral annular velocity (m/s) 0.18 0.18 0.17 0.20
Estimate of left ventricular ﬁlling pressure (E/e’) 5.5 5.6 6.2 0.04
:
3:30 p.m.
1040-96 Luminal Area Change by Multimodality Tissue Tracking 
Ultrasonography - A New Noninvasive Method for 
Assessment of Carotid Artery Function
Wen-Chung Yu, Thomas M. Helle-Valle, Alban Redheuil, Joao A.C. Lima, Johns Hopkins 
University, School of Medicine, Baltimore, MD
Background: Stiffness of the common carotid artery (CCA) is an early markers of CVD. 
Distensibility and compliance, which reﬂect the relationship between vessel distension 
and pulse pressure, are measures of arterial stiffness. However, assessment of vessel 
distension are limited to 1-dimensional measures of diameter by ultrasound. We have 
recently introduced and validated multimodality tissue tracking (MTT) as a new, simple 
method for 2-dimensional quantiﬁcation of cardiac and vascular deformation. We 
hypothesize that luminal area change (LAC) by MTT is superior to diameter changes for 
assessment of CCA stiffness.
Methods: In 23 healthy individuals (age 22-69), systolic Bp was an average of 6 
measurements and carotid Bp was calculated using tonometry. Long- and short-axis 
recordings of the right CCA were obtained by ultrasound. LAC was automatically calculated 
by MTT pattern-matching algorithm (Fig. 1). Diameters and IMT were measured from 
long-axis recordings. Distensibility and compliance were calculated as proportional and 
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1040-100 Similar Aortic Stiffness but Decreased Wave Reﬂections 
in Human Immunodeﬁciency Virus Infected Naive 
Patients: The Role of Subclinical Inﬂammation
Dimitris Tsiachris, Chalalambos Vlachopoulos, Helen Sambatakou, Ilias Mariolis, 
Nikos Ioakeimidis, Dimitris Terentes, Katerina Baou, Athanasios J. Archimandritis, 
Christodoulos Stefanadis, 1st Cardiology Clinic, University of Athens, Hippokration 
Hospital, Athens, Greece, 2nd Department of Internal Medicine, University of Athens, 
Hippokration Hospital, Athens, Greece
Background: The pathogenesis of increased cardiovascular risk in human 
immunodeﬁciency virus (HIV) infected patients and the role of HIV infection, per se, 
as a risk factor for accelerated arteriosclerosis remains questionable. Our aim was to 
investigate the impact of HIV infection on vascular properties along with markers of 
subclinical inﬂammation in HIV naive (untreated) patients.
Methods: We studied 55 HIV-infected naive patients but without AIDS (aged 33 years, 
52 males, 30 smokers) and 31 healthy individuals matched for age, sex and smoking 
status. Aortic augmentation index (AIx) and augmented pressure (AP) were assessed 
using applanation tonometry of the radial artery. Carotid femoral pulse wave velocity 
(PWV) was estimated by means of an automated method (Complior SP). Moreover, in all 
subjects venous blood samples were drawn for estimation of high-sensitivity C-reactive 
protein (hs-CRP), interleukin-6 (IL-6).
Results: HIV patients compared to controls had lower diastolic brachial blood pressure 
(BP) (by 4.8 mmHg, p=0.003), higher brachial pulse pressure (by 3.7 mmHg, p=0.045), 
decreased aortic systolic and diastolic BP (by 4.6 mmHg, p=0.049, and by 5.7 mmHg, 
p=0.017), while there was no difference in aortic pulse pressure and PWV values. In 
addition, heart rate was increased (by 6.4 bpm, p=0.012) and AIx along with AP were 
decreased (by 6.4%, p=0.048 and by 3.3 mmHg, p=0.010) in subjects with HIV infection. 
HIV-infected patients compared with controls had signiﬁcantly increased values of log 
hs-CRP (p=0.007) and log IL-6 (p=0.048).
Conclusions:HIV infected naive patients without AIDS compared with controls are 
characterized by similar values of large artery stiffness and decreased wave reﬂections. 
Peripheral vasodilatation is suggested to be the predominant mechanism, induced 
probably by the chronic subclinical inﬂammation as reﬂected by increased inﬂammatory 
markers in this setting. These ﬁndings provide further insight into the pathogenesis of 
HIV-related cardiovascular risk.
3:30 p.m.
1040-101 The Short-Term Effect of Tea Consumption on Aortic 
Stiffness and Wave Reﬂections
Nikolaos Alexopoulos, Charalambos Vlachopoulos, Katerina Baou, Dimitrios Terentes-
Printzios, Konstantinos Aznaouridis, Nikolaos Ioakeimidis, Ioanna Dima, Christodoulos 
Stefanadis, Athens Medical School, Hippokration Hospital, Athens, Greece
Background: Tea consumption has been associated with reduced cardiovascular risk. 
Tea consumption has beneﬁcial effect on endothelial function, which is mainly attributed 
to its ﬂavonoid content. On the other hand, tea acutely increases blood pressure, aortic 
stiffness, and wave reﬂections, mainly due to its caffeine content. We aimed at evaluating 
the short-term effect of tea on aortic stiffness and wave reﬂections.
Methods: Twelve healthy individuals (age 31.5±3.5, 6 males, 6 smokers) were studied in 
a randomized single-blind crossover design at the beginning and at the end of a 2-week 
consumption of: i) black tea (6 g/day), ii) green tea (6 g/day), and iii) placebo (hot water). 
Carotid-femoral pulse wave velocity (PWV) was measured as an index of aortic stiffness 
using the Complior® device. Augmentation Index (AIx) was measured as an index of 
wave reﬂections using the SphygmoCor® device. The central (aortic) pressures were also 
calculated by the SphygmoCor® device.
Results: Both black and green tea reduced PWV compared to placebo (by 0.42 and 0.32 
m/sec, 2<0.05 for both, left ﬁgure). Furthermore, both black and green tea reduced AIx 
(by 3.7 and 3.4%, 2<0.05 and 2<0.01 respectively, right ﬁgure). Neither black nor green 
tea had any effect on brachial or aortic blood pressure.
Conclusions: Both black and green tea short-term consumption reduces aortic stiffness 
and wave reﬂections in healthy individuals. These ﬁndings may account for the beneﬁcial 
effect of tea consumption on cardiovascular risk.
3:30 p.m.
1040-98 Albuminuria Within Normal Range Correlates With 
Ambulatory Arterial Stiffness Index and Endothelial 
Dysfunction in Hypertensives: A Cross-Sectional Study
Alexandros Kasiakogias, Costas Tsiouﬁs, Costas Thomopoulos, Dimitris Syrseloudis, 
Ioannis Andrikou, Giorgos Metallinos, Panagiotis Tolis, Kostas Toutouzas, Dimitris 
Tousoulis, Christodoulos Stefanadis, First Cardiology Clinic, University of Athens, 
Hippokration Hospital, Athens, Greece
Background: We investigated the correlations between diverse surrogates of vascular 
dysfunction and arterial stiffness by means of ambulatory arterial stiffness index (AASI) 
in hypertensives.
Methods: 264 consecutive untreated hypertensives (aged 48±6 years, 176 males, 
133 smokers, ofﬁce BP 149±12/96±8mmHg) were studied. Subjects underwent 
echocardiography and ambulatory BP monitoring while 24 hour, daytime and nighttime 
AASI (24hAASI, dAASI, nAASI) were estimated. From a morning blood sample a full 
metabolic proﬁle and asymmetric dimethyl-arginine (ADMA) levels were estimated while 
from serum creatinine glomerular ﬁltration rate (GFR) was assessed. Finally from two 
non consecutive morning urine samples albumin/creatinine ratio (ACR) was measured 
and subjects were divided in those with high and those with low ACR levels (cut-off point 
10.04 mg/mmol).
Results: Hypertensives with high compared to those with low ACR levels demonstrated 
higher levels of logADMA and triglycerides (-0.25±0.08 vs. -0.30±0.09 p=0.001 and 167±66 
vs. 142±68mg/dl, p=0.006, respectively). Hypertensives with high compared to those with 
low ACR levels did not differ regarding age (47±7 vs. 48±5 years), sex (60 vs. 63% men), 
body mass index , (29.8±3 vs. 29.2±3 kg/m2), smoking status (52% vs. 50%) and 24h 
systolic/diastolic BP (138±7 vs. 139±7, 85±6 vs. 85±7, respectively), metabolic proﬁle and 
eGFR (p=NS for all). The two groups did not differ regarding 24hAASI and dAASI (0.38±0.03 
vs. 0.38±0.04 and 0.37±0.04 vs. 0.37±0.06, respectively, p=NS for both) while nAASI was 
increased in hypertensives with higher ACR (0.39±0.04 vs. 0.37±0.07, p=0.002). LogACR 
was correlated with age (r=0.19, p=0.004), body mass index (r=0.15, p=0.023), 24h systolic 
BP (r=0.29, p<0.001), dAASI (r=0.16, p=0.01), nAASI (r=0.15, p=0.02), and logADMA 
(r=0.25, p<0.0001). By applying a multivariate model independent predictors of increased 
ACR levels were nAASI, ADMA and 24h systolic BP (R2=0.27, p<0.001).
Conclusions: Increased levels of urinary albumin excretion even within normal range are 
associated with the nighttime component of ambulatory arterial stiffness and ADMA.
3:30 p.m.
1040-99 Combined Effects of Atorvastatin and Metformin on 
Post-Glucose Loading Levels of sE-Selectin and Tumor 
Necrosis Factor-A, in Patients With Diabetes Mellitus
Aikaterini Konniari, Dimitris Tousoulis, Charalambos Antoniades, Aggeliki Nikolopoulou, 
Anna-Maria Kampoli, Costas Tentolouris, Elli Stefanadi, Alexios Antonopoulos, 
Gerasimos Siasos, George Latsios, Antigoni Miliou, Christodoulos Stefanadis, 1st 
Cardiology Department, Hippokration Hospital, Athens Medical School, Athens, Greece
Background: Statin treatment improves survival in patients with atherosclerosis, but 
their effect on the glucose-induced variations of inﬂammatory markers, is unknown. We 
examined the effect of atorvastatin administration in addition to anti-diabetic treatment or 
diet, on glucose-induced variations of inﬂammatory molecules in patients with T2DM.
Methods: Seventy subjects with newly diagnosed T2DM were randomised to receive 
metformin 850mg/d(M, n=17), metformin 850mg/d + atorvastatin 10mg/d (M+A, n=16), 
atorvastatin 10mg/d with dietary instructions (A+D, n=18) or diet only (D, n=19). All subjects 
underwent glucose loading (75g oral glucose) at baseline and after 4 weeks of treatment. 
Blood samples were obtained at baseline and at 3 hours post-loading for determination of 
serum tumor necrosis factor-A (TNF-A) and soluble E-selectin (sE-sel) by ELISA.
Results: Serum TNF-A remained unchanged after loading at baseline in D (1.2±0.07 
to 1.2±0.2pg/ml p=NS) and it was reduced after 4 weeks (1.62±0.2 to 1.22±0.1pg/ml 
p<0.05). TNF-A levels remained unchanged in M at baseline (1.3±0.14 to 1.3±0.16pg/ml 
p=NS) and after treatment (1.91±0.2 to 1.88±0.3pg/ml p=NS) and were reduced in M+A 
(1.76±0.2 to 1.63±0.2pg/ml p<0.05) but not in A (from 1.37±0.2 to 1.17±0.12pg/ml p=NS 
at baseline and from 1.18±0.09 to 1.06±0.08pg/ml p=NS after treatment). Serum sE-sel 
remained unchanged after loading at baseline in D (42.5±2.6ng/ml to 48.5±4.5 ng/ml 
p=NS) and was reduced after 4 weeks (44.6±2.8 to 40.3±3.0 ng/ml p<0.01). sE-sel levels 
remained unchanged in M at baseline (53.0±4.9ng/ml to 49.7±5.3 ng/ml p=NS) and after 
treatment (44.5±3.4 to 43.3±3.9 ng/ml p=NS after treatment), and were reduced in M+A 
(44.2±5.6 to 40.5±6.2 ng/ml p=NS at baseline, and 40.8±5.4 to 36.8±5.1 ng/ml p<0.05 
after treatment), but not in A (39.7±6.6 to 35.5±6.1 ng/ml p=NS at baseline to 35.6±5.8 to 
33.6±6.5 ng/ml p=NS after treatment).
Conclusions: Treatment with atorvastatin reduces the post-glucose loading levels of sE-
selectin and TNF-A, only when it is administered with metformin in patients with diabetes 
mellitus. These ﬁndings provide new insights on the pleiotropic effects of atorvastatin in 
diabetes mellitus.
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1040-104 Changes in Autonomic Responses Associated With 
Orthostatic Training in Vasovagal Syncope in a 
Randomized, Placebo-Controlled, Pilot Study
Maw Pin Tan, Julia L. Newton, Janine C. Gray, Tom J. Chadwick, Samiran Nath, Steve 
W. Parry, Newcastle University, Newcastle upon Tyne, United Kingdom, Royal Victoria 
Inﬁrmary, Newcastle upon Tyne, United Kingdom
Background: Vasovagal syncope (VVS) is the commonest cause of syncope. While 
most cases can be managed by reassurance and conservative advice, treatment options 
are limited for sufferers of recurrent, debilitating symptoms. We conducted a placebo-
controlled, pilot study for orthostatic training in VVS to detect possible alterations in 
autonomic responses, and to evaluate the feasibility of a larger study.
Methods: Consecutive patients diagnosed with VVS following a positive head-up tilt-table 
test were randomized to daily orthostatic training for 40 minutes daily for six months or 
sham training. Heart rate variability (HRV) and baroreﬂex sensitivity (BRS) during 10 
minutes’ supine rest were assessed at weeks 0, 1, 4 and 24, using continuous ECG and 
non-invasive blood pressure monitoring (Taskforce™, CNSystems, Austria).
Results: Twenty-two participants were randomized to orthostatic training (n=12) or 
placebo (n=10). Increases in low and high frequency HRV were observed in the treatment 
group compared to placebo at week 4 (elog difference =3.22;95%CI=1.06,9.86 and elog diff
erence
=3.19;95%CI=1.03,10.59) and week 24 (elog difference =2.11;95%CI=0.72,6.17 and 
2.13;95%CI=0.52,8.79). Orthostatic training was also associated with improvements 
in up and down slope BRS evident at week 4 (elog difference =1.59;95%CI=0.84,3.03 and 
1.79;95%CI=1.00,3.22) and sustained to week 24 (elog difference =1.75;95%CI=1.01,3.06 and 
1.53;95%CI=0.66,2.68).
Conclusion: Orthostatic training is associated with overall enhancement in autonomic 
tone in patients with VVS. This study was the ﬁrst placebo-controlled study on orthostatic 
training. Our results also demonstrate a plausible physiological basis for this form of 
treatment. A large-scale, multi-centre placebo-controlled study on orthostatic training is 
now needed.
3:30 p.m.
1040-105 Retroﬁt Particle Traps Reduce Exposure to Fine 
Particulate Air Pollution and Prevent Vascular 
Dysfunction in Man
Nicholas L. Mills, Magnus Lundbäck, Stefan Barath, Andrew J. Lucking, Jeremy P. 
Langrish, Ken Donaldson, Nicholas A. Boon, Thomas Sandström, Anders Blomberg, 
David E. Newby, The University of Edinburgh, Edinburgh, United Kingdom, Umeå 
University, Umeå, Sweden
Background: Exposure to air pollution and road trafﬁc may be a trigger for acute 
myocardial infarction. Diesel exhaust is a major contributor to urban air pollution and has 
detrimental effects on vascular function in healthy men and patients with coronary heart 
disease. Whilst diesel exhaust is a complex mixture of gases and particles, cardiovascular 
toxicity is thought to be attributable to the ﬁne particulate components. We assess the 
potential for a commercially available retroﬁt particle trap to reduce particulate emissions 
and attenuate the adverse vascular effects of diesel exhaust.
Methods: Dilute diesel exhaust was generated during urban running conditions at 
an average particle concentration of ~300 μIC2Ograms/m3. Using a double blind-
randomised crossover design, 18 healthy volunteers were exposed on three occasions 
to ﬁltered air, diesel exhaust, and ﬁltered diesel exhaust using a retroﬁt particle trap. Two 
hours after each exposure, forearm blood ﬂow was assessed using venous occlusion 
plethysmography before and during intra-arterial infusion of acetylcholine, bradykinin and 
sodium nitroprusside.
Results: The particle trap reduced particulate concentrations by 98% (320±10 to 7.2±2.0 
μIC2Ograms/m3, P<0.0001), without altering nitrogen oxide (NOx) concentrations (6.4±0.4 
versus 5.9±0.5 ppm, P=0.26). There was a dose-dependent increase in forearm blood ﬂow 
to both endothelial-dependent and -independent vasodilators. However vasodilatation was 
impaired following exposure to diesel exhaust compared to both ﬁltered air and ﬁltered 
diesel exhaust in response to acetylcholine (P<0.001) and bradykinin (P<0.001).
Conclusions: The use of retroﬁt particle traps to reduce particulate emissions from 
3:30 p.m.
1040-102 Vascular Dysfunction Measured by Digital Thermal 
Reactivity Is Strongly Associated With the Severity of 
Obstructive Coronary Artery Disease
David Hersh, Naser Ahmadi, Morteza Naghavi, Harvey Hecht, Lenox Hill Cardiovascular 
Insititute, New York, NY
Background: Digital Thermal Monitoring (DTM) of vascular reactivity is a new test of 
vascular function that has been shown to correlate with the Framingham Risk Score and 
coronary calcium score. This study evaluates whether DTM correlates with the severity of 
coronary artery disease (CAD) measured by invasive cardiac angiography (ICA).
Methods: 180 subjects, age 64±13 years, 73% male, were studied. Each underwent 
DTM during a 5 minute supra systolic arm cuff occlusion and ICA. Fingertip temperature 
rebound (TR) was calculated as the DTM index of vascular function.
Results: TR decreased from normal (1.78±0.32) to non-obstructive CAD (<50% stenosis) 
(1.64±0.24) to obstructive CAD (>50% stenosis) (1.05±0.14) (p =0.0001). After adjusting 
for age, gender and cardiac risk factors, the odds ratio (OR) of the lowest vs. upper 2 
tertiles of TR was 3.44 (95% CI 1.2-6.7, p=0.0001) for obstructive CAD, and 1.66 (95% CI 
1.08 p=0.008) for non-obstructive CAD as compared to normal coronaries. Additionally, 
the OR of lowest vs. upper 2 tertiles of TR increased from single vessel disease (1.66, 
95% CI 1.03-3.1 p=0.04) to double vessel disease (2.2, 95% CI 1.1-6.8 p=0.01) and triple 
vessel disease (9.8, 95%CI 1.2-12.4 p=0.002) independent of cardiac risk factors.
Conclusions: Vascular dysfunction measured by DTM correlated well with the severity 
of CAD independent of age, gender and risk factors. Further studies are needed to 
corroborate our ﬁndings and deﬁne the clinical utility of DTM for cardiovascular risk 
assessment. 
3:30 p.m.
1040-103 Increased Nitric Oxide Degradation by Oxidative Stress 
and Decreased Nitric Oxide Production by Endothelial 
Nitric Oxide Synthase Cause Severe Derangement of 
Venous Nitric Oxide Balance in Decompensated Heart 
Failure
Elaine Wan, Loredana Bucciarelli, Alicia Mecklai, Marc Klapholz, Sanja Jelic, Duygu 
Onat, Tessa Adams, Thierry H. LeJemtel, Ulrich P. Jorde, Marvin A. Konstam, Paolo C. 
Colombo, Columbia University, New York, NY
Background: Endothelial nitric oxide (NO)-mediated control of the venous tone is critical 
in heart failure (HF). Veins contain >70% of the systemic blood volume. Thus, relatively 
small volume reductions in veins increase central blood volume and cardiac ﬁlling
pressures. Increased NO degradation by oxidative stress and decreased NO production 
by endothelial NO synthase (eNOS) may cause vasoconstriction and thereby promote 
decompensation. Herein, we investigated venous NO production and degradation in pts 
with compensated and decompensated HF. Methods: 5 pts (age 51±18 yrs, LVEF 16±4%) 
with decompensated HF requiring hospitalization, 7 pts (age 49±7 yrs, LVEF 28±8%) with 
compensated HF, and 7 healthy subjects (age 44±8 yrs) were studied. Endothelial cells 
were collected from arm veins using angiocatheters and endovascular wires. Nitrotyrosine 
(NT) (a product of NO degradation), eNOS and phospho-eNOS (the activated form of 
eNOS) were measured by quantitative immunoﬂuorescence using Adobe Photoshop. 
eNOS activity = phospho-eNOS/eNOS. Venous NO score = (phospho-eNOS/eNOS) / 
NT. Results: NT was higher and eNOS activity lower in decompensated HF (Figure). 
Venous NO score was reduced in ADHF pts, reﬂecting severe derangement of NO 
balance. Conclusions: Increased NO degradation and decreased NO production cause 
a profound derangement of venous NO balance in decompensated HF. Reduced NO in 
veins may increase central blood volume and thereby contribute to the pathophysiology 
of decompensation.
A444  ABSTRACTS - Vascular Disease JACC March 10, 2009
Va
sc
ul
ar
 D
is
ea
se
artery disase (CAD).
Methods: 180 subjects were included in the study. DNA was isolated from 90 consecutive 
patients with angiographically proven early onset CAD and 90 control subjects with no 
signiﬁcant coronary obstruction angiographically. Multifactor Dimensionality Reduction 
(MDR) analysis was performed to seek a model of coronary artery disease based on 5 
genetic polymorphisms and conventional risk criteria.
Results: Genotype frequencies showed no signiﬁcant differences between CAD 
patients and CAD free controls. Advanced analysis detected a signiﬁcant MDR model 
with 4 genes. When total number of the conventional risk factors is taken as the 4th
dimension in addition to the 3 out of 4 genes, a different model is formed which achieves 
similar prediction of CAD compared to the gene only model. The paraoxonase and 
eNOS polymorphisms displayed signiﬁcant synergy (non-additive) and the others were 
moderately non-additive.
Conclusions: Gene-gene and gene-environmental risk criteria interactions could form 
signiﬁcant models in predicting early onset CAD.
3:30 p.m.
1040-109 Ethnic Differences in Oxidative Stress: Preliminary 
Results From the META-Health Study
Alanna A. Morris, Dean Jones, Yusuf Ahmed, Neli Stoyanova, Zhimin Chen, Liping Zhao, 
Gary H. Gibbons, Rebecca Din-Dzietham, Arshed A. Quyyumi, Emory University School 
of Medicine, Atlanta, GA, Morehouse School of Medicine, Atlanta, GA
Background: Compared to Caucasians, African-Americans (AA) continue to suffer 
from a disproportionate burden of cardiovascular disease (CVD), that can only partly be 
explained by disparities in the prevalence of risk factors for CVD. Exposure to risk factors 
promotes vascular oxidative stress that precipitates endothelial dysfunction and ultimately 
atherosclerosis. We hypothesized that measures of oxidative stress are a more accurate 
estimate of risk and will be higher in AA compared to Caucasians.
Methods: We measured CVD risk factors in a randomly selected sample of AA and 
Caucasian residents from metropolitan Atlanta, enrolled in the Morehouse-Emory 
Partnership to Eliminate Cardiovascular Disparities (META-Health) study. Oxidative 
stress was estimated as plasma levels of glutathione (GSH), an important intracellular 
anti-oxidant thiol, its oxidized disulﬁde form (GSSG), and their redox state Eh GSH/GSSG, 
calculated using the Nernst equation.
Results: Of the 436 participants aged 51+10 years, 68.2% were female and 52.5% were 
AA. AA had signiﬁcantly higher waist circumference (105+59 cm vs. 97+17 cm, p=0.01), 
higher systolic BP (123+20 vs. 118+17 mmHg, p=.009), higher diastolic BP (79+12 vs. 
76+10 mmHg, p=.02), lower triglyceride levels (98+40 vs. 136+85 mg/dL, p<.0001), and 
lower total cholesterol levels (198+42 vs. 206+42 mg/dL, p=.04). There were no ethnic 
differences between other lipoprotein levels or glucose. AA had signiﬁcantly greater 
oxidative stress evident as lower levels of GSH (1.37+0.6 vs.1.60+0.6, p=0.0001) 
and higher EhGSH/GSSG (-127.0+12.6 vs. -130.6+10.4, p=.01). Ethnicity remained 
an independent predictor of these markers of oxidative stress even after multivariate 
adjustment for age, gender, hypertension, diabetes, body mass index, and lipid levels 
(GSH, p=.005 and EhGSH/GSSG, p=.003).
Conclusions: In this random community-based population, AA had higher levels of 
oxidative stress compared to Caucasians, even after adjustment for differences in CVD 
risk factor burden. Whether measures of oxidative stress are a better reﬂection of CVD 
risk in AA than conventional risk factor assessment requires further investigation.
3:30 p.m.
1040-110 Combination of Nebivolol and Sildenaﬁl Reverses 
Erectile Dysfunction in Diabetic Rats
Javier Angulo, R. González-Corrochano, P. Cuevas, B. Cuevas, Harold Wright, I. Sáenz 
de Tejada, Instituto de Medicina Sexual and Dept. Investigación, Hospital Ramón y 
Cajal, Madrid, Spain
Background: PDE5 inhibitors amplify cGMP in response to nitric oxide (NO). Diabetic 
erectile dysfunction (ED) is related to reduced NO bioavailability. Acute administration 
of nebivolol, a vasodilating, cardioselective B1-adrenergic receptor antagonist (B-ARA),
increases systemic NO and cGMP levels and enhances erectile responses in normal 
rats. We evaluated chronic nebivolol administration on erectile function in diabetic rats 
with and without sildenaﬁl.
diesel engines may prevent the adverse vascular effects of exposure to diesel exhaust. 
Given these beneﬁcial effects on surrogate biomarkers of cardiovascular health, the use 
of retroﬁt particle traps on all diesel-powered vehicles may have substantial public health 
beneﬁt and reduce the burden of cardiovascular disease.
3:30 p.m.
1040-106 Advanced Stable Angina Is Associated With Increased 
Serum Levels of Insulin Like Growth Factor-1
Pawel Burchardt, Witold Nowak, Anna Gozdzicka-Jozeﬁak, Rafal Link, Tomasz Grotowski, 
Tomasz Siminiak, University of Medical Science, Poznan, Poland, Poznan, Poland
Background:IGF-1 plays an important role in artery homeostasis. Our aim was to evaluate 
IGF-1 gene promoter P1 polymorphism, its inﬂuence on IGF-1 serum level changes as 
well as their relation to atherosclerosis in patients, scheduled for coronarography.
Methods:Every patient had performed coronary angiography with Gensini score 
calculation. IGF-1, IGFBP3 (IGF- binding protein3) and lipid levels were measured in 
all patients..We evaluated DNA from 101 patients, isolated from blood cells, which was 
ampliﬁed by using polymerase chain reaction, then analyzed by single strand conformation 
polymorphism technique and automatically sequenced. In addition,
Results: We noticed signiﬁcant increase of serum IGF-1 levels in patients with advanced 
arteriosclerosis (in group with 3 vessel disease 215.0±71.3 vs 176.7±34.2 ng/ml p=0.04 
and with high Gensini score 231.4 ± 59.3 vs 181.0 ± 37.8 ng/ml p=0.01).
We found correlation of IGF-1 and IGFBP3 with parameters of lipids metabolism. IGF-1 
was correlated with total cholesterol (TC) (R=0.238, p=0.02), LDL cholesterol (R=0.204, 
p=0.04) and TG (R=0.250, p=0.01).
We found different genotypes for ﬁve, P1 promoter polymorphisms of IGF-1 gene (RS 
35767, RS 5742612, RS 228837, RS 11829693). There were no signiﬁcant associations 
between observed single nucleotide polymorphism (SNP) and coronary atherosclerosis 
(due to number of culprit lesions or Gensinini scale score) nor with levels of circulating 
IGF-1 and nor IGFBP3.
Conclusions: We observed signiﬁcantly higher circulating levels of IGF-1 and IGFBP3 
in group of patients with advanced stable angina. Investigation of possible clinical 
importance of the molecular mechanism of IGF-1 cascade and its association with lipids 
and glucose metabolism in CAD patients should be established and would require data 
from larger group of subjects.
3:30 p.m.
1040-107 Heart Rate as a Predictor of Cardiovascular Risk in 
Stable Coronary Disease
Jennifer E. Ho, David D. Waters, Vera Bittner, David DeMicco, Andrei Breazna, University 
of California, San Francisco, CA, University of Alabama at Birmingham, Birmingham, AL
Background: Resting heart rate has been shown to predict cardiovascular events in 
patients with coronary heart disease (CHD) and left ventricular dysfunction. The aim 
of this post hoc analysis of the Treating to New Targets (TNT) trial was to determine 
the effect of resting heart rate on major cardiovascular events in a broad population of 
patients with stable CHD.
Methods: A total of 10,001 patients with stable documented CHD were randomized to 
atorvastatin 80 or 10mg/day and followed for a median of 4.9 years. A total of 9,580 with 
complete data for baseline heart rate and clinical predictors were included in this analysis. 
The primary end point was the occurrence of a ﬁrst major cardiovascular event (CHD 
death, nonfatal myocardial infarction, resuscitated cardiac arrest, or stroke).
Results: Overall, the mean age was 61±9 years and 81% were male. Atorvastatin 
80mg was associated with a 22% relative risk reduction in major cardiovascular events 
compared with 10mg (p<0.001). Of 9,580 patients, 21% had a baseline heart rate q
70 bpm, and 79% had a heart rate < 70 bpm. Patients with higher heart rates were 
more likely to have a history of coronary bypass surgery (54 vs 44%), congestive heart 
failure (12 vs 6%), diabetes (23 vs 13%), current smoking (18 vs 12%), and less likely 
to have undergone angioplasty (49 vs 56%) (p<0.01 for all comparisons). The rate of 
major cardiovascular events was 11.9% in those with baseline heart rate q 70 bpm, 
compared with 8.8% in those with heart rate < 70 bpm (HR 1.38, 95% CI 1.19-1.59, 
p<0.01). After adjustment for differences in baseline characteristics, baseline heart rate 
q 70 bpm remained a signiﬁcant independent predictor of major cardiovascular events 
when compared with heart rates < 70 bpm (HR 1.19, 95% CI 1.02-1.38, p=0.03). There 
was no signiﬁcant interaction between baseline heart rate and response to atorvastatin 
treatment (p=0.52).
Conclusions: In patients with stable CHD, a baseline heart rate q 70 bpm was predictive 
of major cardiovascular events compared with a resting heart rate < 70 bpm. This increase 
in risk was only partially explained by baseline differences, and suggests that heart rate 
should be considered an independent risk factor for cardiovascular events.
3:30 p.m.
1040-108 Interaction Among MTHFR, PAI-1, ACE, PON and ecNOS 
Gene Polymorphisms Can Predict the Presence and 
Severity of Early Onset Coronary Artery Disease
Mehmet A. Agirbasli, Hasan S. Ozturhan, Korkut Ulucan, Deniz Agirbasli, Deniz Sevinc, 
Kelli Ryckman, Scott M. Williams, A. Ilter Guney, Marmara University Medical Center, 
Istanbul, Turkey, Vanderbilt University Medical Center, Nashville, TN, Turkey
We evaluated the combined effects of 5 different genetic polymorphisms (Methylene 
tetrahydrofolate reductase C677T, plasminogen activator inhibitor 4G/5G, endothelial 
nitric oxide synthase (eNOS) 3-27 base pair repeat, insertion or deletion of a 287 bp Alu 
repeat sequence polymorhism of angiotensin I converting enzyme and paroxygenase 
Gln192Arg PON1 polymorphisms) on the presence and extent of early onset coronary 
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hypertension 41%). Transthoracic echocardiography, radial artery applanation tonometry, 
and plasma NT-proBNP were obtained at enrolment. Simple and multiple linear regression 
analyses were performed to determine predictors of NT-proBNP level.
Results: Signiﬁcant univariate associations were found between NT-proBNP and age at 
diagnosis, duration of AF, body mass index, type of AF, CFPWV, left atrial (LA) volume 
index, mitral E velocity, mitral E/E’, mitral deceleration time, and use of B-blockers. CFPWV 
independently predicted NT-proBNP after adjusting for hypertension and factors that were 
univariately associated with NT-proBNP. Even in patients with LA volume index <26cc/m2
and LV mass index <100g/m2, CFPWV predicted NT-proBNP (B=0.33, p=0.001; B=0.34,
p<0.001; respectively). The adjusted mean NT-proBNP level in the highest quartile of 
CFPWV (350 pg/ml; 95% CI, 237 - 517 pg/ml) was 5-fold higher than the lowest quartile 
(69 pg/ml; 95% CI, 47 - 103 pg/ml) (p=0.001). CFPWV, in turn, was univariately associated 
with LA volume index, LV mass index, mitral E’ velocity, and mitral E/E’.
Conclusions: In young AF patients without structural heart disease, CFPWV 
independently predicts NT-proBNP level, an association likely mediated by LV diastolic 
wall stress. This association, observed at an early stage-before atrial and ventricular 
remodeling-suggests that therapeutic modiﬁcation of arterial stiffness may be beneﬁcial 
in patients with AF.
3:30 p.m.
1040-113 Gender Differences in the Risk of Ischemic Stroke 
Associated With Aortic Arch Plaques
Cesare Russo, Zhezhen Jin, Tatjana Rundek, Shunichi Homma, Ralph L. Sacco, Marco 
R. Di Tullio, Columbia University, New York, NY, University of Miami, Miami, FL
Background:Aortic arch plaques (AP) are a risk factor for ischemic stroke (IS). It is 
unclear if the risk varies by gender.
Aim:To assess if the risk of IS associated with AP is different between men (M) and 
women (W).
Methods:We performed transesophageal echocardiography in patients with acute IS as 
part of the APRIS (Aortic Plaque and Risk of Ischemic Stroke) Study and in age- and 
sex-matched controls. AP were classiﬁed as small if 2 to 3.9 mm thick and large if q 4 
mm thick. Complex features (ulcerations and/or mobile components) were also assessed. 
Risk of IS from AP was assessed separately in M and W by logistic regression analysis, 
and odds ratios (OR) and 95% conﬁdence intervals (CI) were obtained.
Results:464 subjects (255 stroke patients, 209 controls) were studied (mean age 69±9 
years). W were 46% (122 cases, 93 controls). In stroke patients, the frequency of large 
AP was not signiﬁcantly different between M and W (46% vs. 52%, p=0.3), while large 
complex AP were more frequent in W than M (26% vs. 16%, p<0.05). In controls, no 
signiﬁcant differences in AP frequencies were seen between M and W.
In univariate analysis, age, hypertension, diabetes and serum ﬁbrinogen were predictors 
of IS in both M and W, atrial ﬁbrillation was only in W. The table shows the risk of IS 
associated with AP in M and W.
Conclusions:Large AP are associated with increased risk of IS in both men and women. 
Complex AP are associated with a higher risk of IS among women. Further studies are 
needed to clarify the nature of this association.
Men Women
Unadjusted OR 95% CI Unadjusted OR 95% CI
No Plaque Ref. Ref.
Small Plaque 1.20 0.64-2.25 1.27 0.64-2.54
Large Plaque 2.55 1.37-4.74 4.84 2.33-10.04
Large Complex Plaque 3.02 1.23-7.43 11.67 3.65-37.29
Adjusted OR 95% CI Adjusted OR 95% CI
Small Plaque 1.09 0.56-2.12 1.02 0.45-2.32
Large Plaque 2.19 1.13-4.23 3.13 1.33-7.33
Large Complex Plaque 2.11 0.81-5.51 5.72 1.59-20.59
3:30 p.m.
1040-114 Relationship Between the Incidence, Location and 
Extent of Atherosclerosis in the Thoracic Aorta and the 
Extent of Coronary Artery Disease
Xiaoyan Gu, Yihua He, Michael C. Kontos, Zhian Li, Walter Paulsen, James A. Arrowood, 
George W. Vetrovec, J V Nixon, VCU School of Medicine, Richmond, VA, Beijing Anzhen 
Hospital, Beijing, People’s Republic of China
Background: Atherosclerotic lesions in the thoracic aorta detected by transesophageal 
echocardiography (TEE) have been correlated with coronary artery disease (CAD). The 
aim of the present study was to determine whether simple or complex aortic plaques 
seen on TEE correlate with the extent of CAD and to assess the location and severity of 
aortic atherosclerosis with CAD. Methods: The study population consisted of 188 TEE 
pts who also underwent coronary angiography. Atherosclerotic plaques seen on TEE 
were deﬁned as (1) complex plaques in the presence of protruding atheroma of more 
than 4 mm thickness, mobile debris, or plaque ulceration, or (2) simple plaques when 
the plaques lacked these morphologic features. The extent of CAD was divided into four 
groups (0, 1, 2, 3) according to the number of coronary vessels with >70% stenosis. 
Results: The numbers of CAD pts with 0, 1, 2, and 3 vessel disease were 99, 31, 28, and 
30 respectively. Compared to group 0 pts (no CAD; n=99), pts with CAD (groups 1, 2, 3; 
Methods: Streptozotocin (60 mg/kg, i.p.)-induced diabetic rats were left untreated for 8 
weeks and then treated with the ß-ARAs, atenolol or nebivolol (3 mg/kg/day, s.c.) or vehicle 
(DMSO/PEG300) for 10 days (8 rats per group). Erectile responses were measured via 
intracavernosal pressure increases to cavernosal nerve electrical stimulation (3 and 
10 Hz). The acute effects of sildenaﬁl (0.3 mg/kg, i.v.) on erectile responses were also 
evaluated.
Results: B-ARAs had no signiﬁcant effect on glycemia or mean arterial pressure, but 
signiﬁcantly reduced heart rate. Vehicle-treated diabetic rats presented impaired erectile 
responses (58.9%/62.4% of response compared with non-diabetic rats at 3 Hz/10 Hz, 
respectively). Sildenaﬁl failed to completely restore erectile function (74.6%/76.4% of 
response in non-diabetic rats). A similar effect was observed in atenolol-treated diabetic 
rats (52.6%/50.8% of response in non diabetic rats without sildenaﬁl and 63.6%/65.4% with 
sildenaﬁl). Conversely, nebivolol signiﬁcantly improved erectile responses in diabetic rats 
(88.2%/91.9% of response in non-diabetic rats), and, after sildenaﬁl, ED was completely 
reversed in nebivolol-treated diabetic rats (112.8%/107.9% of response in non-diabetic rats).
Conclusions: Nebivolol, but not atenolol, enhanced erectile function in untreated 
diabetic rats and completely restored it to normal in sildenaﬁl-treated diabetic rats. 
These results provide a mechanistic basis for the low incidence of erectile dysfunction 
seen in hypertensive patients treated with nebivolol. Furthermore, its administration 
presents potential therapeutic advantages for the treatment of diabetic ED, especially in 
combination with PDE5 inhibitors.
3:30 p.m.
1040-111 Acute Venous Hypertension and Congestion Coupled 
With Analysis of Endothelial Gene Expression 
Proﬁling and Circulating Neurohormons: A New Model 
to Characterize the Endothelial and Inﬂammatory 
Response to Acute Mechanical Stress in Humans
Paolo C. Colombo, Duygu Onat, Moritz Kebschull, Jenny Z. Xiang, Tessa Adams, Paola 
Bolli, Loredana Bucciarelli, Alicea Mecklai, Schmidt Ann Marie, Hani N. Sabbah, Ulrich 
P. Jorde, Columbia University, New York, NY
Background: Intravascular pressures and congestion progressively increase 7-14d before 
hospitalization for acute decompensated heart failure (ADHF). Whether congestion itself 
promotes progression to ADHF by causing endothelial derangement and neurohormonal 
activation is unknown. Herein, we introduce a new model of venous hypertension and 
congestion to characterize endothelial and inﬂammatory response to acute mechanical 
stress. Methods: 4 healthy subjects were studied. Venous arm pressure was increased to 
30mmHg by inﬂating a pressure cuff. Endothelial cells were sampled using endovascular 
wires before and after 60m of venous hypertension. Endothelial RNA was hybridized with 
Affymetrix HG-U133 2.0 Microarray. Results: No adverse event was noted. BP, HR, O2 
saturation did not change. 2,622 probe sets were differentially expressed before vs. after 
venous hypertension (F.D.R.<0.05). Gene ontology identiﬁed 15 differentially expressed 
classes linked to inﬂammation, immunity and kinase signaling (Figure). Plasma 
interleukin-6 and endothelin-1 were increased in the congested arm (p<0.05), but not in 
the control arm. Conclusions: We documented feasibility and safety of using a model 
of venous hypertension and congestion to characterize endothelial and neurohormonal 
response to acute mechanical stress. Our preliminary results support the hypothesis that 
congestion itself may contribute to the pathobiology of ADHF by causing progressive 
endothelial derangement and inﬂammation.
3:30 p.m.
1040-112 Carotid-Femoral Pulse Wave Velocity Predicts 
N-Terminal Pro-B-Type Natriuretic Peptide Level in 
Young Atrial Fibrillation Patients Without Structural 
Heart Disease
Lin Y. Chen, Bee C. Tai, David C. Foo, Raymond C. Wong, Chwee N. Quay, Lingli Gong, 
Hla-Yee Daw, Lieng H. Ling, National University of Singapore, Singapore, Singapore, 
National University Hospital, Singapore, Singapore
Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) elevation is found 
in atrial ﬁbrillation (AF) patients with and without heart failure and predicts adverse 
cardiovascular outcomes. Because raised NT-proBNP may result from increased left 
ventricular (LV) diastolic wall stress, we hypothesized that variation in carotid-femoral 
pulse wave velocity (CFPWV)-an index of conduit arterial stiffness-predicts NT-proBNP in 
young AF patients without structural heart disease.
Methods: We included 117 unrelated patients without structural heart disease and 
with AF onset <65 years of age (mean age at diagnosis: 48.5 ± 10.9 years; male 82%; 
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stress status remain unaffected after methionine loading. These ﬁndings suggest that 
any activation of methylation processes by methionine-loading, fails to induce further 
elevation of plasma ADMA in these patients.
3:30 p.m.
1040-117 Prevalence and Correlates of Increased Carotid Intimal-
Medial Thickness in a Population-Based Sample of 
American Indians: The Strong Heart Study
Zhibin Li, Lu Cai, Ingrid Hriljac, Lyle G. Best, Elisa T. Lee, Barbara V. Howard, Richard B. 
Devereux, Mary J. Roman, Weill Cornell Medical College, New York, NY
Background: Carotid intimal-medial thickness (CIMT) has been related to cardiovascular 
disease (CVD) risk factors and incident CVD in several populations. The present study examines 
relations of CIMT with CVD risk factors and echocardiographic left ventricular (LV) structure and 
function in American Indian participants in the 4th Strong Heart Study examination.
Methods: 3456 American Indians participants (mean age: 40±17 years; 60% female) 
underwent standardized clinical, carotid ultrasound, echocardiographic and laboratory 
examinations. Increased CIMT was deﬁned as distal common carotid artery IMT >1.00 mm.
Results: Increased CIMT was found in 3.8% of participants and was associated with 
older age (64±12 vs. 39±16 years) and male gender (5% vs. 3.1%, both p<0.01). After 
adjustment for age and gender, increased CIMT was associated with hypertension [odd 
ratio (OR) =2.2; 95% conﬁdence interval (CI) = 1.1-4.3) and diabetes (OR=1.9; 95% 
CI= 1.08-3.28, both p<0.05). CIMT was greater in participants with both diabetes and 
hypertension than those with only hypertension or diabetes (0.80±0.18 vs. 0.73±0.16 
mm or 0.71±0.15 mm, respectively, both p<0.005). Analyses adjusted for covariates 
showed that increased CIMT was related to higher body mass index, fasting glucose, 
LDL cholesterol, hemoglobin A1c and with lower HDL cholesterol (all p<0.001). CIMT 
was signiﬁcantly higher in participants with aortic valvular or mitral anular calciﬁcation, 
LV hypertrophy and eccentric LV hypertrophy (all p<0.05). After adjustment for signiﬁcant 
covariates, increased CIMT was associated with increased LV internal dimension, LV wall 
and septum thickness, relative wall thickness, higher LV mass index, lower LV ejection 
fraction and LV mid-wall fractional shortening (all p<0.05).
Conclusion: Increased CIMT in American Indians is independently associated with 
traditional CVD risk factors (male gender, age, diabetes, hypertension, dyslipdemia) as 
well as prognostically-important echocardiographic ﬁndings (aortic valvular and mitral 
anular calciﬁcation, LV hypertrophy and lower LV systolic function).
3:30 p.m.
1040-118 L-arginine Treatment Improves Arterial Performance 
and Prevents the Acute Smoking-Induced Reduction of 
Fibrinolytic Process in Healthy Smokers
Gerasimos Siasos, Dimitris Tousoulis, Charalampos Vlachopoulos, Charalampos 
Antoniades, Konstantinos Zisimos, Elias Gialafos, Zoi Siasou, Aleksis Verveniotis, 
Dimitris Papaeleutheriou, Evangelos Oikonomou, Aris Plastiras, Emmanouil 
Androulakis, Georgios Marinos, Athanasios G. Papavassiliou, Christodoulos Stefanadis, 
Athens Univercity Medical School, Hippokration Hospital, Athens, Greece
Background: L-arginine is the precursor of nitric oxide synthesis. The effect of short-term 
treatment with l-arginine on endothelial function, arterial stiffness and ﬁbrinolytic process 
in smokers under baseline conditions and after acute smoking is unknown.
Methods: We studied the effect of a 3-day oral administration of l-arginine (3x7gr/d) in 12 
healthy smokers (age 24±3yrs) on 3 occasions (day0: baseline, day1 and day3) according 
to a randomized, placebo-controlled, double-blind, cross-over design. Measurements were 
carried out before and 20 min after cigarette smoking. Endothelial function was evaluated 
by ﬂow-mediated dilatation (FMD) of the brachial artery. Carotid-femoral pulse wave velocity 
(PWV) was measured as an index of aortic stiffness and augmentation index (AIx) as a 
measure of arterial wave reﬂections. Circulating levels of tissue plasminogen activator (tPA) 
and soluble intercellular adhesion molecule (sICAM-1) were measured by ELISA.
Results: Compared to placebo, l-arginine improved FMD (from 5.35±0.66% at day0 
to 7.56±0.85, p<0.01 at day1 and 7.19±0.96, p<0.05 at day3). L-arginine induced a 
progressive decrease of PWV (from 5.02±0.19m/s at day0 to 4.72±0.19 at day1 and 
4.62±0.14 at day3, both p<0.01) and AIx (from 7.36±3.36% at day0 to 1.36±3.36 at day1 
and -2.13±3.1 at day 3 both p<0.01). Acute smoking in day 0 induced a rapid elevation 
of PWV (by 0.39±0.09m/s) and AIx (by 3.85±0.42%), p<0.01 for both. L-arginine (days 
1,3) blunted the smoking-induced increase in AIx and PWV in no statistical signiﬁcant 
values. Acute smoking induced a signiﬁcant reduction of tPA in the placebo group (from 
6.18±0.71ng/ml to 4.52±0.4 at day0, from 5.8±0.7 to 4.1±0.3 at day1, from 6.5±0.7 to 
4.7±0.3 at day3, p<0.05 for all) while l-arginine prevented this effect (from 4.2±0.4ng/
ml to 3.6±0.3 at day1, from 5.5±1 to 4.3±0.5 at day3, p=NS for all). L-arginine reduced 
sICAM-1 at days 1, 3 (from 235.5[198-281] ng/ml at day0 to 217[186-258] at day 1 and 
219[171-292] at day 3 p<0.05 for both).
Conclusion: Short-term administration of l-arginine improves arterial performance, 
prevents the acute smoking-induced reduction of ﬁbrinolytic process and decreases the 
inﬂammatory process in smokers.
n=89) had a signiﬁcantly greater prevalence of aortic plaques, irrespective of the degree 
of plaque complexity or location (p<0.05). Multivariate analysis including age, gender, 
race, hypertension, diabetes mellitus, hypercholesterolemia, smoking and aortic plaque 
found that hypertension (Odds ratio, 3.0; 95%CI, 1.3 to 7.0; p=0.013), diabetes mellitus 
(Odds ratio, 2.4; 95%CI, 1.1 to 4.9; p=0.022) and aortic plaque (Odds ratio, 3.8; 95%CI, 
1.8 to 8.2; p=0.001) were signiﬁcantly associated with CAD, with aortic plaque being 
the most signiﬁcant predictor. There was a signiﬁcant relationship between simple and 
complex aortic plaques and the increasing severity of CAD (p<0.001). Multivariate logistic 
regression analysis showed that the complex plaque in the descending aorta (Odds ratio, 
5.4; 95%CI, 1.8 to 16.4; p=0.003) was the strongest predictor of the presence of CAD. 
Conclusion: Both simple and complex thoracic atherosclerotic plaques detected by TEE 
are associated with increasing severity of CAD. Complex plaque in the descending aorta 
was the strongest predictor of the presence of CAD.
3:30 p.m.
1040-115 Aortic Dilation Is Often Over-Diagnosed: The Effect of 
Indexing Aortic Size to age and Body Surface Area
Anna M. Booher, Elise Woznicki, Kim A. Eagle, David S. Bach, University of Michigan, 
Ann Arbor, MI
Background: Indexing aortic (Ao) size to body suface area (BSA) and age, often not done 
in clinical practice, may be more accurate than using a single cutoff for all patients (pts).
Methods: For 500 consecutive echocardiograms (echos), Ao dimensions were classiﬁed 
as normal (nlAo) or dilated (dilAo) based on standard threshold (>36mm at any site) or 
written comment. Ao size was then compared to published nomograms incorporating BSA 
and age, noting resultant change in classiﬁcation. To establish intraobserver variation, Ao 
size was re-measured in 100 cases (21%).
Results: Overall, 478 of 500 (95.6%) cases were of diagnostic quality and included in 
the analysis; 230 (48.1%) male (Figure 1). Those with dilAo tended to be older (p=0.008), 
male (dilAo 78.3% male vs. nlAo 41.8% male, p<0.001), had larger BSA (p=0.02), and 
had more Ao dimensions recorded (3.3+1.2 vs 1.6+1.0, p<0.001) than the nlAo pts. When 
indexed to BSA and age, 7 (1.8%) of the nlAo pts were found to have dilAo, with a trend 
toward smaller BSA (p=0.07). 44 (53%) of those with a dilAo were found to have nlAo 
when indexed to age and BSA. There were no differences in age, gender or BSA between 
these groups. R2 for intraobserver variation at the sinus of Valsalva was 0.91.
Conclusions: More than half of pts classiﬁed with a dilAo may be within a normal range 
when age and BSA are considered. Pts with smaller BSA may have a dilAo, but be 
overlooked. The clinical implications of these ﬁndings deserve further study. 
3:30 p.m.
1040-116 Mechanisms Regulating Asymmetical-Dimethyl 
Arginine and Lipid Peroxidation in Methionine-Induced 
Homocysteinemia in Hypertensive Patients
Dimitris Tousoulis, George Bouras, Charalambos Antoniades, Kyriakoula Marinou, 
Antigoni Miliou, George Hatzis, Athanasios Trikas, Costas Tentolouris, George Latsios, 
Alexios Antonopoulos, Kostas Toutouzas, Christodoulos Stefanadis, 1st Cardiology 
Department, Hippokration Hospital, Athens Medical School, Athens, Greece
Background: Endothelial nitric oxide synthase (eNOS) inhibitor, asymmetrical-dimethyl 
arginine (ADMA), is a risk factor for atherosclerosis, and is elevated in hypertension. ADMA 
is synthesized by the methylation of arginine as part of the methionine/homocysteine 
cycle and is regulated by oxidative stress in animal models. We investigated the role of 
oxidative stress in the systemic regulation of ADMA synthesis during methionine-induced 
homocysteinemia in hypertensive individuals.
Methods: Thirty-eight hypertensive individuals and 30 healthy controls underwent methionine 
loading (100 mg methionine/Kg body weight), after being randomized to receive vitamin 
C (2gr) and E (800IU) before methionine loading (n=15 hypertensives, n=15 controls), or 
placebo. Lipid peroxides (PEROX) and ADMA were determined at baseline and 4h-PML.
Results: Hypertensives had higher Hcy at baseline (16.8±2.4 vs 10.7±0.5 μmol/L 
p<0.001) and 4hPML (40.6±4.1 vs 32.5±1.5 p<0.05), while methionine induced a 
signiﬁcant elevation in Hcy in all both groups. PEROX levels were increased after 
methionine loading in the placebo group (from 216±33 to 314±43pg/ml p<0.05), an effect 
prevented by antioxidants (from 221±31 to 200±38pg/ml, p=NS). However, plasma ADMA 
was increased in both antioxidants- and placebo- treated groups (from 0.59±0.03 and 
0.61±0.041 to 0.78±0.048 and 0.82±0.038 μM respectively, p<0.01 for both) at 4h-PML. 
On the other hand, in hypertensives PEROX were decreased after methionine loading 
when antioxidants were administered (from 187±29 to 138±34pg/ml, p<0.05) while 
remained unaffected in the placebo group (216±33 to 314±43pg/ml, p=NS). Importantly, 
hypertensives had higher ADMA at baseline (0.96±0.07 vs 0.59±0.02μmol/L) and these 
elevated levels remained unchanged 4hPML (from 0.83±0.09 and 1.14±0.08 to 0.86±0.09 
and 1.18±0.07 μmol/L p=NS for placebo and vitamins treated respectively).
Conclusions: Hypertensives have higher resting ADMA, and both ADMA and oxidative 
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1040-121 Lifelong Exercise Training Demonstrates a Dose 
Dependent Threshold Effect on Central Arterial 
Compliance
Paul S. Bhella, Shigeki Shibata, Jeff L. Hastings, Eric Pacini, Dean Palmer, Benjamin D. 
Levine, University of Texas-Southwestern, Dallas, TX, Presbyterian Hospital of Dallas, 
Dallas, TX
Background: Previously we have shown that sedentary aging leads to decreases in left 
ventricular (LV) and arterial compliance in the elderly. Conversely, Masters athletes who 
trained 6-7 sessions per week throughout their adult lives maintained youthful LV and 
arterial compliance. We hypothesized that preservation of youthful arterial compliance 
may be possible with less rigorous training.
Methods: Elderly male and female subjects (n=31) were recruited from the Aerobics 
Center Longitudinal Study, a well validated study which has prospectively documented 
lifelong exercise training patterns in subjects for the past 25 years. Subjects were stratiﬁed 
into one of four ‘Quads’ based on their history of exercise training (see Table 1). Central 
arterial compliance was quantiﬁed by differences in ultrasound derived pulse wave 
velocity (PWV) between the carotid and femoral artery.
Results: See Table 1. One-way ANOVA testing revealed a signiﬁcant difference (p<0.001) 
among the groups. Neumann-Keuls post-hoc testing identiﬁed a statistically signiﬁcant 
difference between subjects who performed no regular exercise and those who trained 
2-3, 4-5 or 6-7 sessions per week, but not among any of the higher “dose” group.
Conclusions: Lifelong exercise training has a dose-dependent, threshold effect on 
central arterial compliance. Based on these ﬁndings, lifelong exercise training of 2-3 
sessions per week offers similar beneﬁts on arterial compliance as more rigorous lifelong 
training regimens.
Results
Group Quad 1 (n=7) Quad 2 (n=4) Quad 3 (n=7) Quad 4 (n=13)
Lifelong exercise sessions/
wk less than 2 2 to 3 4 to 5 6 to 7
Age +/- S.D. (yr) 71 +/- 3 69 +/- 2 69 +/- 6 68 +/- 3
Peak VO2 +/- S.D.(ml/kg/min) 22.4 +/- 3.6 27.1 +/- 2.7 33.5 +/- 4.4 40.2 +/- 4.8
Central PWW +/- S.D. (cm/s) 1418 +/- 455 860 +/- 49 833 +/- 249 799 +/- 116
3:30 p.m.
1040-119 Novel Perﬂuorinated Alginate Microcapsules for CT and 
MRI Monitoring of Mesenchymal Stem Cell Delivery and 
Engraftment Tracking
Yingli Fu, Dorota A. Kedziorek, Ronald Ouwerkerk, Veronica Crisostomo, Wesley D. 
Gilson, Nicole Azene, Aravind Arepally, Christine H. Lorenz, Steven M. Shea, Jeff WM 
Bulte, Dara L. Kraitchman, Johns Hopkins University, Baltimore, MD, Siemens Corporate 
Research, Baltimore, MD
Background: Stem cell therapy has generated promising results for the management 
of ischemic arterial disease. However, the early destruction of transplanted cells after 
administration and the inability to precisely monitor and track the fate of transplanted 
cells remains problematic. We present here a novel stem cell microencapsulation method 
utilizing perﬂuorooctylbromide (PFOB) impregnated alginate-poly-L-lysine-alginate 
microcapsules (PFOB Caps) for minimally invasive MSC delivery and engraftment 
tracking using clinical CT and MRI scanners.
Methods: Rabbit or human MSCs (1.5x106cells/ml) from bone marrow were mixed 
with PFOB-loaded alginate and extruded from a syringe pump in conjunction with an 
electrostatic droplet generator to form X-ray- and MRI-visible microcapsules. MSCs 
viability was examined and compared between control and PFOB Caps. Using 19F MRI 
and rotational angiograms reconstructed into CT-like images, the minimum detectable 
concentration was determined in phantoms using conventional clinical imaging systems. 
X-ray delivery and tracking of intramuscular injections of PFOB Caps was assessed in a 
rabbit peripheral arterial disease (PAD) model.
Results: The viability of rabbit MSCs encapsulated with PFOB was 90±3% immediately 
after encapsulation and remained high up to 4 weeks post-encapsulation (88±5%). 
PFOB-labeled microcapsules containing human MSCs displayed a signiﬁcant increase 
in cell viability relative to control capsules 65 days post-encapsulation (83±3% for PFOB 
vs. 50±1% for control, P<0.001). Viability of human MSCs in perﬂuorinated capsules was 
maintained up to 100 days, while it decreased sharply to <10% in unlabeled capsules. In
vitro CT and 19F MRI imaging of PFOB Caps demonstrated the ability to detect as few as 
2 and 25 capsules, respectively. In vivo, PFOB visibility on CT images was demonstrated 
relative to unlabeled capsules with persistence of intact microcapsules up to 5 weeks post 
delivery in PAD rabbits.
Conclusion: Encapsulating MSCs in PFOB microcapsules extends viability while 
simultaneously providing a method to deliver and track engraftment of stem cells using 
multiple conventional clinical imaging systems in vivo.
3:30 p.m.
1040-120 The IRAD Classiﬁcation System- A Modern Method 
for Characterizing Mortality Risk of Aortic Dissection 
Based on Time From Symptom Onset, Dissection 
Location, and Treatment Rendered
Eric Isselbacher, Christoph A. Nienaber, Santi Trimarchi, Arturo Evangelista, Jeanna 
V. Cooper, James B. Froehlich, Marek Erlich, Jae Oh, James L. Januzzi, Patrick 
O’Gara, Thoralf Sundt, Kevin M. Harris, Eduardo Bossone, Reed E. Pyeritz, Kim A. 
Eagle, On behalf of the IRAD Investigators, The University of Michigan, Ann Arbor, MI, 
Massachusetts General Hospital, Boston, MA
Background: The classiﬁcation of aortic dissection (AD) into acute (<14 days from 
symptom onset) vs chronic (>14 days) is based on survival estimates of patients treated 
decades ago before modern diagnostic methods and new treatments became available. 
A new classiﬁcation of AD in the modern era, based on a large number of patients will 
provide clinicians with a more precise method of characterizing the interaction of time, 
dissection location, and treatment type with mortality.
Methods: We developed separate Kaplan-Meier survival curves for type A and type B 
AD using the IRAD database. Daily survival was stratiﬁed depending on type of therapy 
provided: (medical), non surgical intervention plus medical therapy (intervent), and open 
surgery plus medical therapy (surgery). The log-rank statistic was used to compare the 
survival curves of each management type within type A and type B AD.
Results: Mortality risk over time, for both type A and type B AD, can be divided into 4 
distinct groups: hyperacute (symptom onset to 24 hours), acute (2-7 days), subacute (8-
21 days) and chronic (>21 days) [ﬁgure]. Mortality risk falls progressively through the 4 
time periods in a highly signiﬁcant way.
Conclusions: The IRAD Classiﬁcation System provides clinicians with a more robust 
method of characterizing AD mortality risk over time than the former method. We believe 
that clinicians will ﬁnd it useful in treating patients, counseling patients and families, and 
studying new diagnostic and treatment methods. 
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guanosine triphosphate pathway, is produced by activated macrophages and serves 
as an activation marker for monocyte/macrophages. We have previously shown that 
neopterin is associated with plaque inﬂammation and destabilization in human coronary 
atherosclerotic lesions (Heart 93; 1537-1541, 2007). The S100 A8/A9 complex is a 
biomarker, expressed in a subset of activated neutrophils and macrophages. Both 
S100A8 and S100A9 are members of S100 family of calcium-binding proteins. In the 
present study, we collected frozen samples of human carotid atherosclerotic plaques, 
and investigated the immunolocalization of neopterin and S100 A8/A9 complex in 
human carotid atherosclerotic plaques. Methods: We investigated frozen tissues of 
40 endarterectomy specimens for extracranial high-grade carotid stenosis, surgically 
obtained. Frozen samples were studied with antibodies against neopterin, S100 A8/A9 
complex, platelets (GPIIb/IIIa, P-selectin), neutrophils (CD66b, myeloperoxidase, and 
elastase), smooth muscle cells, macrophages, and endothelial cells (CD31, CD34, and 
von Willebrand factor). Results: In patients within 30 days after the event, more than 
80% of the carotid plaques showed the presence of platelet thrombi with neutrophil 
inﬁltration. In these lesions, neutrophils were positive for S100 A8/A9, but negative for 
neopterin. In cases from 1 month to 2 months after the events, carotid lesions contained 
repairing tissues with macrophage accumulation, neovascularization, and smooth muscle 
cell proliferation. In these sites, accumulated macrophages showed staining positivity for 
neopterin and S100 A8/A9.
Conclusions: The present study, based on the analysis of frozen sections, suggests that 
S100 A8/A9 complex and neopterin have important roles in tissue response associated 
with plaque instability and inﬂammation in human carotid atherosclerotic lesions.
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0911-3 Thrombotic Events in Patients with Antiplatelet Factor 
4/Heparin: Antibodies After Cardiac Surgery
Anna Vittoria Mattioli, Lorenzo Bonetti, Umberto Carletti, Roberto Vivoli, Giuseppe 
Ambrosio, Giorgio Mattioli, University of Modena and R.E., Modena, Italy, University of 
Perugia, Perugia, Italy
Background. Antibodies to the heparin/platelet factor 4 (PF4) complex are linked to 
the pathogenesis of heparin-induced thrombocytopenia type II, and to the thrombotic 
complications associated with this syndrome. Because these antibodies may activate 
vascular endothelium as well as platelets, their presence may possibly increase the 
risk of thrombotic events. We investigated the long-term relationship between antibody 
concentration and thrombosis.
Methods and results. Two-hundred and ﬁfty patients who had been treated with 
unfractionated heparin as part of cardiac surgery management were included in the study. 
Immunoassay ELISA test was used to detect the presence and the plasma concentration of 
heparin-PF4 antibodies. Follow-up lasted one year and new thrombotic events (myocardial 
infarction, stroke, pulmonary embolism), and death from any cause, were evaluated.
Seventy-nine of 250 patients (31.6 %) developed anti-PF4/heparin antibodies after 
cardiac surgery. At baseline, platelet count did not differ between the antibody-positive 
and -negative groups; however, the nadir platelet count was signiﬁcantly lower in patients 
who developed antibody positivity (82,000±31,000/mm3 versus 105,000±52,000/mm3,
p<0.001). Patients with anti-PF4/heparin antibodies were more likely to have 1-year 
death or new myocardial infarction (25.3% versus 10.5%, P<0.001), pulmonary embolism 
(20.2% versus 5.8%, p<0.001) or stroke (12.6% versus 5.8%, P<0.001) than patients 
who were antibody-negative. Patients were categorized in quintiles according to the 
optical density (i.e., antibody concentration). The risk of developing thrombotic events 
markedly increased with increasing quintile of antibody concentration, with the highest 
group showing an OR of 7.68 (4.04-9.20) (p<0.001).
Conclusions. Patients who develop antibodies to the PF4-heparin complex have a 
signiﬁcantly higher rate of thrombotic events during a one year follow-up than those who 
lack these antibodies; within this group the risk of developing thrombosis increases with 
increasing plasma concentrations of antibodies.
4:45 p.m.
0911-4 Comparison of Gene-Based Warfarin Dosing Algorithms 
in a Multiethnic Population
Steven A. Lubitz, Stuart A. Scott, Elizabeth B. Rothlauf, Arun Agarwal, Inga Peter, Dana 
Doheny, Sarina van der Zee, Malgorzata Jaremko, Robert J. Desnick, Jonathan L. 
Halperin, Mount Sinai School of Medicine, New York, NY
Background: Gene-based dosing algorithms to predict therapeutic warfarin dosage 
have been developed largely in racially homogenous populations. Since warfarin dose 
requirements may vary between races, we assessed the performance of published 
algorithms in a racially diverse and multiethnic population.
Methods: We collected clinical information and DNA samples from 95 patients on warfarin 
with a goal INR of 2-3. Stable, therapeutic doses were compared to predicted dose 
requirements using 10 regression algorithms accounting for variants in the VKORC1 and 
CYP2C9 genes (Sconce ’05, Wadelius ’05, Takahashi ’06, Tham ’06, Anderson ’07, Miao 
’07, Zhu ’07, Gage ’08, Wadelius ’08, Wu ’08). Adjusted R2 statistics were used to compare 
algorithm performance. Additional covariates tested with each model included race, 
3:30 p.m.
1040-122 The Incidence of Contrast-Induced Nephropathy 
Following Isosmolar Contrast Media Is Less Than Low 
Osmolar Contrast Media: A Prospective Multicenter 
Study
Ronald P. Karlsberg, Suhail Y. Dohad, V. Multicenter Investigators, Cardiovascular 
Research Institute of Southern California, Beverly Hills, CA
Background: To compare the incidence of CIN following IOCM (iodixanol) versus LOCM 
(iopamidol, ioversol, iohexol, iopromide), we studied patients with peripheral arterial 
occlusive disease (PAOD) who previously underwent intravenous computed tomographic 
angiography (IV CTA) with IOCM.
Methods: 265 patients (mean age: 64.7 ± 10.9, 63.8% male) underwent IV CTA of the 
abdominal aorta and runoff with iodixanol (320 mg I/mL). Three to 72 days later, 253 
patients (mean age: 64.4 ± 10.8, 63.2% male) underwent invasive intraarterial digital 
subtraction angiography and intervention (IA DSA) with contrast agent according to each 
centers normal practice. CIN was deﬁned as a creatinine increase of q25% from baseline, 
24 hours following IA DSA.
Results: 148 IA DSA patients (58.5%) received IOCM and 105(41.5%) LOCM (iopamidol 
92, ioversol 8, iohexol 3, iopromide 2). Baseline risk factors, average contrast dose 
and hydration were comparable between the IOCM and LOCM groups except for renal 
function: Prior to DSA 8.1% IOCM patients (12/148) versus 2.9% LOCM patients (3/105) 
had renal dysfunction (>1.5 ml/dl). 
IV CTA: IOCM IA DSA: IOCM or LOCM
N # CIN % CIN N # CIN % CIN
IOCM 265 20 7.50% 148 8* 5.4%*
LOCM 0 - - 105 14* 13.3%*
Total 265 20 7.50% 253 22 8.70%
(* p = 0.027 (59% relative risk reduction)
Of 14 patients with CIN receiving LOCM, 13 had iopamidol, 1 had ioversol. CIN rate was 
not different between IV CTA and IA DSA. However when CIN developed after IA DSA it 
was more likely in patients who received LOCM than IOCM.
Conclusion: In patients with PAOD undergoing repeat contrast load with IA DSA after IV CTA, 
the incidence of CIN was 59% less for patients who received IOCM compared to LOCM.
3:30 p.m.
1040-123 Percutaneous Transluminal Angioplasy and Stenting of 
Extracranial Vertebral Artery Stenoses
Michel Henry, Isabelle Henry, Antonios Polydorou, Ad. Polydorou, Michelle Hugel, 
Michel HENRY, NANCY, France
Purpose: To evaluate the safety and efﬁciency of angioplasty and stenting of symptomatic 
vertebral artery (VA) stenosis.
Material and methods: 86 angioplasties attempted in 80 patients (M:60) mean age 
67,8 ± 6,7 Y. left 48. All patients had multivascular diseases (carotid stenoses: 55, 
subclavian:22, renal: 12, peripheral vascular diseases: 22, coronary diseases: 56). 84 
lesions were atheromatous, 2 inﬂammatory diseases. Mean lesion length: 9,5 ± 2,8 mm 
Mean % stenosis 82.9 +/- 7.9 mean arterial diameter: 4,8 ± 0,6 mm (4-6). 79 lesions at 
VO segment (ostium) 5 at V1 segment and 2 at V2 segments.
Indications for angioplasty included: dizziness (80), bilateral weakness (11), visual 
changes (11), diplopia (10), drop attacks (14), TIA (8), ataxia (5). A protection device 
(ﬁlter) was used in 5 patients. 14 subclavian artery angioplasties performed at the same 
time of VA angioplasty, 5 carotid angioplasties. All angioplasties performed by femoral 
approach, 2 brachial approach attempted after failure of femoral approach.
Results:Technical success 84/86. 2 failures in elderly patients with very tortuous calciﬁed 
arteries. 6 lesions treated by angioplasty alone (3 VO lesions, ﬁrst 3 patients, 2 V1, 1 V2 
lesion). 1 patient with inﬂammatory disease treated by cutting balloon alone. 74 lesions 
stented with balloon expandable stents : (7 DES). 3 V1 and 1 V2 lesions treated with self-
expandable stents. Complication: 1 TTA
Clinical success 78/80
Post-procedure arterial diameter: 4,55 ± 0,8 mm (4-6). Mean residual stenosis 2,2 ± 3,5 %. 
6 patients (9%) developed symptomatic restenosis, 3 after PTA alone, 1 after PTA and stent 
(1 occlusion treated medically, 5 stenoses successfully treated with balloon angioplasty). 
Mean follow-up: 34,1 +/- 28,5 months Visible Debris removed in 4/5 ﬁlters (80%)
Conclusion: Endovascular treatment of symptomatic VAS can be performed safely with 
a high technical success rate, a low complication rate, a low restenosis rate and a durable 
clinical success. Stents seem to improve immediate and long-term results. The role of 
protection devices has to be discussed
3:30 p.m.
1040-124 S100 A8/A9 Complex Expression and Neopterin 
Expression Are Associated With Plaque Instability and 
Inﬂammation in Human Carotid Atherosclerotic Lesions
Chizuko Kitabayashi, Shoichi Ehara, Yoshihiro Ikura, Masashi Nakagawa, Junko Arimoto, 
Nobuyuki Shirai, Kenichi Sugioka, Takeshi Hozumi, Takahiko Naruko, Minoru Yoshiyama, 
Makiko Ueda, Osaka City University Graduate School of Medicine, Osaka, Japan
Background: Atherosclerotic plaque instability may not be conﬁned to coronary arteries 
but may also involve carotid arteries. Enhanced activation of the monocyte-macrophage 
system may contribute signiﬁcantly to plaque instability. Neopterin, a by-product of the 
JACC March 10, 2009 ABSTRACTS - Vascular Disease  A449
Vascular D
isease
5:30 p.m.
0911-7 Right Ventricular Mass Index Predicts Pulmonary 
Vascular Resistance in Pulmonary Arterial 
Hypertension: Baseline Cardiac MRI Results of the 
COMPASS-3 Trial
Himanshu Gupta, Ravi Desai, Steven G. Lloyd, Fernando Torres, Francisco Soto, Myung 
Park, Chad McQueen, Srinivas Murali, Raymond Benza, University of Alabama at 
Birmingham, Birmingham, AL, Allegheny General Hospital, Pittsburgh, PA
Background: Right heart catheterization (RHC) is the gold standard for assessing pulmonary 
arterial hypertension (PAH). The role of cardiac MRI (cMRI) in PAH is not well deﬁned. We 
analyzed the relationship between cMRI and RHC in PAH patients from the COMPASS 3 
study, a multi-center trial, evaluating goal based combination therapy in PAH.
Methods: Comprehensive cMRI was performed within 48 hours of RHC in 42 treatment 
naïve PAH patients. Left ventricular and right ventricular (RV) geometric and mechanical 
indices were obtained. Correlation and regression analysis were performed to evaluate 
cMRI predictors of RHC hemodynamics.
Results: Pulmonary vascular resistance (PVR) showed correlation with RV ejection 
fraction (r=-0.58, p=0.0002), RV mass index (RVMI) (r=0.706, p<0.0001), RV stroke 
volume index (r=-0.65, p<0.0001), right atrial area (r=0.54, p=0.0002), and RV end 
diastolic (r=0.51, p=0.001) and end systolic volumes (r=0.58, p=0.0001). When ﬁtted to 
a regression model with RVMI and RV ejection fraction as predictors of PVR, both the 
variables remained signiﬁcant. The model gives an R-squared value of 0.56 which was 
mostly driven by the correlation of PVR with RVMI.
Conclusions: In this study, increased RV mass index by cMRI predicts increased PVR 
in PAH. cMRI may provide a novel non-invasive method for diagnosing and assessing 
prognosis in PAH. 
ACC.POSTER CONTRIBUTIONS
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1049-93 Novel Approaches to the Diagnosis and Assessment of 
Takayasu’s Arteritis: Serum MMP-3 Determination and 
Fluorodeoxyglucose PET/CT
Tetsuo Kamiishi, Tokyo Medical and Dental university, Tokyo, Japan
Although progresses in management of arterial diseases are remarkable, recent clinical 
characteristics of Takayasu’s arteritis (TA) have not been reported. Consecutive 83 patients 
with TA in a single center were analyzed. Ten patients received immunosuppressants in 
addition to corticosteroid, 14 received surgical treatments and 18 had moderate to severe 
aortic regurgitation. Major vascular complications are signiﬁcantly less in patients who 
were diagnosed more than 10 years ago (n=60) as compared to patients whose diagnosis 
was made during the last 10 years (n=23). Nineteen patients showed recurrence of 
inﬂammation as evidenced by an exacerbation of clinical symptoms during the last 2 year. 
Serum matrix metalloproteinase-3 (MMP-3), CRP and ESR were measured repeatedly. 
Sensitivity and speciﬁcity of CRP values for predicting clinical recurrence were 74% and 
74%, respectively. In contrast, those of MMP-3 values were 95% and 67%. Eighteen of 
19 patients showed normalization of CRP value during the convalescent stage. However, 
only 1 of 34 patients whose MMP-3 was normal during the follow-up period showed 
recurrence. Thus, high values of MMP-3 could be a predictor for clinical recurrence 
even if CRP is persistently negative. PET/CT scan was positive in 7 patients with clinical 
symptoms and was negative in 3 without inﬂammation. This modality was extremely useful 
to identify patients with recurrence and localization of inﬂammation. We conclude that 
recent development of diagnostic modalities has brought early and accurate diagnosis of 
TA leading to an attenuation of major complications. MMP-3 can be a useful biomarker to 
assess disease activity, even during the chronic stage of remission.
concomitant medications, and number of medications known to interact with warfarin.
Results: The mean patient age was 69 ± 13 years; 63 (65%) were male. 67 (71%) 
were white, 16 (17%) black, 11 (12%) Hispanic, and 1 (1%) Asian. The indication for 
anticoagulation was atrial ﬁbrillation in 75 patients (79%). The median warfarin dose 
was 34 mg/wk (interquartile range 20-53), and did not differ across races (p=0.54). 
Warfarin doses differed signiﬁcantly across genotypes for tested VKORC1 (p<0.001) but 
not CYP2C9 alleles (p=0.13). On average, subjects were taking 5.7 ± 2.8 concurrent 
medications. 35 subjects (37%) were taking 1, and 25 (26%) at least 2 medications 
that interact with warfarin. Gene-based dosing algorithms accounted for 31-55% of the 
variation in warfarin dose requirements. For algorithms that did not adjust for race, the 
inclusion of race increased the proportion of explained variation by 2-5%. Neither the 
number of concomitant medications nor the number interacting with warfarin added to the 
predictive value of the models.
Conclusion: Existing gene-based dosing algorithms explain a third to half the variability 
in warfarin dose requirements in this ethnically diverse cohort. The inclusion of race 
modestly enhanced the performance of published gene-based algorithms.
5:00 p.m.
0911-5 Mortality in Patients With Pulmonary Arterial 
Hypertension in the Modern Era: Data From the Quality 
Enhancement Research Initiative 
Michael A. Mathier, Ronald J. Oudiz, Anatoly Langer, Alina Dragomir, Amparo 
Casanova, Maria Altshuler, Philip Clements, Victor F. Tapson, Richard N. Channick, 
Lewis J. Rubin, Vallerie V. McLaughlin, University of Pittsburgh, Pittsburgh, PA, 
University of Michigan, Ann Arbor, MI
Background: Mortality in patients with pulmonary arterial hypertension (PAH) was 
measured as part of a quality enhancement research initiative (QuERI) in 782 patients 
with PAH among 60 US specialist physicians.
Methods: Physicians were asked to enroll PAH patients (known or newly diagnosed) and 
provide data on clinical variables and survival.
Results: Mortality was examined 6 and 12 months after study enrollment. The 6 month 
mortality rate (among the 548 patients with data available for analysis) was 7.9%. The 
12 month mortality rate (among the 371 patients with data available for analysis) was 
21%. The 12 month mortality among patients with WHO class II, III, and IV symptoms 
was 8.6%, 29.3% and 45.5% respectively. These high mortality rates were seen despite 
widespread use of PAH-speciﬁc therapies: 25% of patients were on a prostanoid, 28% 
on sildenaﬁl, 43% on bosentan, and 22% on combination therapy. Univariate predictors 
of mortality were examined in the 677 patients with available data at 6 or 12 months. 
Signiﬁcant predictors of mortality included (OR [95% CI]): WHO class III/IV vs. I/II (3.2 
[2.0, 5.0]); physical exam evidence of right heart failure, e.g. elevated JVP (2.1 [1.3, 3.5]), 
peripheral edema (3.4 [1.8, 6.6]), and ascites (3.4 [1.5, 7.8]); and underlying scleroderma 
(2.0 [1.3, 3.1]. Interestingly, increasing body mass index (BMI) seemed to confer a 
protective effect, with each 1 kg/m2 increase being associated with an OR for mortality 
of 0.95 [0.92, 0.98].
Conclusion: Despite advances in PAH diagnosis and treatment, mortality remains 
unacceptably high. Predictors of mortality include advanced functional status, clinical 
evidence of right heart failure, and a diagnosis of scleroderma. In addition, there may 
be an “obesity paradox” in patients with PAH similar to that seen in patients with CHF: 
higher BMI was associated with lower mortality. Further studies will be needed to conﬁrm 
these observations.
5:15 p.m.
0911-6 Impact of Moderate Altitude Staging on Pulmonary 
Arterial Pressure During Ascent to High Altitude
Aaron L. Baggish, Charles S. Fulco, Stephen Muza, Paul B. Rock, Beth Beidleman, 
Allen Cymerman, Kibar Yared, David Systrom, Malissa J. Wood, Arthur E. Weyman, 
Michael H. Picard, N. Stuart Harris, Massachusetts General Hospital, Boston, MA, 
United States Army Research Institute of Environmental Medicine, Natick, MA
Background: New onset pulmonary hypertension during high altitude ascent is the 
primary trigger for high altitude pulmonary edema. Acute hypoxic exposure underlies 
these processes. Effective strategies for minimizing pulmonary arterial pressure rise 
during altitude ascent are lacking. Staged ascent (SA), deﬁned as temporary residence 
at moderate altitude prior to high altitude ascent, reduces the incidence and severity of 
non-cardiopulmonary altitude sickness. The effect of SA on pulmonary arterial pressure 
during ascent to high altitude is unknown.
Methods: Healthy males (n=10, age=20 ± 2 years) were studied at sea level (SL), after 
direct ascent (DA) to simulated altitude (hypobaric chamber, 4300 m) and again after SA 
(7 days spent at moderate altitude = 2200 m, followed by rapid, passive ascent) to 4300 
m terrestrial altitude. Doppler echocardiography was used to calculate mean pulmonary 
arterial pressure (mPAP). To examine the relationship between mPAP and oxygenation, 
measurements of alveolar oxygen pressure (PAO2) and arterial oxygen saturation (SaO2) 
were performed.
Results: All individuals had normal mPAP (14±3 mmHg, range = 6-18 mmHg) at SL. After 
DA, mPAP increased by 164% to 37 ± 8 mmHg (p=0.004) and was strongly correlated 
with both PAO2 (r2=0.57, p=0.011) and SaO2 (r2=0.64, p=0.005). mPAP during SA (25 ± 6 
mmHg) was 48% lower (p<0.001) than mPAP during DA. In contrast to DA, mPAP during 
SA was not signiﬁcantly related to either measure of oxygenation (PAO2 r2=0.002, p=0.91; 
SaO2 r2=0.004, p=0.86).
Conclusions: Staging at moderate altitude appears to signiﬁcantly attenuate PAP increase 
during ascent to high altitude and may be protective against high altitude pulmonary 
edema. In addition, the uncoupling of PAP and oxygenation during staged ascent may 
reﬂect an important adaptive reduction in hypoxic pulmonary vascular reactivity.
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good accuracy of the ultrafast echo technique for real time PWV evaluation in vitro, wth 
feasibility and reproducibility in healthy subjects. This technique has the potential for 
clinical application to detect early atherosclerois, monitor cardiovascular drug therapy 
and detect other vascular diseases which alter PWV.
9:30 a.m.
1049-96 Proximal Thoracic Aorta Dimension and Outcomes 
in Acute Type B Dissection: Insights From the 
International Registry of Acute Aortic Dissection 
(IRAD)
Anna M. Booher, Eric Isselbacher, Christoph A. Nienaber, James B. Froehlich, 
Santi Trimarchi, Jeanna V. Cooper, Stefanos Demertzis, Gabriel Meinhardt, Vijay S. 
Ramanath, James L. Januzzi, Kevin M. Harris, Patrick O’Gara, Thoralf Sundt, Reed E. 
Pyeritz, Kim A. Eagle, On behalf of the IRAD Investigators, The University of Michigan, 
Ann Arbor, MI
Background: It is not well known if the size of the proximal thoracic aorta (pTA) at 
presentation predicts features of presentation and outcomes in patients with acute type 
B aortic dissection.
Methods: The IRAD database was queried for all pts with acute type B dissection who 
had documentation of pTA size (annulus, aortic root, sinotubular junction or ascending 
aorta) at the time of initial presentation. Pts were categorized according to pTA diameters 
of < 4.0cm, 4.1-4.5cm and > 4.6cm. These three groups were compared using a chi 
squared analysis to assess for differences between the groups.
Results: Four hundred and eighteen pts met inclusion criteria; 219 pts (69.6%) were 
male with a mean age of 63.2 + 13.5 years. A pTA diameter of < 4cm was noted in 250 
pts (59.8%), 4.1-4.5 cm in 105 pts (25.1%) and > 4.6cm in 63pts (15.1%). Pts with a pTA 
size >4.6cm were more likely to be male (p=0.01), have Marfan syndrome (p <0.001) 
and known aortic valve disease (p=0.01). At presentation, pts with pTA size > 4.6cm 
were more likely to have an abnormal aortic contour on chest radiography (p=0.03) and 
a murmur of aortic insufﬁciency (p=0.003). A non signiﬁcant trend toward increased 
incidence of myocardial ischemia/infarction (p=0.07) and hypotension (p=0.08) was 
seen in pts with a pTA diameter of 4.1-4.5cm. In pts with a pTA of >4.6cm, there was an 
overall increased need for surgical intervention (p=0.01); in particular there was a higher 
rate of open surgical procedures and aortic valve replacement (p=0.003). There was no 
difference in overall mortality or cause of death between the three groups.
Conclusions: Enlarged pTA dimensions in pts with acute type B aortic dissection does 
not appear to predict an increased risk of mortality, but is associated with an increased 
need for an open surgical intervention and the risks inherent in these procedures.
9:30 a.m.
1049-97 Predicting Critical Peripheral Arterial Disease in 
Patients With Stable Coronary Arterial Disease: A 
Simple Risk Prediction Score
Apurva Badheka, Samrat Bhat, Mohammad A. Kizilbash, Neha Garg, Ankit Rathod, 
Sony Jacob, Luis Afonso, Wayne State University, Detroit, MI
Background: Factors predicting development of critical peripheral arterial disease (PAD) 
in patients with stable coronary arterial disease (CAD) are not well deﬁned.
Methods: The multicenter “Prevention of Events with Angiotensin Converting Enzyme 
Inhibition (PEACE) Trial” (n=8290) compared trandolapril against placebo in patients 
with CAD and preserved ejection fraction. End point studied was critical PAD requiring 
angioplasty, bypass grafting or aneurysm repair. Risk variables associated with critical 
PAD on multivariable analyses were assigned points based on level of risk. Statistical 
modeling was used to formulate a risk score.
Results: 303 (3.7%) patients developed critical PAD in NHLBI PEACE Limited Access 
dataset on follow up (mean 4.6 yrs/patient). Signiﬁcant predictors (OR, 95% CI, assigned 
points) were intermittent claudication (3.85, 2.89-5.12, 34), smoking (2.25, 1.56-3.23, 20), 
hypertension (1.004, 1.001-1.007, 16), CABG (1.68, 1.31-2.14, 13), diabetes (1.39, 1.03-
1.87, 8), age (1.03, 1.01-1.05, 0.7/yr), serum cholesterol (1.004, 1.001-1.007, 0.1/unit) 
and BMI (0.97, 0.94-0.99, -1/unit). A cutoff of >74 points identiﬁed patients at highest 
risk. Incident PAD was common (8 events / 1000 patient years) and was associated with 
increased composite outcome of cardiovascular death, MI, PTCA or CABG (HR 1.82, 
95% CI 1.50-2.22, p<0.001).
Conclusion: Risk stratiﬁcation using our simple PAD score may identify vulnerable 
patients for further investigation and targeted therapy. 
9:30 a.m.
1049-94 Trends in Management and Outcomes of Acute Aortic 
Dissection: Lessons Learned From the First 2242 
Patients Enrolled in the International Registry of Acute 
Aortic Dissection (IRAD)
Thomas T. Tsai, Jeanna V. Cooper, Elise M. Woznicki, Christoph A. Nienaber, Eric 
Isselbacher, Santi Trimarchi, Anna M. Booher, Arturo Evangelista, Eduardo Bossone, 
Gabriel Meinhardt, Rossella Fattori, Reed E. Pyeritz, Kim A. Eagle, James B. Froehlich, 
On behalf of the IRAD Investigators, The University of Michigan, Ann Arbor, MI
Background: Acute aortic dissection (AAD) has a high mortality despite advances in 
management and therapy. Whether the treatment or outcome has changed in the last 
decade is unknown.
Methods: We analyzed 2242 AAD patients in IRAD between 1/1/96 to 1/31/2008 divided 
into two equal groups (G1 & G2). G1 (type A=701, type B=420) were enrolled from 
1/1/96 to 10/15/00 and G2 (type A=732, type B=389) from 10/16/00 to 1/31/2008. Clinical 
features, imaging ﬁndings, treatment and outcome were compared between the 2 groups 
stratiﬁed by type.
Results: Mean age was 61.1±14.4 years, 68.9% were male. Demographics and clinical 
features were similar between the two groups. However, patients with type B in G2 were 
younger (61.5±14.4 years vs 64.6±13.3, p=0.002) and both types in G2 were more likely 
transfers (type A: 80.2 vs 70.1%, type B: 79.3 vs 68.0%, both p<0.001). G2 patients were 
more likely to get a CT as the ﬁrst diagnostic test (71.9 vs 64.2%, p<0.001) and less 
likely to receive a TEE (31.0 vs 23.7%, p<0.001). In G2, signiﬁcantly more patients were 
treated with surgery for type A and endovascular therapy for Type B (Table). Overall (A 
& B) in-hospital mortality was lower in G2 (p=0.05) but stratiﬁed by type did not reach 
signiﬁcance.
Conclusion: Over 12 years and 2242 patients, more AAD patients are being treated 
with surgery and endovascular therapy with a decrease in overall mortality although no 
signiﬁcant difference stratiﬁed by type. CT has emerged as the standard initial test in AAD. 
Variable 1996-2000 (G1)(n=1121)
2000-2008 (G2)
(n=1121) p-value
Type A Aortic Dissection n=1433 (63.9%)
Management: <0.001*
-Surgery (%) 559 (79.7) 664 (90.7) <0.001
-Medical/Endovascular (%) 142 (20.3) 68 (9.3) <0.001
Mortality:
-Surgery (%) 131 (21.4) 142 (21.4) 0.39
-Medical/Endovascular (%) 75 (55.6) 44 (68.8) 0.07
-Overall (%) 209 (29.8) 189 (25.8) 0.09
Type B Aortic Dissection n=809 (36.1%)
Management: 0.007*
-Surgery (%) 72 (17.1) 73 (18.8) 0.55
-Medical (%) 297 (70.7) 240 (61.7) 0.007
-Endovascular (%) 51 (12.1) 76 (19.5) 0.004
Mortality:
-Surgery (%) 22 (30.6) 9 (12.3) 0.005
-Medical (%) 29 (9.8) 20 (8.3) 0.57
-Endovascular (%) 5 (9.8) 9 (11.8) 0.72
-Overall (%) 56 (13.3) 38 (9.8) 0.11
Type A & B Mortality 265 (23.6) 227 (20.2) 0.05
*overall p-value between managements
9:30 a.m.
1049-95 Real-Time Local Evaluation of Arterial Pulse Wave 
Velocity Using Ultrafast Echo Imaging
Mathieu Pernot, Mathieu Couade, Mickael Tanter, Robert A. Levine, Joseph Emmerich, 
Mathias Fink, Emmanuel Messas, Médecine Vasculaire, Hôpital Européen Georges 
Pompidou,Faculté de Médecine Paris Descartes, Paris, France, INSERM U765, Paris, France
Background. Pulse Wave Velocity (PWV) is recognized as a powerful predictive factor for 
cardiovascular morbimortality but its practical evaluation remains complex. We propose a 
novel technique for measuring PWV in real time, locally and non-invasively on peripheral 
arteries using an ultrafast scanner at ultra-high frame rate (up to 10,000 Hz) that can 
visualize wave propagation velocities up to 10 m/sec without aliasing. Objectives. The
goal of this study was to validate this technique in vitro and show its feasibility in 30 
healthy patients using conventional sonographic probes. Methods. In vitro experiments 
were performed on arterial phantoms made of water-ﬁlled rubber tubes embedded 
in tissue-mimicking gel and connected to a pulsatile ﬂow pump (Harvard apparatus® 
Pulsatile blood pomp 0-100 ml, 60 cardiac cycles per minutes, stroke volume 20cc) 
which generates a pulsatile ﬂow comparable to the human. The arterial phantom was 
imaged using a conventional linear ultrasonic probe (8MHz) connected to an ultrafast 
scanner (10,000 images/s). The arterial wall velocities were obtained instantaneously 
from conventional speckle tracking techniques and the PWV and elastic modulus were 
derived. Finally, an in vivo study on the common carotid artery of 30 healthy volunteers 
was conducted to show the feasibility and reproducibility of this technique. Results. The 
PWV was measured accurately for 5 arterial phantoms with a mean of 8.6m/sec (from 
5.2 to 12 m/s). The elastic modulus of the arterial phantom derived using the Moens-
Korteweg equation correlated well with that from gold standard rheological measurements 
(n=5, r²=0.88, p<0.01). In vivo studies on healthy volunteers found a mean carotid PWV 
of 5.5±1m/s (from 4.5 m/s to 7 m/s) consistent with common literature values, with good 
intra- and interobserver variability (<10% of the mean). Conclusions. These data suggest 
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1049-100 Small Artery but Not Large Artery Elasticity Predicts 
Coronary Heart Disease Events Beyond Coronary 
Calcium Score and Carotid Intima-Media Thickness 
in an Asymptomatic Population: Results of the 
Multiethnic Study of Atherosclerosis (MESA)
Daniel A. Duprez, David R. Jacobs, Jr., Pamela L. Lutsey, David A. Bluemke, Lyndia C. 
Brumback, Joseph Polak, Richard A. Kronmal, University of Minnesota, Minneapolis, MN
Background: Coronary calcium score (CAC) and carotid intima-media thickness (cIMT) 
have been considered as signiﬁcant predictors for coronary heart disease (CHD). It is 
unknown if large (LAE) and small (SAE) artery elasticity can predict cardiovascular disease 
(CVD) events beyond these previous markers and blood pressure (BP). We examined the 
prognostic value of LAE and SAE on CHD events in the MESA cohort study.
Methods: 6047 women and men of white, African American, Hispanic, and Chinese 
ethnicity, aged 45-84 years and free of clinically CVD, were recruited in 6 US communities. 
Pulse wave contour registration at the radial artery was performed at baseline using radial 
tonometry. LAE and SAE were derived from diastolic pulse contour analysis. Carotid 
ultrasound and coronary computed tomography were performed at baseline. Median 
follow-up of 4 years resulted in 165 adjudicated CHD events.
Results:Table 1 presents proportional hazards regression models (HR) for CHD events 
adjusted as indicated.
Model 1: adjusted for age, race, gender, site, height, cIMT and CAC
Model 2: adjusted for variables in model 1 plus heart rate, systolic and diastolic BP, use of 
antihypertensive medication, BMI, ever and current smoking, total and HDL-cholesterol, 
triglycerides, use of cholesterol lowering medication, and diabetes
Conclusions: In asymptomatic subjects free of overt CVD, SAE in contrast to LAE 
added predictive information for CHD events, beyond carotid IMT, CAC score and other 
cardiovascular risk factors.
Table 1
LAE continuous (SD unit: 
5.6 ml/mmHgx10)
SAE continuous (SD 
unit: 2.8 ml/mmHgx100)
Adjustment HR (95% upper, lower) P HR (95% upper, lower) P
Model 1 0.93 (0.77, 1.12) 0.43 0.73 (0.57, 0.93) 0.01
Model 2 1.00 (0.82, 1.21) 0.99 0.77 (0.60, 0.99) 0.04
9:30 a.m.
1049-101 Adherence to Evidence Based Therapy Guidelines in 
Patients Undergoing Peripheral Arterial Interventions
Amber M. Shah, Liliana Kuvlieva, Khaled Ziada, Hussam Hamdalla, David C. Booth, 
John C. Gurley, David J. Moliterno, Debabrata Mukherjee, University of Kentucky 
Medical Center, Lexington, KY
Background: Peripheral arterial disease (PAD) is associated with increased cardiovascular 
events. Therapy with statins, antiplatelet agents, beta blockers and angiotensin converting 
enzyme inhibitors (ACEi) reduces cardiovascular events in patients with PAD. We 
assessed physician adherence to such therapies in patients presenting for percutaneous 
interventions for PAD.
Methods: We collected data on consecutive patients that presented for interventions for 
PAD from January 2006 to May 2008. Patients’ medication list and blood pressure (BP) 
while in hospital was reviewed. We looked for contraindications to therapy in case of 
patients not on appropriate therapies such as aspirin, clopidogrel, statins, beta blockers, 
and ACEi or angiotensin receptor blockers (ARB). Percentage of patients not receiving 
appropriate therapy without contraindications to such therapy was calculated.
Results: 120 patients underwent 133 interventions for PAD (Age 63.6 ± 11.8 years, 
41.9% males, Body mass index 28.3 ± 6.1 kg/m2, 83.8% with known hypertension). BP 
was not at goal in 68.5% patients. Only 50.4% patients were on all of the appropriate 
medications. Table shows percentage of patients not receiving these medications.
Conclusions: Only 50% of all patients with PAD receive optimal evidence-based 
cardiovascular risk reduction therapy. Physician adherence of risk reduction therapy 
particularly with statins, ACEi, ARB’s, and beta blockers needs to be strongly encouraged 
to optimize outcomes in these patients.
Percentage of patients NOT receiving appropriate risk reduction therapy
Medication lacking in patient 
regimen Percentage patients (%) 95% Conﬁdence Interval
ACEi or ARB 30.1 22.2 - 38.0
Beta blockers 18.8 12.1 - 25.5
Statins 12.8 7.1 - 18.5
Clopidogrel 3.8 0.5 - 7.0
Aspirin 1.5 (-0.6) - 3.6
One of these medications 33.8 25.7 - 42.0
Two of these medications 14.3 8.3 - 20.3
Three of these medications 1.5 (-0.6) - 3.6
9:30 a.m.
1049-98 Complete Separation of the Stent Fracture Does Not 
Affect Patency in the Femoro-Politeal Artery
Kuniyasu Ikeoka, Osamu Iida, Shinsuke Nanto, Masaaki Uematsu, Takakazu Morozumi, 
Kenji Kawamoto, Shin Okamoto, Kansai Rosai Hospital, Hyogo, Japan
Background: Stent fracture has been shown to affect long-term patency in the femoro-
popliteal artery (FPA). However, whether the morphology of stent fracture inﬂuences the 
patency remains unknown.Methods: We investigated the relation between patency and 
stent fracture morphology in consecutive 333 de novo lesions in the FPA that received 
provisional stenting with nitinol stents (Luminexx, Bard: 90 lesions and Smart, Cordis: 243 
lesions). Patients gave consent to receive follow-up duplex ultrasound (16±12 months 
later). Stent fracture was diagnosed by X-ray with multiple projections. The morphology 
of the stent fracture was classiﬁed based on the Viva Physicians, Inc. Research Program 
(I = single tine fracture, II = multiple tine fractures, III = stent fracture(s) with preserved 
alignment of the components, IV = stent fracture(s) with mal-alignment of the components, 
V = stent fracture(s) in a trans-axial spiral conﬁguration). Patency was determined by 
duplex ultrasonography at follow-up as peak systolic velocity ratio > 2.4.
Results: Stent fracture occurred in 55 lesions (I =10, II= 32,III=13) and restenosis rate at 
follow-up was 20% (67/333) . Although type II stent fracture revealed the worst patency rates 
(51%, 51%, 45%, 45% at 1, 2, 3, 4 year; p<0.01), neither type I(100%, 75% at 1, 2 year, 
p=0.68) nor type III(92% 92% 92% 92% at 1, 2, 3, 4 year; p=0.18) affected the patency .
Conclusions: Complete separation of the stent does not affect patency in the FPA 
stenting. 
9:30 a.m.
1049-99 The Status of Peripheral Arterial Disease Instruction in 
Medical School
Aron I. Schwarcz, Aimee Quijano, Jeffrey W. Olin, Robert J. Ostfeld, Monteﬁore Medical 
Center, Bronx, NY
Background: Peripheral arterial disease (PAD) refers to atherosclerotic disease in 
the aorta and lower extremity arteries. It affects approximately 8 million Americans 
and it is associated with a markedly increased cardiovascular morbidity and mortality. 
Nevertheless, there is poor awareness of this disease amongst both the general 
population and physicians. There have been many initiatives to increase both public and 
physician awareness of PAD. However, to our knowledge, there have been no studies 
assessing PAD education in medical school. The purpose of this study was to assess the 
status of PAD instruction during medical school.
Methods: During orientation to an internal medicine residency program in New York City, 
incoming interns were given a 19-question multiple-choice questionnaire. The questions 
fell into one of four categories: 1) Prevalence, 2) Screening, 3) Treatment, 4) Outcome. 
Percent correct and their corresponding ranges are reported.
Results: Sixty-two incoming interns for the 2008-2009 academic year were queried. They 
had attended 39 different medical schools, thirty in the United States and nine foreign. 
Their average age was 27.5+/-2.6 years and 63.8% of them were female. Fifty-eight 
(93.5%) returned the questionnaire. All returned questionnaires were analyzed and 
unanswered questions were graded as incorrect. Of the 1102 multiple-choice questions 
asked (58 interns x 19 multiple-choice questions per questionnaire), 460 (41.7%, range 
10.5%-73.7%) were answered correctly. Forty-eight point nine percent (range 0% to 
100%) answered the prevalence questions correctly, 33.8% (range 0% to 80%) answered 
the screening questions correctly, 45.0% (range 0% to 87.5%) answered the treatment 
category correctly and 42.5% (range 0% to 100%) answered the outcomes questions 
correctly.
Conclusions: The knowledge of peripheral arterial disease among incoming interns is 
poor. More optimal education regarding peripheral arterial disease during medical school 
is advised. Given the signiﬁcant beneﬁts that lifestyle and medical therapies have for 
patients with peripheral arterial disease, these ﬁndings, if conﬁrmed in larger studies, 
should be a call to action.
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1049-104 A Novel Simple Method to Detect Peripheral Arterial 
Disease in Patients Whose Resting ABI Between 0.9-1
Kai-Hung Cheng, Feng-Hsien Lin, Chih-Sheng Chu, Kun-Tai Lee, Tsyh-Jyi Hsieh, 
Ho-Ming Su, Tsung-Hsien Lin, Wen-Chol Voon, Sheng-Hsiung Sheu, Wen-Ter Lai, 
Department of Cardiology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung 
Medical University, Kaohsiung, Taiwan,ROC
Background: Ankle-brachial index (ABI) is one of the noninvasive tests for patients 
with peripheral artery disease (PAD). Value of ABI between 1.0 and 1.3 reﬂects normal 
functioning of PA. An ABI of less than 0.9 is considered abnormal and is 95 % sensitive for 
angiographically veriﬁed PAD. However, all cause mortality increased since ABI a1.0 and 
diagnostic accuracy of PAD with resting ABI between 0.9-1.0 remained controversial.
Methods: Between October 2005 and August 2008, 25 patients (8F, mean 69.5 yrs) 
with PAD suspicion and symptoms of claudication having resting ABI >0.9 but a1.0 were 
enrolled. There were 26 lower limbs ﬁtted the criteria. After resting ABI and pulse wave 
velocity (PWV) was measured, sublingual nitroglycerine (NTG, 0.6mg) was given. After 
3-4 minutes of NTG, the 2nd ABI and PWV was reevaluated. Gadolinium(Gd)-enhanced 
MRA was performed from aorta to lower extremities for diagnosis of PAD. The I $PWV I 
was deﬁned as the absolute value of PWV after NTG minus that before NTG.
Results: The mean of resting ABI was 0.96±0.03 of the 31 limbs in which 24 of 31 had 
signiﬁcant PAD. After sublingual NTG, the ABI decreased to <0.9 (0.85±0.04) in 12/31 
limbs in which 12/12 had signiﬁcant PAD. The ABI remained between 0.9 and 1.0 in 
another 19 limbs in which 12/19 limbs had signiﬁcant PAD. Therefore, the sensitivity was 
100 % but speciﬁcity was 38.9%. When I$PWVI>360 cm/s was added to the post-NTG 
ABI data, both the test speciﬁcity and the sensitivity could be improved to 92 % and 83.3 
% respectively.
Conclusions: For patients with resting ABI >0.9 but a1.0, ABI and PWV after sublingual 
NTG is a novel noninvasive method to increase the diagnosis accuracy of PAD.
9:30 a.m.
1049-105 Descending Aortic Diameter of q 6.0 Is a Poor Predictor 
of Type B Aortic Dissection
Santi Trimarchi, Stuart Hutchison, Eric Isselbacher, Linda Pape, Jeanna V. Cooper, 
James B. Froehlich, Arturo Evangelista, Gabriel Meinhardt, Joshua Beckman, Truls 
Myrmel, Kim A. Eagle, Reed E. Pyeritz, Alan T. Hirsch, Christoph A. Nienaber, On behalf 
of the IRAD Investigators, IRCCS Policlinico San Donato, San Donato, Italy, University 
of Rostock, Rostock, Germany
Background: The risk of acute type B aortic dissection (B-AAD) is known to increase 
with descending thoracic aortic diameter. Establishing a diameter threshold value that 
discriminates low from high risk of acute dissection is critical. Current indications are 
to treat at a diameter of q6.0 cm or q5.5 cm in cases with heritable disorders such as 
Marfan syndrome.
Methods: We examined the descending aortic diameter at presentation of 389 cases of 
type B-AAD enrolled in the International Registry of Aortic Dissection between 1996 and 
2005 where diameter data was available. We subsequently investigated the relationship 
of the current threshold to presentation and mortality.
Results: Mean age was 63.3 years ±13.7 and 69% were male. Mean maximum diameter 
at B-AAD was 4.56±1.44 cm. Only 17% of patients had an aortic diameter greater than 
6.0 cm. Marfan syndrome cases, representing only 3.9% of the cohort, did not have 
signiﬁcantly larger aortic diameters at dissection (4.8 vs 4.5 cm; p=0.57).
Increasing diameter was associated with increasing risk of mortality. The mean diameter 
of non-survivors was greater than that of survivors (5.13 vs 4.49 cm; p=0.006). Patients 
with a descending aorta q 6.0 had a higher mortality (24.2% vs 8.4%, p<0.001).
Conclusions: The large majority of patients with B-AAD present with descending aortic 
diameters < 6.0 cm, and do not fall within the guidelines of current aortic intervention/
surgery. Methods other than diameter measurement are needed to identify patients at 
risk of dissection. 
9:30 a.m.
1049-102 Run-Off Below the Ankle as an Important Determinant 
of Major Amputation in Patients With End-Stage Renal 
Disease and Critical Limb Ischemia
Kenji Kawamoto, Shinsuke Nanto, Masaaki Uematsu, Takakazu Morozumi, Tetsuya 
Watanabe, Seiki Nagata, Masaki Awata, Toshinari Ohnishi, Osamu Iida, Fusako Sera, Hitoshi 
Minamiguchi, Masamichi Yano, Shin Okamoto, Kuniyasu Ikeoka, Haruyo Yasui, Nobuaki 
Tanaka, Takayuki Ishihara, Tomoharu Dohi, Kansai Rosai Hospital, amagasaki, Japan
Background: Endovascular therapy (EVT) in patients with critical limb ischemia (CLI) 
has demonstrated comparable amputation free survival to bypass surgery. However, 
amputation free survival rate in patients with end-stage renal disease (ESRD) remains 
poor. We sought to elucidate the factors leading to the major amputation in patients with 
ESRD and CLI underwent complete revascularization by EVT.
Methods: Among consecutive 259 patients with CLI of Rutherford 4 to 6 who underwent 
EVT between April 2003 and August 2008, 118 patients in ESRD (male = 93; median 
age 68 years) with 143 limbs showing CLI were enrolled: Rutherford 4 = 23 limbs (16%), 
5= 89 limbs (62%), and 6 = 31 limbs (22%). Patients were followed up for 13±12 months. 
Patients were classiﬁed as amputation group versus non-amputation group. Factors 
leading to major amputation were explored by single regression analysis and subsequent 
multivariate analysis.
Results: Major amputation rate was 22% (32/143 limbs). Diabetic patients, CRP and run-
off below the ankle(BA) after EVT were chosen as independent variables related to the 
major amputation by single regression analysis (P<0.05). By multivariate analysis, poor 
run-off below the ankle was the strongest factor associated with the major amputation 
in those patients. Conclusion: Poor run-off below the ankle was the strongest factor 
leading to the major amputation in patients with end-stage renal disease and critical limb 
ischemia who underwent EVT. 
9:30 a.m.
1049-103 High-Risk Features of Carotid Artery Stent Patients: 
Preliminary Results From the CARE Registry
H. Vernon Anderson, Christopher J. White, Irene L. Katzan, Kenneth A. Rosenﬁeld, Phil 
G. Jones, John A. Spertus, Christopher U. Cates, Kalon K. Ho, Michael R. Jaff, Sari P. 
Caldwell, John Rumsfeld, Ralph G. Brindis, University of Texas Health Science Center 
Houston, Houston, TX
Background: Carotid stenting (CAS) is an alternative to carotid endarterectomy (CEA) in 
selected patients with features that make CEA high risk. The ACC-NCDR in conjunction 
with other specialty societies, established the Carotid Artery Revascularization and 
Endarterectomy (CARE) Registry, providing a comprehensive national database of 
carotid revascularization.
Methods: The CARE Registry has written deﬁnitions, a data dictionary, uniform collection 
tools, and quality control checks. High risk features for CEA consist of 15 elements from 
the 2007 clinical expert consensus document developed by the multispecialty society 
consortium. We examined these high-risk clinical features among the initial patients 
undergoing CAS in the CARE Registry.
Results: There were 3159 CAS procedures submitted from 107 participating sites from 
01/2007 through 03/2008. A single carotid lesion was treated in 99%, while 1% had >1 
lesion treated. A single stent was deployed in 95%, and q2 stents in 5%. The anatomic 
and clinical features that characterized patients as high risk for CEA are shown in the 
Table. 
Anatomic risk features n % Medical comorbidities n %
CEA restenosis 491 16 Chronic renal disease 1263 40
Difﬁcult surgical access 480 15 Chronic lung disease 889 28
Contralateral carotid occl 331 11 Age q80 years 631 20
Prior radical neck surgery 174 5.5 Severe CAD 577 18
Prior radiation therapy 167 5.3 NYHA Class III/IV 408 13
Tracheostomy present 47 1.5 CCS Class III/IV angina 375 12
Prior laryngeal nerve palsy 11 0.4 MI <6weeks 83 2.6
Cardiac surgery planned 74 2.3
(categories are not mutually exclusive)
Conclusions: Medical comorbidities accounted for most of the high risk features of CAS 
patients in the CARE Registry, while difﬁcult surgical anatomy was less common but still 
extremely important. Better understanding of these features underlying procedural risk 
will be needed for both appropriate risk adjustments as well as outcomes assessments 
in this novel procedure.
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1049-108 Viability Imaging of Encapsulated Mesenchymal Stem 
Cells Using Bioluminescence
Dorota A. Kedziorek, Piotr Walczak, Yingli Fu, Nicole Azene, Jeff W.M. Bulte, Dara L. 
Kraitchman, Johns Hopkins University, Baltimore, MD
Background: To enhance survival of mesenchymal stem cells (MSCs) for arteriogenesis 
induction therapies and avoid immunosuppressive regimes, alginate-poly-L-lysine (PLL)-
alginate (APA) microcapsules were developed. The addition of perﬂuoroctylbromide 
(PFOB) to the alginate microencapsulation enables X-ray and magnetic resonance 
imaging and also enhances local oxygen tension. However, cell viability within the 
microcapsules cannot be directly determined, particularly post transplantation. In the 
present study, we combined reporter gene method to track cell survival with X-ray 
detection of the microcapsules.
Methods: Rabbit MSCs were transfected with tri-fusion multimodality reporter gene 
containing: red ﬂuorescence protein, truncated thymidine kinase (SPECT/PET reporter) 
and ﬁreﬂy luciferase (bioluminescence imaging (BLI) reporter). MSCs expressing the 
TF reporter were encapsulated in the PFOB microcapsules. Crosslinking for capsule 
stabilization was performed with three concentration of PLL (0.005%, 0.025% and 
0.05%). BLI was used to evaluate cell survival in vitro and in a rabbit model of peripheral 
arterial disease.
Results: Encapsulation with PLL at concentration of a 0.05% was not cytotoxic. BLI 
of encapsulated MSCs was not blocked by encapsulation itself in APA and PFOB 
microcapsules. Higher PLL concentrations, which are associated with more stable pores 
in APA capsules, correlated with a higher BLI signal. BLI signal was slightly reduced in 
alginate encapsulated cells (~80% for 0.05% PLL capsules). PFOB further reduced the BLI 
signal (~35-45% of non-PFOB APA capsules). After intramuscular injection of encapsulated 
cells BLI signal was easily detectable and enabled the assessment of cell survival.
Conclusion: BLI allows monitoring viability of transplanted encapsulated cells. Crosslinking 
with PLL concentrations of a 0.05% is safe with pores enabling free diffusion of small 
molecules (e.g. luciferin). Expression of the triple-fusion reporter gene by microencapsulated 
MSCs allows monitoring cell viability with BLI and PFOB component in the capsule facilitates 
tracking their position and placement with conventional X-ray imaging.
9:30 a.m.
1049-109 Carotid Angioplasty and Stenting in Octogenarians. Is it 
Safe?
Michel Henry, I. Henry, A. Polydorou, A. D. Polydorou, A. D. Polydorou, M. Hugel, Michel 
HENRY, NANCY, France
Purpose: Elderly patients have a higher risk of complications in carotid endarterectomy. 
The aim of the study was to evaluate whether carotid artery stenting (CAS) performed in 
octogenarians also increases the procedure related risk.
Methods: 897 patients (male 648) mean age 70.9 ± 9.3 years underwent 957 CAS for 
de novo lesions (n=876) restenoses (n=55) post radiation (n=14) inﬂammatory arteritis 
(n=10) post trauma aneurysms (n=2). Indications for treatment: symptomatic carotid 
stenosis > 70 % (n=577) or asymptomatic stenosis > 80 %. Patients were separated 
into 2 age groups: > 80 y (128 patients, 131 CAS) and <80 y (769 patients, 826 CAS). 
187 CAS performed without protection (N.P-) 6 patients >80 y, 770 with protection (NP+) 
(occlusion balloon: 334, ﬁlters: 431, reversal ﬂow: 6) 125 patients >80y. Data analysis 
included neurological complications, death and myocardial infarction (MI) rate at 30 days, 
anatomical particularities. Technical points will be described depending on the age of 
the patient.
Results: Technical success
< 80 years: 824/826
>80 years: 130/131
30 day outcomes 
> 80 Y. < 80 Y.
TOTAL NP- NP + TOTAL NP- NP +
NBR 131 6 1258 826 181 645
T.I.A. 2(1,5%) 1 (17%)
1
(0,8%)
10
(1,2%)
3
(1,7%) 7 (1,1%)
MINOR STROKE 1(0,8%) 1 (17%) 0 5 (0,6%)
2
(1,1%) 3 (0,5%)
MAJOR STROKE 0 0 0 3 (0,4%) 2(1,1%) 1 (0,2%)
RETINAL EMBOLUS 0 0 0 4 (0,5%) 0 4 (0,6%)
HYPERPERFUSION
SYNDROME 0 0 0 3 (0,4%) 0 3 (0,5%)
DEATH
FATAL STROKE
NON FATAL STROKE
0 0 0
5 (0,6%)
4 (0,5%)
1 (0,1%)
2
(1,1%)
2
(1,1%)
0
3 (0,5%)
2 (0,3%)
1 (0,2%)
MI 0 0 0 1 (0.1%) 0 1 (0.2%)
DEATH / STROKE 1(0,8%) 1 (17%) 0
13
(1,6%)
6
(3,3%) 7 (1,2%)
DEATH / STROKE / M.I. 1(0,8%) 1 (17%) 0
14
(1,7%)
6
(3,3%) 8 (1,32%)
Conclusion: CAS can be performed in elderly patients without higher risk than in younger 
patients. But good indications, a meticulous technique, protection devices are mandatory 
and some technical points must be pointed out to avoid neurological complications and 
failures.
9:30 a.m.
1049-106 Cross-Classiﬁcation of Microalbuminuria With Reduced 
Glomerular Filtration Rate and Peripheral Arterial 
Disease Among US Adults
Usman Baber, Devin M. Mann, Daichi Simbo, Mark Woodward, Jeffrey W. Olin, Paul 
Muntner, Mount Sinai School of Medicine, New York, NY
Background: Chronic kidney disease (CKD), deﬁned by either a reduction in estimated 
glomerular ﬁltration rate (eGFR) or the presence of microalbuminuria (MA), is associated 
with an increased risk for peripheral arterial disease (PAD). The presence of both MA and 
reduced eGFR may identify a subgroup of adults at particularly high risk for PAD.
Methods: US adults q 40 years of age (n=7109) participating in the 1999-2004 National 
Health and Nutrition Examination Survey were classiﬁed into 4 groups based on the 
presence or absence of reduced eGFR (< 60 ml/min/1.73m2) or MA (urinary albumin to 
creatinine ratio q30 mg/g). PAD was deﬁned as ankle-brachial index < 0.9.
Results: The prevalence of MA was 10.3% and 7.9% had reduced eGFR. Of those with 
reduced eGFR, 24.3% also had MA; of those with MA, 18.5% had reduced eGFR. The 
prevalence of both MA and reduced eGFR was 1.9%. The prevalence of PAD was highest 
in those with both reduced eGFR and MA (Figure). After multivariable adjustment for 
demographics, laboratory measures, and co-morbidities including diabetes mellitus, the 
odds ratios of PAD for adults with MA alone, reduced eGFR alone and both reduced 
eGFR and MA, compared to those without MA and reduced eGFR, were 1.74 (95% CI: 
1.18-2.56), 1.64 (95% CI: 1.14-2.35) and 2.38 (95% CI: 1.42-4.14), respectively.
Conclusion: MA is a common ﬁnding among adults with reduced eGFR. The co-existence 
of MA and reduced eGFR is associated with a high prevalence of PAD and may be useful 
in identifying patients with vascular disease. 
9:30 a.m.
1049-107 Neovascularization and Vasa Vasorum Correlates With 
Cardiovascular Events in 159 Patients
Daniel Staub, Mita B. Patel, Anjan Tibrewala, David Ludden, Jocelyn Spoon, Timothy 
Smith, Adele Liuzzo, Philip Kilcullen, Blai Coll, Steven B. Feinstein, Rush University 
Medical Center, Chicago, IL
Background: Histological data associates proliferation of adventitial vasa vasorum (VV) 
and intraplaque neovascularization (NEO) with more unstable vascular disease. As VV 
and NEO can be reliably visualized using contrast enhanced ultrasound imaging, we 
correlated the presence of carotid NEO and VV with cardiovascular events.
Methods: We retrospectively analyzed 186 carotid ultrasound studies in 159 patients 
(age 64±11 years, 58% male) using contrast enhancement for the presence of plaque, 
and categorized the presence of NEO as absent (Grade 0) or existent (Grade 1) and 
determined the degree of VV as low (Grade 0), moderate (Grade 1), or abundant (Grade 
2). These ﬁndings were correlated with the clinical data including cardiovascular risk 
factors, established cardiovascular disease and the history of cardiovascular events 
(myocardial infarction and stroke).
Results: The presence of carotid plaque was correlated with risk factors, cardiovascular 
disease and events (p<0.05 for all). In patients with present plaque no association 
between NEO and risk factors as well as cardiovascular disease could be found. However, 
patients with existent NEO had signiﬁcantly more cardiovascular events (33 versus 12%, 
p=0.012) and more pronounced VV (Grade 2 14 versus 57%, p<0.001) than in patients 
without detectable NEO (Table).
Conclusion: Plaque neovascularization and VV correlates with cardiovascular events in 
159 patients undergoing contrast enhanced carotid ultrasound.
Findings on carotid arteries contrast enhanced ultrasound imaging
No
Plaque
(n=39)
Plaque
(n=120) P-value
NEO
Grade 0 
(n=51)
NEO
Grade 1 
(n=60)
P-value
Diabetes mellitus, % 11 36 0.002 43 30 0.169
Hypertension, % 39 77 <0.001 76 75 1.000
Smoker, % 41 52 0.272 54 50 0.705
Hypercholesterolemia, % 87 93 0.308 92 93 1.000
Cardiovascular Disease, 
% 21 72 <0.001 65 77 0.208
Cardiovascular Event, % 8 24 0.037 12 33 0.012
VV Grade 0, % 26 13 25 2
VV Grade 1, % 59 49 59 42
VV Grade 2, % 15 38 0.017 16 57 <0.001
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lavage to reach a paO2/FiO2 ratio <160, followed by instillation of human meconium (1 ml/
kg, 20 % in saline). Hemodynamics and ventilatory parameters were recorded. Animals 
were randomized into 4 groups to receive either no active treatment (control, FiO2 = 0.4, 
n=10), iloprost (Ventavis®, 5 μg inhaled, n=9), NO (20 ppm inhaled, n=9), or bosentan (5 
mg/kg i.v., n=6). Measurements were repeated at 30 minutes interval.
Results: Instillation of meconium resulted in a stable ALI condition for >4 h. Percent 
changes of maximal treatment effects vs. baseline are as shown (table):
Iloprost selectively improved PH without reducing SVR. In contrast, bosentan and NO 
reduced pulmonary as well as arterial pressure. Concomitantly, iloprost was the only drug 
studied that showed an increase in cardiac output.
Conclusions: Inhaled iloprost, but not NO and bosentan, selectively reduces pulmonary 
arterial pressure and increases cardiac output in an inhomogenous lung injury model. 
Due to this hemodynamic proﬁle, inhaled iloprost appears to be a promising treatment 
option of MAS-induced PH.
Group mPAP Cardiac Output Systemic Blood Pressure PVR/SVR
control -1.4±10.2 -2.4±13.4 -3.0±12.4 21.6±44.1
iloprost -15.0±7.9*§ 8.3±9.5*§ 0.5±3.8 -7.3±8.8§
NO -15.5±6.2*§ -7.5±14.3*# -5.8±9.2# 5.9±13.4#
bosentan -29.3±8.2*§# -4.9±9.7# -30.1±4.3*§# 27.5±41.5#
PVR/SVR: Pulmonary to systemic vascular resistance ratio; mPAP: Mean pulmonary 
artery pressure. Data shown as mean %-changes ± SD vs. baseline.* p<0.05 baseline 
vs. max effect,§ p<0.05 vs. control, # p<0.05 vs. iloprost 
9:30 a.m.
1049-113 Endothelin Is Not Elevated in Acute Pulmonary 
Embolism
Maciej Kostrubiec, Justyna Pedowska-Wloszek, Michal Ciurzynski, Piotr Bienias, 
Szymon Pacho, Marzena Piaskalska, Piotr Pruszczyk, The Medical University of 
Warsaw, Warsaw, Poland
Background: In acute pulmonary embolism (APE) the increase of pulmonary vascular 
resistance depends on the thromboli load and potentially on the pulmonary bed 
contraction caused by neurohormonal reaction. Plasma levels of endothelin were reported 
to be elevated in pulmonary arterial hypertension. However, there are only a few studies 
assessing endothelin in patients with APE.
Methods: Therefore in our study we evaluated endothelin concentration in 55 patients 
(29M, 26F, age 57±19yrs) with conﬁrmed APE for potential value in risk stratiﬁcation. 
Patients were compared with 24 healthy volunteers at similar age. On admission blood 
samples were collected for plasma endothelin concentration. The quantitative assessment 
of right ventricular (RV) function was performed by echocardiography. Predeﬁned 
endpoints of the study included all-cause mortality, and serious adverse events (SAE). 
SAE comprised at least one of the following in-hospital adverse clinical events: death, 
cardiopulmonary resuscitation, thrombolysis, or the need for intravenous catecholamines 
infusion. All events were recorded up to 30 days after the diagnosis of APE.
Results: Endothelin concentrations were similar in APE patients and in control group 
(1.41(0.22-9.68)pg/mL vs. 1.62(0.27-8.92)pg/mL; p=NS). There was no differences in 
endothelin levels between APE patients with and without RV dysfunction (1.46(0.38-4.54)
pg/mL vs. 1.41(0.22-9.68)pg/mL; p=NS). Endothelin concentration did not differ between 
patients with SAE and APE group with event-free clinical course (3.19(0,38-4,27)pg/mL 
vs. 1,38(0,22-9,68)pg/mL; p=NS). There was no signiﬁcant correlation between ET levels 
and blood saturation, time from the ﬁrst symptoms, heart rate, blood pressure, tricuspid 
valve regurgitation pressure gradient and other echocardiographic parameters.
Conclusions: We concluded that plasma endothelin concentrations assessed on 
admission are not elevated in patients with APE and it does not play as important role 
in acute phase of increase of pressure in pulmonary arteries as in chronic pulmonary 
hypertension.
9:30 a.m.
1049-114 Glucose Increases Adiponectin Levels In Subjects With 
Impaired Glucose Tolerance: The Role of Endothelial 
Function
Dimitris Tousoulis, Aikaterini Konniari, Charalambos Antoniades, Aggeliki Nikolopoulou, 
Nikos Papageorgiou, Antigoni Miliou, Costas Tentolouris, Kostas Toutouzas, Gerasimos 
Siasos, Elli Stefanadi, Alexios Antonopoulos, Costas Tsiouﬁs, Christodoulos Stefanadis, 
1st Cardiology Department, Hippokration Hospital, Athens Medical School, Athens, 
Greece
Background: Adiponectin is an adipokine with beneﬁcial effect on vascular function. 
Adiponectin levels are decreased in diabetes mellitus (DM), but it is unclear how impaired 
glucose tolerance (IGT) or glucose intake affects adiponectin release from adipocytes. 
We examined the effect of glucose on serum adiponectin/insulin and endothelial function, 
in subjects with IGT, patients with DM and healthy individuals.
Methods: The study population consisted of 113 subjects: 19 with IGT, 78 with DM and 
16 controls. All subjects underwent glucose loading (75g oral glucose), and blood samples 
were obtained at baseline and after 3 hours. Endothelial function was evaluated by gauge-
strain plethysmography at baseline and every 1h, and endothelium-dependent dilation 
(EDD) was determined. Adiponectin and insulin were measured at baseline and at 3h.
Results: Glucose loading increased adiponectin levels in healthy (70.1±8.5 to 80.8±11.4 
ng/ml, p<0.05) and IGT (52.6±4.5 to 61.3±6.5 ng/ml p<0.05) but not in DM (55.9±3.5 
to 56.8±3.5 ng/ml). Although insulin was correlated with adiponectin both at baseline 
(r=-0.375, p=0.0001) and at 3h (r=-0.286, p=0.006), insulin variations did not follow the 
same pattern (healthy: 6.55±0.65 to 9.25±1.17 IU/L p<0.05, IGT:11.6±2.7 to 17.6±4.9IU/L 
9:30 a.m.
1049-110 Functional Autoantibodies Aganst G-Protein Coupled 
Receptors in Sera of Patients With Pulmonary 
Arterial Hypertension: Potential Involvement in the 
Pathogenesis of the Disease
Michael Dandel, Gerd Wallukat, Angela Englert, Hans B. Lehmkuhl, Roland Hetzer, 
Deutsches Herzzentrum Berlin, Berlin, Germany, Germany
Background: Pulmonary arterial A1-adrenergic receptors (A1-AR) show particularly 
high sensitivity for noradrenaline (NA). NA plasma levels are elevated in patients with 
pulmonary arterial hypertension (PAH) and there is evidence that vasodilative and 
antiproliferative effects of calcium-blockers, prostacyclin and adenosin are mainly based 
on their ability to antagonize intracellular signals caused by A1-AR stimulation. In PAH 
production of endothelin-1 (ET-1) is increased and elevated plasma levels correlate with 
severity of the disease. After detection of agonistic antibodies against the ETA receptor 
and the A1-AR in PAH patients’ sera we assessed their prevalence and properties.
Methods: Using spontaneously beating rat neonatal cardiomyocytes as bioassay we 
analyzed PAH patients sera with regard to the presence of functional autoantibodies (AABs) 
aganst G-protein coupled receptors. AABs were puriﬁed by afﬁnity chromatorgrapgy.
Results: Of 54 PAH patients, 51 (94%) were tested positive for AABs against A1-AR and/
or ETA and only 3 showed no evidence of these AABs. Among the 51 positive patients, 38 
(75%) showed AABs against both A1-AR and ETA and 13 (25%) had AABs only against 
A1-ARs. AABs against A1-ARs exerted agonistic dose-dependent positive chronotropic 
effects which were blocked by prazosine (A1-AR blocker). AABs against ETA exerted 
agonistic negative chronotropic effects, which were blocked by BQ610 (ETA antagonist). 
Both AAB types induced permanent stimulation without desensitization of the receptor 
mediated signal cascade. ﬁrst attempts to eliminate in 4 patients these AABs against the 
A1-AR and ETA (which appeared to belong to the IgG3 and IgG2 subclass, respectively) 
by immunoadsorbtion showed good short-term results.
Conclusions: The vast majority of PAH patients were tested positive for functional serum 
AABs against ETA and A1-AR. These AABs activated the receptors like the corresponding 
agonists but prevent the desensitization of the receptor mediated signal cascade normally 
seen by ongoing receptor stimulation. Our results suggest that these AABs are involved 
in PAH pathogenesis. AAB removal by immunoadsorbtion might be a possible new 
therapeutic approach.
9:30 a.m.
1049-111 Left Ventricular Strain and Strain Rate by Two-
Dimensional Speckle Tracking in Chronic 
Thromboembolic Pulmonary Hypertension Before and 
After Pulmonary Thromboendarterectomy
Nicholas Olson, Jason P. Brown, Andrew M. Kahn, William R. Auger, Michael M. Madani, 
Thomas J. Waltman, Daniel G. Blanchard, University of California San Diego, San 
Diego, CA
Introduction: Diastolic underﬁlling and chamber distortion are common in chronic 
thromboembolic pulmonary hypertension (CTEPH) and improve following pulmonary 
thromboendarterectomy (PTE). However, LV systolic function appears grossly normal 
(other than septal ﬂattening) before and after PTE. 2D speckle tracking is a novel way 
to quantify LV global and regional function via strain and strain rate (SR) analysis. We 
evaluated LV systolic function in CTEPH using 2D speckle tracking to assess LV radial 
and circumferential (circ) strain and SR.
Methods: 30 consecutive CTEPH pts with adequate images were studied pre- and post-
PTE. Right heart catheterizations (RHC) were also performed. Echo studies were done 
7.4 days pre-PTE and 9.2 days post. 2D speckle tracking was analyzed in the parasternal 
mid short-axis plane. We measured (1) global peak systolic circ strain/SR and (2) peak 
radial strain/SR in the posterior and inferoseptal LV segments.
Results: RHC showed decreases in mean PAP from 44 to 29 mmHg (p<0.001), PVR 
from 865 to 319 dyn cm/s5 (p<0.001), and a rise in cardiac output from 3.9 to 5.0 l/min 
(p<0.001). LV circ strain became more negative by 11% following PTE (from a baseline 
of -20.9% to -23.2%, p<0.001). Circ SR decreased slightly but non-signiﬁcantly post-PTE 
by 7% (from -1.5/s, p=0.07). Posterior wall radial strain increased 15% post-PTE (from 
31.2%, p<0.001). Posterior wall radial SR increased 6% after PTE (from 1.8/s, p<0.05). 
However, inferoseptal wall radial strain did not change post-PTE (p=0.14).
Conclusions: The hemodynamic improvements after PTE were associated with (1) an 
absolute increase in the extent of LV circumferential shortening and posterior LV wall 
thickening (strain), and (2) a slight absolute increase in SR. These changes may stem 
from improved LV ﬁlling post-PTE and a Starling effect. Changes in strain did not occur in 
the septum, possibly due to RV ischemia and/or postoperative stunning. 
9:30 a.m.
1049-112 Inhaled Iloprost Improves gas Exchange and 
Hemodynamics in Acute Lung Injury Secondary to 
Meconium Aspiration
Eva M. Becker, Lisa Schurer, Martin Rosenbruch, Jürgen Kohlmeyer, Katja Schaefer, 
Kathrin Kuhlebrock, Volker Laux, Stefan Schaefer, Hubert Trübel, Bayer Schering 
Pharma, Wuppertal, Germany, University Witten/Herdecke, Witten, Germany
Background: Meconium aspiration (MAS) is a life threatening condition in newborns, with 
acute lung injury (ALI) and secondary pulmonary hypertension (PH). We investigated the 
efﬁcacy of inhaled iloprost, an approved treatment for pulmonary arterial hypertension, in 
comparison to nitric oxide (NO) and the endothelin receptor antagonist bosentan.
Methods: ALI was induced in 7-wk old minipigs (body weight 4-5 kg) by repeated pulmonary 
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1049-117 Usefulness of Helical Computed Tomography for the 
Detection of Free Floating Thrombi in Right Heart in 
Acute Pulmonary Embolism
NIcolas Mansencal, David Attias, Vincent Caille, Jean-Pierre Pelage, Julie Guiader, 
Imad Abi Nasr, François Jardin, Pascal Lacombe, Antoine Vieillard-Baron, Olivier 
Dubourg, Hôpital Ambroise Paré, AP-HP, Boulogne, France
Background. Pulmonary embolism (PE) may be associated to free ﬂoating thrombi in 
right heart (FFTRH), with a worse prognosis. Echocardiography was the single imaging 
tool for their detection, allowing to initiate appropriate treatment. The aim of this study was 
to assess the prevalence of FFTRH by a systemic use of transthoracic echocardiography 
in a large series of patients with acute PE and the accuracy of helical computed 
tomography (CT) for their detection.
Methods. We studied 340 consecutive patients presenting with acute PE. All patients 
underwent CT and echocardiography. Echocardiography was the gold standard for the 
detection of FFTRH and CT was systematically used for their detection.
Results. Prevalence of FFTRH was 3.5% in our population of PE. Dyspnea, cardiogenic 
shock, cardiac arrest and tachycardia were more frequently found in patients with FFTRH. 
Measurements of right ventricle was well-correlated between echocardiography and CT 
(r = 0.76 for the right to left ventricular area ratio, with good agreement). Sensitivity and 
speciﬁcity of CT for the detection of FFTRH was respectively 100% (95% CI: 74% to 
100%) and 97% (95% CI: 95% to 99%), whereas positive and negative predictive values 
were 57% (95% CI: 34% to 78%) and 100% (95% CI: 99% to 100%), respectively.
Conclusion. In the present study, prevalence of FFTRH was 3.5% and clinical 
presentation of FFTRH differs from PE without FFTRH. Helical CT is an accurate for the 
detection of FFTRH. An FFTRH detected by CT should lead to urge echocardiography.
9:30 a.m.
1049-118 Increased Oxidative Stress Correlates With Pulmonary 
Vascular Response to Vasodilators in Pulmonary Artery 
Hypertension Patients
Pablo Castro, Luigi Gabrielli, Fabrizio Fasce, Hugo Verdejo, Douglas Greig, Silvana 
Llevaneras, Marcela Ferrada, Claudia Hernandez, Ivan Godoy, Lorena Garcia, 
Rosemarie Mellado, Pablo Sepulveda, Sergio Lavandero, Pontiﬁcia Universidad Católica 
de Chile, Santiago, Chile
Background: Pulmonary Arterial Hypertension (PAH) is characterized by endothelial 
dysfunction and vascular remodeling. The role of oxidative stress, inﬂammation and 
its relation with peripheral endothelial function and pulmonary vascular response to 
vasodilators remains unknown.
Methods: PAH patients diagnosed by right cardiac catheterization with a pulmonary CT-
scan negative for pulmonary embolism and a control group matched by age and gender 
were included. Malondialdehyde (MDA), xanthine oxidase (XO) and vascular adhesion 
molecule (VCAM) were measured in all subjects. Peripheral endothelium-dependent 
vasoreactivity was assessed using brachial artery blood ﬂow-mediated dilation (FMD). 
Transthoracic echocardiography pre and post Iloprost inhalation was performed.
Results: Fifteen patients (mean age 37 ± 7, 60% female) and 15 controls were included. 
Baseline (mean ± SD):
PAH Control p *
FMD (%) 2.8 ± 0.6 8.7 ± 0,6 < 0.001
XO (U/mL) 0.039 ± 0.005 0.034 ± 0.004 0.02
MDA (μM) 0.64 ± 0.17 0.34 ± 0.15 < 0.001
VCAM 1167.4 ± 337 965.3± 267 0.09
* t-student
Iloprost in PAH patients improved cardiac output (3.68 ±0.6 L/min to 4.12 ± 1.2; p=0.02) 
and pulmonary vascular resistance (3.4 ± 0.9 Wood U to 2.94 ± 1.1; p=0.01). A signiﬁcant 
correlation between cardiac output improvement and FMD (R= 0.7, p<0.01) was found. XO 
showed a strong correlation with FMD (R= -0.8, p<0.01), pulmonary vascular resistance 
decrease (R= -0.9, p<0.01) and cardiac output improvement (R=-0.7, p=0.01).
Conclusion: PAH patients present elevated oxidative stress markers and impaired FMD at 
baseline. These parameters correlates with pulmonary vascular response to vasodilators.
9:30 a.m.
1049-119 Immuno-Inﬂammatory Effects of Bosentan Therapy in 
Patients With Severe Pulmonary Arterial Hypertension: 
Relation to Clinical and Hemodynamic Responses
George K. Karavolias, Stamatis Adamopoulos, Georgia Karabela, Aggeliki Gkouziouta, 
Dimitrios Tsiapras, George Dombroglou, Panagiota Georgiadou, Alexandros 
Kouloubinis, Eleana Koutrouli, Antigoni Chaidaroglou, Dimitrios Degiannnis, Vassilis 
Voudris, Onassis Cardiac Surgery Center, Athens, Greece
Background: Bosentan, is an oral, type A and B endothelin receptor antagonist which 
improves exercise capacity and hemodynamics in patients (pts) with pulmonary arterial 
hypertension (PAH). We sought to investigate the short- and long-term anti-inﬂammatory 
effects of bosentan therapy (Tx) in pts with severe PAH.
Methods: An open label study was performed in 15 pts (43±12.8 years, 8 male) with 
severe primary PAH who were in NYHA III-IV, despite the conventional treatment. Pts 
received additional Tx with bosentan, 125 mg daily for 1 month (m), followed by 250 
mg daily for 11 m. Study endpoints included 6-min walking distance (6MWD), mean 
pulmonary artery pressure (mPA) and pulmonary vascular resistance (PVR), soluble 
endothelial adhesion molecules (ICAM-1 and VCAM-1) and interleukin-6 (IL-6). Pts were 
assessed at baseline, 2m and 12m after initiation of bosentan.
p<0.05, and DM: 10.24±0.89 to 20.99±2.37 IU/L p<0.0001). There was no association 
between the changes of insulin and those of adiponectin (p=NS). EDD was decreased 
after loading in healthy (from 76.6±5.2% to 63.0±6.6%, 57.0±6.5% and 89.3±6.3% for 0h, 
1h, 2h and 3h, p<0.05 for 0h vs 2h), in IGT (from 92.8±6.4% to 66.9±6.1%, 68.6±6.8% 
and 85.6±6.1% for 0h, 1h, 2h and 3h, p<0.01 for 0h vs 2h) and DM (from 86.1±5.1% to 
60.7±2.4%, 54.6±2.3% and 75.2±2.8% for 0h, 1h, 2h and 3h, p<0.01 for 0h vs 1h, 2h 
and p<0.05 vs 3h).
Conclusions: Glucose intake increases serum adiponectin in healthy individuals 
and subjects with impaired glucose tolerance, but not in those with DM. This effect is 
independent of insulin variations. Glucose impairs endothelial function, an effect which 
is more profound in patients with DM. These ﬁndings provide new insights into the 
associations between insulin, adiponectin and endothelial function in diabetes mellitus.
9:30 a.m.
1049-115 Treatment of Pulmonary Arterial Hypertension: Data 
From the Quality Enhancement Research Initiative
Vallerie V. McLaughlin, Anatoly Langer, Alina Dragomir, Amparo Casanova, Maria 
Altshuler, Ronald J. Oudiz, Michael Mathier, Philip Clements, Victor F. Tapson, Richard 
N. Channick, Lewis J. Rubin, University of Michigan Health System, Ann Arbor, MI, 
Canadian Heart Research Centre, Toronto, ON, Canada
Background: Implementation of ACCP Recommendations for the Management of 
Pulmonary Arterial Hypertension (PAH) was studied in quality enhancement research 
initiative (QuERI) that enrolled 782 patients among 60 US specialists.
Methods: Physicians enrolled PAH patients (known or newly diagnosed) and provided 
data on their medical management.
Results: PAH etiology was idiopathic: 38%, familial: 3%, and had associated conditions 
in 59%; connective tissue disorders: 30%, drug exposure: 7%, congenital systemic-
to-pulmonary shunt: 7%, portal hypertension: 4%, HIV: 4% and signiﬁcant venous or 
capillary involvement in 1%. WHO class was available in 742 patients: class I - 8%, II 
- 39%, III - 48%, IV - 5%.
Among 115 patients on CCB, 53 (46%) were being treated speciﬁcally for PAH and of these 
91% had right heart catheterization but only 41% had acute vasoreactivity testing performed 
and only 13% had positive response. Recommended PAH therapy of anticoagulants 
(warfarin) was used in 26% overall: class I - 22%, II - 25%, III - 29%, IV - 17%.
Diuretics were used in 27%, 30%, 39% and 34% of class I, II, III, and IV, respectively.
Conclusions: Medical management of PAH is complex with frequent use of multiple 
therapies. Despite this, half of patients have class III or IV symptoms. Vasoreactivity testing 
to direct CCB treatment was not performed in the majority of patients. Anticoagulation was 
used in a minority of patients and was unrelated to functional class. Greater adherence to 
ACCP guidelines is recommended.
Data on disease-speciﬁc treatments at baseline was available in 
751patients:
Overall Alone
No disease speciﬁc treatment 31.1%
Epoprostenol, inhaled iloprost, treprostinil (PGI) 24.8% 10.1%
Sildenaﬁl (SID) 28.0% 11.1%
Bosentan (BOS) 42.8% 26.1%
Combination: 21.6%
PGI & SID 10.0%
BOS & SID 12.0%
PGI & BOS 9.8%
PGI & BOS & SID 5.1%
9:30 a.m.
1049-116 Fibrinolytic Effect of On-Pump Compared With Off-
Pump in Stable Multivessel Coronary Artery Bypass 
Surgery: A Prospective Randomized Study
Felipe Paulitsch, Neuza Lopes, David Schneider, Burton E. Sobel, Dalton Chamone, 
Cibele Garzillo, Roberto Rached, Luis Dallan, Noedir Stolf, Whady Hueb, Heart Institute 
University of Sao Paulo, Sao Paulo, Brazil
Background: We determined the inﬂuence of on-pump compared with off-pump bypass 
surgery on ﬁbrinolysis.
Methods: Patients were assigned prospectively and randomly to either on-pump (n=41) 
or off-pump (n=51) surgery. Baseline proﬁles were similar between the groups. Markers 
of inﬂammation and ﬁbrinolysis were characterized before, 1 hour, and 24 hours after the 
procedure. Surgical and anesthetic techniques were standardized for both groups. ELISA 
was used to determine the concentration of C-reactive protein, ﬁbrinogen, D-dimers, and 
plasminogen activator inhibitor type 1.
Results: The concentration of C-reactive protein did not change appreciably immediately 
after surgery in either group but increased in a parallel fashion 24 hours after either on-
pump or off-pump surgery (p<0.01). The concentration of ﬁbrinogen tended to be less 
immediately after surgery and, similar to the trend with C-reactive protein, increased in 
both groups 24 hours later. By contrast, the concentration of D-dimer was signiﬁcantly 
greater immediately after surgery in the on-pump compared with the off-pump group 
(p<0.01). Although the concentration of plasminogen activator inhibitor type 1 levels 
increased signiﬁcantly in both groups immediately after the procedure (p<0.01), the 
increment was greater in the on-pump group (p<0.01).
Conclusion: On-pump compared with off-pump is more prothrombotic and associated 
with constrained ﬁbrinolysis as reﬂected by, respectively, the increased concentrations of 
D-dimer and increased concentrations of plasminogen activator inhibitor type 1.
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0917-5 Association Between Paraoxonase 1 Activity and 
Carotid Intima-Media Thickness in Patients With 
Hypertension
Woo-In Yang, Sang-Hak Lee, Young-Guk Ko, Seok-Min Kang, Donghoon Choi, Jong-
Won Ha, Yangsoo Jang, Namsik Chung, Won-Heum Shim, Seung-Yun Cho, Severance 
Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea
Background: Paraoxonase 1 (PON1), a high density lipoprotein-associated enzyme, has 
been reported to have antioxidant effects, but it remains to be clariﬁed whether PON1 
possesse atheroprotective property in human. The aim of this study was to evaluate 
the association between PON1 activity and carotid intima-media thickness (IMT), an 
important surrogate marker of atherosclerosis.
Method: Three hundred sixty-ﬁve patients with hypertension (male: 57%, mean age: 58 
yrs) were enrolled in this study. Patients’ clinical characteristics were recorded and serum 
PON1 activity were measured. Carotid IMT was measured by high-resolution ultrasound 
at both common carotid artery and averaged. Determinants of IMT were then analyzed 
by logistic regression analyses.
Results: Among 365 patients, 35 (10%) had diabetes mellitus and 111 (31%) had 
hyperlipidemia. Mean PON1 activity was 0.010 ± 0.004 U/L and mean carotid IMT was 
0.66 ± 0.12 mm. In logistic regression analyses, lower PON1 activity (r=0.181, p=0.001) 
were identiﬁed as independent determinants of carotid IMT (Table 1). 
Conclusion: Lower PON1 activity was identiﬁed as an independent determinant of carotid 
IMT. In hypertensive patients, PON1 activity may reﬂect early atherosclerotic change.
Determinants of carotid IMT in patients with hypertension
Univariate 
analyses/
parameter 
ß
Univariate 
analyses/
SE
Univariate 
analyses/ p 
value
Multivariate 
analyses/
parameter ß
Multivariate 
analyses/
SE
Multivariate 
analyses/ p 
value
age 0.007 0.004 0.06 0.007 0.004 0.09
DM 0.102 0.130 0.78 - - -
BMI -0.012 0.013 0.37 - - -
Total 
cholesterol 0.001 0.001 0.40 - - -
Triglyceride 0.001 0.000 0.04 0.001 0.000 0.06
HDL-
cholesterol -0.004 0.004 0.26 - - -
LDL-
cholesterol 0.000 0.001 0.68 - - -
hsCRP -0.004 0.011 0.74 - - -
PON1 -0.789 0.227 0.01 -0.205 0.066 <0.01
11:15 a.m.
0917-6 A Single Measurement of Plasma N-Terminal Pro-
B-Type Natriuretic Peptide (NT-proBNP) to Predict 
Perioperative Cardiac Events in Patients Undergoing 
Noncardiac Vascular Surgery
Ji Hyun Yang, Hyun Chul Jo, Hye Jin Noh, Young Keun On, Duk-Kyung Kim, Seung-
Hyuk Choi, Samsung Medical Center, Seoul, South Korea
Background: Identiﬁcation of patients at high risk for perioperative cardiac events 
(POCE) is important. Many noninvasive tests are being used to predict perioperative 
cardiac complications. This study aimed to determine whether preoperative measurement 
of plasma NT-proBNP could predict POCEs when compared with conventional cardiac 
risk factors and imaging studies in patients who underwent major vascular surgery.
Methods: Patients who were scheduled for major noncardiac vascular surgery were 
prospectively enrolled. Clinical risk factors were used to categorize patients by the Revised 
Cardiac Risk Index (RCRI). NT-proBNP, and stress thallium scan were also evaluated. 
POCE was the composite of acute myocardial infarction, congestive heart failure including 
acute pulmonary edema, or primary cardiac death within 5 days after surgery. Receiver 
operating characteristic (ROC) curves were used to assess and compare prognostic 
value of NT-proBNP with RCRI and modiﬁed RCRI; including signiﬁcant perfusion defect 
[large (> 3 walls), moderate to severely decreased, reversible defect] on thallium scan, 
chronic renal insufﬁciency (creatinine clearance less than 30 ml/min or on dialysis), NT-
proBNP level above 75 percentile and abdominal aortic surgery.
Results: A total of 456 patients [410 (89.9%) men with a mean age of 65.6 ± 10.3 years] 
had a median NT-proBNP level of 107.4 pg/ml. POCEs occurred in 64 (14%) patients. 
After adjustment for confounders, signiﬁcant perfusion defects on thallium scan (OR 
4.9, 95% CI 1.2 to 19.9, p=.026), NT-proBNP level of above 355 pg/ml (OR 4.4, 95% 
CI 2.4 to 9.2, p<.001), chronic renal insufﬁciency (OR 3.5, 95% CI 1.4 to 8.6, p=.006), 
and abdominal aortic surgery (OR 2.3, 95% CI 1.3 to 4.3, p=.007) were independent 
predictors for POCEs. The area under the ROC curves for predicting POCEs did not show 
statistical difference among NT-proBNP, RCRI and modiﬁed RCRI (0.72 for NT-proBNP, 
0.68 for RCRI, and 0.74 for modiﬁed RCRI; p>0.05).
Conclusions: Preoperative measurement of NT-proBNP provides useful information to 
predict POCEs as a single parameter and may help guide risk stratiﬁcation of high risk 
patients undergoing major noncardiac vascular surgery.
Results:
Baseline
(BSL) 2m 12m
BSL vs 
2m
BSL vs 
12m
2m vs 
12m
6MWD
(meters) 275.8±149.2 345.5±120.1 385.7±139.1 p<0.01 p<0.001 p:NS
mPA (mm 
Hg) 59.8±15.4 55.5±17.3 52.7±18.4 p:NS p<0.01 p:NS
PVR (WU) 11.2±4.4 9.6±4.5 7.9±4.1 p<0.01 p<0.001 p<0.01
ICAM-1
(ng/ml) 527.0±141.6 395.0±77.3 440.8±129.1 p<0.001 p<0.01 p:NS
VCAM-1
(ng/ml) 1002.2±70.9 855.9±282.8 1011.3±451.8 p<0.07 p:NS p:NS
IL-6 (pg/
ml) 35.2±26.1 14.1±20.2 8.0±15.3 p<0.001 p<0.001 p:NS
Values are expressed as mean ± 1 SD.
At 2m, there was an improvement in 6MWD (p<0.01) and a marked fall in PVR (p<0.01), 
ICAM-1 and IL-6 (p<0.001). At 12m, 6MWD and PVR remained signiﬁcantly improved 
(p<0.001), mPA decreased (p<0.01) and ICAM-1 and IL-6 remained signiﬁcantly lower. A 
signiﬁcant correlation was found between the reduction in PVR and IL-6 at 2 m (R=0.6, 
p<0.05)
Conclusions: Favourable anti-inﬂammatory effects of bosentan are mainly expressed 
within the ﬁrst 2 m of Tx and are associated with clinical and hemodynamic improvement. 
The sustained beneﬁts of bosentan Tx could be attributed to its additional pleiotropic 
effects.
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10:45 a.m.
0917-4 Determinants of Thoracic and Abdominal Aortic 
Diameter by Computed Tomography in the Framingham 
Heart Study: The Inﬂuence of Gender, Age, and Body 
Surface Area
Ian S. Rogers, Joseph M. Massaro, Quynh A. Truong, Amir A. Mahabadi, Caroline S. 
Fox, Eric M. Isselbacher, Udo Hoffmann, Christopher J. O’Donnell, Massachusetts 
General Hospital, Boston, MA, NHLBI Framingham Heart Study, Framingham, MA
INTRO: Early detection of aortic aneurysms is critical due to the very high rate of mortality 
associated with their rupture. We aimed to determine the mean CT-based diameters of the 
aorta in a community based cohort asymptomatic from aortic disease and the inﬂuence of 
gender, age, and body surface area (BSA).
METHODS: Non-contrast CT was performed between 2002 and 2005 in 1377 subjects 
(age 60 ± 9 years, 53% women) from the offspring cohort of the Framingham Heart Study. 
Anterior-posterior and transverse axial diameters were measured at the level of the right 
pulmonary artery for the ascending and descending thoracic aorta and 5cm above and 
just above the aortoiliac bifurcation for the abdominal aorta. Reproducibility analysis was 
performed in a representative subset of 100 participants.
RESULTS: Inter- and intra-observer variability was excellent (intraclass correlation: 0.91 
- 0.98, all p<0.0001). Table 1 details the mean aortic diameters and the correlations with 
age and BSA. A signiﬁcant difference (< 0.0001) in diameter was observed between 
men and women for all measurements. Signiﬁcant modest to moderate correlations were 
observed between diameter and age (0.22 - 0.50) and BSA (0.17 - 0.37).
CONCLUSION: The average diameters of the thoracic and abdominal aorta are larger in 
men than in women and correlate signiﬁcantly with age and BSA. These measurements 
are highly reproducible. Age, gender, and BSA-adjusted reference ranges for aortic 
dimensions on CT may improve detection of aortic aneurysms. 
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the ﬁve clones. While the scrambled miR did not have any effect on the morphology of 
the CSCs, the antagomiR of miR-20a had a profound morphological effect on the CSCs 
starting at 2 days and peaking at 4 days causing the CSCs to have numerous membrane 
projections. Loss of miR-20a also caused tube formation as early as two hours and at ﬁve 
hours increased the capacity and speed of the CSCs to form tubes in the matrigel assay 
(105 connections) relative to the scramble miR controls (35 connections).
Conclusion: Multiple angiogenic transcripts are targets of miR-20a. We propose that loss 
of miR-20a in CSCs will increase the expression of angiogenic genes and improve the 
CSCs vasculogenic potential that is necessary for cardiac regenerative therapy.
2:15 p.m.
0921-4 Pattern of Angiogenesis Regulators Expressed in 
Vulnerable Coronary Atheroma Favors Formation of 
Immature and Leaky Neovessels: A Role for VEGF and 
Angiopoietin-1 in Determining Plaque Stability
Randolph Hutter, Walter Speidl, Valentin Fuster, Pedro Moreno, Gerhard Bauriedel, 
Annapoorna Kini, Juan Jose Badimon, Sarmin Sharma, Mount Sinai School of 
Medicine, New York, NY
Background: Angiogenesis is a tightly regulated process of neovessel formation that 
involves maturation and pruning of immature leaky vessels into stable microvessels. 
The initial formation of neovessels is driven by Vascular Endothelial Growth Factor 
(VEGF) whereas the maturation process is mediated by Angiopoietin-1 (Ang-1). Plaque 
vulnerability is associated with increased numbers of leaky neovessels resulting in 
extravasation of erythrocytes contributing to inﬂammation. Therefore, we evaluated the 
expression of VEGF and Ang-1 in human coronary atheroma comparing vulnerable to 
stable lesions .
Methods and Results: The expression of VEGF and Ang-1 in coronary atherectomy 
samples (n=30) was evaluated by immunohistochemistry (data presented as mean 
± SEM). In atherectomy samples from patients with unstable angina (n=15) VEGF 
expression was observed in extra-cellular as well as intra-cellular location and was 
selectively increased in inﬂammatory cells surrounding neovessels compared to stable 
lesions (28 ± 4 % vs. 5 ± 2 %, P<0.05). The expression of VEGF was associated with 
high neovessel content and intra-plaque hemorrhage (P<0.05). Immuno-ﬂuoresecence 
double labeling also showed a close co-localization between VEGF expression and areas 
with intra-plaque hemorrhage. In contrast, Ang-1 expression was signiﬁcantly increased 
in atherectomy samples from patients with stable angina and located within and around 
alpha-actin positive cells. The intra-cellular expression of Ang-1 comprised up to 22 ± 9 
% of intimal cells in these tissues. In tissue from patients with unstable angina expression 
of Ang-1 was nearly absent.
Conclusions: We are reporting for the ﬁrst time in vulnerable coronary atheroma a 
dramatic reversal in the ratio between VEGF and Ang-1 expression with a predominance 
of VEGF over Ang-1. This imbalance favors continued formation of immature neovessels 
without sufﬁcient maturation and stabilization signals. Further studies are necessary 
evaluating the circulating levels of these key angiogenesis regulators in patients. 
Enhancing Ang-1 expression in vulnerable plaque might be a future therapeutic tool to 
favorably modulate arterial lesion biology.
2:30 p.m.
0921-5 Resident Cardiac Stem Cells in the Left Atrial 
Appendage: An Untapped Source
Avishag Korkus, Chaim Lotan, Ronen Beeri, Cardiovascular Research Center, Heart 
Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Background: In the past few years compelling evidence has accumulated suggesting 
that the heart may retain some regenerative potential, in reaction to pathologic stresses. 
Cardiac stem cells (CSC) were demonstrated to concentrate in specialized niches, rather 
than be uniformly distributed throughout the heart. Inferring from other organs, niches of 
stem cells are likely to be found mainly in crypt-like area. Thus, we hypothesized that the 
left atrial appendage (LAA) is a very likely place to ﬁnd stem cells.
Methods: LAA tissue from mouse and rat was cut into 1- to 2 mm2 pieces, washed and 
digested three times with trypsin and collagenase IV. The remaining tissue fragments 
were cultured as explants in complete explant medium (CEM). After three weeks, a 
layer of ﬁbroblast like cells outgrew from the adherent explants. Undifferentiated cells 
that grew as self-adherent clusters-cardiospheres over this layer were characterized by 
speciﬁc stains for stem cell (c-kit) and cardiac progenitor cell (GATA4) markers. To assess 
clonality, single cells were seeded on matrigel and expanded in DMEM - Ham’s F12(1:1) 
medium containing growth factors.
Results: The round undifferentiated cells grew in large numbers around the explant. 
These cells stained positive for c-kit and GATA4. Clones of up to 15 cells grew 4 days 
after separate seeding of a single cell. In one case, spontaneous differentiation occurred 
with spontaneous contraction.
Conclusions: We have isolated, in substantial numbers, multiplying and clonogenic
cells from LAA of mice and rats. These cells exhibit a cardiac stem cell phenotype. This 
preliminary study suggests that the LAA may be a source of cardiac stem cells. These 
may be used for potential cardiac replacement therapies, and to better understand the 
mechanisms driving cardiomyocytes to reenter the cell cycle.
11:30 a.m.
0917-7 Assessment of Endothelial Function by Peripheral 
Arterial Tonometry Predicts Cardiovascular Events 
Beyond the Framingham Risk Score
Ronen Rubinshtein, Jeffrey T. Kuvin, Morgan Sofﬂer, Ryan J. Lennon, Rebecca E. 
Nelson, Geralyn M. Pumper, Lilach O. Lerman, Amir Lerman, Mayo Clinic, Rochester, 
MN, Tufts - New England Medical Center, Boston, MA
Background: Coronary endothelial dysfunction has been shown to predict major adverse 
cardiovascular events (MACE). We examined whether endothelial dysfunction, as detected 
by non-invasive peripheral arterial tonometry (EndoPAT), can predict late MACE.
Methods: Reactive hyperemia (RH) was induced following upper arm occlusion of 
systolic blood pressure in 270 outpatients (54±12 yrs, 48% female). RH index (RHI) and 
the logarithmic scaled RHI (F_RHI) were calculated from the ratio between the digital 
pulse volume during RH and at baseline. We then examined pts for MACE (Cardiac death, 
myocardial infarction, revascularization or cardiac hospitalization) during a median 5.8 
yrs follow-up (IQR 4.4-8). Cox models were used to estimate the association of EndoPAT 
results and MACE adjusted for the Framingham score (FRS).
Results: During follow-up, MACE occurred in 85 pts (31%). MACE rate was 49% in pts 
with RHI<1.46 vs 26% in pts with RHIq1.46 (p=0.041), and 39% in pts with F_RHI<0.42 
vs 25% of pts with F_RHIq0.42 (p=0.024) (Figure). Multivariate analysis identiﬁed F_
RHI<0.4 as an independent predictor of cardiac hospitalizations (p=0.002).
Conclusions: A low RH signal detected by EndoPAT, consistent with endothelial 
dysfunction, was associated with higher MACE rate during follow-up. F_RHI was an 
independent predictor of cardiac hospitalizations beyond the traditional FRS. Assessment 
of peripheral vascular function in addition to the FRS may be useful for identiﬁcation of 
pts at risk for cardiac events.
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2:00 p.m.
0921-3 Loss of miR-20a Promotes Vasculogenesis of Cardiac 
Stem Cells
Lina A. Shehadeh, Salil Sharma, Claudia D. Rodrigues, Nanette H. Bishopric, University 
of Miami Miller School of Medicine, Miami, FL
Background: The vasculogenic potential of cardiac stem cells (CSCs) could be a major 
determinant of the extent of cardiac regeneration. Members of the MicroRNA 17~92 
cluster, in particular miR-20a, have multiple predicted angiogenic gene targets including 
Vegf-a, Hif1a, Sox4, Egln3, Dnm2 and p300. Our lab has isolated and characterized a 
series of CSC clones that have widely disparate vasculogenic potential based on speed 
of tube formation in an in vitro Matrigel assay.
Hypothesis: Loss of miR-20a in CSC clones will enhance the expression of angiogenic 
genes and hence increase the vasculogenic potential of CSCs.
Methods: Genome-wide expression of the ﬁve clones was performed on Affymetrix 
MOE-430_2 arrays. GeneSpring 9.0 was used to ﬁnd the transcripts that clustered the 
ﬁve clones according to their phenotypic index from the least vasculogenic to the most 
vasculogenic. CSCs were cultured for 3 days in endothelial basal media and transfected 
with a locked nucleic acid (LNA) antagomiR against miR-20a or a control scrambled 
miR. Morphology was assessed by ﬂuorescence microscopy for the next 4 days. Matrigel 
assay was performed 4 days after transfection and Image J software was used to count 
connections between cells.
Results: Expression of Sox4 was highly correlated with the speed of tube formation by 
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Table 1: Blood Pressure, VEGF and sFlt (1) in the study groups
Mean (SD) Hypertensive Pregnant (n=31)
Normotensive 
Pregnant (n=31)
Non-pregnant
healthy controls 
(n=40)
p-value
Age(years) 32 (6) 29 (6) 29(8) 0.178
Median (IQR) Parity 2 (0-3) 1 (0-2) 0 (0-0) < 0.0001
SBP (mm Hg) 131(16) 111 (9) 119 (9) < 0.0001
DBP (mm Hg) 87 (11) 66 (6) 76 (8) < 0.0001
Median (IQR) VEGF 
levels (pg/ ml) 185 (0-680) * 340(30-1750) 590 (240-1500) < 0.05
Median (IQR) sFlt (1) 
levels (pg/ ml) 13 (7-500) 15 (7-380) † 5 (0-160) < 0.05
VEGF: sFlt (1) ratio 0.01 (0-0.03) 0.01 (0-0.02) 0.03† (0.01-0.08) <0.05
VEGF levels correlated to sFlt (1) levels (Spearman r = 0.34, p<0.005) 
DBP: Diastolic Blood Pressure; SBP: Systolic Blood Pressure; sFlt (1): soluble fms-like 
tyrosine kinase 1; VEGF: Vascular Endothelial Growth Factor.
Between group analyses by ANOVA with Tukey post hoc test and Kruskal Wallis test 
with Dunn’s post hoc test, as appropriate
*Signiﬁcantly lower than healthy controls
† Signiﬁcantly higher than healthy controls
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0921-6 Coadministration of Adenovirus Associated VEGF 
and Ang-1 Enhances Collateral Vascularization 
and Reduces Ventricular Remodeling in Myocardial 
Infarction Model of Type I Diabetic Rats
Samson Mathews Samuel, Yozu Akita, Debayon Paul, Mahesh Thirunavukkarasu, 
Lijun Zhan, Chuanfu Li, Nilanjana Maulik, University of Connecticut Medical Center, 
Farmington, CT
Diabetes impairs myocardial angiogenesis in response to ischemia leading to profound 
ventricular remodeling. Although the effects of overexpressing VEGF have been studied 
in inducing myocardial angiogenesis, the formation of functional vessels still remains a 
challenge. Angiopoetin-1 (Ang-1) acts synergistically with VEGF as a stimulus for vessel 
maturation. Therefore in the present study we have evaluated the reversal of diabetes 
mediated impairment of angiogenesis in myocardial infarction (MI) model of streptozotocin 
induced Type I diabetic rats by intramyocardial administration of a combination of 
adenovirus encoding VEGF & Ang-1 (Ad-VEGF165 + Ad-Ang-1), after MI. Rats were 
divided into: 1) Control MI (CMI), 2) Diabetic MI (DMI) 3) DMI + Ad-LZ (DLZMI) & 4) DMI 
+ {Ad-VEGF+Ad-Ang1} (DVAMI). MI was induced by permanent Left Anterior Descending 
(LAD) coronary artery ligation immediately after which Ad-LZ or {Ad-VEGF165 + Ad-
Ang-1} was administered at multiple sites into the left anterior free wall adjacent to the 
point of ligation to the DLZMI or DVAMI group respectively. We observed reduced infarct 
size (51±4.9 vs 63±6.2, %), myocardial ﬁbrosis, increased capillary (1135±45 vs 797±31, 
counts/mm2), arteriolar (4.1±0.4 vs 2.15±0.04, counts/mm2) density 7 days after treatment 
in conjunction with reduced ventricular remodeling as assessed by echocardiography 
30 days after gene delivery in the DVAMI compared to DLZMI. There was decrease 
in the left ventricular inner diameter (8.7±0.6 vs 10.3±0.4, mm) & increase in ejection
fraction (45±4.2 vs 39±4.9, %), fractional shortening (26±2.6 vs 20±2.9, %) in the DVAMI 
compared to DLZMI. Western blot revealed increased expression of VEGF, Flt-1, Flk-1, 
Ang-1, Tie-2 & survivin, 2 & 4 days after gene delivery while immunohistochemistry after 7 
days showed increased expression of VEGF & Ang-1 in the DVAMI. These preclinical data 
demonstrates the efﬁcacy of coadministration of adenovirus encoding VEGF & Ang-1 in 
increasing collateral vascular perfusion & reducing ventricular remodeling in the infarcted 
myocardium of diabetic rats, supporting the development of a combination gene therapy 
to induce myocardial angiogenesis in a diabetic milieu.
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0921-7 Vascular Endothelial Growth Factor and Soluble FMS-
Like Tyrosine Kinase 1 in Hypertension in Pregnancy
Vellore J. Karthikeyan, Shahirose Jessani, Balu Balakrishnan, Deirdre A. Lane, Sabah 
Baghdadi, D Gareth Beevers, Gregory Y H Lip, University Department of Medicine, 
Birmingham, United Kingdom
Background Abnormalities in angiogenesis in the maternal vasculature are implicated 
in the pathogenesis of hypertensive disorders in pregnancy. Vascular Endothelial 
Growth Factor (VEGF) and its soluble receptor fms-like tyrosine kinase 1 [sFlt (1)] are 
altered in such pregnancies. We hypothesized that the VEGF: sFlt (1) ratio is altered in 
(hypertensive) pregnant women compared to non-pregnant healthy controls.
Methods Hypertensive pregnant (HBP) women (n=31), >20 weeks gestation attending 
the ante-natal hypertension clinic [blood pressures (BP) >140/90 mm Hg untreated or a
140/90 mm Hg treated) were recruited. VEGF and sFlt (1) were both measured by ELISA. 
Controls included normotensive pregnant (NBP, n=31) and non-pregnant healthy women 
(HC, n=40); The VEGF: sFlt (1) ratio was expressed in the three groups.
Results We recruited 102 women [mean (SD) age 31 (7) years]. VEGF levels were 
markedly lower in the HBP women (p<0.05). sFlt (1) levels were raised in NBP group 
compared with HC (p<0.05); the VEGF: sFlt (1) ratio was lower in pregnant women 
compared with non-pregnant women (p<0.05). A signiﬁcant correlation was noted 
between the two markers (p<0.05).
Conclusion Our ﬁndings conﬁrm the inﬂuence of angiogenic factors on maternal 
vasculature in the development of hypertension in pregnancy. Further studies exploring 
an association of these factors with markers of endothelial dysfunction and repair and 
clinical outcomes are required. 
